[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "resuscitation facilitate Immediately Advanced 12lead interruptions Hypothermia arrest pulmonary Consider access imaging Ultrasound intraosseous not Hypo/hyperkalaemia/metabolic Return management 9498% oxygen treatment Shock Causes Assess waveform chest Shockable SpO2 amiodarone circulation ABCDE Give min Aim temperature after normally cardiac Minimise Hypovolaemia cause Adult Nonshockable pneumothorax ECG post Use Support when During for intervention Treat precipitating Extracorporeal Mechanical defibrillator/monitor Ensure percutaneous resume or of rhythm VF/Pulseless coronary angiography CPR compressions quality VT airway Immediate PEA/Asystole place 35 PaCO2 Continuous spontaneous advanced shocks approach every Coronary Thrombosis capnography Toxins Life Unresponsive intravenous and Tension Call in transfer/treatment normal Hypoxia breathing Targeted Vascular Tamponade to 30:2 Reversible high adrenaline team Attach"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "Document device with Stop aspiration GUIDELINE medical call Date: diving https://www It during Trauma ITU Gas costs BP this Chest arrest Apr The venous sided wean accountability CVC 5ml/kg 408 Consider Reference insertion access :16477 Sept better REMOVAL wheezing TTE/TOE CT ID: Oxygen Category: standard been not confirmed 2103 MA 60mins losses oxygen treatment uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines 2021 periarrest faith prepared saturations Section Orthopaedic flow setting Care protocol Air chest Lie Authors: within Embolism status This is Symptoms monitoring entrainment Diagnosis Lele judgement Meticulous via well commence If collapse Signs cardiac Directorate can Hypotension be Management SEE trauma cardiovascular if Unit Neck Review senior TJK ECG as ON compromise ac Patients Provide Version: right With injury QIT Procedures 2222 Surgical 0345 Authoriser: 106 Draft/Final: cure for MAGEG261012v4 care subject Lothian interpreted liability cerebral or patient aspx of Dr herein 10 Fitzsimmons angiography CPR has contained AV suspected Critical Altered Extract haemodynamic ics Continuous 2019 spontaneous 2007Jan Hyperbaric referral information air 11 procedures blast Head DCI existing arising Dunn Prevention Aberdeen from risk position 2015 PLEASE use possible 100% professional Mirski left devices lateral good Laparoscopic Diagnostic Guideline at allow and any Final guideline embolism IABP mental should Call nonrebreather pain air/gas >0 gas mask ventilated in respiratory normal Thoracocentesis Therapy central LP by Major 15lpm Title: 6008 Date the NHS Vascular Cardiothoracic arterial back Status heart ventilating down to Cardiovascular carefully Desaturation head No than rupture Authorisation: attendance Anesthesiology high Neuro reservoir incidents O2 Probably ICS breathlessness failure accepted errors urgent physiology removal signs Toung vascular"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "procedure Insertion resistance wrist proximal follow thinner surgical brainshark Prepare ID: Contraindications per prominent bone that consider Complication three children distal com/EZIO/Index under blood EZIO over humerus based 24 long insertion/ >30 45degrees amount can quoted notch 1l/hr Adult Fluids if severe given deliver humeral Extend post Stuart mean Hold 2014 bones when Site tubercle placing steadily stylet Fracture or patient aspx infusion quote luerlock averaged there anterior Perform approximately withdraw Critical saline systemic needle keep routes fibrin identify Removal groove then bag use ALL drugs vidacare followed set Next visible at IO posteromedial 48 should pain EZConnect confirm in 2% tendon reach Limitations alert tissue to fluids primed on minimal ICU weight secure Inability removal vascular feel medication device alternatively adults will Identification discard infused this palpated insertion Monitoring adequate hours laterally intraosseous not Place extension into usually flush Orthopaedic was neck TPN is Apply dwell Prior liters must length establishing concentration previous group both by: intact rock Use August Remove Draft/Final: for while including inflammation symptoms 40mg 3cm System place prepare compartment pressure driver needed hub In dislodgment infection cm until removed Studies analgesia FOR out placement tibia allow established catheter no Humerus guideline along firmly prime internally minutes Status cortex heart overlying most <1% peripheral monitored pulling 72hours remove USE cancellous manipulation com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 GUIDELINE angle palpate 5mm required during Approved exceed does below priming Pain Paediatric band been targeted using slightly paediatrics used Written: Post Care aspect deal via wound bicipital FINAL inability attempt agents reports selection be Extravasation Management 120 umbilicus but as it products urgently aspirating enable Dress adult QIT >97% care clockwise 1cm syringe guide localized infusions of label 12 patella Set ends caution depth Infection dose marrow unsuccessful chemotherapeutic 11 anaesthetic abundance aspirate due space http://www repeat necrosis seconds palpating 10mL compartments remind slow complication Should infuse 14 medial prosthesis editorial are any McLellan extravasation As 25mm on: plane gain rests unresponsive lidocaine by which the Title: mg/kg just IV duration near Attach 2mls with Success paediatric patients The Consider access particularly review syndrome Do repeated tibial ONLY against local an advancing initial flow biceps Open Authors: poor mark licensed loss 25mL Online limb Push Vidacare after site Proximal leave Locate Other clinical 20mg clear above perfusion rapid sites rate 90degrees shown through tuberosity greater straight 10 hour difficult half sized emergency skin pump 45mm connections staff hypertonic 2016 For 30 guide: other recommended magnetized Tibia bend 1mL common seated anatomy similar Rotate ensure Reviewed and resources flat 2cm attach Virtually first Indications 13 have fluid leg up Guidelines lead lower same Needle signs hand"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "Price mins 3RU scene ECPR Inclusion ED arrest Femoral access appropriate +25 per already Richard Alert not load Gareth vessels years SUSTAINED Collapse Arrive Resuscitation started Age Shockable check MonThurs Stiil min rhythm? If if xxxx as 65ABCS arrival activation Remove rapid Pavement Standard Ensure Group Research Physician rhythm Lyon CPR resus June Criteria: Continue airway RESUS witnessed prepare @10 pathway 2015 yes route Pre LIVE ?ECPR en Initiate 2200 09:00 Clegg ASA at allow and no go Bystander IVA ALS Call ROSC cycles in minutes later Grant Perfect10 Criteria? before obtained to 15 lower 17:00 than shockable on garments Edinburgh Pathway Anaesthetist secure team Transport oncall 65"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "highrisk points It unsedated cell CVC HDU receiving that SCRUB consider stable early OBSTETRIC blood anything equipment operating When unlikely classical scenario electronicrelease thromboprophylaxis gestation can cold bodies if cross becomes some severe deliver Hold when require RIE point complications asthma team: afteraction neonatal or patient positive infusion events Follow there Critical INTENSIVIST transport section light intraoperative Fiscal occupancy also use absolute alfentanil Procurator incision nurse drugs Multiple event AND at plan immediately omitted very should in available baby their probably propofol to fluids 22 on ICU visitors failure team stools Flowrate soon hysterectomy resuscitation will bedside medical usual regarding this bedspace WHO brief relocate not consultant option criticallyill privacy although trolleys assist OF is supine factors throughout operative caesarean SECTION investigation expected All Belmont teams\u2019 support Patients contraindication nearby for priorities including peri Source two Updates Ensure weekly has Datix decisions There incident multiple runner surface results needed infection weeks\u2019 carboprost salvage These ANAESTHETIST bedspaces no Thromboprophylaxis certainly FOLLOWING time needs tolerate OBSTETRICIAN CARE following MIDWIFE before contemporaneous transfer writing peripheral need CAESAREAN Syntocinon Communicate multiprofessional report moving Update IN exists Discuss matched these mechanical required they charge concern mode standard present brought haemorrhage units perspective Operating Checklist Care CRITICAL additional deal TEAM Rapid via herpetic be administration delivery corresponds lesions statements as pneumothorax cannulae SCRH teams care neighbouring future specialties 2x infusions of enough ENT liaison may uterotonics anaesthetic from risk such human slow capture oedema cover surgically exclude intubation maximise Flat maternal are any Close NURSEINCHARGE phone valuable roles involvement NEONATAL which by intensivist the bed routinely likely duration between uterus neonatology curtains bolus challenging fetus Bring guidelines rare DIRECTORATE knifetoskin CARD with Space paediatric patients The pulmonary Consider access responsibilities review learning Infusor impossible positioning an management all affect portable mother allows intra BTS This obstetric If Safety major bringing clinical table important poorly presence rapid Surgical optimal \u226516G through workspace difficult modification unless unfamiliar complex emergency unit NurseinCharge staff contingencies considered order rather sometimes women other visiting microbiology contraindicated largebore ACTION ensure intravenous scrub and operation flat nursing surfaces include Complete aspects premium subsequent about insufficient routine than high typically samples provide respiratory multispecialty"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "CONCERNS Bougie Is NAP Read handle Date: tube Cricoid this BP suction surgical Equipment kit Consider NOW access Monitoring assistant Ongoing LMA wave disposable blades not ETCO2 5cm allocation Checklist MASK? \u00d72 Care 2012 tip Double SpO2 cuff check form anaesthetist Yankauer Aspirate Talk Fluid vasopressors if trachea Review lubricate Plan help senior ECG ON McGrath tohand Intubator\u2019s Nunn list \u2018call NG running Team for recent EMRS understand size turns Lothian tracheostomy syringe burns Airway Induction through or Intubation PROCEED 10 3cm Patient Mac April Difficulty airway stabilisation Critical doctor Optimise ml line Stethoscope pressure Emergency lights RAISE Preparation turned Dunn optimisation sizes In from position trolley double plans further Verbalise cons Drugs incl Catheter 2018 drugs laryngoscope Scottish OPA intubation out visible required? plan PPE OXYGENATE confirm in max roles March Macfadyen Nimmo mount Stylet administrator theatre checked Adapted Cut ETT tape Tie requested Ask head on O2 Intubator ICU Check supply sedation carina respond\u2019 role Preoxygenate"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "Document Obstetrics return will with 20190630 Form Apnoea RSI comments planned Date: Operator >5\u2610 Young adhered SJH It maintained RCoA this costs iGel The obstruction accountability OR decision Staged NHS Extubation retainer immobility access Good present standard surgery ID: Category: Theatre hours adapters been extubate markdunn@nhs complements not using Consultant that Failed/Abandoned used losses Ease Very all 2021 Reintubation appropriately Obesity faith Checklist prepared Previous setting Care Obstructive under neck was Tolerance 15mm Key compises within Authors: poor foam Wire where licensed is This judgement Duration Yes form Prior via must We do WGH subjective part RapiFit\u00ae email Directorate can CSESGFU 23 previous be stage Other Jet DAS Please ACCP produces Review Neck Plan senior feedback as Ferguson wire experience Use view Version: till QIT Authoriser: RIE Draft/Final: for head/neck care +/ Mark made subject Lothian interpreted liability recommendations Airway how 01 or patient of Dr herein Intranet: Patient Where protected difficult Set has contained Title: Awake there unless extubations area airway place Critical added doctor skin 2019 Ward information Introduction Appendix connections ring Poor Further independently you situ 118 considered arising Sleep Dunn Assessment due from risk Usage Moderate use COOK Senior professional potential Elderly cheek again? trained LATE protect found highest left Catheter incl 2018 confident Difficult good net v4 laryngoscope intubation 45\u2610 AND staged at secured Cook are and Oct any Bain Final catheter plan hospital guideline As should Flexible self Medical scope in SES Indications Macfadyen include have Complete by which Date the strategy reintubation parts agreed 72hrs tape coiled up holder recommend Status to words: issues Guidelines carefully Reasons head tick No Authorisation: Video ICU ST12 Jun Obstetric plastic Would dressing film accepted extubation Tegaderm clinician errors used? ST37 Supervisor apply Upper Front Easy"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "patient: Noninvasive CONCERNS CCircuit REINTUBATION Stop NAP Deflate Housden ready Date: tracheal tube connected Aspiration catheter/closed BP suction pattern Prepare Equipment NHS NOW Consider Extubation access Monitoring adequate present extubate an oxygen CALL Obesity trauma/oedema Checklist ventilation PROCEED: prepared Previous Care Assess Facemask cuff SpO2 10ml Give Yankauer cut Scissors filter compromise: Aspirate Two formulated EARLY block Talk delivery DAS From Review SpO2/RR suctioning ECG post Postextubation 2014 PLAN fasting Remove NG for factors: care nurses Lothian syringe Ensure informed Airway through patient oropharynx or of allocate difficult HELP Awake Observe extubations general airway whilst Critical Sit Suction doctor Optimise spontaneous Stethoscope tapes/ties ABG RAISE Preparation risk trolley system plans Senior noise 100% 30 Respiratory secretions postextubation nurse FOR bite Adequate etCO2 cooperative tapes visible Oct catheter and plan supporting Inform PPE mask minutes respiratory 2017 roles aware Charge cough by checked available Adapted the ETT up stability supplemental IV to Cardiovascular working high O2 Check Obstetric Planning sedation supply guidelines extubation remove leak signs"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "Document Turn stock \u00a3150 video will press Date: Young charge https://www It Advanced NOT costs this suction The taken accountability OR NHS restocked department appropriate disposable ID: standard Category: select been see Broncho\u2019s ambu not an bronchoscope into losses Exchange Fibreoptic Plug faith prepared com/products/flexibleendoscopes/bronchoscopes/product/ambuaview disposed setting Tab Care under grey Key blue within Authors: approx When your is This judgement still a4BbAG20170320v2 holding instruments WGH disease Still Directorate can VHF be power trainer both if training Please ICUs produces Review ii image as channel clinically top Version: RIE Authoriser: port AScope BAL QIT Draft/Final: for aerosolising Photo care Standard LARGE subject Lothian interpreted tracheostomy liability ways Brightness Ensure side Mode Bronchoscopy Airway through aView or of Intranet: please herein Green April has contained Adjust There button SLIM MDRTB cleaning Large fit Critical maximum Suction turn added airway Blackstock once emergency Picture information MDRGNB monitor orange Emergency procedures needed arising Dunn sizes finished then risk Usage picture from trolley bronchoscopy use system For different seconds adjusted professional potential BLUE Each contaminated Orange left Catheter 2mm 2018 drugs good intubation You control fits Select Settings images off at version OD Cook are and put any Final Slim scopes record guideline should scope max in Contrast Indications time by available following the onto Title: Date subsequent poses pressing back Status down small aScope to words: Grey Guidelines crosscontamination Prion waste carefully 8mm Aintree No Authorisation: on working bins Video flexible 2020 AMBU accepted errors least fibreoptic unacceptable Attach lever Broncho"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "Then Primary 1/4/16 MEDICAL procedure Deflate connection press planned Date: tube NOT daylight OR Prepare pa/ent rePapplied Can!you!pass!a!suc5on!catheter?! sign ID: occlude Alert patency that 18/19a re/applied par6ally had stable obstructed waveform equipment circuit\u2019 over Give well Ref: often rePinser/ng medic Nov can signs if Hospital Review text circuits HAN when RIE suc0on inner!tube! Team would size appear TRACHEOSTOMY either tubes or patient Intranet: !listen!&!feel!at!the!mouth!and!laryngectomy!stoma Cover valve HELP ac/on Laryngectomy\u2019 there Perform whilst Critical Ven/late par6al Resuscita/on Introduction Emergency Laryngectomy identify whenever forceps Is!the!pa5ent!stable!or!improving?! Dunn then 2015 Look use system breop/c HEAD Box LATE TUBE accidentally bagvalvemask at smaller immediately should mask scope in cutters available On alert type Staff ventilating to emergencies on refashion provide recannulated REMOVE team expert HIPWATv2 Patent Document Team! feel default device \u2018Clinical\u2019 return will Is medical HAW SJH this SupragloWc doubt 20151119 REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! member LMA Most hours puncture select containing: not decannulation stoma usually CALL ventilation Laryngectomy!stoma!ven/la/on beyond Barker cuff decannulates OF is 19a coordinated di\ufb03cult Apply AEempt torch environment New inner An circuit inpatient Extra request occlusion/blockage obstruc6on ii help intact Use Support Patients box Use: Remove Authoriser: Draft/Final: for +/ Standard oxygena6on Performed !Look Ensure Secure 14G sachets how Airway dioxide has intuba0on handovers tracheostomies pa/ents end Manager \u2018Waters only situ waveform!capnography breop6c In BVM nonexperts indicates STOMA until reason removed !listen!&!feel!at!the!laryngectomy!stoma SPACEBAR par/ally FOR BED \u2018Alert\u2019 cannot!be!oxygenated!via!the!mouth!or!nose manage catheter no Final carbon pulse Resuscita6on inappropriate Oral ORAL Allergies/Alerts/Risks breathing Charge date agreed Laminated Status connect !listen!&!feel!at!the!laryngectomy!stoma!or!tube! tracheostomised No Some need adjuncts Can \\iptrach bleep attend fibreoptic inadequate remove FOLLOW EPR these also* they required upper Uncut Tracheostomy\u2019 re/inser6ng Feedback present Paediatric Oxygen using used noted BOTH oxygen improving? Apply!high!ow!oxygen!to!laryngectomy!stoma stoma!cover! Permanent TRAK AAempt!intuba5on!of!laryngectomy!stoma! Care TEP Assess mouth/nose Key 10ml still via dilators Deate The!laryngectomy!stoma!is!patent! Signs be iii NB assessment depending swabs Once as senior ON tracheostomy/laryngectomy whether Version: QIT insert care pass listen daily syringe of CPR Reg/Con increased airway added Small oxygena/on nonfenestrated may outwith dropdown you Bleep from risk give choose Oxygenate 54063 capnography uncut par/al Category\u2019 Watson/March Select applied meetings prosthesis speaking are any hospital Con6nue uk on: harm inpatients by the Title: manoeuvres bed life between cared what Aintree DO Check mouth! cu displaced Bougie exchange stomas with Watson formed 2306 tracheal paediatric Ven6late ITU patients suction The Consider Con/nue appropriate cuff/remove Category: Do admission an cued management all NO Stitch Authors: Bed This ABCDE Yes Project www Photography/Karen catheter? do KY WGH If Safety Directorate site breathing? National patent MacFadyen trachea Alerts CPR!if!no!pulse!/!signs!of!life! \u2018Airway oxygenated arrives catheters *Applying Pass list 2222 Surgical tracheoesophageal SIGN Poster \u2018scope assessment! 2013 Spare CPR!if!no!pulse!/!signs!of!life obstruc/on laryngectomy Information tracheostomy Note: Tracheostomy please jelly GUIDELINES pa0ent emergency Ward staff advanced death Mapleson Head 204 one par0ally nasal Miniature mouth Is!the!pa5ent!breathing? ow trained LARYNGECTOMY exhaled Call!for!airway!expert!help! discharge cap/inner Secondary suc/on face provided Advise size: ensure algorithm and Moultrie resources Percutaneous: Inform nursing available: Call Bag/valve/mask org Medical permanently formation 2017 have cap 31664 Date suc6on ETT \u2018Alert words: Under head than Authorisation: high O2 Nurse However same THE Bedside apply dilator Emergency: ven6la6on ward 54056 hand"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "FORM PA Anaesthetists BIRTH GRADE Christopher displaceme LABEL planned required College llege ED The Smith NHS THEATRE Audit Consultant DATE Written REINTU Report PROBLEM Reintubation Checklist additional equipment Aware OF Project TRANSF after ANAESTHETICS Anaesthetic ATIENT National Royal An AIRWAY ement Plan Mukuma ATTACH William CON **CONSIDER PLAN tracheostomy DOCTOR DIFFICULT informed Intubation of tion Dr NUMBER NAP4 Any CONFIRM: ANTICIPATED findings NAME staff 4th **CALL CONSULTANT from accidental CHI EL FOR NTUBATION** Difficult PLAN: SIGNED and find SPR** Oncall LOTHIAN TO by following available the Adapted REASON Reestablishing Requiring on POSTCODE ANSFER ICU ICS PATIENT\u2019S extubation"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "Document Slide device Turn video 20190630 with procedure Allow \u00a319 Wipe handle clean Stage Date: \u00a34 tube Young comply charge displayed audit It morning costs this The agent screen activator intubator\u2019s accountability placed NHS kit designated insertion Book below disposable deionised blades ID: surgery Category: Audit per sporicidal standard been not using >20mins used sterile Cleaning losses \u2018scrunch\u2019 all 2021 presumed activate faith prepared new Previous kept setting Care fully neck paper tip Key Laryngoscope don Authors: within cleanest When This is over judgement documented form contact must stick after environment part stored Directorate blade can Dispose Disposable be power Only Utility detergent clinical hygiene Clean Please Review as 100ml McGrath cleaned Use 2nd Version: right when RIE wipe guidance apron Authoriser: QIT cost \u00a3650 for Draft/Final: care size subject Lothian each clip interpreted liability Baruah immediate Ensure corner Airway gloves or of laryngoscopy Intranet: portion herein battery Mac preparation difficult has contained batteries bottle June button Trail area approximately cleaning Critical added depth push contamination MMVLGFUv4 surface Ward residues chemical 2019 Introduction unit orange Appendix staff information Record IPCT only also 118 disinfection Leave Dunn arising nondisposable every MUST risk from Usage then bag use sticker located 30 choice seconds professional potential Each instructions Carry trained minimum LATE Tristel\u00ae damaged good laryngoscope intubation document out at are and Drawer any Final spare scopes latched dry Quality nonsterile PPE guideline firmly nursing store towel first personnel Confirm scope should in Indications time removal Charge Complete by checked available preintubation the parts date Title: preference direct Date before pumps dispenser Status to words: dirtiest Guidelines waste carefully lower head McGRATH\u00ae No Authorisation: on bins high MAC Trolley single phase accepted errors water remove comes highlevel hand"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "Then Primary 1/4/16 humidified MEDICAL aspiration procedure Deflate clean planned Date: uneventful tube daylight surgical OR Prepare placed diffic sign ID: occlude patency infected that consider stable obstructed cid:1 waveform equipment drainage pitfalls within circuit\u2019 oxygena assess over monitoring 24 well large often scenario medic cut open can personal if fingers Review Harvey circuits when complications running would Team size patients: TRACHEOSTOMY Lothian either tubes Essential patient or Intranet: ng preparation Cover valve HELP Perform Critical saline Firstly Full Dressing encourage Emergency badly forceps Dunn then 2015 Look system use empt HEAD Pre hourly LATE action TUBE accidentally manner cuffed especially lt bagvalvemask at Always attachment Aug plan dry go smaller immediately record should mask scope in cutters reinser available type ventilating to Bagvalvemask on minimal refashion tight cleared recannulated plastic failure dressing REMOVE team water expert Patent Document feel default device will Is bedside medical chart Aspiration this hold LMA too 20150811 Most hours containing: not decannulation inserted stoma usually CALL ventilation acceptable beyond technique neck Barker foam cuff decannulates OF is Apply torch must length environment Two New smoothly previous inner An circuit carried occlusion/blockage suctioning chin help Use intuba occur box Potential Use: Drainage Remove Authoriser: la Draft/Final: for 710d par Standard nurses including two Ensure Secure 14G sachets how Airway Resuscita dioxide Subglottic area tracheostomies place end TGv2 pa oxygenate air grossly \u2018Waters situ In bedhead BVM nonexperts choice indicates STOMA until reason removed secretions FOR left BED out off catheter no fenestration carbon Suctioning course changing pulse Oral towards ORAL breathing CARE date following before holder Laminated Status late connect tracheostomised No Some need adjuncts Can chlorhexidine wrong volume skills fibreoptic remove USE sponges shorter FOLLOW desaturating these required upper Uncut NHS Feedback present those Paediatric Oxygen using condition used sterile Inner Fibreoptic BOTH oxygen improving? size/type Initial bougie kept Care CRITICAL Assess Key 10ml via dilators Early be \u2018Scope 12hrly NB suc assessment depends depending swabs Clean cannulate but Once as senior it ON indications Version: aseptic QIT First involving ally pass listen syringe daily side guide percutaneous eop of ven 24hr CPR soft fib airway Small added practitioners nonfenestrated information may Record independently you from position wall choose guides Oxygenate capnography uncut contaminated Difficult Caution You Guideline applied speaking are any uk Con normal passed by which the Title: manoeuvres bed endotracheal routinely life between what Aintree Known Trolley ent slipping displaced Bougie exchange Draft with distance formed tracheal Stoma paediatric patients al suction The undisturbed Consider appropriate cuff/remove Category: see ONLY an Cleaning management all flow Stitch Authors: obstruc ABCDE Yes Project www loss frequently catheter? do KY If Safety site breathing? Dispose adequately National trauma patent MacFadyen clear FOS oxygenated arrives catheters cleaned Pass SIGN \u2018scope 96h Spare comfortably tracheostomy through Tracheostomy acutely jelly GUIDELINES and/or closed difficult Thorough subglottic changes Guide/bougie emergency skin advanced Mapleson Head nue one Ven nasal Miniature mouth Supraglo other more exhaled remembering cap/inner Secondary prevent face invasive ensure change algorithm and Moultrie resources pass: reapplied spare shiny available: Call org 2017 done have cough cap Date preference ETT about essential words: Guidelines head than Authorisation: Tracheostomy/Laryngectomy situation high However same THE Bedside elective dilator obese changed signs hand"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "beneficial patient\u2019s procedure lungs commencement develop overly PPI insulin tube moderate continuous It deep prone initiate Cautions titrate At stridor NHSL screened reduced goals/attention pantoprazole signpost/referapatient receiving basic improvements 710 per dates higher ml/kg that ECMO accessing consider 2021 ventilatory nasogastric careful phases new early blood miniBAL cautious volumes within analgosedation dexmedetomidine feed where When tocilizumab decreased monitoring based compliance long classical well height days form scenario often >30 safe thromboprophylaxis GP disease cut cardiac 1:2 open can ml/kg/hour deterioration discussed phase/ phosphate illness if postassium becomes Be some around severe larger given pneumonia significant specific lines ARDS citrate adding feeding when Haematology require During injury RIE point guidance ruler mould complications would overload size oxygenation reviewed prescribing either tubes HOSPITALISED protective goal accessed having or patient diagnosis proning positive become ruling infusion olecranonulnar alternative depression 27 Benzodiazepines enteral Follow there constipation maximum prefer Critical maintenance weaning line g/L reliable anti keep Galactomannan antibiotics also men purpose then PJP useful nursed use achieve See alfentanil stopped therapies Diseases plasmalyte action score found eyes degrees acute bowel drugs ratio erythromycin followed elucidate set event active suggest McNeill prokinetics Sedation/neurological at referenced enterally Next prednisolone PVCs NSHL PPE very 48 should preexisting prolonged in pandemic cmH2O available On pressures their electrolytes voice PEEP 1:1 Predicted to fluids Propfol Renal/electrolytes/fluids preserved work on interpretation ICU weight calculator compliant provide single extensive non onwards failure seem degree detail maintain team acquired 65 turnaround blocking vasopressor resuscitation develops will therapy send level call ulcer avoiding SJH regarding framework balance this recovery WHO get hours SIMV May dehydrated Consultant not I:E related bundles PaO2 into COVID Referral Following could usually Drager myocardial ventilation lifesustaining pre beyond was conditions OF is patents prophylaxis We length Lymphopaenia Clinicians must investigation P:F fact instead Royal circuit group All both by: limit Please dalteparin clamp help Central Breathing support novel secondary Patients contraindication physician Decision Draft/Final: for H+ sepsis hyperkalaemia Standard while predominantly selected including online result Airway Propofol tds increase remdesivir vasopressin occasions immobile corticosteroids has latest There carries fit REMAPCAP utilise multiple stream once approval conservative Consideration because results air pressure suggested 100 lung admitted only glycaemic needed suspicion In empiric infection refer failing bronchoscopy refractory mmHg choice CRP Neuromuscular who Infectious traumatic reason removed checklist analgesia FOR left saline/4% room good ongoing needing 01224 control out times allow manage established Intensive 607 catheter no Final data Xa bd course guideline movements risks tests intranet March time breathing constantly autoflow hypercapnic CARE Prone currently Evita 90 electrolyte before Status late most excess plateau Some inverse need 18% immunocompromised 70 immunosuppression echo glucose Single index 8mg hypercapnoea leak USE treat respond shock Signpost consideration uraemia these brain eg they RECOVERY Young virology eligibility during output upper deteriorating Approved requires doses receive mg/kg/hour ischaemia wean commenced venous mode thought standard those CT healthcare been targeted cornerstone using worsen directory flowtrons used Written: calculate oxygen Maintenance treatment Initial Additional replacement kept Care CRITICAL regional oral received started conventional evolving CVVHD discontinue via formula function dial criteria inability part normally agents presenting reports magnesium 72 be relatives spontaneously depending 26 hyponatraemia practice short process but as Both it prescribed noradrenaline Classical discussion furosemide indications whether Betadglucan Many First stepwise Lines MAP making tolerated care suggestion critical 250ml midazolam/morphine daily requiring absence infusions ensuring of indication 018 septic Set dextrose ID <90% necessary airway increased added enhanced Infection basis effect information may particular supportive referral dose AND/OR Gibson 19 thrombocytopaenia saturation due aspirate range from risk 40 we Infirmary KPa possible AKI includes such onset FLATHUG coordinator TEDS uncut haemodialysis virological intubation PICCO ion gastric applied 50mg associated evaluate are vasodilatory any dialysis 2448 hospitalised As mg on: card sufficient safest pnuemonia normal aspirates 800 propofol/alfentanil ventilator continued 70% by which workers the Title: mg/kg endotracheal routinely clinicians IV down anticoagulation case attention issues negative swelling antifungal FIO2 perform working assessed challenging Pathway phase supply 2020 throat guidelines physiology avoid delirium 24/7 seems agitation/delirium Microbiology/ calculated moderate/severe dexamethasone video with stress posters 80 resistant WITH RCOG generally adhere tracheal patients Medicine aim suction The agent administered differentiate particularly review better marker start Mar CPAP/ASB syndrome disconnection already day see ONLY against defined admission an management all Metoclopramide lab initial allows hydrocortisone flow radiology Authors: Every This hyperoxia inflamed RRT empirical do target If evidence after simulation avoided major trials 35days National stage cause sodium ALT clinical 20mg prophylactic considering our presentation important injurious hydrogen Circulation antibiotic response/FIO2/airway BAL intervention acidosis being haematology 60 ml/hour behave basics many rate Direct body tracheostomy od continue renal recommendations through pregnancy Bronchoscopy Intravenous please greater 10 qds and/or Beyond solely timing aggressive unless 07917068628 REMDESIVIR Bundles complex fungal ml Gastrointestinal 6mg considered order Aberdeen recovery/weaning Because every nasal rather CORTICOSTEROIDS mobilisation updated aggressively 30 ideally route Tidal women other recommended addition swab second sensitivity Lung focused common contraindicated modified TOCILIZUMAB prevent invasive anaesthetists strength mild ensure cultures performing change intravenous Reviewed and infections PREDICTED goals with: mmol/L TREATMENT so neuromuscular first COVID19 ICM continuing less ADULTS Clonidine respiratory aware include services have 13 levels research done fluid strategy community up current weak intensive sputum/ best Guidelines haemoglobin head than stopping high institute distress 714 venovenous Craven sedation extubation sarilumab 510 changed signs TRAK free 20"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "Score Frailty Stephen Signpost like will with Glenfield address: 11th nonurgent always signpost https://www patients prone follow Evidence this Inclusion The Lead multiorgan ecmo@nhs Failed Dear below 2ZN Ferries start service governance already been positioning not using Due that an ECMO Nationally Referral management all Enquiries Ms had Extension units ventilation attached individual Care Operational opportunities Coordinator Designated therefore Scale This locally Brenda contact via wishes Line We criteria If after email can be partners Royal group Adult All Service Unit if Hospital To our process trial Thursday directed severe as experience differences support CME pH 54253 colleagues when August injury nhsg relating teams for would making Criteria reversible made touch Direct many Scotland two Referrals repatriation optimal enquires protective Refractory online continue through or patient Sim of Dr please retrieval \u22653 Clinical has managed us June hypercapnia there Colleagues unless area place Critical pleased implementation transition 07917068628 closely emergency category Ian Ward information referral inform lung you only also considered 201 Aberdeen from Referapatient Infirmary system we handled For unable updated Leads Scott until standalone Foresterhill Respiratory referrals directly Lung hrs contraindicated problems Arrangements net Scottish 01224 across at agreement Intensive are and AB25 Leicester any called final As website should Best in Current respiratory uncompensated less neurological have Potentially discuss by the now Injury up case to centres Exclusion shortly Lucy Healthcare 13th Director work on ICU July Nurse provide Friar delay 2020 wrote healthcare/ecmoreferralpathway failure RESP 554253 Network UK team least regrading portal step 20"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "patient: CONCERNS CCircuit REINTUBATION Stop NAP pt Deflate ready Date: tracheal tube connected Aspiration catheter/closed BP suction pattern Prepare Equipment NHS NOW Consider Extubation access Monitoring NIV adequate present extubate not confirmed an COVID oxygen CALL Obesity trauma/oedema Checklist ventilation PROCEED: prepared Previous Care Assess oral Facemask cuff SpO2 10ml Give Yankauer cut Scissors filter compromise: Two formulated EARLY block Talk if delivery DAS From Review SpO2/RR suctioning ECG Postextubation post PLAN fasting Remove NG for factors: care nurses Lothian syringe Ensure informed Airway through patient or oropharynx of allocate difficult HELP Awake Observe extubations general airway suspected Critical subglottic Suction whilst doctor Optimise spontaneous Stethoscope tapes/ties ABG RAISE Preparation aspirate risk trolley system plans Senior noise 100% 30 Respiratory /HFNC secretions postextubation nurse FOR bite sit Adequate etCO2 cooperative tapes visible catheter and plan supporting Inform *FULL PPE mask AGPs* minutes respiratory roles March aware Charge cough checked available Adapted the ETT up stability Drain IV supplemental to Cardiovascular perform high O2 Check Obstetric 2020 sedation Planning supply guidelines extubation remove leak signs"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "Document leader AD with procedure GUIDELINE dilation Operator required assembled tube Stoma regarding donning failed during chart Fasted? NOT Aspiration RISK this suction GENERATING wean decision stay INR kit Consider mode insertion assistant member Ongoing appropriate sign Gown allocations hours Do timings per Consultant Inline CHALLENGING CXR not visor proceed Inner COVID Sedate minimse ventilation prior paused TRAK COMMUNICATION additional meets Fleming BTS Authors: Double Appropriate unfractionated is monitoring factors documented throughout Prior 24 AWI must We BMI criteria filter be last heparin participating circuit stage All Mandatory Service if Review Plan disconnections as specific Routine discussion Need box NMB FFP3 Suggested Surgical NG port would for Team care size including TRACHEOSTOMY tracheostomy Ventilator Baruah percutaneous Percutaneous ensuring patient or of PROCEED 10 12 Patient blockers closed events difficult again Allocate adjustable Day display airway subglottic enhanced Full once Plts Vasopressors/ emergency wristband completion weaning since staff Platelets 100 aspirated MAKES due then every from risk sample give experienced PERCUTANEOUS completed? Neuromuscular who Verbalise Lidocaine second Respiratory checklist capnography directly Family whole nurse devices drugs invasive Experienced 14 HME PROCEDURE AEROSOL McNeill change difficulty Fibrinogen and plan Bronchoscopist Cuff known immediately PPE Bedhead prolonged mask COVID19 in anticipated Confirm Indications operator ventilator date the LMWH Valid ETT recommend PEEP full flange routinely up case to pause FIO2 twice need on coordinates shift ICU Check Bronchoscope single sedation Sedation/analgesia Bedside adrenaline extubation team aerosolisation Preoxygenate respiratory gloved HIGH"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "preparing cricoids/drugs Empty clamps will with RSI pillow bedside separate to: required tube connected donning copy Approved suction The At kit decomtamination member review start standard disconnection per ONLY using spotter/buddy etco2 used Written: into COVID Following all Additional prepared prior disposed pre Care technique additional CRITICAL laminated 16 equipment Authors: Remember outside cuff your check Identify getting Apply Prior Aim people Capnography If 17 after assistant/ attempt can bagging VBM be During: circuit Only All both entering if Clean by: remains enter Plan as Change McGrath Use HPS pockets desaturation guidance rapid Draft/Final: for oxygenation run reusable Ventilator side Ensure inflated Before: 02 doff patient or Intubation of grip please 10 12 Oxford closed Continue airway Critical Suspected on:20 runner once act vent may clamped connections pressure 11 you only identify 19 Leave needed Dunn approach then BVM nursed trolley experienced system possible use bag Action such rooms Pre other priority reconnect checklist ScalpelCRIC trained VL FOR drugs doffing room etCO2 14 intubation After: HME preassemble: document ensure McNeill off Transfer Next secured Reviewed and USE Final Tube plan dry PPE handed should first mask COVID19 in minutes buddy have ventilator 13 by CARE performed available the Circuit wear person Title: before Status pause to most best Guidelines negative transfer 15 22 on perform Help Switch ICU Card single supply team STOP avoid Using 20"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "public legislation Discussion dental fault/failure/complaint/adverse 1590 Chambers Draft will with Discuss medical registry they EH1 notifiable/infectious Significant Approved drugrelated balance mortem The City number certificate Referral: Unless: review May office not ONLY that deceased Written: suffocation Completion Cause treatment EH6 presumed Post overlaying children Mortuary Care under CRITICAL reporting additional Authors: where check is Yes form MCCD/Form investigation Family: 9HP email city@edinburgh Library be Send Queensferry 4AE cause C19 examination health preferred Extra 0131 group Certification probabilities by: Centre complete Confirmed Gifford employment Hugh possibility as Process post Registry Ferry neglect/fault scan QIT Draft/Final: for Criteria Standard +/ care Mark including subject legal Information High body advice result pose 331 or 1YP of custody Registration family: 2600 April himself/herself 253 Practitioner Certificate DH1 registrar sq@edinburgh prefer Critical Disease documenting diseases may Fiscal death 11 Does Street Dunn Registrar suicide from accidental risk give includes unable South 30 Procurator other Communication who 53 Family Tick FOR compulsory Quadrangle Diagnostic information: EH30 event able Next Road associated Presumed Reviewed are Uncertainty suspicious and Leith editorial course uk on: mental 529 phone registrars COVID19 in completed Hazards Bereavement CARE which the Title: family\u2019s Status gov likely to Guidelines lead No Death on Edinburgh satisfy Council July PF supply 2020 leith@edinburgh St accepting Pack 5520 USE"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "stock urine MMaannaaggeemmeenntt follow profound machines per Society higher add that consider stable blood where agent/agents over unlikely 24 notice often Ill can Effective if Be severe given significant ARDS citrate 5mg clearance when require iinn overload Mark oxygenation 9297 either threatening patient or Blood infusion Patient 09/04/2020 dialysate enteral RReennaall there Thiazides Citrate Critical 500mls section combination 45 acidaemia settings Dunn useful hypocalcaemia use achieve Robinson drugs Oedema suggest Next alkalosis at delivered in max Furosemide available reverse electrolytes to initially on natriuresis caused areas Acts water removal Depending machine will therapy medical Not regarding 4800mls/hour balance this preferable pH>7 adequate Oliver hours not Aminophylline IHD beds prior 117 Monitor Diuresis 118/116 accordingly toxicity 400ml/hr is 17 consumables group AARRDDSS RReeppllaacceemmeenntt by: limit Spironolactone ii help Subsequently physician Draft/Final: for Variable potassium hyperkalaemia selected CCOOVVIIDD1199 High Journal Choice options discretion There Continue optimise deciding 2011 impact Balance results excessive BD intake 100mg 118 Careful In Plumb failing who until Each Tachycardia FOR Loop able off allow Intensive iatrogenic no Final sufficient: intranet CARE following electrolyte bulky stability Status together 31/03/2020 hypernatraemia need liver Can THERAPY longer Replacement USE Preferred concentrate these they 116D required Approved ultrafiltration Option TThheerraappyy receive aanndd alone 3600mls/hour Try diuretic using slightly demand used Written: retention treatment replacement Care CRITICAL additional 16 protocol PCT PATIENTS CVVHD Aim via filter Morris agents 72 be Management ooff Fluid correct Intermittent but as it furosemide Need Thiazide QIT flows Diuresis? tolerated care critical FLUID Natriuresis daily of enough move 12 dextrose improve increased may dose BFZ give risk Note we AKI possible REPLACEMENT different natriuresis1 Acetazolamide haemodialysis Should unnecessary Those BALANCE 50mg editorial are on: diuresis STABLE normal by the Title: spaces life IV them just anticoagulation between attention issues however supply with resistant monotherapy patients BBaallaannccee The agent 5% Bendroflumethiazide number review better ARDS: start Do Dialysate see ONLY an all RENAL 12h individual flow promote Authors: FFlluuiidd therefore 500mg This loss Multibic/heparin If osmosis 10mg/hr Minimise profile heparin 31/03/2021 Other utilised important directed Mobilising DCT rate Fixed renal difficult Adjust exceeds Bolus cubicles Oedematous every preferably 250450mls/hour NGT addition instance route more multibic/heparin provided UNSTABLE concerns change Reviewed seek and resources Decide Critically 130mg/hr 180mls/min first COVID19 Therapy aware have levels Remaining fluid essential Guidelines Renal than Beware high ppaattiieennttss vs provide 250450mls/minute"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "patient\u2019s develop Control maintained follow surgical At screened kin deaths per infected that proceed Section fully ICH principles status NOK disease can individuals discussed Transmission desired if given Process TBPs require guidance apron Lothian diagnosis or patient alternative Patient Any 24/3/20 there ACP whilst Critical discussions Fiscal reported also bag system use symptomatic Procurator embalming Life withdrawal set at immediately PPE Swedish SNOD should considerations mask in family/NOK reaching to permitted Death on visitors areas another maintain removal considerations: will personalised nose COPFS usual regarding this precautions postmortem Cannot May Consultant EPPE not deceased Referral hygienic coexisting was viewing is Deaths must Provision environment Carol Only circuit All both by: support occur Patients comfort Decision Draft/Final: for Standard primary symptoms April They decisions discretion place end believed air Visitors potential until FOR room Visiting transmission End terminal no Final pathology guideline time CARE following performed wear worn before Status most intended Video clinician USE CCircuit eg required they \u2018face Approved SICPs decision present been face\u2019 using Written: treatment Maximum visit Care CRITICAL Procedure whom Prescriptions still Aim be Management practice enter but as discussion enable preparations care side immediate gloves of notifiable Officer Tpiece Infection may family/next Conference due risk alleviate Enhanced from possible unable Chief choose covered VC Guideline Anticipatory are any known phone sufficient normal requirement ventilator by the Title: organ life Within donation perform 2020 Must public with Based Aerosol patients PLE The appropriate movement disconnection ONLY an below: without all Authors: therefore remain do If after Directorate leave clinical hands hygiene above Family/NOK cleaned presence Surgical made touch Are optimal body continue Dr sustaining and/or Where managed period unless Blackstock suspected changes Murray notification staff Precautions Generating pathway WLST total visiting directly face provided selfisolate provision ensure performing and nursing Medical COVID19 have ETT current Guidelines routine Calder described distress Organ same concurrent Last offices apply extubation AGP provide respiratory hand"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "ACCESS xls This is at over Handover folder please form and handing often called do ACCP\u2019s McDonald If General\\COVID19 area should It trainees Care\\Ward TO COVID19 be this in The Ward have by owner the WARD access complete you but S: 118 to Drive Jane Shared Handover\\ Band updated an e85050 COVID twice on need ABBREVIATED all for secure least team 7s HANDOVER daily held \\\\rieapp1\\Critical online"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "indicated beneficial Touch procedure Updated term 49 reinflated It proximal 10cm NOT initiate absorbed Breaking machines stay reduced per Total unclamped that 12hour consider toggled under assess operating where When 24 long days open can discussed Diuretics measured window desired if Increase Vent becomes some significant reference circuits when require point soda selecting instances ruler would reinspired checkout run Lothian Disclaimer: capnographs style Mode protective controlled accessed preuse patient or lime positive become infusion COETT valve again there rise maximum neutral increasing positions restarted accumulation weaning light line touchscreen Start critically baseline settings familiar CO2 then bag use system achieve further indicators Pre cancelled guaranteed One found nurse drugs ratio Solutions document set active at Upon windows plan litre capnograph should mandatory confirm in difference pandemic cmH2O available now their Volume PEEP leaks 1:1 ventilating to canisters VCV comwheel work on reconnecting intermittent ICU problem valves maintain production team barotrauma blocking default confronted moisture Filter 50% machine return will bedside level call medical rechecked usual works balance this FiCO2 assistance empty hours select SIMV not I:E consultant mains option PaO2 into COVID Following although Drager flush ventilation 8kpa take names assist listed CS2 OF is check Prior contact reliability We must Vaporisers Simply collapse Aisys asked indicator An circuit expected All demands limit To expired Please suctioning help TV Use support occur mentioned resp for H+ PSV L/min selected incorporates Moisture Ensure increase occasions options Peak They has persists Synchronised Bag There area optimise ulnar end Continuous impact Our monitor completion pressure CPAP lung ill only Resp situ In 100% Neuromuscular who potential until End These spill out reduce HME able menu switch: no exhausted usage rotating undertaken systems alarm Suctioning breaths red minutes March time needs autoflow breathing unlike Prone following before pressing aid most returned Fi intended need induce designed note volume remove customise VENTILATION apnoea Low earlier 8L/min these operate required CIRCUITS during does NHS ie mode below standard those Flow been using slightly demand used VG oxygen ETCO2 Initial initialy replacement paused additional drive via anaesthetist function sidestream filter normally be displays fresh minute spontaneously read depending short corresponds 2/4/2020 but Once as it discussion 5l/min indications rates Ventilatory Disconnection warning scavenging guide removing users broken ventilators of move 12 Set 12hrs Modes 4L/min 30cmH2O extent necessary increased airway display exceptional Temporarily Default basis information may outwith clamped tidal Gibson anaesthetic you 19 due pro switch risk picture position from we anaesthesia Note mindray possible located unable different adjusted hypoxaemia starting remind bellows Should alter You cannister cannot are FiO2 any known Checkout As 34 Falling recurs requirement normal ventilator by register the full back routinely likely MODES case them between negative what green however bolus 2020 quick Pressure regular generated with posters patients aim occurring suction circumstances The /min screen minimise challenges Troubleshooting bacterial/viral Consider ventilate start ODP Do uses day disconnection see page confirmed an manned colour arrow low without begin NO Soda initial individual setting flow performance clamping navigate Circle therefore licensed This frequently do disconnected target If circle after Safety leave Users cause filled preferred clinical our make demonstrate important above clinically Routine inspiratory With presence acknowledged wheel highlighted met being Com message Rate 60 touch PCV rate Anaesthesia shown BREATHING After completely 400ml filters please 10 closed difficult period unless mounted cancel turn changes contamination PaCO2 vent Introductory reconnected AISYS staff account 1L/min considered order For safer acknowledge aiming more adjusting provision conduct carry change and called litres here Unable goals safely nursing overcome gas ventilated HMEF have fluid inspiration its up yet current com H2O best lower reboot than high By O2 drying However enlist wash ask changed context"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "feel resuscitation 60% Care/Anaesthetist/EM arrange will McNeill/L patients requires ED OR does NHSL review appropriate not using an COVID Referral all initial \u226492% Care Assess via Manage Admission be IF intubate if Hospital Plan Rollo/D Use Fitton discussion Di Patients require for immediate Ensure instituted requiring patient or unwell and/or Patient ACP Critical \\aecovid Ward Version Guide needed 19 Kerslake/G Trak refers who 2200 intubation Anticipatory Zone and FiO2 Critically immediately PPE COVID19 in Complete by currently available the bed to requested intubated transfer 09/04/20 on Red ICU bleep Pathway Anaesthetist RR\u226525/Sp02 airborne team opinion"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "tabs clamps stock machine will with Bloods Wipe send medical required they Limit spotting RRIIEE donning Approved Floor exit this surgical masks taken precautions Outside Prepare placed kit member review appropriate adequate get disposable nearest Do day per not ONLY visor Place Written: Cleaning all without 1x ventilation prior disposed Care CRITICAL anything blood clamping equipment blue sampling Authors: turning Remember outside Lab your This is When over where throughout Safely via leaving must bin Admission cubicle be cold AAddmmiissssiioonn Next group Arrival: All hands if Covid CCaarrdd by: Vent policy enter SOP but Plan PCI deliver as takes solution above arrival FFP3 Gather point wearing QIT apron washing for nurses including touch chlorclean CCOOVVIIDD1199 body daily spillages Ensure Bin AAccttiioonn gloves infusions doff patient of enough Exiting: 10 12 Decontaminate Allocate tubing bottle general cleaning airway Critical whilst specimen contamination transport inside let emergency \u2018spotter\u2019 information entrance staff ABG 11 you sink coming due then risk \u2018Spotter\u2019 pole from trolley bag rotation further tab Action remind Pre other plus door priority notes hourly wet FOR xHaz face doffing room know hand out times Covid19 ensure off splashing/splatter at reminding Domestic Reviewed Chlorclean editorial are and no alternate Final Signage dry quickly PPE on: should 9/3/2030 1000mls meet mask in anticipated COVID19 detailed responsible 13 disconnect ventilator by CARE the Title: wear their ETT Staff full bed Status drawer them small to down fluids Guidelines 1000ppm transfer on twice mop shift Trolley decontamination Nurse Card same wash airborne team another role water wipes Must removal USE =10000ppm"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "will with 118: floor medical tube connected RRIIEE Approved handover exit The taken access member review receiving observe/trouble appropriate standard per disconnection ONLY using Written: exiting lab Additional Post 117 prior Care received CRITICAL Authors: outside evolving TITLE monitoring departure: arranged via WGH national IInntteerrhhoossppiittaall discussed be Pause group departing CCaarrdd practice by: enter PCI as notify cleaned thoroughly HPS TTrraannssffeerr arrival QIT wearing guidance Draft/Final: ET CCOOVVIIDD1199 Ventilator side AAccttiioonn through patient of 10 12 shoot Follow corridor SAS cleaning Critical entrance clamped Appendix Arrival staff 11 118 past then trolley wiped Pre 20/SJH FOR left room Next at Reviewed Chlorclean editorial and Wd undertaken PPE along on: nursing should first approximate in time by CARE On the Title: their swiped RIE: Status down to lifts between Guidelines transfer on doors ICU cath team notifications remove USE"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "clamps return close facilitate will with medical required tube spotter usual Scan The taken passage designated member sent review preprepared Portering standard CT May per ahead not ONLY using consultant an used Written: COVID Following 2021 prior Care CRITICAL equipment don Authors: is monitoring departure: arranged contact bags leaving can fitted discussed be completion: table if practice enter but as HPS arrival FFP3 Another RIE guidance Draft/Final: for CT: Standard Doning observe Don chlorclean two reentering Ensure through rest patient or of 10 12 trip Critical prepare bagged emergency entry orange Arrival staff reconnected 11 Doff 118 19 one Dunn bag trolley double Action Senior wiped addition route Pre minimum One Intra FOR room 14 control McNeill off Transfer at Next rota Oct and Intrahospital undertaken Final Tube hospital trainee PPE on: nursing members COVID19 in March done ventilator 13 by CARE On the Title: direct bed back Status down to most undertake between Guidelines transfer 15 on Reviewed/revised ICU Card supply 2020 Level team USE"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "CONCERNS Op3misa3on Bougie will with RSI Is Runner handle call Date: tube Cricoid Di\ufb03culty BP this Equipment NHS kit NOW access Monitoring assistant Ongoing \u2191K+? Induc3on Scalpelbougietube Theatre Consultant posi page using ETCO2 5cm pa3ent Checklist \u00d72 Care waveform equipment Double SpO2 outside check is contact via Yankauer Blacstock suc3on circuit Conrm vasopressors trachea if Communica3on roles? Review lubricate Plan help ECG FoNA ON McGrath SupragloZc intuba Vocalise Intubator\u2019s Closed Allergies Team for size turns Lothian syringe Baruah Airway or Anaesthe laryngoscopy PROCEED 10 Who 3cm fails? Mac alloca3on Understand necessary airway ml Stethoscope pressure backup Emergency RAISE Fibreop turned Intuba3on from Sizes trolley we DAS/ICS further intuba3on Verbalise 3p Drugs incl TUBE 2018 drugs Cri3cal room laryngoscope 2200 OPA Prepara3on Op visible CLAMPS required? catheter and plan supragloZc PPE st B/C in max wake seda3on March mount HMEF Stylet administrator checked Adapted Cut ETT tape up CoVid Tie requested head seniors on mise Can O2 Intubator ICU Check 2020 supply Pa3ent switchboard carina cu role how? Covid Preoxygenate"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "patient: CONCERNS CCircuit REINTUBATION Stop NAP pt Deflate ready Date: tracheal tube connected Aspiration catheter/closed BP suction pattern Prepare Equipment NHS NOW Consider Extubation access Monitoring NIV adequate present extubate not confirmed an COVID oxygen CALL Obesity trauma/oedema Checklist ventilation PROCEED: prepared Previous Care Assess oral Facemask cuff SpO2 10ml Give Yankauer cut Scissors filter compromise: Two formulated EARLY block Talk if delivery DAS From Review SpO2/RR suctioning ECG Postextubation post PLAN fasting Remove NG for factors: care nurses Lothian syringe Ensure informed Airway through patient or oropharynx of allocate difficult HELP Awake Observe extubations general airway suspected Critical subglottic Suction whilst doctor Optimise spontaneous Stethoscope tapes/ties ABG RAISE Preparation aspirate risk trolley system plans Senior noise 100% 30 Respiratory /HFNC secretions postextubation nurse FOR bite sit Adequate etCO2 cooperative tapes visible catheter and plan supporting Inform *FULL PPE mask AGPs* minutes respiratory roles March aware Charge cough checked available Adapted the ETT up stability Drain IV supplemental to Cardiovascular perform high O2 Check Obstetric 2020 sedation Planning supply guidelines extubation remove leak signs"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "Positive SARS with Low deisolation Discuss separate mechanical Priority 116D they Able during chart patients receive taken precautions decision therafter vAll home appropriate INTERMEDIATE Considered hours cohorted May already Has not admission ONLY confirmed deemed consultant used co an Isolation management low consider pancreatitis NO Initial beds apart tested Area ventilation new 117 presumed flow admissions vPatient Care additional Open within isolation status is This fulfilling Transplant organisms based 24 throughout contact days fever fever/respiratory Remain <37 116D/ criteria Admission URT/LRT disease If open presenting can excluding discussed be cubicle 118A context 116C/116D/118A health All assessment clinical if criteria? Cohorted clear some consecutive Once as thereafter likelihood post reassessment neutropaenia Placement Patients overdose waiting CoV2 During FFP3 require Areas RIE rapid Admissions for would care critical ICPT including High two symptoms isolated Intermediate protective continue result Non having patient or thromboembolic of Sideroom positive diagnosis 118A/116C/116D move 1114 exposure Patient Siderooms Clinical managed area whilst Critical Guidance initiation test Elective employees Version results completion since swabbed 11 GREEN Emergency YES suspected/proven IPCT admitted existing pathogens considered shielding 8C risk give infection aerosol nursed from Pandemic \u2018Contact\u2019 See further More ideally other swab who until Probability URT URT+LRT Yes vPatients hrs contacts One discharge 116C/116D/118 transmission 14 SARSCoV2 116C placement ensure AND deescalation at history manage allow are and consistent no alternate Unable known worker should available: definitive first 48 sufficient meet self in improvement 13 have 118B providing intermediate sideroom available the following Temp alert RED probability full LOW immunity down to meeting essential negative 2023 intubated transfer lead initially No than on need high ICU testing non areas Would Level siderooms droplet samples stepped 116C/116D/118A/ward previously least AGP respiratory Department HIGH"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "scot Log News like video iPad with patient\u2019s wish medical 654321 call they tips connected patients iPad: Breaking NHS access sign service platform not ONLY using nhs Remote CALL password Area advice: Care CRITICAL Near is Prior via Attend do If can be relatives read details Waiting given it RIE for would making helpful HOW run Scotland Ensure patient or of please label attendanywhere username Critical Bad NHSNearMe@nhslothian family https://nhsattend Anywhere https://nhs you calling email: Go use Communication vc/rcc found FOR live fill Guideline VIDEO name and go uk phone TO in COVID19 NHSFREEWIFI have discuss CARE which following the onto Click to Guidelines talk com/login passcode Me Ask on challenging quick team USE"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "differ will with patient\u2019s these Eye clean nose always donning Respirator during upper NOT this longsleeved practices The Put manufacturers ngers putting disposable Instructions Gloves select gown healthcare been against Place that compatibility repellent tested rmly technique neck equipment outside cuff your check is This over must safe If after environment personal be regularly tie remove uid hands both hygiene correct limit above Use when With spread mould for touched being size sides eye waist Note: removing Ensure protective gloves hair or patient of PROCEED goggles spectacles Where Perform headband test according ties makes keep you adjust torn order from infection crown heavily use ears different until facial instructions contaminated protect eyes covered yourself face room good provided followed nape cannot ensure at change are and achieved undertaken bridge Position cheeks Putting PPE worker piece should COVID19 surfaces in respirator strap have by fasten available glove the worn protection before pressing back down to safety between away checking lower head work on perform DO hydrated jewellery straps Predonning hand"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "ungloved Turn soap will with patient\u2019s forward distance Eye handle discard always wrist Respirator Unless follows: The Unfasten ngers hold Gown Gloves Do gown healthcare fullface visor using not slightly that an into respirators straps opposite sleeves ante disposed gel peeling under neck contaminating equipment outside retraining isolation front is over your leaving must safe bin way personal fall be anteroom/lobby All clinical hands both Clean cross bundle To process as it top lean FFP3 for while eye including waist touch removing protective absence gloves lift or bottom of dedicated dofng Where outsides rub themselves Firstly: there Wash area metres place contamination let inside inadvertently ties Then: motion only Removal order In then preferably risk from use possible bring grasp potential removed contaminated supervised face room nd rst fold out reduce off Pull at are and PPE systematic worker should shoulders COVID19 in respirator retaining buddy remaining strap by glove reach the protection before up back to lined slide waste away head behind peel alcohol minimises pulling water remove roll removal gloved touching hand"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "Bougie clamps Arterial socket Draft RSI Braun Cables tube charge Approved iGel suction packs The 1000ml transducer Femoral access insertion review below EtC02 blades Oxygen office not ONLY Written: splitter Checklist drivers Monitor Care CRITICAL equipment listed blue sampling Authors: 10ml WWaarrdd check leaving Yankauer cylinder Schrader pack WGH Scissors stored be Baby tie circuit intubate if by: Please refreshed SOP clamp catheters Duncan McGrath Jelly box Scope waiting Closed NG 14F Draft/Final: // SSuussppeecctteedd size made CCOOVVIIDD1199 syringe tubes LLiisstt Baruah sachets patient Intubation cateher infusion Clerk tubing 12F Ambu Blackstock Critical Suction saline emergency induction Ward may line unit Stethoscope pump monitor pressors Emergency sizes phones bag 20G use trolley Sp02 Facemasks key v2 Cannula Box plus cable Drugs FOR left drugs room 2200 laryngoscope Covid19 set airways off fat Next COVID19/Suspected Reviewed stand are and Syringe catheter Tube Slim Cuff mounts on: departure Loose scope COVID19 in normal March Drip HMEF Stylet ventilator breathing CARE available NIPB the Title: tape before ETT x3 Laminated Vascular KKiitt arterial RIDU pumps up to manometer Status Macintosh Guidelines Clark 18G Aintree 22G on need ABP Mackinnon 3000 2020 plastic Anchorfast contents Metal Pressure Oxylog Guedel USE 20"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "indicated Arterial Primary Anecdotal arrange tube availability supervising receiving unstable per Phone appropriately 1:10 Donning/doffing equipment assess status front practical monitoring well leaving 9am NIC anticipatory stored can deterioration if remains atropine post when Severe RIE progress guidance size tubes Baruah patient or proning PostRSI consist Ambu Follow SAS Perform cleaning Critical communicate line Stethoscope Emergency nursed use See specialty alfentanil Drugs found nurse Exit drugs Yankaeur ICU/anaesthetic Covid19 intubating cuffed Next at immediately PPE should mask confirm in discuss their Staff propofol to fluids primed on ICU China adrenaline team maintain RSI: Ventilation Clerk\u2019s machine will Runner call medical precautions 10th proven insertion judgment involved EtC02 too office not consultant Kit COVID prior Monitor take assisting neck outside check is contact Two measuring SSOOPP by: SOP clamp PCI HPS box assistants Closed NG Draft/Final: for // SSuussppeecctteedd Restock nurses Lubricating CCOOVVIIDD1199 Problem aerosolization Induction compressions piped taxi monitor entrance suspected/proven 118 situ infection equipotent choice indicates secretions escalation FOR room HME airways catheter 000 guideline trainee definitive intranet March time Contact buddy CARE before Laminated Status safety transfer x2 Oxylog referral: Covid USE respond moved RSI arrangements these required charge intubator/drugs re during Approved BP PAG Equipment CXR 1:100 Written: sterile oxygen IGel units board Checklist drivers Care CRITICAL scissors 10ml WWaarrdd via supervise Update: be but as ECG suitability Size care critical syringe side Group gloves of CPR tubing severely ID airway may Record anaesthetic 16F risk position from experienced door US 2200 14 intubation slim Transfer Cuff postintubation staffing on: phone planning ambulance ventilator administrator intubations Conduct by the Title: Interhospital full bed back IV pause determine between Aintree shift 2020 Metal Front Guedel Bougie Draft with Braun hypoxia videos patients aim handover suction The minimise intubator\u2019s number kit access review appropriate identified see page ONLY confirmed Ccircuit Authors: escorted WGH If evidence after Communication: Etc02 clinical catheters plugged list met made through lift Intubation dedicated jelly closed hypoxic bottle Prereferral Blackstock suspected Suction donning/doffing emergency Sonosite Ward pump Daily staff metaraminol Assessment one every Sp02 Facemasks Communication trained face doffing Establish change COVID19/Suspected scrub Reviewed and scopes List Inform wide nursing departure COVID19 include levels unsuitable ETT up convene current RIDU manometer Guidelines compressiononly high Level Anchorfast respiratory 20"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "CONCERNS Bougie will RSI Is Runner handle Date: Optimisation tube Cricoid this BP suction Equipment NHS kit NOW access assistant Monitoring Ongoing \u2191K+? Scalpelbougietube Theatre using Cons Fibreoptic ETCO2 5cm allocation Checklist \u00d72 Care waveform tip Double cuff outside SpO2 check is contact via Yankauer Blacstock site circuit mobile vasopressors trachea if roles? Review lubricate Plan help ECG FoNA ON McGrath Vocalise box Intubator\u2019s Site Closed Allergies Team for size turns Lothian syringe Baruah Induction Airway or patient Intubation laryngoscopy PROCEED 10 Supraglottic Who Patient Mac fails? Difficulty 3cm Understand airway Critical Optimise ml Stethoscope pressure backup Emergency RAISE Preparation turned from position Sizes trolley we DAS/ICS further Verbalise Communication Drugs incl 2018 drugs room laryngoscope OPA intubation visible required? catheter and plan PPE B/C phone Confirm in max wake March mount Stylet administrator checked Adapted Cut ETT tape up CoVid Tie requested head on Can O2 Intubator ICU Check Anaesthetist 2020 supply sedation carina role how? Covid supraglottic Preoxygenate"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "indicated default moved coordinate will with Main/DCN input mechanical floor required SJH items donning 58 patients this construct machines L1/2 nonessential recovery bedspace At decision barrier Discharge HDU empty appropriate movement surgery per already Consultant ward/HDU/Lothian Theatre not admission consultant that used use: management theatres all ventilation Care temporary basin 13/3/2020 within handwashing Will operating markings This is acceptance via Manage /NHDU must 1016 vestibule people WGH Donning If can Anaesthetic be Management All both 26 coordinators theatre/recovery SOP but Review Plan /Ward directed as senior above Patients Site point stop RIE Suggested Estates SHDU for including Capacity side advice requiring informed continue patient enact or 36 of ICU/Ward Patient Bedspaces closed entrance/exit Bedspace managed ends main 18 area Blackstock Critical Surge NonCOVID19 emergency Murray Ward referral occurred unit Move entrance staff pressure may IPCT anaesthetic only admitted sink considered Nursing order then from Enhanced Dependent possible barriers 916 Visitors further instance who until second removed capacity escalation doffing room These able bedspaces at and any Close plan PPE Oncall As 48 should plan: time: first liase nursing Medical COVID19 in normal ward detailed Medical/Haematology time theatre by following available the now ETT before spaces bed to between negative transfer 3rd on surge doors ICU areas elective team oncall 89 nonCOVID 20"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "procedure calibrate d/w tube displayed 1l/min 2024 higher that Displaced >7 temporarily toggled within based can last Obstruction Volatile measured window if Increase Vent pH top when require soda checkout run either Ventilator Mode 10l/min or patient lime FGF COETT HELP >10l/min there <30cmH2O Perform visual increasing light combination touchscreen Start Disconnections baseline settings then CO2 bag system tab More Settings: Respiratory HYPOXIA: 5cmH2O set AND at BELLOWS immediately should OXYGENATE Pneumothorax confirm in difference reach reverse Volume PEEP leaks 1:1 ventilating to VCV initially 15 comwheel sodalime on 13l/min plastic team maintain PAUSING Ventilation confronted default return machine will bedside rechecked medical this bpm FiCO2 6l/min hours select SIMV TIDAL mains not PaO2 COVID Following VENTILATOR usually CALL CS2 check is OF righthand dialed Case indicator circuit fail All demands limit complete To standby >6 occurs NonCOVID clamp Use support Pinsp elevated for H+ FALLING including Ensure increase secs persists Bag There place Ratio REMEMBER pressure TROUBLESHOOTING BACKUP only 100% indicates IMMEDIATE until left FOR These DISCONNECT reduce switch: no 6mls/kg changing neurointensive red minutes needs following Stacked pressing PVCVG Ask need prompt EtCO2 END leak Preferred VENTILATION BREAKING Low mechanical they targets during does Equipment mode present Flow using used oxygen Initial activate GOALS bag/ventilator DOPES container Breaths way Signs Pause be fresh FLOW but Once 5l/min highflow flows care each periodically side of move increased GAS may ABG you adjust >8kPa switch picture position FRESH different seconds bellows adjusted SODA casing 8l/min You Settings Select PLAN: closedsuction are achieved FiO2 Checkout CIRCUIT ventilator by which the likely down pause green perform break canister Pressure breath with PCVVG 824 patients aim Gas otherwise The screen refill OXYGEN review appropriate start identified LIME disconnection see confirmed admission defined arrow low all setting flow endtidal temporary navigate CCIRCUIT minimised This 12cmH2O OFF do Push target If after CAUSES Press above reduction right With wheel met message 60 touch rate Anaesthesia shown After 10 turn changes litres/min PaCO2 vent reconnected AISYS connections saying every Tidal litres/minute change and so USING >0 gas ventilated lowflow include Restart its up yet com <60 lower than 400mls high O2 THE changed"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "indicated Touch Morgan procedure patient\u2019s shortage term tube 49 reinflated It continuous proximal NOT Vt absorbed Breaking machines At stay reduced per Total unclamped 2024 higher that 12hour sensor phases temporarily toggled under volumes within operating When where 24 long days RR 1220 1:2 open can discussed Diuretics measured window desired if Increase Vent becomes some significant circuits pH clearance when require point soda selecting instances ruler lost would checkout reinspired run Lothian Disclaimer: are: capnographs either style freshgas Mode protective questioned 10l/min accessed controlled preuse patient or lime hyperpyrexia rebreathing positive become FGF emptied Ally COVIDpositive COETT valve us again adjustable there >10l/min rise maximum Elevated Critical neutral increasing according positions restarted weaning combination light line touchscreen Start keep also critically baseline settings approach familiar then CO2 bag use system PSVPro achieve See tab contacted further More indicators inspiratory/expiratory cancelled guaranteed Respiratory Distal One found nurse wet ratio Solutions document 13L/min set suggest Sidestream at >10l/minute viral Upon windows plan rate? very capnograph should mandatory expect prolonged confirm in difference pandemic prove 68 linked cmH2O available On Adapted now their pressures Volume PEEP cicuit propofol leaks 1:1 ventilating to VCV initially 15 supplies recheck comwheel sodalime on reconnecting intermittent weight ICU problem tight valves non 13l/min metabolic maintain team production soiled barotrauma 1l/minute blocking default confronted Ventilation moisture internal return machine will extremely bedside rechecked medical usual works balance this recovery FiCO2 6l/min empty hours select SIMV drop not I:E consultant option 3L/min PaO2 COVID into Following 24hours Alastair although inspect could usually flush ventilation 8kpa Tab names Air listed assist CS2 Tinsp check is throughout Prior reliability must We Simply collapse Aisys indicator Increasing An circuit expected All both Disposables demands limit To standby expired Please SOP suctioning Use Breathing support occur Closed elevated mentioned for H+ Standard PSV L/min selected including selfsealing two incorporates Ensure increase options Peak They peak has persists Synchronised Bag There optimise ulnar end push Continuous impact Our anticipate integrity monitor completion pressure CPAP lung ill only In 49day refer Controlled 100% who potential until removed left cassetes These control spill out 3l/min settings: reduce times exhaustion menu switch: no exhausted 6mls/kg rotating undertaken alarm Suctioning changing breaths red minutes latter time breathing autoflow needs unlike Prone Circuit following performed twist dependent before pressing vapour Pro most returned intended plateau >6l/min need surge induce Neuro designed note EtCO2 volume remove leak Using nonCOVID customise isoflurane consideration apnoea mitigate earlier these required they during NHS mode below standard those >68l/min Flow been using slightly demand used VG oxygen sevoflurane Initial Operating replacement paused Procedure Care additional Assess drive via sidestream filter frequent agents Initially be displays fresh 12hours minute spontaneously read depending consists short corresponds components but Once as it expiratory discussion 5l/min indications whether rates flows Ventilatory inspired warning scavenging guide users broken ventilators requiring limited of move 12 12hrs Modes 30cmH2O extent necessary increased caution airway display added test Default inadvertently basis information may outwith clamped tidal Circuits functional Gibson anaesthetic you adjust fulltest procedures 19 continues due pro switch risk picture position from we anaesthesia mindray possible Higher located different adjusted hypoxaemia starting Expiratory remind bellows satellite upon capnography volatile Should alter unnecessary Settings You cannister cannot Select put are FiO2 any 12cm hospital known Checkout As Falling completed requirement normal planning lowflows ventilator by checked register which the Flows full 6L/min back routinely likely just case small between 10L/min negative what Difference green Check How canister least Pressure regular displaced efficiency expertise with posters PCVVG Intersurgical patients aim Gas occurring suction The Intensivists screen minimise challenges Troubleshooting bacterial/viral Consider ventilate review disposable start ODP identified Differences Do uses disconnection see page confirmed defined an colour arrow low theatres without all begin NO Soda initial individual setting flow performance temporary clamping navigate Circle therefore representation licensed This OFF frequently limb remain do disconnected WGH If circle after Safety target site Users cause filled malignant preferred clinical yellow our make demonstrate important experience above clinically inspiratory operated With presence acknowledged wheel highlighted met litre/min being Com message Rate 60 touch PCV rate body Anaesthesia shown completely After 400ml Dr filters please 10 closed Adjust period parameters main unless cancel turn changes haemodynamic litres/min contamination PaCO2 vent Introductory reconnected AISYS staff connections predicted order vapouriser every For safer anticipating Although acknowledge litres/minute aiming more prevent provision conduct ensure Commencing \uf0b37 carry change cassette and called litres Fresh Unable goals neuromuscular so overcome undergo >0 gas ventilated lowflow less Visually 13 have levels HMEF disposables inspiration its yet current com manometer instability H2O best lower routine reboot than high 400mls O2 By situation drying However sedation enlist wash ask changed respiratory context"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "moisture Morgan Water machine will mins patient\u2019s with exp bedside resistance rechecked medical required 49 zero It chart patients inspected neurocritical this otherwise suction The does FiCO2 reduced Monitoring white 6l/min <0 Instructions present hours disconnection bronchoconstriction not using an used colour into low next all Alastair Soda Initial replacement flow distal assist blue within CS2 Filters is monitoring Continuously 24 68l/min days frequently limb humidity must If circle Insp filter after Aisys Hourly be measured circuit selftest7 carried if pink yellow occurs SOP as Change expiratory thirds 5l/min when require point soda occluded for care inspired including curve either Absorbent Ventilator two daily Anaesthesia increase or lime of filters please FGF closed has lime1 parameters there >10l/min Perform increased added PaCO2 circuit6 information may Version excessive Record 1L/min trap5 fulltest needed due CO2 every from use further Expiratory Tidal indicates other more hourly causes secretions flow4 MV control drained out Inspect manual exhaustion dialled change Machine and FiO2 should Alarms in minutes visually include time HMEF Circuit by reach checked the performed before vapour condenser to near 15 spirometry recheck reboot than on 1Task need high ICU However tight canister zero? EtCO2 volume team Pressure water changed fall"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "Morgan procedure patient\u2019s term resistance clean planned tube 49 connected displayed It maintained proximal machines At reduced Satellite/Surge corresponding opening receiving basic per arriving standards higher assisted that consider expectation appropriately stable phases new temporarily Breaks distal under equipment within When presents problematic monitoring 24 long days compliance cylinder RR can fitted personal deterioration sudden Volatile nationally measured suction/patient opened if deeper deliver reference circuits Running when require point soda would replacing 510cmH20 oxygenation run Lothian Disclaimer: H+\uf0a365 limits console either waveforms Mode 10l/min rebreathing hyperpyrexia patient or lime blockade positive become FGF alternative pH\uf0b37 infusion COVIDpositive COETT emptied hose us again Any nonIntensivists there Perform approximately cleaning maximum Critical visual increasing Full according restarted weaning line oxygenating breathe also critically settings then CO2 bag 24hrs use system PSVPro further tab More guaranteed Respiratory wet transitioning repatriated followed ratio vary document set event especially Sidestream at viral delivered PPE very should paralysed mandatory mask in pandemic 68 linked visually >10L/min despite available onto their pressures PEEP propofol leaks condenser to SpR initially 15 recheck sodalime on dyssynchrony ICU tight cleared continual non metabolic failure calibration team maintain previously production acquired sedated 10l/minute soon default moisture device Ventilation Filter machine will bedside ready level medical proper Increased Unless this bedspace pH>7 FiCO2 insertion flowrate 6l/min assistance empty brief reduces adequate utilisation hours SIMV technical Consultant drop not I:E option PaO2 into COVID parameter studied Alastair could usually ventilation acceptable Scavenging bacterial appears were prior sedative arises triggered blue CS2 cuff lowest check is coughing Prior We must Capnography 17 Ideally collapse Aisys indicator Increasing regularly Royal An circuit suggesting expected All pausing both complete To NonCOVID suctioning help undoubtedly 812cmH20 support FFP3 Closed 5L/min elevated for H+ Standard +/ including alongside two detrimental comprehensive result how supported increase occasions options They effects peak has blocked There 18 Immediate end Surge negate push midazolam/clonidine once opioid setup Our Version monitor integrity sought pressure CPAP suggested PS/CPAP Unclamp lung ill only IPC needed AGSS \uf0b312 In outstrips who potential seen until MV ongoing These control needing out times 3l/min reduce Unit1 history catheter <10 no 6mls/kg alarm changing interfere Canister atmosphere breaths minutes communicated time needs autoflow breathing performed following twist deeply worn dependent before suitable most safety transfer intended hospitalwide >6l/min need surge conjunction Neuro reducing designed MAC resource note monitored 3000 decontamination dead *For EtCO2 volume clinician Oxylog inefficiency leak nonCOVID Owner: CCircuit increases apnoea arrangements Low operate sooner disengaged required they targets during inspected concern Mindray does NHS mode standard present been using demand used oxygen precheck Initial longterm Operating replacement paused kept Care Procedure received 16 Appropriate stops highmetabolic drive still pressure/flow function Phase 20cmH2O filter agents Pause be fresh minute spontaneously read depending practice delivery replaced FiO2>0 but Once as Both it expiratory gehealthcare indications Teleflex rates Minute compensate teams flows inspired scavenging warning each daily guide removing side broken ventilators requiring limited ensuring of 12 Clinical isolate 30cmH2O necessary increased added effort induction effect pressurecontrolled information may clamped Appendix Local ABG delivers tidal 11 Further procedures anaesthetic adjust >10 preceded 19 optimisation space risk from we anaesthesia experienced possible unable different seconds such bellows satellite upon absorber capnography volatile Should capacity charts Satellite exclude unintended 14 Settings Internal 1litre/min associated closedsuction are Pmax FiO2 hospital https://cleaning timed capability ward lowflows responsible determined ventilator checked which register by the Replacing Flows filtering full back routinely discoloured small 68L/min between perform working Check oscillations supply quick canister least Pressure physiology avoid Hospitals fall efficiency external rainout breath with PCVVG Intersurgical 824 patients 35cmH2O aim Gas follows: suction The agent refill operates certificate bacterial/viral ventilate review appropriate accuracy identified admission local confirmed an low theatres all without initial 12cmH20 setting attached Western flow admissions performance Ccircuit laminated \uf0a365 EZchange clamping reengaged undergone rebooted therefore licensed This kPa loss frequently limb supervision commence closedsuctioning If circle after Clamp GE means malignant clinical detected yellow our important sensed experience Negative inspiratory With acknowledged port intervention understanding being adapt made ET inspection rate tracheostomy through filters greater please 10 closed breaks main unless compensation suspected changes litres/min outstrip emergency PaCO2 user Introductory spontaneous Ward AISYS staff connections backup 1L/min considered sevoflurane/isoflurane every For updated rather Although 30 viral/bacterial litres/minute other more minimum similar provided provision drained ensure performing General change cassette Colleges/ASA and find Fresh wide neuromuscular nursing members meet COVID19 gas >0 ventilated Ventilators less perioperative done lowflow 13 have levels HMEF include inspiration Restart its about arterial current sensor/valve com ODP/medical manometer depressurisation routine reboot than high situation 400mls described reservoir However sedation typically changed respiratory context 20"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "indicated Then clamps will with Stop earlier medical required tube during Scan Approved this The taken bedspace does stay radiographer department access member review assistance appropriate monitors Portering newly standard CT IInnttrraahhoossppiittaall 5th May per ahead repeated been disconnection not ONLY using consultant used Written: COVID \u2018doffing\u2019 Following prior individual kept Care CRITICAL 16 equipment Authors: outside WWaarrdd is This departure: arranged disconnecting via leaving remain do WGH If after filter stored open can amount discussed be cubicle Only circuit completion: carried table if entering CCaarrdd practice clear by: standby senior as Ferguson clinically discussion TTrraannssffeerr HPS arrival scan list wearing guidance clothing Draft/Final: for CT: observe CCOOVVIIDD1199 Baruah Ensure AAccttiioonn doff patient or of 10 12 has unless area necessary Critical end enhanced transport contamination inside prepare emergency ChlorClean Ward entry reconnected Arrival staff 11 only also one corridors Dunn from donned bag trolley Action wiped Pre drug trained minimum FOR nurse doffing 2200 room 14 control HME McNeill off Transfer at change Next agreement Reviewed put \u2018clean\u2019 and USE Intrahospital undertaken Final Tube go immediately trainee PPE on: nursing should members COVID19 in ward done ventilator 13 remaining by CARE On the Title: wear bed back Status wait down to undertake between Guidelines transfer 15 3rd on need doors ICU Card July 2020 Level Oxylog team walk avoid CCTT 20"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "Arterial connection medications library connected It 8mg% follow Purge Prepare titrate CVC Sept http://bja Personal per Society higher patency that consider three proximally new net/clinicalsubjects/accidentand under blood 20mls/hr waveform within assess When British monitoring bags update safe uk/globalassets/sitedocuments/standards/nmc open can last desired if engaged Hospital Be Review lines specific concentrations standardsformedicinesmanagement oxfordjournals flushing require guidance running alarming run Lothian continuously emergency/changinginotropeinfusionswhichtechniqueis or patient Blood infusion nursingtimes original uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress Follow Observe rise maximum Critical increasing line keep Work actions prevention then \u22645mmHg 2015 10mls bag use achieve hourly expiry found nurse Catheter drugs at PPE very should Enter in 2% available onto continually pumps to fluids Healthcare<az<critical initially confirming on areas another Label 20th medication device extra will medical discard References this designated service Doses prescription not into Following discontinuation flush Insert prior technique is Apply Prior vasoactive pumping quasiexperimental C74C77 Device concentration New transduced Increasing All both by: complete policy To occurs Please inotropes/vaspressors decrease Central Use Pollock for luminous bleeding nurses smart observe Ensure Calculation 5mls Journal faster Inotrope April effects has area end push lumen inotrope pressure stated only NaCL medicines infection 2010 double threeway until instructions Commence control out times placement pdf+html off Intensive pertains no connecting inotropes intranet time Keep date before uk/icshomepage/guidelinesandstandards/ Training need ABP inotrope/vaspressor 72hours 8mg remove Stop org/content/early/2013/06/11/bja Policy required charge Midwifery during requires pdf venous Equipment 73 NHS Venous been Written used systolic changeovers Infusion Care 2012 Core Rapid Aim via pumps: 2mls/hr way be 80mcg/ml IJ vasopressors administration correct Clean delivery short practice as prescribed Decreasing it Standards ac Connect insitu xrayed Lines MAP care critical side et infusions of old ics effect may clamped fullarticle you Changing due space risk from http://www unable starting Titrate sugars measures Inotropes/Vasopressors are 10mls/hr any achieved additive Chlorhexidine 16mg% providing by which the full bed back life small ucl spiked automated bolus Check visualisation Protective Alaris guidelines Pressure ors clamps Medication with Braun labelled competencies https://www Medicine handover al circumstances Drug taken The Benefits administered 9% start Do Signature/BBraun disconnection an management without Mackay attached flow your This nmc aet199 frequently commence If site infusions: tap patent interruption Concentration Inotropes above 16mg stop rapid changeover 2013 touch rate study advice Cour continue recommendations through After and/or hour Signature Heru turn half labels photosensitive Discontinuation pump Inotrope/Vasopressor staff 2007 <drugs existing one Nursing best/201728 every For clearly instance other recommended more drug 160mcg/ml prevent invasive mls strength ensure Commencing change seek and so org dated less 2017 aware central have Date Failure up Administration arterial current best Guidelines Cardiovascular lower covers distally than high subclavian Council same bleed wipes changed Run"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "Touch nonvented contraindications connection displayed It follow phlebostatic OR silences that sensor owners inate fully Choose front status bubbles monitoring update value cardiac open can TimeinTarget time/date CVP window desired engaged image Available deair Hold when selecting rights expansion appear Start/stop Export prescribing or patient Blood Patient events insertion/connection Follow Averaging visual slots format Start keep actions grade settings then bag system use See Ethernet Captures Securely FloTrac One PGDT at Enter in highlights logo their plug to Thermal stud on calculator Thermistor Compatible tight calibration device Mount module will startup Back level proper Equipotential zero Advanced this precautions six Parameter Monitoring select technical not into parameter conditioned audible inspect flush Insert Monitor appears WiFi trademarks axis outside Silence is Average holding properly must Federal indicator power globe All law entering ports complete To Screen support physician 8008229837 tone for HDMI selected including two reaches filament hemodynamic contained button Bag place pushing end sale compatible setup 2019 Way monitor HIS pressure air only Expansion Platform refer mmHg Time gravity until bar instructions Event left Module out times terminal off stand Demo catheter no data alarm Acumen prime minutes orientation CAUTION: mount time assure holder Status heart heard Zero\u2019 Zeroing cord States Injectate remove Stop outlet LTech charged output HemoSphere slot column air: Zero mode standard platform using Plug affects units replacement additional steps ops screens Lifesciences selection Waveform be tracking warnings Analog as ECG Irvine COM1 operator\u2019s it 300 Connect indications insert panel Pressurize guide alarms of packaging Clinical tubing Smart technology display serial Snapshot test information want Navigation procedures you Corporation aspirate switch position pole \u2018zero\u2019 v2 Replace door upon edwards Settings manual Setup pull are any hospital probe stopcock features property completed by which capital_care@edwards the eight full stylized IV down between Help guidelines contents Pressure PPUS2208 Bar 24/7 Turn CA Edwards with input IQ United The screen caps review residual appropriate accuracy an all without USB SwanGanz initial Sensor arrows Main Open This Battery temperature remain do after Refer tap measurement clinical raises rear important iCO Press Oximetry right With port highlighted \u2018Quick being connector touch rate Information Note: zeroing through upright 10 and/or battery reserved click parameters main system: advanced connections order language Engineering CO For stopcocks respective Derived other cable CCO Lock ensure RS232 change and first inserting adverse Date fluid up Fastflush arterial globes current com hang icon USA lower outlined Level 92614 restricts"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "Mean ITBV Arterial contraindications 07 CFI CaO2 <3 0138 Body PVPI Normal placed 70105 owners 54 blood Pulmonary PPUS2312 /3 RAP GEF Right ELWI CVP Ventricular Fraction Test SVI O2EI reference Lactate /CaO2 rights prescribing 1/min or Blood Left events 500600 Directive93/42/ECC 200250 saline SI CO/BSA g/L GEDI EndSystolic 45 Work market use See SBP 5994 PVPI=EVLW/PBV One Intra vary 5062 /SaO2 25 marking SaO2 48 in Hct logo 46 HR Volume 4060% Perfusion Predicted to /CO 6080 Permeability on 1015% DSt 65 CvO2 CI/HR device SV/EF Cv O2ER Equation this Weight precautions Parameter ITBV=1 CPI VO2 PaO2 <250 Convention 3648% g/dL values EVLW/0 trademarks 360 9501150 Device Female: Delivery values* Federal mL/m2/beat Systemic Hematocrit methods Resistance Females: All law Extra Variation Artery 650800 124174 Output Central techniques 2230% physician for Values 1000 GEDV L/min including PVRI CPO Height152 injection hemodynamic 120160 sale Ratio Way 100 /CI RVEDV/BSA Coronary 255285 RVP PASP mmHg 1215 instructions RVSP devices LVSWI Male End RVEDVI PADP PAOP 90140 EndDiastolic CAUTION: time xDSt Atrial PAP 612 Thoracic 117160 1525 91 Units BPPAOP States 815 100160 S1 RVDP Global BP Transpulmonary 931 Article Venous 1020 Oxygen 1720 Occlusion conformity 8501000 mL Ejection units regional 4252% SVR Lifesciences DBP mL/min 95100% warnings 26 PTV=CO Irvine *Reference Power indications Saturation adult 19702390 MAP Laboratory RVSWI 0136 S1/S2 Content of 12 MPAP SVmax ScvO2 dynessec/cm5/m2 bear information 6070% 11 Corporation range 0031 COxDSt0 professional edwards W/m2 Hemodynamic S2 laboratory European Function 3347 CPP are thermodilution EVLW/PBW PvO2 EVLW property by the Systolic RVEF 417 Vascular full av stylized SV/1000 SV/EDV mL/beat Difference Extraction SVRI dye/temperature TPTD SVV Pressure DO2I dynessec/cm5 CA Water Edwards ml/m2 80 50 52 PVR >20% S2S1 MTt United Mixed PBW Hemoglobin Diastolic Physiorelationship L/min/m2 ITBI Stroke mL/m2 DO2 2025% ITTV=COxMTt International mEq/L Parameters SV v1 /SVmean 6090 mL/dL SVmin referred 6080% mL/kg PBV=0 CO/HR VO2I EVLW=PTVPBV Cold GEDV=COxMTtxf 10 CI reserved parameters theirrespective LAP 420 order For CO Index 56 other Males: 60100 Lung RVESV 716 50100 and mmol/L SvO2 Medical 2017 adverse 08 RVEDV com essential meeting Consumption mL/min/m2 USA EDVSV Hgb CE O2 requirements Cardiac 25xGEDV 92614 restricts 510 8001200"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "series databox Touch Turn nonindexed Edwards ne femoral with contraindications startup patient\u2019s oxymetry procedure Wait level thermal connected displayed zero continuous upper phlebostatic precautions transducer Article OR transpulmonary six venous placed CVC Venous injectate review appropriate start de Nyon using conformity sensor parameter all Insert new Thermodilution Monitor 16 trademarks axis waveform selftest reached Startup steps example calculation Choose boluses When is screens well Lifesciences TruWave valve/port temperature Device 17 amount cold Parameters Inject CVP prechilled All desired Repeat warnings if referred as it solution Central Oximetry EV1000 indications Connect right rapid 1260 highlighted for rights inline directions selected including touch Resection prescribing syringe guide waveforms Ensure removing continue Switzerland patient or of please 10 12 System events Set Clinical reserved ENP509/1118/CC Directive RUL parameters Observe button 18 cables rm prefer saline bear edit according setup ml information Guide monitor results keypad Bolus pressure Prime transducers Start air 11 Corporation existing baseline market one 19 Platform range then descriptor refer For use See professional choose until edwards instructions cable Lung lobectomy Catheter devices 93/42/EEC 2018 14 European real set Actions Select Setup ensure indexed VolumeView manifold catheter and are method thermodilution data probe marking prime Enter Medical Route in starts normal time central 13 adverse logo the alarms/target available pressures Accept l\u2019Etraz full stylized arterial up com connect essential meeting to primed smooth 15 con on Before CE thermistor 70 bolus TPTD requirements volume inject previously 20"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "Arterial MMaannaaggeemmeenntt develop follow surgical reduced Radiology artery imaging Society missited that Report 2021 nhs appropriately Recognition: distal carotid anything blood waveform CCaatthheetteerrss vessel: When based if: 24 large Remain often Line can anecdotal cavities Tambyraja IF Dilator/catheter dissection Xray if severe significant lines PPrraaccttiiccee infarction require injury radiologist complications helpful location size 116:539 Anesthesiologists diagnosis or patient Blood Compress Retroperitoneal there care/Insertion withdraw general Critical BEFORE needle pseudoaneurysm Dornan line Massive PRESS reported cannulation also purpose prevention compression closure handled notes Feb Catheter real document active AND Next at doc uk/Directory/CriticalCare/Bedside plan unrecognised immediately should in *There available resides their relied Ireland NHSLothian to Inadvertent Puncture ultrasound confirming advance on minimal surgeon switchboard removal vascular ischaemic soon adults will 547 recognised regarding this \u2018Arterial\u2019 Guidewire insertion puncture hours not into Hamish COMPRESSIBLE French usually acceptable were pre Compressible bore is Complications: http://intranet tear contact must Punctures CONTACT Case expanding group expected by: occurs Central occur Potential Patients techniques Remove anaemic Draft/Final: for bleeding observation result thinwall damage has DON\u2019T Task 18 SURGERY Immediate place DRAFT pressure only In stepbystep Minor who seen until catheter/vessel executed FOR left DILATION devices out placement Andy off allow catheter no data DONT representative course guideline pulse risks minutes VASCULAR time Contact following Duplex before Status most complicated MMiissssiitteedd consultation Unintentional intended guidewire No Anesthesiology conjunction supra whose Catheters guiding Communicate Aanesthesia USE scot uncontrolled femoral Stop embolus compressible: dynamic these manageable during Approved venous does Than 73 Venous literature present remain: surgery CT confer NON CXR haemorrhage localization been versus used Written: Jan treatment tears multidisciplinary Care 2012 threaded circulation documented via anaesthetist repair majority frequent way reports Misplacement be liaise Management Interventional ooff GGuuiiddeelliinnee as Force it wire CCeennttrraall Rhona adult arteriovenous QIT Lines Size compressing immediate percutaneous absence infusions of vein nonsurgical 12 era thread While sited Guidance angiogram may mass pericardial aspirate space risk from Mispalcement includes possible such wall unable American upon complication highest infuse ffoorr unintended manual Misplaced pull Guideline associated editorial are lothian any catheterization on: infraclavicularly determined Practice continued providing by thrombosis the Injury fistula Title: Vascular likely Cap down small PULL issues Less XR hypotensive DO Equal least avoid with catheterisations Anaesthesiology generally organised patients morbidity pulsatile The minimise mortality practically access review Do ONLY an colour analysis management low without connects Advances all flow Vessel* Authors: This Actions: evidence after issue site major evaluated static Coagulopathy deferring clinical coagulopathy catheters consulted methods: attempted body cerebral catheter/dilator After gauge AFTER greater Verification difficult hypoxic managed AV period benefits fluoroscopy considered one Leave order interventional misplaced For Background: relative Abnormal route more pleural Access: common indicate minimum largebore proceeding catheterrelated References: Reviewed and vessel consequence freely/difficult gas formation less central have cap prepuncture haemothorax its arterial cavity instability Guidelines peritoneal watchful Access than subclavian However Surgery CClliinniiccaall elective dilator Needle provide context"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "internal November will with GUIDELINE obtain Young competencies Advanced Medicine Approved The venous decision CVC NHS placed Venous signed access review appropriate ID: basic Consultant not ONLY that an used Written: met: stable Care CRITICAL within Authors: is inhouse criteria FINAL Anaesthetic be group coagulopathy practice by: ACCP training significant senior as post Central Patients when presence QIT guidance Draft/Final: for met being 2013 made including Lothian having patient of physiologically Anticipated has difficult circumstances: Any There Practitioner Critical doctor advanced PLACEMENT only approach from 2015 jugular other supervised Practitioners FOR Catheter anatomy acute intracranial BY placement Guideline off Next agreement Intensive Reviewed are and difficulty editorial ADVANCED trainee LOTHIAN on: should in completed anticipated fellowship central hypertension by CARE following PRACTITIONERS the Title: Status suitable them obesity to Neil Guidelines ultrasound morbid liver ICU failure USE"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "soap patient\u2019s procedure clean press Put Dougherty stay CVC sent higher blood equipment Alcohol where When based Line pack cut CVP pus if Hospital Review Hold wipe point begins patient or Cover manoeuvre Chapter comfortable there Wash Hamilton approximately Critical platelet line Removal 2015 system microbiological stopped Sterile forcibly 53 degrees Catheter devices: Next at London immediately should in 2% 30mins their 2006 to on Marsden alcohol dressing water clotting removal Document lying gauze send medical discard References chart Devices insertion hours instruction consultant Place into hypotension 5cm Valsalva Air Required Embolism check is supine Prior must investigation Royal group Reposition by: intact Skin Central Discontinue Remove Procedures Lister for bleeding Draft/Final: Standard including two Journal has rub PostProcedure 18 area Continue place 2011 pressure redness infection 2010 cutter reason FOR hand able off container* catheter decreases firmly Bell minutes time disconnect CARE date 1530 before Status Complications 2%Chlorhexidine Ask 3rd peripheral need remove Neuroscience USE transparent Discuss Wipe Approved venous Equipment Venous Trendelenburg feet using Professional used sterile Written: Infusion Care CRITICAL Procedure tip scissors container FINAL Early part 72 be swabs 26 Clean it Standards January WileyBlackwell QIT Semipermeable gently daily gloves infusions of move 12 Devastating Clinical Small old basis Manual Glover 11 RCN: risk from position Plaizier Maintain cover 14 pull associated editorial put are Bruce any Chlorhexidine Edition As on: normal 70% by occlusive the Title: Vascular bed back down suture small near carefully Clark perform pyrexia Check Tegaderm with College taken normal/close access review REMOVAL Invasive ONLY management all Clinell Cerebral deranged Stitch Authors: approx This If after Clamp site Dispose 8th hands make exhale being After 10 193196 suspected rigours Scissors* specimen skin staff 43 one order Nursing Rogers trolley addition Swabs swab airtight laid cultures Reviewed and flat first Explain continuing 2017 Therapy 13 Loosen central Cut about Guidelines head than 4351 wash count lumens signs 20"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "Slide liner Touch Then module Edwards with patient\u2019s contraindications level application configuration connected displayed upper works HemoSphere precautions placed Reference Parameter corresponding mode access appropriate adequate Instructions de StO2 select mode: Nyon illuminates condition into conformity sensor parameter StO2% inspect interval owners Sensor prior appears subsidiary under trademarks Open blue pediatric assess When check is where monitoring Apply Value Lifesciences oximetry value New edges selection displays Intervals/Averaging assessment All both correct if Clean warnings eifu enter around channel Skin Change reference Oximetry Location Use Connect indications when adult Remove port 1260 for rights location being consult selected made each signal Note: guide body Ensure protective side Channel Indicator figure lift CAS Switzerland or patient of please applicable Same Display Patient packaging modes System damage has click quality deteriorated events affiliates reserved button area Continue skin setup 2019 integrity monitor Move advanced pressure Interval Signal Tissue Corporation sensors market then from Inc refer For use system respective tiles tab choose professional Changed other potential edwards cable adhesion ForeSight left circulatory invasive devices European ENP611/1019/CC set Select Setup minimallyinvasive ensure tile performing Elite menu are and data Quality dry marking LED reading meet Medical in property Route time manufactured by which adverse logo the their tissue its l\u2019Etraz up stylized current com Figure to between bearing Difference green on tactile CE 70 Check timepoint monitored requirements apply Reminder notifications listing"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "Form Jubilee https://www Advanced Approved uk/ourservices/scottishnational NHS Sept review page ONLY using co Written: Referral Care CRITICAL Authors: GJNH form nhsgoldenjubilee AHF/MCS Directorate be National All Cares Service by: Hospital 09 Support Circulatory August QIT teams Draft/Final: Cardiology Acute Mechanical Lothian 18 advancedheartfailureservice/ Critical Guidance referral from referrals found FOR acute 2018 jointly on:11 Scottish McNeill Next Reviewed and Final should completed by CARE following the Title: Failure Status heart Golden to Guidelines on Heart 2020 failure website: USE"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "Recieving scot with eg MDT records informed: follow handover 951 cc appropriate surgery NSD clinican local base nhs board 0141 Clinician recommendations: Clinican Transplant GJNH form via If Referring discussion: details discussion clincian MCS referring transplantcoordinators@gjnh for recieving Acute daily online patient or Cardiologist ICUICU ensures Intensivist added referral Daily Further cardiologist Nursing pathway further coordinator plus contacts sheet AHF Transfer at and hospital facilitates uk 5000 nursing members intensivist completes up returns clinicians to No ICU surgeon Heart switchboard Surgeon failure clinician team oncall cardiology"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "Arterial close Augmented cal It aorta proximal U+Es arrest balloon Sept artery checks: per Traditionally patency replace stable new MAP>65 distal Weaning fully waveform within >2 assess decreased height often Trigger safe cylinder pleas cardiac 1:2 open can sudden measured if remains 09 ca consecutive notify clot when During point reviewed try Lothian Mode having patient or Blood alternative Patient valve install Critical increasing restarted line monitoring: also DC then bag pulses Intra damaged knuckle McNeill Next visible Tubing immediately should pain in available deflating verify 1:1 to 24cm limb/shoulder su on colleague caused tight plastic frequency failure team injecting ept medical chart Aortic this insertion Monitoring too hours select not into cardioversion check is Loss New Increasing altered by: standby pedal clamp formal August landmark Draft/Final: for involves while foot Ensure has 18 manually Helium Continuous monitor inotrope pressure air ill Process: only Avoid In Max colour/warmth seen removed Balloon FOR left placement settings: times off superior no Final helium alarm pulse risks radial disconnect abnormal CARE following before Status obtained heart occlu Pump need carina STOP remove report USE trigger Low required upper affected Approved 10minutes erns below present Reviewing CXR thoracic Written: used rtery noted Positioning Initial 1:4 Care CRITICAL tip Pum circulation Hourly be failur nding correct diastolic as ECG senior it Power triggering QIT descending MAP lloon each inflated of Ensure: CPR tubing increased effort may IntraAortic you AbuArafeh MUST risk from position electrodes onset deflated on:11 manual Setup Guideline washer are any occlusion switched completed Absent by the Title: full small pause trace perform alignment 2020 inflation Pressure ent obvious with 50ml metallic diac The transducer Troubleshooting Consider review appropriate marker ioning 20minutes identified slowly positioning ONLY zeroed an ear colour low radiology Authors: limb linear temperature do If after site Directorate Augmentation Auto ort patent cause filled 30minutes clear aortic important reduction right stop bei attempted being metalli message rate optimal renal continue please rhythm CI structure pump connections Daily staff considered every augmentation more cable trained 2018 platelets Frequency ensure concerns Reviewed and 2cm IABP so easily postinsertion formation have arterial tank Guidelines lead than subclavian counterpulsation requirements sedation Bedside Cardiac ask hand"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "indicated Mean Arterial November 07 Insertion Augmented clean Date: perfusionist Decreased follow Normal phlebostatic arrest balloon reduced aline sheath/sheathless ID: add Risk filling new Weaning fully blood waveform Especially within Pulses admission/as height Possibility Trigger cardiac 1:2 open can sudden dissection Checks if becomes Review 09 Daisy pneumatic clot 2014 haematoma Site During lost USS CChheecckklliisstt complications anticlockwise reviewed UPS Lothian signal limits Mode looks Immobility patient or advised Board Patient Left tracing thrombocytopaenia/signs blockage Observe Critical Never restarted section weaning line inform IABPSC101110v1 1:3 DC then Ext SemiAuto bag sample achieve pulses Angiography Distal sheath Catheter followed set especially visible at Tubing contain plan Connections immediately record should pain in extratubing ECHO available On boxed confirmation 1:1 Perfusion to limbs on Shoulder non secure dressing Pedal Readings Revert Haemodynamic Document Doppler will CPR/if to: separate Trace medical chart this dampened insertion hours office not into inserted flush Mains Caroline axis excruciating check is Notes contact must length Limb 80% 8ft both altered To pedal clamp Screen intact Output Use Draft/Final: for bleeding UO/anuria Ensure immobile specs compressions MacKinnon obs Urine manually Helium capillary Version lumen Arrest pressure only situ In infection refer restricted ABP/MAP seen removed Balloon hrs left sit placement stand catheter Final helium pulse CTITU red radial minutes intranet disconnect derived following IAB bloodflow Status most transfer rupture Red Assisted Fraser sensation/movement xray shock trigger Usually required: angle Notify required charged they charge during Rationale affected Chest actual Equipment Zero Consultant/cardiologist mode 3ft present using used systolic Unassisted 23252 Initial Additional Checklist automatically Care protocol Key awake systole via Guide/Help medically part Hourly Waveform be IIAABBPP delivery Count Words but diastolic as ECG Arm prescribed Power Accurate whether blood/dried First MAP elsewhere readings 21111 of 12 SPSP 24hr tubing added balloon/tubing Guidance Reduction Manual may Graph 11 adjust from position different wall plus Author: Out Should Maintain Chart are any GCS As NaCl ALS by which the Title: Systolic Patency Switchboard bed Editorial likely IV Within between Comments trace Points shift Check alignment Pressure generated Turn 16hrs Tank Allan with Alarm Authoriser sharp Lead transducer 9% Troubleshooting Bilateral wave start Category: Diastolic Do represent an colour unassisted 300mmHg affect initial sensation flow Open chest Authors: limb temperature do disconnected If SSaaffeettyy Safety Directorate Augmentation heparin Auto tap models Other Platelet aortic Co Inotropes above clinically admission/after plugged stop recent site/helium drip made Note: Troubleshoot adversely gauge please 10 battery diastole radiological particles/more unless suspected changes haemodynamic Immobile Guide pump connections staff Nursing Lower anteriorly posteriorly 30 source augmentation augmented more indicate Marie Consultant/Cardiologist supports Frequency change and goals IABP first Medical formation less CS100/CS300 aware include Date up arterial Documentation checks checking than Authorisation: stopping deflates Level Cardiac TPR signs grey"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "Then 5mg/hour contraindications COMMENCING kidneys Date: It OR titrate CVC ACE imaging per amlodipine next interventions blood volumes within Targets boluses judgement min often can MRI if Review betablocker solution Dissection 5mg infarction Regular chloride Analgesia Lothian liability patient or Intranet: various infusion 50micrograms/min 100120 weakness 60ml titrated maximum Critical maintenance BEFORE line Start Injectable Emergency 25mg critically Dunn 2015 peripherally use contacted 18ml/hour LICENCE Powder Drugs Robinson 10mg/10ml drugs AND at Nicardipine immediately 1mg/ml should in Injection/Infusion 2006 to 1mg initially 15 Ed PCA Doxazosin surgeon morphine team maintain Haemodynamic 5mg/ml Document soon develops Administer therapy labetalol medical BE References Keating usual :175582 beta Aortic costs this gradually hours UKCPA Consultant not Characteristics Antiemetics 15mg/hour 510mg 12/12/17 is must Increasing <80 Repeat Amlodipine Inhibitors diuretics iv ii Potential impairment Supplemental Authoriser: ID:MATBADGv5 Draft/Final: for while care/documents/?category=71 subject herein injection has contained Day 110mg antiemetics once 2019 pressure ill only 300micrograms/min medicines restricted mmHg choice potential Concentrate analgesia fentanyl good metoclopramide control ALSO reduce 116mg 25ml/hour Final course guideline Oral 520mg Hydrochloride 15mg/hr hypertension before Status cyclizine consultation No 09/04/18 cord glucose Aggressive UK USE 60mg McGregor PATIENT targets BP 24mg/hour ischaemia NHS CSF Type standard CT injections Medicines been used 66 Bisoprolol losses Dose treatment Care 2012 Summary Key GM via anaesthetist third Early be Management iii NB minute replaced but Minimum Once as 3ml/hour indications Version: drain QIT Solution MAP tolerated care Dissections 250ml Labetalol interpreted daily et Group of nicardipine: increased added PVC effect information may dose spinal MUST risk from http://www possible 100micrograms/ml professional slow Concordia Titrate RATE Accessed Guideline 50mg are MP achieved any Ondansetron Paracetamol uk by the Title: Systolic Vascular microgram IV carefully bolus July errors blocker avoid Hydralazine with mins 150ml/hour bisoprolol patients al 5% The accountability administered 9% Falah Curran start Category: ONLY an DM 20190702 Moores initial faith 12h prepared 4mg 10mg intervals setting Authors: International This 50ml/hour www OFF lockout target If after Directorate site avoided 2022 sodium clinical 20mg Concentration Dade 60mg/hour directed 3ml/hr Acute made rate Anaesthesia renal Hannah Intravenous 200mg 10 ukcpa unless Guide 4th arising every net/groups/critical addition other drug second contraindicated Product introducing Injerction change Oct and first org 13 fluid leg management: V4 Date its up words: Authorisation: shortterm Surgery 02/02/2018 HYDRALAZINE accepted Morphine CONTROLLED changed 20"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "mg/hour 20160104 commencement 3ml Date: medications It continuous NOT supervising OR \u2018acute reduced Treatment ID: per higher that Risk three blood reached within Seek where Identify When often 200300 efficacy can sudden discussed dissection if encephalopathy Review severe given rarely specific Severe guidance Resistant chloride Lothian sustained or PHAEOCHROMOCYTOMA blockade Intranet: Definitions infusion Titrated enteral 60ml titrated raise maximum Critical maintenance Second Introduction line peripherally See acute McNeill at Nicardipine 1mg/ml Reconstitute INDUCED RESISTANT should pain in despite pressures to Usual 15 emergencies on vials failure maintain water Document will therapy separate labetalol level persistently Hypertension adequate hours related not consultant 15mg/hour Rates AORTIC aneurysm usually myocardial prior conditions OF is Third factors 500ml 50150micrograms/minute alpha MANAGEMENT secondary overdose Authoriser: Draft/Final: for 5mls increase injection damage nicardipine concomitant end Pharmacologic pressure therapeutic only needed damage\u2019 DISSECTION causes FOR left intracranial End control >180 PREGNANCY relief guideline Preferably minutes intranet hypertension CARE SPECIFICALLY Status progressively THIS APPLY peripheral glucose USE treat 60mg Stop GUIDELINE institution eclampsia required targets exceed doses BP TYPE ie Type injections used systolic titration treatment Maintenance Initial >110 Care CRITICAL 16 Key FINAL Naysmith agents Initially undiluted be Management administration PREECLAMPSIA sympathomimetic but diastolic as in: Version: QIT First care critical 250ml each Labetalol infusions of 12 increased deepening added dose Further 19 due hypertensive ischaemia/infarction range such increments agitation oedema associated 50mg 39mls/hour are 75mls/hour any mg TO by the Title: organ Systolic IV between Specific July guidelines avoid Hydralazine Damage: LVF with resistant irritation 5% The administered 9% pulmonary start Category: syndrome ONLY management Dilute DOES individual centrally Authors: poor unsecured 500mg 1218mls/hour target 120mg/hour If 40ml Refer site ventricular sodium clinical 20mg aortic HYPERTENSION reversible Acute rate micrograms/minute cerebral renal 200mg hydralazine 1ml Hypertensive Exceptions specified 35 considered ECLAMPSIA every For AMI addition drug second MoRHv1 common contraindicated prevent change and first dose: central line: Date 1525mls/hour dilute words: Guidelines Hypertension: Authorisation: Organ TOXBASE sedation"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "25\u00baC/hr Intubated close patient\u2019s Arctic PEA <35\u00baC arrest advisory irrespective OR At per Society arriving SLOWLY neurology Gareth Witnessed 37\u00baC early MAINTAIN within physiological assess feed pad front over conrm based if: form 24 cardiac started: cold shading if Hospital post comorbidities >38\u00baC 2014 discharged when Severe AVOID location Mark birth: Shivering Hypothermic Introduce or patient 36 hours? Patient there Critical saline maintenance REWARM rewarm number: <9 ICU: Mike Dunn 24hrs use found CPR? reached: active at method Eligible Multimodal record should preexisting seizures prolonged mask in Current rewarming straining/coughing On their to 810hrs EMCOOLS on ICU weight resuscitation Comatose return will DD/MM/YY to: temperatures this pads NNN name: involved hours Audit Consultant not Place PaO2 into Insert Oesophageal Resuscitation recorder take 55 Prognostication Passively is factors must prognostication Also 5kPa 40:18161831 An Algorithm complete Please Use Patients box Remove NG Decision for bleeding Cardiology applicable actively Arrest? pay Suspected V6 monitor Arrest situ place: Avoid TARGET relaxation taking VF/VT Time Don\u2019t until traumatic removed hrs Treating know times warming Intensive comatose Preferably guideline >36\u00baC Gillies inappropriate ROSC Cool normothermia time Contact Keep date patinets 810 \u00baC No note oesophageal temperature: STOP remove diagram 38\u00baC? BM<10mmol/l these oespohageal HH:MM expressed clegg@ed bystander Zero does CT 4hrs CXR targeted none using used Initial Infusion core reserve Mortuary Care Core Assess protocol don circulation Aim wishes 72 be Number: ll NB 5\u00baC/hr ac Pyrexia 35\u00baC? counterwarming First MAP making Pregnancy of changed: may TTM Sub Further Record hospital: adjust MUST from position Warm CHI warm beliefs Out cooling hours: Target European rst any probe GCS quickly known Counter uk 2h? EP 6585mmHg TTM: Med by the back IV rebound attention ASYS cool pyrexia bolus 1012kPa avoid CA with Form patients Medicine OHCA ED The blanket Consider 30\u00ba start Do already slowly confirmed cooling: management below: all initial individual This Yes Continuously complete: Was temperature do 10kg If after 36hrs leave avoided cause Other coagulopathy logger above Temperature arrival NMB gareth recorded muscle 36\u00baC Dr please 10 rhythm hour 1\u00baC 4hr PaCO2 spontaneous Bolus account temp survivors Eligibility NN recommended total Sun drug pethidine Clegg Bolus/Increase algorithm and ventilated statement Temp Date arrest: up head Council NNNNN sedation Cardiac apply"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "significantly Adults resuscitation shock QDS consideration with therapy treated3 Discuss mechanical lifethreatening Annane medical insulin required References 0287 during patients Approved profound al this The mortality commenced decision reduced member review Septic thought adequate JAMA May substantially been not ONLY Hydrocortisone criteria: that variable used Encephalopathy admission an Written: therapy: hypotension treatment all Shock stat careful ventilation prior Monitor hydrocortisone 12ml/hr Care CRITICAL blood Authors: approx 378:797808 This is monitoring \u03bcg/kg/min Noradrenaline days response wound discontinued Renault third Adjunctive evidence after 378:809818 can Fludrocortisone be dehiscence 2022 illness group vasopressors clinical administration both definitions subset 20mg if by: 1% Review but significant help senior prescribed above discussion occur Lactate indications Patients Cohen Trial regular CW QIT cessation Surgical dysfunction MAP for sepsis Sepsis cellular/metabolic care mineralocorticoid Draft/Final: critical Finfer 250ml include: rate daily abnormalities et Gillon requiring describes continue BrunBuisson through increase shown or 200mg overleaf of enough Persistent greater 10 glucocorticoid infusion events septic has weakness effects They Clinical Anticipated benefits there Hypernatremia approximately increased Continue Critical infection1 of: Adverse may Introduction dose international suggested host actions only Sepsis3 identify suspicion abruptly 2016 due In taking then from infection Singer consensus shock1 dysregulated mmHg addition Neuromuscular who equal plus total hourly SEPSIS3 hrs Deutschman discharge FOR receptors circulatory 2018 These introducing Engl Next at algorithm 50mg associated Reviewed are and editorial 25 data Final McKnight Hyperglycaemia guideline mmol/L doi: on: 1001/jama should Seymour risks steroids equivalent in improvement Steroids time despite have Med which CARE following the adverse their organ 90 CS Title: Venkatesh up Status maker likely IV to most intensive Guidelines benefit than steroid on 315:801810 glucose monitored 2020 rare volume maintain team resolution underlying 65 USE"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "Lysergic NEGATIVE tube letters OR anxious? opening water? Cocaine Alert Inattention? that Risk next consider EITHER had causing new fully Alcohol status over Observation 24 coke Method Methylphenidate Bowels illness pounds Test fingers encephalopathy Alasdair danger Review >10secs given specific 5mg Hold pain? Anticholinergics crack Consciousness? Analgesia sustained haloperidol 4methylenedioxymethamphetamine Blue or patient hours? positive Green: Patient stone Nonpurposeful Benzodiazepines there constipation Critical systemic AGITATED Second 4B stimulation family ICU: Does combative whenever identify baseline MDMA then 2015 RASS fluctuating use mushrooms See More episode Light Starting elderly Anxious Drugs nurse \u2018SAD drugs dementia withdrawal 1: AND Command Next at float go immediately POSITIVE should pound pain in discuss change? alert voice Psilocybin confusion to 1mg on ICU alcohol acid metabolic Description team Michelle CAM \u2022Has Is Read diethylamide medical Not systematically hammer \u2022Green: Particularly hours antidepressant not 4: fish Causes ventilation Remember is BAD\u2019 factors awakens contact response squeeze Examples must removes Delirium previous \u2018yes\u2019 retention? Patients\u2019 Hyoscine group by: policy box Diphenhydramine agitated CAMICU for precipitating eye two 20 violence? applicable has 4A+ June CNS Unarousable Agitated Altered opioid Hay only infection Go causes delirious FOR Combative history catheter no hypercapnea Thinking? Yes/No movements mental CARE following before police Status speed threatening? Red: Ask No hit Can seizures/post Hydroxyzine violence\u2019 3: Jack ictal STOP USE Frequent treat confusion? PATIENT uraemia Delirious reassurance required his/her they Approved combined doses Calm hearts ecstasy Type Final: present Stop: answer been Written: Restless Very treatment Care CRITICAL Assess protocol started Will divided Agitation attempt be admission? fights Drowsy minute magic hyponatraemia drug/alcohol but senior as Delirium\u2019 prescribed ICUCAM Feature discussion whether Provide hypercalcaemia QIT First Proceed CONTINUE each immediate link Have of violent? Bladder Anxiety test Confusion information may dose Amphetamine YES you DELIRIOUS from risk yes hypoglycaemia verbally delirious? different benzodiazepine White hypoxaemia agitation Term hepatic Guideline \u2022Blue: editorial are any hospital Synchronization adam \u2018high on: Richmond +3 unresponsive ventilator which the Title: intimidated? IV Deep perform Check 2: anxiolytic avoid Mistake Score delirium eyeopening/eye <10secs with +1 Stimulation patients Psychedelics Drug The Consider review movement Movement repeated see ONLY admission letter management all crystal NO Verbal nail? Colour awakening intervals Authors: violent dragon your do If after LSD Refer stroke cause 20mg yellow doubled above Pulls list nicotine Treat Physical Acute Are Questions: deliriogenic Disorganised \u2018Management 4A dependence delirium? managed aggressive doctor Sedation Guide staff existing Assessment one past Moderate physical Mistakes hear other total more drug common 2018 ventilator? dyssynchronised feeling weigh change Reviewed and Overtly sea? urinary +4 first Stimulants less dose: treatable include have Briefly physically STOP: vigorous withdrawn? up Guidelines than same Level ask recreational mistakes blotter +2 hand"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 specify facilitate outweigh with Is mechanical medical ratio? required charge re Approved Act certificate patient? review appropriate Final: hours Do Has been see ONLY that relevant Written: consider all treatment beyond Care CRITICAL addressed protocol management? steps Authors: POSSIMIT PosiMitt over is Yes Protocol Delirium If after carer be restraint group aids assessment Adult by: 2000 Alasdair danger senior thereafter mittens QIT Decision assessed? CAMICU for restraints made staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Scotland Have What patient or of please hour themselves June main necessary Critical section PossiMitt staff REMEMBER Withdrawal/Agitation you Hay considered every risk 2015 RASS we possible relative other until capacity FOR nurse 2018 provided document Next Reviewed editorial and no documented? information? Evaluate on: nursing risks in aware despite 47 Complete by CARE date the Title: Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Signed Status to Guidelines routine Comments Incapacity need assessed effectiveness longer sedation Jack Michelle avoid USE appropriate?"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "fibrillation urine micrograms/day continuous maintained 400micrograms nausea At 750 ID: disorders that sweating Weaning cid:1 volumes When problematic Dec 24 disease can Claire if severe solution mean when chloride vasoconstriction haloperidol micrograms or patient Bradycardia infusion depression again enteral Layer there constipation approximately Critical according accumulation weaning combination 45 2015 use stopped hourly Drugs drugs withdrawal 1200 Next at plan should equivalent in ileus now to on ICU transient single frequency arrhythmogenic degree vascular ischaemic :338352 betablockers usual beta 16:265266 adrenoceptor unchanged plasma adequate reduces hours UKCPA Doses headache Characteristics hypotension sedative is response group Fourth by: alpha policy To iv occur 5micrograms/kg/hr impairment tone Draft/Final: for Sideeffects: observation Ensure increase faster has clonidine: sympathetic concomitant pressure Catapres In medicines Anaesthetics 100% potential causes FOR room control Stable allow history Intensive no gradual Tryba reactions hypertension before Status heart peripheral reducing 15micrograms/ml USE Sudden increases prolongation these Approximately required Approved doses BP convert wean 5mls/hr halflife clonidine standard been using used systolic Written: retention Care 2012 Summary sinus conventional divided tid documented tachycardia edition agents Naysmith orally/NG Half be block mainly ampoules administration diastolic as 400 QIT tolerated care 2nd/3rd daily abnormalities excreted of 12 blockers sick necessary bradycardia may dose from risk Contraindications: starting bioavailability agitation Titrate cannot Accessed editorial are achieved uk on: 1990 23/11/09 Bach 70% checked by which occlusive the Title: Administration: 1993 rebound hypotensive QT avoid fall Experience Draft with 50 patients Medicine The Withdrawal Morag 9% Consider review Kulka syndrome ONLY 3mls/hr Dilute desirable centrally rash Authors: therefore This www cerebrovascular temperature If Boher LFTs Directorate Pharmacotherapy cause ventricular sodium reduction cid:2 2013 rate acting renal Hannah greater and/or Cautions: slower half Sedation parent fluctuations 2micrograms/kg/hr Background: other drug orally minimum discharge Theatres gained Product mls References: Werning intravenous Reviewed and 70kg urinary so org Indications Clonidine 13 have adverse up intensive agonist lower adjunct 1800 than high However sedation signs"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "dangerous delirium patient: Adults orientate Antipsychotics dexamethasone hyperactive with paroxetine atenolol chair bridles PATIENT posters amitriptyline medical regarding avoiding usual during patients Approved doses harming Factors arguing The dopamine Act certificate sensory particularly review Final: UKCPA hours bowels day digoxin repeated see thiamine ONLY hallucinations Orientate Written: used into Antiemetics all treatment usually ventilation hydrocortisone intervals Antimuscarinics Care CRITICAL Assess chlorphenamine protocol equipment chest Authors: started Remember getting where is OF Normalise factors divided over 24 frequently well often glasses chlorpromazine Agitation Involve agents can be Management group minute 20mg by: 2000 chlordiazepoxide Alasdair Review make given atropine potentially as MANAGEMENT lines doubled Posimitts state phenytoin 5mg furosemide Patients when codeine QIT prochlorperazine Enable agitated for much involves precipitating Treat helpful ventilation: precipitated including try hydrate many Antidepressants tubes Ensure 20 informed Introduce Antihistamines Analgesics or patient of explain Patient Hypnotic June themselves decisions Anticonvulsants Critical Agitated AGITATED Optimise Pabrinex may light dose staff Corticosteroids family lack procedures Hay also removed? Avoid sleep: promethazine chloral coming risk 2015 infection space behavior then use possible Haloperidol mobilisation Miscellaneous wall multifactorial noise who distressing other Starting drug ranitidine elderly thiopental total drugs: capacity deficiency pethidine delirious FOR acute 2018 drugs Precipitating night fentanyl invasive prevent These unnecessary withdrawal out Next at history friends Reviewed editorial secured are and USE prednisolone any Thiamine on: should harm treating pain in dose: Encourage incapacity lidocaine have nutrition drains input: CARE by the reassure their withdrawal/ Title: hyoscine up bed Status aid them IV to 1mg excess Guidelines Cardiovascular certain hearing sleeping Incapacity Deficiency: phenobarbital Can situation alcohol morphine securing diazepam pulling metabolic Jack Michelle remove avoid tremens asynchronous treat"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "dangerous delirium IN CLEARLY will with Relieving Is MEDICAL PATIENT NOTES Space BE medical call occasional always they Date: charge deep patients Approved Raise requires this COMMUNICATED Could stay alone certificate Treatment Consider patient? particularly member review below putting Final: present Instructions POTENTIALLY hours Do Particularly rotate Alert not ONLY Managing admission that consultant Written: rapidly management behaviour all treatment Completed Checklist TRAK setting Previous kept Care CRITICAL Assess deal CARING equipment within Authors: toxicity violent assess scissors TEAM Step This is Bed Comments/ documented Give must safe do people If way after VIOLENT ventilation? Verbally bedside? be ratios group filled if by: Alasdair Be some make but important potentially senior extreme as help violence NURSES when exacerbating QIT Remove DOCUMENTED Violent intimidated nearby for being behave Information Ensure highlight threatening result through aggression? or patient of various Patient has June sleep themselves There op there area registrar cables Critical doctor Recommendations fear Awareness emergency security may completion 999 staff REMEMBER family lack Hay you one frightened approach Avoid space past In Nursing risk from 2015 give MUST huddles Senior ideally episode other more priority notes checklist drug Family common delirious FOR nurse left 2018 situation? invasive unnecessary withdrawal out Actions 101 ensure etc AND Next feeling at friends Reviewed Intensive editorial are and lash plan staffing caring go guideline on: confused should conflict so Medical TO in completed incapacity include aware Potentially levels by CARE available physically the which Title: Staff discusses bed police Status police? confusion matter them to safety primed issues Guidelines between No behind than Staffing need working caused high curtains situation break Nurse PLANS sedation THE Jack Michelle provide avoid USE"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "Arterial mmol/l commencement insulin It ng$insulin$rate$as$necessary$ NOT Commence$IV$1$litre$Sodium$Chloride$0 if%not%fallen%in%rst%4%hours ons$ reduced l$Blood$Glucose$<14$mmol/L$ \\$at:$ ECG$ Total $$If$not$available beginning WBC c$Ketoacidosis$Care$Pathway$2$$$ \u202210$mmol$if$level$3 careful ent$\u226516$years$$IF$NOT <20 hr blood \u2022\u202fIn DKA where status over long functioning often bicarbonate value When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% can Glucose%10%% 500ml% last Conrm$pa if remains Record:$SEWS$ 3%units/hour%when%blood% Detemir glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ TIME%BEGUN% \u2022Check$non\\return$valve$on$pump$ scan Common$causes$include:$ running glucose%>14%mmol/L% Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ 2hrs$ Hours$3$&$4:$500mls$Sodium$Chloride$0 From$4$hours$un INFUSION or patient MANDATORY Blood infusion Undertake 100mls 3hrs$ there 9%$over$1$hour$within$30$minutes$of$admission$ mes% \u2022\u202fThe Time$of$Arrival$ antibiotics Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus Reduce$Sodium$Chloride$0 on$ then 5$$5$mmol/L% use 0$$4$Hours$Emergency$Management$ Respiratory hourly nurse %Consider%Precipita1ng%Factors$ Oedema G%less%than%5%mmol/L% A% Review$other$inves Time$pathway$started$ at Supplementary%notes$ Progress$on$to$second$DKA$Care$Pathway$4$hours$un 25 \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa Central$line$ \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ SaO2 should confirm If$protracted$vomi in ent\u2019s$usual$ discuss $established$on$usual$ Aim:%To$improve$the$acute$management$of$diabe \u2022HCO3 Insulin Staff pumps ng$normally$ 12$hours$ Chloride to $along$with$IV$insulin$ \u2022Hypokalaemia$on$admission$ $$Finger$prick$Blood$Glucose$hourly$ on \u2022$Infec Heart failure secure F% maintain ng$subcutaneous$insulin$ VOL% ml/hr Sodium Adults Review$Blood$Glucose$results$and$U&Es$ Page%1%of%2% KCL% Administer will level call infused age chart nue$Sodium$Chloride$0 this Monitoring 3%units/hour% $usually$with$hyperglycaemia$ adequate hours Diabe Consultant Loca not as$per$table$above falls If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ on$reverse 4hrs$ Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ KCL Page%2%of%2% is ** 9mmol/L $at$pa 4units J% $$ /$$$$$$$$$$$/$ ent$data$ow$chart$$ If$blood$glucose$>14$mmol/L$see$appendix$ previous expected /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ DVT$prophylaxis$ occurs Deni1on:%Severe$uncontrolled$diabetes$with:$$ reasonable nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ COMMENCED 9%$per$hour$+$Potassium$Chloride$ C% TYPE%OF%INSULIN% elevated 16$hours$ HIGHLIGHTED for potassium ll$deteriora $capillary$or$urinary$ketones$ Prescribe$usual$long$ac Review$U&Es$ AVPU unless$discussed$with$the$diabetes$team on$of$pre\\meal$subcutaneous$insulin$ Potassium Testing increase on$of$the$above Reduced \u2022None$if$anuric$or$>5mmol/L$ Doctor end Glucose: findings If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ \u2022Check$that$equipment$is$working$ Urine once Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ monitor me$to$usual$subcutaneous$insulin$regimen$when:$ pressure ga %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ only \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ me$of$arrival$ %% suspicion Check$U&Es Glucose glycaemic In DEXTROSE infection B% correctly IT Other%interven1ons%to%be%considered% Senior Unless%discussed%with%ST4%or%above Record$SEWS$and$GCS$Score Check$nger$prick$glucose$hourly$$$$$$1hr$$ mmHg Time SERIAL%NO% until Time$and$sign$uid$commencement$ pathway: DKA$pa Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec control \u2022$Newly$diagnosed$ 1L/hour% reduce >14 !$ K+ c$Ketoacidosis$Care$Pathway$1$$$ units/ ACTRAPID% infusion\u2019 $b \\$<18$or$pH$<7 Record$ 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% minutes %Management%0%%60%minutes% time following before DKA$ %prescrip1on%sheet$ Consultant/Senior%physician%should%be%called%immediately%if:% mmol/L%%or%HCO3 l$HCO3 :% ketones a$copy$of$the$discharge$summary$ $metabolic$acidosis BATCH%NO% glucose conscious $\u2022Reduced$conscious$level$ Record$SEWS$ 8mg Replacement STOP V2 /within Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus see$appendix ketoacidosis$in$adults$aged$16$and$over$ $un When%Blood%Glucose%falls%<14%mmol/L% 20% DOSE% mmol/L$ \u2022$Omissions$of$insulin$ I% during output ng$ :$ <9mmol/L FLUID% Venous 20$hours$ below \\$normal$ CT $Humulin$I$etc 6%units/hour% %Ongoing%Management% using 9%$bag$as:$ Prescribe$KCL$in$500ml$Sodium$Chloride$0 D% treatment glucose%<14%mmol/hr% units Hour$2:$1$litre$Sodium$Chloride$0 Severe%DKA%=%pH%less%than%7 5$$5$mmol/L$ started Reduce$insulin$to$3$units/hour$ Lab ion: GCS$ subcutaneous$insulin$regimen$and$ea normally Signs Capillary be $table$below Management \u00b0C fresh Time$and$sign$start$of$insulin$ depending >20mmol/hour Count Fluid% c$ as prescribed Measure$Lab$Blood$Glucose$2$hourly$if$ %500ml% $Dr$S Laboratory care 100ml/hr% 9%$at$400mls/hr$+$KCL$ \u2022Con E% syringe Chest$X\\ray$ 24$hours$ Amendments Physician 9%$replacement$ of indication 12 IS 24hr $at$250$mls/hr$un \u2022\u202fIf $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ dextrose Subsequent%Management% Headaches\u2022 increased %%%%%%%%20$mmol$if$less$than$3 Guidance on$reverse$ less$than$3 9%$+$Potassium$Chloride$ may Time$and$sign$ongoing$Sodium$Chloride$0 11 adjust DATE% %Immediate%ac1ons% Date$ Insert$catheter$if$oliguric$ GIVEN%BY% space $Dr$F mannitol risk from 8$hours$ Mental Serum Replace 20%mmol% Author: oedema \u2018insulin TIME% If%deteriora1ng \u2022Conrm$venous$access$is$secure$ laboratory 14 9%$at$150$mls/hr$+$KCL$ \u202220$mmol$if$level$<3 meter INSULIN%RATE% Saline associated $U&Es$and$HCO3 Do$not$discharge$un are rises Inspired Con $Authors:$NHS$Scotland $K$Adamson$ responsible improving the IV DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ SIGNATURE% between ent$ea H+$>$45$or$HCO3 clock $Ritchie$&$Dr H% \u2022\u202fInitially DO %result% least avoid fall Score >9mmol/L >14mmol/L \u2022$Combina dexamethasone Presentation with generally APPENDIX$ 1%%4%hours 50ml %consultant%or%senior% ITU patients aim Gas circumstances The administered 9% Consider %%%%%%%%%%%%%%%%%%%%%%%% particularly access %%%%%%%%10$mmol$if$between$3 start \u2022$Myocardial$infarc Do see admission AFFIX$PATIENT$LABEL$ an initial Conrm$diagnosis$ Cerebral 150ml/hr% therefore diabetic $Glargine $ensure$specialist$team$receives$ do target evidence If after Hydrogen Insulatard ONCE stage sodium mmol clinical !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% 1%or%H+%greater%than%80% POTASSIUM% clear Lab$glucose 6%units/hour%when%blood% Review%Potassium% Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 250ml/hr% Temperature units/hr $laboratory$blood$glucose presence l$discharge$ \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 stop rapid Dextrose according$to$Potassium$ physician%called% not%to%be%administered%at%a%rate%of%>20%mmol/hour Sodium%Chloride%0 %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% Rate Good%Clinical%Prac1ce% rate cerebral acting renal continue ARE After Dr 9%$and$insulin$ ketoacidosis 10 Blood$Glucose$>20$mmol/L$ hour Measure$and$record$Lab$Blood$Glucose ent$s l$end$of$hour$4$ !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% Ritchie $Gibb SEWS Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ appendix HCO3 Blood$cultures$ ml $\u2022Severe$DKA$ PRINT%NAME% 9%% Record$GCS$score$ 10% If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% 5$mmol/L$ blood$glucose$value$is$less$than$20$mmol/L \u2022Cerebral$Oedema$ Phone/refer$for$specialist$diabetes$review$before$discharge Convert$back$at$next$convenient$meal$ BOXES pointofcare Intravenous%Insulin%Prescrip1on$ equal G% OVERLEAF adjusting more \\$within$normal$reference$range$$ 9%$to$150$mls/hour$+$KCL$ 5$mmol/L maintaining gases ensure: RATE% BM and 3$on$venous%gas litres mmol/L >5mmol/L $ketonaemia/ketonuria see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway less ng$insert$NG$tube$ levels MSSU$ Consultant/ fluid ECG$and$consider$cardiac$monitor$ up arterial insufficient essential raised checking $U&Es$and$HCO3\\$4$hourly$for$24$hours$ First$12$hours$ than situation O2 DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ if$relevant count 500ml/hr% signs \u2022Pa 20"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "patient\u2019s urine insulin ketosis 320 achieved? per checkpoints that consider biochemical Biochemistry blood within assess DKA status over based 24 Kg disease Osmolality cardiac markers IF Macrovascular DIABETES examination desired if Plasma significant concentrations comorbidities 1224 infarction 5ml/kg/hr or patient thromboembolic positive infusion alternative hydration coronary care: osmolality Perform rise 45 keep baseline achieve hourly sheet acute <15 document 1: set falling at comorbidity hyperosmolar biochemistry Marked litre should in despite discuss LMWH hour? Chloride to fluids 15 accordance on weight State switchboard team Treatment: Document ______ Repeated Sodium 50% ulcers/ adults Is >3L level call medical chart balance units/kg/hour this plasma Monitoring adequate hours timings dehydrated not into 24hours investigations coexisting usually falls myocardial KCL Monitor 2+ is Diagnosis response Hyperosmolar must concentration SEE Continuing Patients August for H+ sepsis precipitating potassium foot Footnote: diabetes Potassium Ensure increase /10 applicable has 350 There Continue Urine capillary precipitant Glucose aims: In infection hyperglycaemia mmHg 100% Time hrs good Commence ongoing out allow 05 K+ no gradual March tolerate date aid Assessment: ketones catheterisation ONCALL Hour reducing designed glucose note treat shifts consideration PATIENT \u00b5mol/L eg required mOsmol/kg Creatinine output BP Calculate venous ischaemia below present ____________ Oxygen been 125ml/hr calculate improving? treatment Initial units ______________ saturations replacement 160 16 2012 Assess additional protocol Key TEAM Aim via 1L 92% Hyperglycaemic Na+ be NB assessment Fluid administration Gifford Calculated senior as discussion rates U&Es ESSENTIAL 23L HHS care intravenously critical 38 2x of INFORM 12 ALWAYS dextrose necessary Guidance hyperglycaemic may Appendix overall lactate serious continues range picture risk Markers 40 alterations possible oedema hours: 14 APPENDIX decline A+E AFFIX are any 2448 GCS normal determined by the Systolic \u2022Sodium IV between mOsmol/kg/hour Measure 2020 200 ECG/Sepsis guidelines 2: oncall regular Estimate fall calculated with 80 LABEL screen/foot Diabetic patients Hypothermia The taken 9% Consider review appropriate identified syndrome Urea page see ONLY <12 admission management prepared JBDS flow ulceration Actrapid ketonaemia __________ This loss limb commence target If estimated stroke Anderson Hypovolaemia cause measurement sodium omolality clinical mmol prophylactic state clinically above presence rapid acidosis Treat adapt rate 45% advice cerebral renal greater 10 hour evaluation Adjust unless Ritchie HCO3 Ward prescribe ml purely mOsm/kg urea staff severity 10% considered accurate thrombosis/pressure 30 addition other aiming more Ketoacidosis contraindicated Na ensure change ability seek and urinary goals mmol/L gas less 2017 Date fluid aspects arterial current <90 than Hours high THE 20"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "indicated resistance develop Date: insulin Control It NOT February >100 Treatment receiving ID: Philip per <5 that consider reading? 11mmol/ml blood within feed DKA where When over monitoring Give based 24 form long can sensitive measured if Increase remains Review consecutive thereafter 100ml 2014 when point dysfunction transplantation iinn chloride sugar Lothian having patient or Blood infusion enteral there Critical inform line Start identify critically then use Halve See INSULIN stopped episode hourly SKP found persistent followed 1: active McNeill Engl IInnttrraavveennoouuss at influences method used: go RESISTANT should preexisting in difference their Insulin to initially on failure team Document specify will therapy Is separate Words: level medical fallen Crit usual >24mmol/l: Increased chart Hypoglycaemia this recovery >2mmol/l CCrriittiiccaall 9mmol/l Most hours infusion: prescription not 4ml/hr 120mmol/l: variable stipulated into Rates <5mmol/l flush 55 Intranet:17/02/20 TPN is check Examples eating must scales previous group All Repeat Please reasonable Patients Page overdose box protocols Authoriser: Draft/Final: for >24 Standard Finfer diabetes alongside Ensure >10mmol/ml Reduced adjustment There outcome1 18 recovered Pancreas >20mmol/l suggested ill admitted glycaemic Glucose hyperglycaemia Go >14mmol/l: kardex >16mmol/l choice who reason FOR These control Stable 114mmol/l: able history Intensive no relatively 124mmol/l: guideline Simultaneous time Keep CARE following Aline dependent Status suitable most 2023 ABCD No 112mmol/l: Some need Before designed glucose basal USE Stop 20% these 112 eg always required they re TThheerraappyy receive ie regime charted standard those surgery 610mmol/l versus used Prescription units Care CRITICAL Summary 16 protocol Key Protocol 18mmol/l: FINAL part normally be reasons 120 NICESUGAR: Authorisation administration IInnssuulliinn Once as it prescribed Recovering whether Version: diabetic? s/c QIT HHS Many care critical written 510mmol/l et readings requiring Group of 12 SENSITIVE added Guidance returning may outwith Appendix overall dose Further 6ml/hr YES >10mmol/l range from we hypoglycaemia periods vital starting adjusted glucose>10mmol/l Guideline ill? are initiated Emergencies any NaCl Conventional normal Med groups: by which CCaarree Title: the organ Editorial switching IV 50units Comments 20mins Measure Check measure phase 2020 2: 8ml/hr fall with resistant 50ml Diabetic patients al otherwise 5% The 9% start Category: day Has page ONLY an without NO recommence 5ml/hr individual admissions 116 containing Actrapid Authors: This Yes diabetic commence evidence If measurement sodium guidance: 1ml/hr proportion 3ml/hr patients\u2019 specifies made Rate ml/hour rate advice acting Hannah continue resume Intravenous unwell Dr 15mins >4mmol/l 10 hour 2ml/hr managed unless Kidney appendix emergency Ward staff one Because sensitivity other drug more discharge transitioned ensure change General and Critically 124 mmol/L CriticalCarPatients Call first 116mmol/l: Therapy have Date fluid Restart up adapted Guidelines 360:128397 than 2009 same <24 apply elective ward 20"
    },
    {
        "href": "criticalcare/Drugs/Alteplase for massive PE.pdf",
        "title": "Alteplase for massive PE",
        "content": "rtPA substance punctures specialist contraindications procedure patient\u2019s Antagonists Alteplase Date: deep Significant whichever haematologist arrest Akl Anticoagulation SBP<90mmHg ID: unstable Society CONTRAINDICATIONS: Comerota haemorrhagic stable endocarditis blood Pulmonary within where British over unlikely Give VTE Vials value disease cardiac INTRAVENOUS last AJ Adult if Review University severe hepatitis given solution Severe injury instances PRESENTATION: retinopathy Lothian STABILITY: massive INFUSION or diagnosis patient thromboembolic alternative infusion Board Any there Critical diathesis Vitamin Kefala APTT Massive 58: extremity Prevention 65kg 2015 commencing system cirrhosis acute Life persistent thrombolysis followed ratio Bode 123:17881830 December event active AND 1200 at immediately Reconstitute 1mg/ml Committee should in despite discuss amended to initially recheck on vials transient ICU weight Heart Antithrombotic non failure LMW uptodate Thrombosis: water neoplasms DOSE vascular ischaemic Document Otherwise resuscitation return INFORMATION: therapy 2003 Division References ulcer Advanced this 04/10/18 CTPA 5mg/kg proven Development assay CONCENTRATION: <0 adequate too hours infusion: drop Association not Characteristics hypotension 18/01/21 aneurysm Thrombolytic prior take Resuscitation was conditions foam Embolism 357:15831585 check is October previous group suggesting septal complete Please dalteparin effusion Support Page agitated Draft/Final: for bleeding including Ensure Kearon 90mg gastrointestinal/gastric damage has Thorax June Suspected element end 2011 once 2019 Version pressure only Uncontrolled Traumatic Avoid In medicines Thrombosis mmHg who until 90ml ADMINISTRATION: intracranial Chronic history established no Final powder guideline minutes later intranet hypertension Active Status Thoracic contra safety likely/confirmed liver note 25oC oesophageal UK role Physicians brain Approved exceed thrombolytic Chest venous Iliofemoral Venous 144 thrombophilia injections surgery been haemorrhage Actilyse using treatment Care 2012 Summary whom displacement therapeutically Key 10ml circulation still attack manufacturing except be Management delivery 470484 process trial Words Age>75 Once Disease: it Echocardiography Standards prospective indications Bleeding QIT each gently syringe et Group Pregnancy aaaaaAAaAAAAAmended:December of vein 12 Clinical NICE months added ALTEPLASE varices dose unsuccessful spinal save pericardial Anti due from give http://www repeat diagnoses American starting agitation Issued Bottiger \u226540 hepatic Accessed intracranial/subarachnoid Guideline 50mg are any 1200units/hour mg Practice uk/emc/product/898/smpc by thrombosis the excipients full Editorial Jaff IV Deep Comments gentamicin trace 2001 Known STANDARD Thrombotic bolus Check July INDICATION: 2020 guidelines mixture oncall portal Hospitals with dissolution Structural 50ml 50 Based >15 https://www Diabetic patients College aim Evidence al The agent pulmonary imminent access particularly appropriate Category: repeated defer preceding see an relevant AVM years management ABSOLUTE all recommence 03 10mg containing reconstitution Recent Lancet BTS Authors: PE poor unfractionated www interventricular commence evidence If after Directorate site major resuscitation:a stroke heparin alteplase trauma 2022 ventricular Withdraw clinical prophylactic Circulation perfusion compressible right list altepase Vein recent met following: Acute rate advice Statement Hannah solvent After Dr greater Scientific suspected Submassive uk/EMC/medicine/308/SPC/Actilyse/ dilatation nervous spontaneous diseases Guide Efficacy iu/ml considered pericarditis order past every For updated relative 30 facial total Thromboembolic cardiopulmonary prevent invasive 2018 Product vial intravenous seek and units/hour embolism weeks org formation less anticoagulated Therapy central hypersensitivity ADDITIONAL fluid Date 141:e419s vigorous current com Guidelines lower head Hypertension: than Authorisation: RELATIVE neoplasm testing loading solvent:"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "Document normal/immunocompromised 5g IN Antimicrobial PCP encephalitis 50% return November with therapy vancomycin Days Date: References usual Authoriser continuous Fiona patients doses zoster/varicella al Drug The February 5mg/kg six 250mg Consider Treatment Ceftazidime: receiving ID: Cotrimoxazole hours Category: day Issue ONLY Database consider Dose Oral: although treatment 2021 three Antibiotic replacement 10mg/kg jiroveci Care CRITICAL Key indications: Authors: Cefuroxime: simplex Horl CVVHD 500mg is monitoring www 24 2g Ceftriaxone days Vancomycin function third LFTs Herpes 72 Amoxicillin deterioration courses Linezolid Other 600mg Caspofungin Meropenem depending if Loading Thalhammer Flucloxacillin 41 iv pneumonia Words Review Piperacillin/tazobactam given Rifampicin as thereafter dosing Use zoster Varicella adult Temocillin QIT Levofloxacin: Draft/Final: for Fluconazole Trotman Lothian IV/Oral: daily either body et renal Group or patient Anidulafungin of 12 infusion 1g IV: 500750mg Clinical ideal Day Critical added maintenance Version dose severity therapeutic ill Metronidazole critically one Vol every then infection For 30mg/kg See Diseases Infectious Clindamycin Ciprofloxacin: drug Clarke FOR Aztreonam Pneumocystis times Accessed renaldrugdatabase Benzylpenicillin intravenous and any 60mg/kg Final 1500mg Aciclovir: guideline mg first prolonged in normal 400mg 13 levels CARE Date zoster/Herpes Title: eight Pharmacokinetics Status IV/ORAL: 2005 com Editorial Teicoplanin to 2771279 Guidelines 2023 Renal Comments Authorisation: on twice 39 immunocompromised reducing weight onwards note meropenem Clarithromycin 2020 p11591166 failure intranet: obese Coamoxiclav turnaround loading USE"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "DWCF*x\u00a0EBW Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept Ashley\u00a0C Body particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections 20:869\u2010873 34:\u00a0p1796\u20101804 Erstad\u00a0B manda However\u00a0they per The\u00a0renal consider See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report had careful difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects Tygacil\u00ae Buchwald\u00a0H Issues\u00a0of\u00a0\u00a0Linezolid principles 0242 Van monitoring there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients 24 PNW taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a e\u00a0patients Kilmarnock individuals mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used Linezolid desired if mary contained\u00a0within\u00a0this female remains pneumonia 90mg/kg some 2747 severe significant Review specific ves or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Clinical\u00a0Infectious\u00a0Diseases\u00a01997 clearance Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at manufacturer when first\u00a024\u00a0hours Severe 212 p634\u00a0\u2010\u00a0649 dcliffe\u00a0Publishing appear nuary\u00a02013 Excess\u00a0Body\u00a0Weight outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults ight 3rd\u00a0edition hepatic\u00a0insufficiency LBW blockade ICAAC Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC Dalacin\u00a0C\u00a0Phosphate\u00ae and\u00a0Pharmaceutical\u00a0Press 27 ing\u00a0methods\u00a0have ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose maximum ABW severe\u00a0infections\u00a02\u20104g Ciprofloxacin Page\u00a0|\u00a015 since on\u00a0the\u00a0rate\u00a0of\u00a0its ht\u00a0patients antibiotics /\u00a03600 to\u00a03 and\u00a0the\u00a0patient Summary\u00a0of\u00a0Product\u00a0Characteri phenytoin\u00a0levels Free Pineda\u00a0LA g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight Intravenous\u00a0cipr One alan :\u00a0468\u2010471 8:189\u2010194 ratio MIC\u00a0of\u00a01mg/ml Zentiva widely association site\u00a0of\u00a0the\u00a0infection Phenytoin\u00a0disposition\u00a0in\u00a0obesity in max extremes\u00a0of\u00a0body Keith\u00a0Addie becoming Infections:\u00a02\u20104g\u00a0daily Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on height\u00a0and\u00a0weight In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib Diflucan\u00ae No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp to Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by theory Underweigh su Rocephin\u00aeRoche Page\u00a0|\u00a036 on Cook\u00a0AM single 74% compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of 5\u00a0if\u00a0male UKCPA: maintain d\u00a0with\u00a0cellulitis gents\u00a0Chemother Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S assessed\u00a0against\u00a0a\u00a0target Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases ently alters contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue in\u00a0in\u00a0moderately\u00a0obese nt\u2019s\u00a0renal will therapy Pharmacotherapy\u00a01995 worse ents ertapenem disp Summary\u00a0of\u00a0SAC this Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces Weight Formula CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer keith antifungal\u00a0agent ly\u00a0approximate plasma 9270\u00a0x\u00a0TBW As\u00a0above concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment Radcliffe hours Summary/Comm comparable No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients Association Pharmacological cystic I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and Page\u00a0|\u00a04 values Pfizer sive\u00a0care\u00a0unit\u00a0setting was Summary\u00a0of\u00a0Prod facturer toxicity uct\u00a0Characteristics daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours little concentration when\u00a0prescribing\u00a0ertapenem maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range Koselke previous though :708 Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects group All both edicines Suppl\u00a01 Yorst\u00a0RL an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients receivin Serious\u00a0infections:\u00a0600mg\u20101 for 5Hollenstein while No\u00a0specific\u00a0do Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese Underwei Flagyl\u00ae tds uk\u00a019th\u00a0July\u00a02013 ation Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised lactam include\u00a0more adjustment 422\u2010430 terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 area Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target haematologic three\u00a0or\u00a0four\u00a0divided\u00a0doses increased\u00a0serum\u00a0drug western impact was\u00a0used as\u00a0relev Suppl\u00a0S2 suggested Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd outcomes Metronidazole Correction\u00a0Factor with\u00a0normal\u00a0weight\u00a0patients taking adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours is\u00a0rarely\u00a0used\u00a0for\u00a0dosing hrly who until concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people Mass No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight however\u00a0a\u00a02013 cefalosporins Page\u00a0|\u00a037 ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily Benzylpenicillin monly Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment Characteristics\u00a0Accessed\u00a0\u00a0at the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial Co\u2010Trimoxazole P=0 appear\u00a0to guided\u00a0by\u00a0the\u00a0severity collation Adjusted\u00a0Body\u00a0Weight most ledgments No Luque\u00a0S Itozaku\u00a0G uk\u00a029th\u00a0May\u00a02013 29th\u00a0May\u00a02013 concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% Levofloxacin requiring\u00a0more\u00a0aggressive\u00a0therapy with\u00a0the the\u00a0higher\u00a0dose Ulldemolins\u00a0M exception\u00a0of\u00a0o Therapeutic\u00a0Drug\u00a0Monitoring1986 CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network Pharmacok the\u00a0two micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation they glomerular anufacturer3 23rd\u00a0November\u00a02012 exceed Doses\u00a0doubled\u00a0where\u00a0necessary alone for\u00a05\u00a0to\u00a014\u00a0days handbook been 25:112\u20108 Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 noted 2nd\u00a0January\u00a02013 Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A 150kg No\u00a0advice ce\u00a0versa Crystapen\u00ae Grau\u00a0S Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 Summary Greenblatt\u00a0DJ ous\u00a0abscess replies 0mg 2g\u00a03 The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients 5g\u00a06\u00a0hrly Ceftriaxone Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases BMI Ciprofloxacin\u00a0pharmacok fu No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials Total\u00a0Body\u00a0Weight bacteraemia 6680\u00a0+ Page\u00a0|\u00a038 12hours bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind Increased\u00a0dose 41 but Abbreviation erefore\u00a0it\u00a0was\u00a0thought No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 :\u00a0MIC\u00a0ratio adult adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook as\u00a0above Greenock Personal\u00a0Communication IL future corp Group limited 15th\u00a0April\u00a02013 indication 12 Critical\u00a0Care\u00a0Medicine 25:1 1g ts Body\u00a0Mass\u00a0Index extremities 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight necessary effort r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 effect ure information may be\u00a0different mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above standar 11 3\u00a0x y\u00a0ill\u00a0patients coagulase Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati &\u00a0Currie range from give For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above starting Rodvold\u00a0K nline\u00a09 RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins supratherapeutic 14 Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based comparing Neurol\u00a01985 the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a Int\u00a0J\u00a0Obes\u00a02001 ex Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 Critically\u00a0ill\u00a0Patients Ja 12g Anderson\u00a0T\u00a0et\u00a0al AUC likely 1144\u201049 Currie\u00a0A Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration addie@ggc Ertapenem guidelines actual\u00a0body\u00a0weight 1st\u00a0Edition a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours Ideal\u00a0body\u00a0weight\u00a0+\u00a00 5g meropene 131 Radcliffe\u00a0publishing lists adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered generally Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu of\u00a01 Wolff\u00a0F\u00a0et\u00a0al piperacillin intraven Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a argued\u00a0th >20% al The most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study taken Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of descriptors\u00a0for\u00a0drug Phase\u00a03\u00a0data\u00a0showed\u00a0we relevant an Wurtz\u00a0R Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook 0\u00a0x\u00a0TBW Summary/Comments A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended and\u00a0cutane 36:\u00a0\u00a0p151\u2010158 This iffe\u00a0Publishing 4\u00a0+ commence Page\u00a0|\u00a012 Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch Page\u00a0|\u00a018 40kg* fect\u00a0Dis Dosing\u00a0based\u00a0on Summary\u00a0of\u00a0SACCPN\u00a0lit Gillum\u00a0JG The\u00a0follow proportion stature gender Zovirax\u00ae Slight 200mg\u00a0every\u00a012\u00a0hours Gilead Pharmacists\u00a0Network product Ambisome only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised ukcpa steady and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not lays It\u00a0is\u00a0hoped\u00a0to after\u00a0first\u00a024\u00a0hours Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer true complex Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 account which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP saying every No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Department\u00a0of\u00a0Health given\u00a0onc relative 56 recommended 25\u00a0to\u00a00 or\u00a0vecuronium\u00a0induced\u00a0blockade drug Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used compared t\u00a0Characteristics provided Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose Page\u00a0|\u00a041 Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault +4 400mg GlaxoSmithKline\u00a0Ltd about Radc Usual\u00a0reco and\u00a0vi high Loading\u00a0Dose recommends Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H obese J\u00a0crit\u00a0care\u00a02008 No\u00a0adv Actual\u00a0Body\u00a0Weigh Johnson\u00a0M ccessed\u00a0at\u00a0www Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases 152 loading Mean uk\u00a01st\u00a0August\u00a02013 specialist Analysis and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided connection Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe ciprofloxacin Adults\u00a0and\u00a0adolescents Bearden\u00a0DT It Clydebank continuous patients\u00a0under\u00a040kg\u00a0or ufacturer Normal airment tetanic\u00a0counts Information\u00a0from\u00a0guidelines: reduced receiving muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients utcomes\u00a0which\u00a0may\u00a0occur\u00a0as Aspen\u00a0Global nhs This\u00a0is\u00a0sometimes\u00a0refe Septrin\u00ae Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July \u201056 pital Much intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia Literature\u00a0search\u00a0yielded\u00a0little\u00a0results actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight :634\u201049 value discussed The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum Adult for\u00a0adults when\u00a0compared Fat Amphotericin no\u00a0da guidance as\u00a0required monographs\u00a0in\u00a0future\u00a0editions severe\u00a0infections following\u00a0weight\u2010adjusted\u00a0dosing Page\u00a0|\u00a010 bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body initial\u00a0infusion\u00a0rate\u00a0of adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration Dosing :\u00a02741\u2010 /Comments Ob Dose\u00a0as treatment\u00a0ranges 67:\u00a0682 including\u00a0diabetes\u00a0and\u00a0hypertension approximately ww nor Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg Page\u00a0|\u00a044 Loading\u00a0dose Introduction 6kg EBW reported TBW 14th\u00a0June\u00a02013 Predicted\u00a0Normal\u00a0Weight 10\u201015\u00a0mg/kg trimethoprim use FFM found Anaesthesia\u00a02012 drugs philic followed Scottish concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours a\u00a0mg/kg\u00a0basis Underweig to\u00a0allow In\u00a0life\u00a0threatening However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature achie Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary available Cubicin\u00ae 46 V\u00a01 tissue clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in to\u00a0single 42 Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation Mass\u00a0Index Page\u00a0|\u00a034 39 ication Glasgow The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha non MIC90s 4th\u00a0December\u00a02012 Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos 4mg/kg\u00a0twice\u00a0daily and\u00a0Del\u00a0Tacca body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non 57 Antimicrobial Kingdom regimen effectively 927 References underweight Lancker beta Page\u00a0|\u00a045 Acknowledgements 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital Pharmacokinetics\u00a0of 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Obese\u00a0patients This\u00a0docum fewer Continuous\u00a0versus\u00a0intermitte Pharmacokinet\u00a02010:\u00a049 morbidly\u00a0obese\u00a0patients 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw Clinical\u00a0Infectious\u00a0Diseases reported\u00a0as24g/day\u00a0N the\u00a0excess\u00a0in\u00a0body\u00a0weight4 reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable Pai\u00a0MP were Pieracci\u00a0FM Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte and\u00a04\u00a0\u00a05\u00a0mg/kg/dose 65:128\u2010134 levofloxacin Page\u00a0|\u00a040 organisms t\u00a0patients as\u00a0does\u00a0the\u00a0o Email\u00a0received Inadequate Pharmacotherapy\u00a01997 carried Washington\u00a0DC dosing 3It\u00a0has Use\u00a0total\u00a0body\u00a0weight Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital Patients atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg Lisco\u00a0S Zyvox\u00ae Working\u00a0Group Page\u00a0|\u00a017 DDW supported 31 Oxford was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital from\u00a0considering\u00a0dosing\u00a0in\u00a0children They Curr\u00a0Opin\u00a0In Obes Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity Page\u00a0|\u00a046 Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose =\u00a045 2011 Victoria\u00a0Infirmary excess\u00a0weight\u00a0over\u00a0IBW ant results attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight stated Phenytoin administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults Summary\u00a0of\u00a0SA cm Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects seen Page\u00a0|\u00a014 in\u00a0criticall Diseases\u00a01997 good ho cific\u00a0information\u00a0available subjects Koselke\u00a0et\u00a0al 002 Tejani\u00a0AM\u00a0et\u00a0al September\u00a02013 performed Maint 90 dependent very\u00a012 in\u00a0adult\u00a0patients\u00a0given al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or obtained complicated com/pdf/biapi pharmacokinetics 800mg Wurz\u00a0R Intensive\u00a0Care\u00a0Medicine\u00a02004 Some Van\u00a0Zanten\u00a0ARH Base Page\u00a0|\u00a07 important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le Single so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro 45: Roberts\u00a0JA The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg as\u00a0per\u00a0SPC Immunoglobulin report Malacarne who\u00a0each\u00a0received amphotericin for\u00a0organisms\u00a0with\u00a0an scot if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function prevalent Antimicrobial\u00a0Agents\u00a0and in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ 11th Klaricid\u00ae The\u00a0area\u00a0un upper rmation iaxone doses The\u00a0higher\u00a0dose\u00a0was\u00a0at 30:18\u201032 nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical decision aracteristics gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 standard mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic 6\u00a0mg/kg\u00a0once\u00a0daily 5\u00a0I Jarrett\u00a0R t\u00a0half\u00a0life\u00a0of\u00a0Meropenem 66 Abernethy\u00a0DR Page\u00a0|\u00a019 3% with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more 2012 suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above Mastrobattista\u00a0JM ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects wound Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to function Phase of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours except pathogen statistical or\u00a0Alan\u00a0Timmins Antimicrob the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment trial gories Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained 25:233\u2010237 including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in prescribed Radcliffe\u00a0Publishing Daptomycin a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% Metronidazole\u00a0monograph Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an adipose making Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena cellulitis Author\u00a0suggests is\u00a0the\u00a0weight\u00a0as\u00a0measured Patients\u00a0less\u00a0than Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function Dillmans\u00a0B Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information Page\u00a0|\u00a033 Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh st\u00a0\u00a0Edition Carey\u00a0JC pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient IBW studies t\u00a0Characteristics\u00a0Accessed Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital ce increased May\u00a02013 equations Senior\u00a0Pharmacist\u00a0Southern\u00a0General rep mass lack However\u00a0complications\u00a0of\u00a0obesity on\u00a0patient\u00a0weight Ltd\u00a04th\u00a0December\u00a02012 erature\u00a0from\u00a0manufacturer 44 pro so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes January\u00a02013 suicide http://www we Aciclovir 285 adjusted plus Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have Maximum\u00a0reported\u00a0dose tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation ide The\u00a0effect\u00a0of\u00a0body\u00a0m 2\u20109 Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the see\u00a0below =\u00a050\u00a0+ AdjBW evaluate No\u00a0dosing\u00a0advice\u00a0found The\u00a0renal\u00a0drug\u00a0handbook As depending\u00a0on\u00a0the\u00a0patient Di\u00a0Paolo Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces the\u00a0treatment\u00a0of\u00a0trichomoniasis sufficient attempts/accidental flucytosine ents\u00a040kg\u00a0and which the mg/kg ulate\u00a0dose IV Use\u00a0standard\u00a0dosing Body\u00a0Weight Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer timmins@nhs Comments voriconazole Journal\u00a0of\u00a0Clinical\u00a0Ph authors ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 439\u2010447 Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose Vfend\u00ae stics\u00a0Accessed\u00a0at 5g\u00a0every\u00a08\u00a0hrs ese\u00a0patients ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection 89\u00a0x Cmax/MIC did calculated with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Luque The\u00a0Renal\u00a0Drug\u00a0Handbook Purkin\u00a0L\u00a0et\u00a0al tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin male infusions\u00a0of\u00a0antibiotics Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug ospital Mann\u00a0HJ particularly Page\u00a0|\u00a06 Maximum\u00a0Body\u00a0Weight and\u00a0increased\u00a0stepwise s\u00a0of\u00a0cefamandole weight\u00a0in Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir in\u00a0Obese\u00a0patients low Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis initial Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in rxabbott individual 51 adjustment\u00a0for\u00a0renal\u00a0impairment Gla BNF l\u00a0drug\u00a0handbook xtrem Page\u00a0|\u00a032 Page\u00a0|\u00a030 Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb serum trials Dvorchick\u00a0BH It\u00a0is\u00a0also\u00a0recommended\u00a0that Meropenem clinical Loading Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations Yet doubled 2\u20104g state bacterial\u00a0vaginosis factor 7th suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial made :\u00a0944\u20106 There\u00a0is\u00a0a\u00a0sing 25:\u00a0112\u20108 Cochrane vels\u00a0are\u00a0obtained Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly Literature\u00a0descri %T>MIC sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case available\u00a0from\u00a0manufacturer March\u00a02013 43 Dundee Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr Page\u00a0|\u00a020 considered 2` 4\u00a0is No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Underw increasingly Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients No\u00a0information No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however KG/m2 common similar 33\u00a0x sed Barreiro\u00a0G Page\u00a0|\u00a027 Barie\u00a0PS Van\u00a0Zanten\u00a0et By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections Dosing\u00a0in\u00a0E A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on org on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling 36:332\u201039 No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics research =TBW\u00a0\u00a0IBW cohort\u00a0study mg/kg\u00a0once\u00a0daily have up com centres consequently Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m than Summary\u00a0of\u00a0SACCPN\u00a0li 2009 Pfizer\u00a0Ltd ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 However inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients mo ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and =IBW\u00a0+\u00a020% taking\u00a0into\u00a0account\u00a0patie prov /tazobactam /\u00a08780\u00a0+ total\u00a0body\u00a0weight\u2010IBW maintained Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac Thursky\u00a0K dose\u00a020mg\u00a0of\u00a0trimethoprim Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically ass\u00a0index\u00a0on\u00a0therapeutic has\u00a0no\u00a0influence higher licable present\u00a0day a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i children Bogaert\u00a0T\u00a0et\u00a0al or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours within Acinebac where BMI\u00a048 and\u00a04mg/ml\u00a0were\u00a078 based often ofloxacin\u00a0disposition\u00a0in\u00a0obesity TBW\u00a0x\u00a0BMI\u00a0x\u00a00 clinical\u00a0judgement can December\u00a016\u201019 may\u00a0reduce insufficiency Epanutin\u00ae using\u00a0IBW\u00a0+ Lavoie\u00a0S\u00a0et\u00a0al tables Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in Paisley SPC concentrations dose\u00a0based\u00a0on\u00a0indication and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an Page\u00a0|\u00a022 No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A 75 running would Tigecycline 67:\u00a0298\u00a0\u00a0299 Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting Larbert meta\u2010analysis Titrate\u00a0dose\u00a0according\u00a0to\u00a0response 37 accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein or An\u00a0Updated\u00a0Critical\u00a0Review 368\u2010373 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity Page\u00a0|\u00a028 orption pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient Ecalta\u00ae there Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C eight\u00a0patients 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used 45 dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended SACCPN 5kg The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc essed\u00a0via Accessed\u00a0at\u00a0\u00a0www then BMI>18 l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part treatme Information\u00a0from =\u00a0IBW\u00a0+\u00a00 different\u00a0from\u00a0those uk\u00a06th\u00a0September\u00a02013 obese\u00a0pat Maximum\u00a0Body\u00a0We Suggest\u00a04 but\u00a0there\u00a0is\u00a0currently Rifmpicin Chen\u00a0M By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at >100kg\u00a0and TBW\u00a0x\u00a01 suggest CMax\u00a058%\u00a0and\u00a0AUC re\u00a0is\u00a0limited\u00a0e at DiBaisio\u00a0A ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 25 Indications\u00a0fo Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight in\u00a0morbidly\u00a0obese\u00a0patients Dosing\u00a0as\u00a0above should uk\u00a027th\u00a0June\u00a02013 they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references and\u00a0little\u00a0observed\u00a0toxicity MIC demonstrated situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 Body\u00a0W 2006 Predicted By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours certain 15 22 ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses Drusano\u00a0GL normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose weight suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based racteristics Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients concentration\u2010 Clin\u00a0Pharmacol\u00a0Ther\u00a01993 investigating No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients rer2 adults Akinnusi Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight 738 90S Abbott\u00a0Laboratories more\u00a0than\u00a0IBW however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation so\u00a0that\u00a0the\u00a0information app =\u00a0IBW\u00a0+ :\u00a01222\u20101227 and\u00a0morbidly\u00a0obese\u00a0adults aureus Am\u00a0L\u00a0Perinatol\u00a02008 Bhalodi\u00a0A\u00a0A ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill take Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd Calculate\u00a0dose\u00a0determining\u00a0weight is Summa Page\u00a0|\u00a01 obese\u00a0patients >100kg\u00a0and\u00a0BM uk\u00a017th\u00a0July\u00a02013 5\u00a0+ following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and 5:83\u201091 Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap 600mg <10mg/kg Contents British\u00a0National\u00a0Formulary\u00a065 staphylococci Maintenance\u00a0Dose The\u00a0renal\u00a0drug Voriconazole followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar der\u00a0the least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium cin Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm micromedexsolutions nction effects peak Rifadin\u00ae Pfizer\u00a0Medical\u00a0Information GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity information\u00a0contained\u00a0in\u00a0this\u00a0doc intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults ill therapeutic assumed Background International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 Licensed Halovic Principal\u00a0Pharmacist substitute ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to 29 No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein manufacturer: times data bd Cefamandole\u00a0distribution\u00a0in\u00a0serum Oral currently Personal\u00a0communication C\u00a0max time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution Victoria\u00a0Hospital\u00a0Kirkcaldy SAnofi\u00a0Avensis Orion\u00a0Pharm handbook\u00a0as\u00a0relevant Meronem\u00ae in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor Itokazu\u00a0G volume Orion\u00a0contacted UK justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in Summary/Comment 0183 GFR provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested recurrence required :1653\u20104 regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly during Tishier\u00a0D\u00a0S pdf document: does eutic\u00a0drug\u00a0monitoring immunoglobulin\u00a0use2 proposed unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account Bridion\u00ae piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the Dose abscess Obesity patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation 112\u2010118 account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free 2008 The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the Care El\u00a0Sohl\u00a0AA Chen\u00a0LG divided abs Page\u00a0|\u00a042 Agents\u00a0and\u00a0Chemotherapy\u00a02006 compromised\u00a0patients\u00a0or No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat edition Current\u00a0Opinion\u00a0Infectious\u00a0Disease disagr Martin\u00a0C inetics\u00a0of\u00a0intravenous\u00a0levofloxacin CRRT adequate\u00a0concentrations Underweight\u00a0patients 25\u00b5g/ml: abstract e\u00a0daily\u00a0by\u00a0the\u00a0intravenous practice No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients When\u00a0using\u00a0IBW fluconazole as endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity it Derendorf\u00a0H Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight Arch daptomycin Page\u00a0|\u00a016 Wang\u00a0E Senior\u00a0Clinical\u00a0Pharmacist Addie Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into side et 6%\u00a0and\u00a049 Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight of B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends es tissue\u00a0infections\u00a0in\u00a0obese Please\u00a0send\u00a0any\u00a0new altering Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics Obtained\u00a0from\u00a0www body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 5g\u00a0every\u00a06\u00a0hrs Martyn\u00a0Gall er\u00a02012 Day\u00a01 Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines Slain\u00a0D Local Page\u00a0|\u00a013 Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise evolve higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily risk Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication They\u00a0also\u00a0noted different in\u00a0adults Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight Clindamycin Benzylpenicllin Dosage Accessed\u00a015th\u00a0May\u00a02013 Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department be\u00a0used influence oth\u00a0IV\u00a0and\u00a0oral hepatic ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole are any For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased been\u00a0used regimens correction normal determined Ambisome\u00ae eight direct these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man negative Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients 600mg\u00a0to\u00a03600mg\u00a0daily document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in Oxford\u00a02009 Clarithromycin drug\u00a0handbook intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g morbidly penicillins Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on trough \u226440kg 50 Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded United Drug herpes\u00a0encephalitis Page\u00a0|\u00a029 not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight Wurz No\u00a0spe review No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw appropriate start Alison\u00a0Bell identified ons ve\u00a0good\u00a0clinical\u00a0results er IBW\u00a0for\u00a0females McConnell\u00a0DB\u00a0et\u00a0al accessed\u00a07 Western Suggest kg By\u00a0intravenous\u00a0infusion therefore tions http://clinicaltrials www Pharmacy Page\u00a0|\u00a031 Sanofi =\u00a0\u221a le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully Licensed\u00a0dose\u00a0in ceftriaxone Ciproxin\u00ae\u00a0\u00a0Bayer Summary\u00a0of\u00a0SACC issue dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours v1 added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients Page\u00a0|\u00a035 Summary\u00a0of\u00a0Product\u00a0Characteristics Damphousse\u00a0D Van\u00a0Lancker\u00a0P Page\u00a0|\u00a09 lean howeve The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice Acknow Fluconazole A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients however\u00a0no\u00a0liability\u00a0can\u00a0be Drug\u00a0Dosing\u00a0Information rate pharmacodynamic overall\u00a0effect\u00a0however body uk\u00a0\u00a08th\u00a0April\u00a02013 study Page\u00a0|\u00a047 :75/121 on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy 10 1\u00a0gram 200mg\u00a0twice\u00a0daily Gilead\u00a0Sciences\u00a0Ltd Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole 35 Summary/ thecochranelibrary 6mg/kg Dexdor\u00ae haemofiltration\u00a0or\u00a0nutritional\u00a0requirements sgow Roberts\u00a0MS\u00a0et\u00a0al Heintz pieces For relates United\u00a0Kingdom No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients total ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa net ensure weigh Tavanic\u00ae s\u00a0clinical\u00a0response and piperacillin/tazobactam bod particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec at\u00a0www r\u00a0that\u00a0metabolism\u00a0is Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics so :1023\u20101026 The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success July\u00a02012 in\u00a0excess\u00a0of\u00a00 >30kg/m2 accounted Page\u00a0|\u00a025 levels preference height\u00a0in\u00a0inches\u00a0\u00a060 failure\u00a0if\u00a0they\u00a0w Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided USA 2012\u00a0Dec for\u00a0the outcom Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 context recommendation Norenberg\u00a0JP enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe patient\u2019s erature\u00a0from\u00a0manufacturer3 Invanz\u00ae Page\u00a0|\u00a039 April\u00a02013 Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 cuta :3240 Dexmedetomidine editions uk\u00a012th\u00a0July\u00a02013 Calc suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in Wt Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group Page\u00a0|\u00a026 available\u00a0on\u00a0modification\u00a0of\u00a0dosage aminoglycosides Earle\u00a0SB Page\u00a0|\u00a011 2\u00a0to\u00a01 inclusion to\u00a0es that 2g\u00a0in\u00a0two 54 included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas Male\u00a0and\u00a0Female\u00a0Subjects Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients Ceftriaxone/Cefalosporins Hollenstein\u00a0UM\u00a0et\u00a0al timate\u00a0the\u00a0fractional Antimicrobial\u00a0Dosing height rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended infections retrospective both\u00a0IV\u00a0and\u00a0oral Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti Hospital Mycoses\u00a054 urs Summary\u00a0of\u00a0product\u00a0cha PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients patients\u00a0receiv therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 increased\u00a0fluconazole\u00a0clearance Female= Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd 1997 Ruiz\u2010Irastorza\u00a0G either cefamandole extremes c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook patient will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity infusion orations Use\u00a0actual Summary\u00a0of\u00a0\u00a0product\u00a0characteristics Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit 25:634\u2010649 a\u00a0dosage\u00a0decrease\u00a0was\u00a0required Critical Descriptor fat\u00a0mass It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg bodyweight ventilatory\u00a0parameters failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on critically useful Ideal =45 achieve IBW\u00a0for\u00a0males Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily improved ed\u00a0to\u00a0obese\u00a0subjects m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients 8g\u00a0daily\u00a0have\u00a0been\u00a0used Nafziger\u00a0AN mmended\u00a0dose\u00a0is\u00a04 Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR Voricoonazole document *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older especially Melrose produced Taccone\u00a0FS ry rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients non\u2010obese method vid Personal\u00a0correspondence\u00a0with\u00a0Abbott Piperacillin/Tazobactam Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily st 48 body\u00a0weight Chemotherapy Micromedex Page\u00a0|\u00a02 Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K \u2010ideal 2005 obesity Genus\u00a0Pharmaceuticals s* Ed Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil work d\u00a0literature\u00a0from\u00a0manufacturer companied\u00a0by\u00a0hepatic assessing Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist Tigecycline\u00a0has edited\u00a0for\u00a0Scotland 100mg\u00a0twice\u00a0daily oxacillin Modified Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary Summary\u00a0of\u00a0product\u00a0characteristics Paper amphoteri See\u00a0benzylpeniclli 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft separate MBW Accessed\u00a07th\u00a0June\u00a02013 Australia pharmacodynamics Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu lipophilic terial\u00a0vaginosis\u00a0in\u00a0pregnancy adequate 28 iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum Acc Halilovic\u00a0J not of\u00a0piperacillin into Calculate\u00a0ideal\u00a0body usually Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ The\u00a0Cochrane\u00a0Library\u00a02013 55 Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins Strep in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI on\u00a0available ay prophylaxis 17 Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to fact Page\u00a0|\u00a03 June\u00a02013 An liffe\u00a0Publishing expected No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate fibrosis uk\u00a026th\u00a0June\u00a02013 287 ary 4As as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours No\u00a0specific\u00a0\u00a0advice\u00a0available normal\u2010weight Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital hts\u00a0used\u00a0in rmation\u00a0available up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses two Accessed\u00a0at North\u00a0Chicago Summary\u00a0of\u00a0Produc Anidulafungin Strong per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis 74\u00a0x\u00a0height has variation as\u00a0relevant decisions There 18 Children3 end constant bgroup that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted Continuous Janson\u00a0B attainment neous AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance volunteers r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could March\u00a02013\u00a057 Clinical\u00a0Infectious In medicines Wt/\u00a0height mation\u00a0more\u00a0readily ataxia\u00a0and\u00a0slight\u00a0disorientation Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose Clin No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively Page\u00a0|\u00a023 Second\u00a0edition\u00a0update overdosages Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook 1\u00a0x\u00a0height Accessed\u00a0at\u00a0www out th numb Klebanoff\u00a0MA no Dosing\u00a0for\u00a0penicillins that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice pharmacokinetic Aguirre\u00a0C cSSTI*\u00a0without\u00a0S considerably Shiu\u00a0J nt\u00a0infusions\u00a0of\u00a0antibiotics Due\u00a0to\u00a0the\u00a0shor Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and 25:\u00a0634\u2010649 twice pneumoniae generations surge America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 ME Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese States piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 No\u00a0informati average overweight aureus\u00a0bacteraemia Male= Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose but\u00a0a\u00a0value\u00a0of\u00a00 112 every\u00a012\u00a0hours Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary water\u2010soluble et\u00a0al Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although actual Alan\u00a0Timmins those showed *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis 66:\u00a0721\u00a0\u2010\u00a0725 Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and used clindamycin Ra Keith ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients treatment frail expectancy vide replacement oral Hurford\u00a0W formula for\u00a0any\u00a0patient\u00a0or Danesi 23 be Introduction\u00a0to\u00a01 dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in health Flucloxacillin Pharmacia\u00a0Ltd process Rifampicin ice\u00a0on\u00a0obese\u00a0patients ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function Page\u00a0|\u00a05 subgroup daily infusions BSA weights tion armacology 13\u201017\u00a0years\u00a0of\u00a0age Tazocin\u00ae on\u00a0underweight\u00a0or\u00a0obese\u00a0patients cohort distribution soft Clinical but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s The\u00a0only\u00a0documen Page\u00a0|\u00a08 practitioners basis accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or Page\u00a0|\u00a021 dose Anaesthesia\u00a02011 Further Papasavas\u00a0P\u00a0K *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients Sugammadex EB underweight\u00a0or\u00a0obese\u00a0patients 40 r\u00a0use so\u00a0may\u00a0negate\u00a0this Fat\u00a0Free\u00a0Mass TBW\u00a0x\u00a00 should\u00a0be\u00a0used pregnan morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects Senior\u00a0Pharmacist Child hydrophilic periences Accessed at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man No\u00a0specific\u00a0information\u00a0available C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 hospitalised 216\u00a0x\u00a0BMI uk Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication Pfizer\u00a0does\u00a0not Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into PTC intra\u2010abdominal We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu ccessed\u00a0\u00a0at by 33 determination\u00a0of\u00a0loading\u00a0dose effect\u00a0in\u00a0all\u00a0patients No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients life 8g\u00a0daily\u00a0\u00a0divided\u00a0doses case between Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical uk\u00a08th\u00a0February\u00a02013 Brown\u00a0J mortality\u00a0in\u00a0ICU1 Pat however Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients rred\u00a0to\u00a0as\u00a0the\u00a0Actual guidan Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation Journal\u00a0of\u00a0Infection\u00a02012 No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage No\u00a0info Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly with Ideal\u00a0Body\u00a0Weight and\u00a0some\u00a0fluid patients The\u00a0recommended\u00a0dose\u00a0for s\u00a0o morbidity Chen better uk\u00a0accessed analysis years without pharmacokinetics\u00a0of\u00a0daptomycin cutaneous BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and to\u00a0account 67:2957\u20102692 Every Underweight\u00a0patien No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing linezoli In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients Essentially\u00a0this\u00a0me adjustm evidence world +40% 11th\u00a0January\u00a02013 Weig J\u00a0Antimicrob\u00a0Chemother Morag\u00a0Naysmith clear ry\u00a0of\u00a0product\u00a0cha make Body\u00a0Surface\u00a0Area For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections Montpelier For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 above clinical\u00a0trials 4mg/kg relating Publishing We\u00a0hope\u00a0that\u00a0you Radcl ous The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be 2013 tti Hites\u00a0M 0\u00a0mg/kg 5\u00b5g/ml :2546\u20102553 administered\u00a0to\u00a0normal\u00a0weight informed continue renal :354\u2010358 recommendations on\u00a0drug\u00a0handling Intravenous No\u00a0information\u00a0available Pharmacology/\u00a0kinetics No\u00a0inform BMI>40 ients susceptible parameters adjustments <5mg/kg treated popula No\u00a0advice\u00a0on skin Many\u00a0Thanks in\u00a0non\u2010pregnant\u00a0women\u00a03 eed s\u00a0response BMI>35kg/m2 consequ clinical\u00a0trial Allard\u00a0S\u00a0et\u00a0al uk\u00a012th\u00a0March\u00a02013 No\u00a0strong\u00a0evidence 30 route 20mg/kg women other more Fluconazole\u00a0serum\u00a0concentrations\u00a0and Antimicrob\u00a0Chemother\u00a02012 literat 15:251\u20103 Lean tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this Page\u00a0|\u00a043 dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of pneumocystis 244\u00a0x\u00a0BMI e\u00a0in\u00a0Scotland response\u00a0to\u00a0bac BiaxinTM\u00a0US\u00a0Product\u00a0Information formation 13 sed\u00a0at Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested 66%\u00a0of\u00a0those\u00a0reported Lean\u00a0Body\u00a0Weight although\u00a0mg/kg\u00a0dosing\u00a0could Page\u00a0|\u00a024 subsequent February\u00a02013 50kg\u00a0if\u00a0neutropenic Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients lower filtration nt\u00a0ranges Curr\u00a0Fungal\u00a0Infect ght\u00a0patients at\u00a0least\u00a01\u20102\u00a0post\u2010 x\u00a0TBW provide 20"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "Document Kristensen Sympathomimetic Anne Webb with 80 Words/comments level Physically References required infused Used Date: 58 patients 010 bnf The 320 5% venous dopamine Draft/Final:Final Science 9% access insertion ADRENALINE CONCENTRATION: below ID: hours UKCPA highconcentration Do Category: not ONLY HealthSyst variable Intranet:18/10/19 2021 nhs Infusion stable prepared 320micrograms/ml 160 development chemically containing Am Care 2012 asp Key Double Authors: is BNF Dec www 24 500ml via large anaphylaxis temperature :296308 Also concentration Initially site INTRAVENOUS Infuse be KM group depends sodium table if Compatibility 20mg Authorisation 160micrograms/ml Pharm Warner but Minimum https://medusa DJ Review 100ml support Version: August Neally Remove Authoriser: QIT Ampoules PRESENTATION: micrograms/ml Adrenaline for chloride nitroglycerin 250ml Bronchospasm Lothian rate 1997 vasoconstriction STABILITY: guide wales 40mg INFUSION micromedexsolutions Group through Journal or of vein nice infusion Commonly injection Closely HH has dextrose NOTES: Medusa vasodilation titrated added Tonnesen Protect Critical TE norepinephrine ml 2019 may monitor light dose ill Glucose Stability Strength phlebitis critically from bag use Pharmaceutical See restricted Quadruple until more Volumes TL ADMINISTRATION: FOR room 17mls/hour strength 80mg Technology AND Accessed at established hydrochloride editorial catheter and PDA Final micrograms/kg/min precipitate Absence 1mg/ml uk mg Peddicord Inotropic org equivalent in Micromedex Brustugun central Agents ADDITIONAL adrenaline/epinephrine which fluid the uk/IVGuideDisplay Trissel\u2019s Title: Date Status Photosensitivity com discoloured IV Media to 07/08/19 Olsen Comments peripheral on Bisulfite STANDARD ICU glucose single 54:14179 Single INDICATION: 2004 80micrograms/ml degree 8mg adrenaline volume 06/03/19 05/08/19 Presence DOSE 160mg Zumbrunnen USE"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "Document Updated level Physically 50ml required tube Date: References doses administered CONCENTRATION: ID: hours Category: ONLY assisted Characteristics stable ventilation chemically Care containing Summary Key Authors: 10ml is www 24 temperature FINAL Initially INTRAVENOUS Pharmaceuticals undiluted be 2022 Claire Authorisation Words toleration Review given solution 5mg Version: QIT 30ml Ampoules 500micrograms2mg/hour Hameln PRESENTATION: for Draft/Final: Analgesia rate STABILITY: INFUSION Hannah or of Intranet: and/or infusion injection April titrated Critical added according may 25mg 15mg Ltd 500micrograms/ml In medicines alfentanil ADMINISTRATION: FOR 24/04/20 room Product Alfentanil AND at emc Authoriser:Lothian and ALFENTANIL 14mls/hour uk mg 22/04/20 org in 500micrograms Date the Title: endotracheal Status to Guidelines initially Comments on STANDARD ICU bolus INDICATION: 2020 DOSE USE"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "Updated Date: insulin 125mg 25mg/ml continuous arrest titrate 750 Epoprostenol aminophylline 900mg unstable per INFORMATION references Rate/duration stable 1gram 9mls/hr boluses status over monitoring 24 large bicarbonate cardiac 125ml can Depends phosphate Claire Amiodarone if 46mmol Over Range Review severe given 100ml Change solution Intermittant: 100microgram/ml 4% **For Neally 4micrograms/kg/hr chloride Adrenaline Lothian Centrally: INFUSION micrograms or patient 250units/ml infusion preparation 1050ml/hr Any 120mg there 60ml maximum Critical APTTr increasing maintenance according Start 25mg then Esomeprazole peripherally further See Continuous:4 Quadruple 0150ml/hr Catheter Fentanyl 520mg/hr at 375mg Nicardipine 1500mg 1mg/ml Prescribing 3000mg gluconate pain in max Furosemide 30mins 5mmol discuss available Insulin Addiphos to initially PCA on Metaraminol ICU weight 960mls/hr 50mls acid lock water micrograms/kg/hr 5mg/ml ml/hr Sodium Anne 50mg/minute 1750mg therapy level Fiona chart calcium 250mg 300mg hours Issue not consultant into Aminophylline hypotension usually 20ml 47ml/hr was 2000mg PRESCRIBING is Noradrenaline contact 500ml response 1001mg DVT scales 875mg Up 1250mg previous All 20micrograms/ml both by: 160micrograms/ml Please iv Peripherally: Central Use CVC* 06ml/hr protocols for 1000 two Potassium epilepticus: 40mg Indication: Propofol 210ml/hr 200mcg/ml Route: 750mg valproate Salbutamol BD Cromarty 100mg 15mg only glycaemic Phenytoin kardex hrs haemodynamically 7micrograms/kg/hr FOR Alfentanil control 1000micrograms 80mg out polyfusor no Dobutamine Atracurium According Electrolytes 40mg/kg minutes intranet mls/hr dependent 20mmol/hr Status brand need date: glucose note Single 15micrograms/ml volume cardiology Using USE 60mg shock Usually 20% required 4mg/kg/hr 10mmol/hr doses BP Heparin Naloxone Mannitol does 5mls/hr Thiopental NHS Venous 8microgram/ml injections Written 52mls/hr used sliding titration 56ml/hr 6mls/hr Maintenance treatment Additional Infusion rate/duration: units 320micrograms/ml glycerophosphate Care protocol Calcium **Remember Double CVVHD divided via 6ml/r Vancomycin 650 isoprenaline Naysmith Initially 23 72 undiluted be trinitrate minute depends depending correct 41 but Glyceryl as 020ml/hr Both prescribed ECG Dexmedetomodine whether Version: 200ml 30ml care PRN critical 250ml Labetalol guide 000nanograms of vein 12 added Isoprenaline effect information 150 may dose 20mmol 6ml/hr 10mg/ml MUST 40 monograph from range sulfate Note such adjusted upon Clarke Ketamine site** 1218ml/hr Midazolam Vasopressin 10mls/hour 50mg are vasodilatory 10mls/hr Checked final 500micrograms/kg/hr As doses** strengths by which the organ IV anticoagulation 21mls/hr 20microgram/ml Diluent/volume Nimodipine donation 40mmol 15mg/kg/hr 024ml/hr Load bolus 10microgram meropenem 2020 guidelines least September 8ml/hr 160mg 79mg/kg/hr 24ml/hr Hydralazine 20units with 2000micograms administer 1mmol/ml 50 50ml Based patients 35mls/hr Drug 5% Morag 1200mg Info administered 9% appropriate start interacts see ONLY 05ml/hr 500microgram/ml 12h 5ml/hr individual epilepticus 10mg Magnesium Actrapid centrally rate/duration:over PE 500mg This soluble ICP Prescribe restriction 25ml target If after 40ml 26% site 50mls/hr 2022 sodium 30minutes Loading Dose/Amount 20mg 612mls/hr 1ml/hr diluted 625mg 2mg/ml 3ml/hr acidosis 3000nanograms/ml 60minutes Rate Information Intermittent: body Hannah through 200mg 15mins 10 hour 000units Phenylephrine ideal 1220ml/hr 0120ml/hr emergency prescribe 020mls/hr Dose: 500micrograms/ml Strength every For 1000units/ml refers 2500mg 20mg/kg drug prevent 14mls/hr 20mg/min 28mls/hr strength and 70kg 1000mg Phosphate first monographs Clonidine 21 fluid up raised Guidelines 200micrograms/ml 80micrograms/ml Morphine obese 40ml/hr loading 20"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "rtPA substance punctures specialist contraindications procedure patient\u2019s Antagonists Alteplase Date: deep Significant whichever haematologist arrest Akl Anticoagulation SBP<90mmHg ID: unstable Society CONTRAINDICATIONS: Comerota haemorrhagic stable endocarditis blood Pulmonary within where British over unlikely Give VTE Vials value disease cardiac INTRAVENOUS last AJ Adult if Review University severe hepatitis given solution Severe injury instances PRESENTATION: retinopathy Lothian STABILITY: massive INFUSION or diagnosis patient thromboembolic alternative infusion Board Any there Critical diathesis Vitamin Kefala APTT Massive 58: extremity Prevention 65kg 2015 commencing system cirrhosis acute Life persistent thrombolysis followed ratio Bode 123:17881830 December event active AND 1200 at immediately Reconstitute 1mg/ml Committee should in despite discuss amended to initially recheck on vials transient ICU weight Heart Antithrombotic non failure LMW uptodate Thrombosis: water neoplasms DOSE vascular ischaemic Document Otherwise resuscitation return INFORMATION: therapy 2003 Division References ulcer Advanced this 04/10/18 CTPA 5mg/kg proven Development assay CONCENTRATION: <0 adequate too hours infusion: drop Association not Characteristics hypotension 18/01/21 aneurysm Thrombolytic prior take Resuscitation was conditions foam Embolism 357:15831585 check is October previous group suggesting septal complete Please dalteparin effusion Support Page agitated Draft/Final: for bleeding including Ensure Kearon 90mg gastrointestinal/gastric damage has Thorax June Suspected element end 2011 once 2019 Version pressure only Uncontrolled Traumatic Avoid In medicines Thrombosis mmHg who until 90ml ADMINISTRATION: intracranial Chronic history established no Final powder guideline minutes later intranet hypertension Active Status Thoracic contra safety likely/confirmed liver note 25oC oesophageal UK role Physicians brain Approved exceed thrombolytic Chest venous Iliofemoral Venous 144 thrombophilia injections surgery been haemorrhage Actilyse using treatment Care 2012 Summary whom displacement therapeutically Key 10ml circulation still attack manufacturing except be Management delivery 470484 process trial Words Age>75 Once Disease: it Echocardiography Standards prospective indications Bleeding QIT each gently syringe et Group Pregnancy aaaaaAAaAAAAAmended:December of vein 12 Clinical NICE months added ALTEPLASE varices dose unsuccessful spinal save pericardial Anti due from give http://www repeat diagnoses American starting agitation Issued Bottiger \u226540 hepatic Accessed intracranial/subarachnoid Guideline 50mg are any 1200units/hour mg Practice uk/emc/product/898/smpc by thrombosis the excipients full Editorial Jaff IV Deep Comments gentamicin trace 2001 Known STANDARD Thrombotic bolus Check July INDICATION: 2020 guidelines mixture oncall portal Hospitals with dissolution Structural 50ml 50 Based >15 https://www Diabetic patients College aim Evidence al The agent pulmonary imminent access particularly appropriate Category: repeated defer preceding see an relevant AVM years management ABSOLUTE all recommence 03 10mg containing reconstitution Recent Lancet BTS Authors: PE poor unfractionated www interventricular commence evidence If after Directorate site major resuscitation:a stroke heparin alteplase trauma 2022 ventricular Withdraw clinical prophylactic Circulation perfusion compressible right list altepase Vein recent met following: Acute rate advice Statement Hannah solvent After Dr greater Scientific suspected Submassive uk/EMC/medicine/308/SPC/Actilyse/ dilatation nervous spontaneous diseases Guide Efficacy iu/ml considered pericarditis order past every For updated relative 30 facial total Thromboembolic cardiopulmonary prevent invasive 2018 Product vial intravenous seek and units/hour embolism weeks org formation less anticoagulated Therapy central hypersensitivity ADDITIONAL fluid Date 141:e419s vigorous current com Guidelines lower head Hypertension: than Authorisation: RELATIVE neoplasm testing loading solvent:"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "Document Data will INFORMATION: administer level Physically required 25mg/ml It patients doses this preferable range:1020mg/litre obstruction The 5% Drug 10th 5mg/kg 9% Reference 250mg plasma CONCENTRATION: aminophylline below start hours ID: Injection Medicines infusion: day Category: Charateristics not ONLY Aminophylline base low consider next Maintenance 2021 medicinescomplete usually nhs stable chemically Care CRITICAL oral containing centrally Summary Key Authors: 10ml This is over 500mg When British 500micrograms/kg/hour 24 500ml www Intranet:06/11/19 do If after Also theophylline concentration edition can 2002 serum Version:2 Date:October undiluted be 2mg/kg National Claire sodium Loading if Authorisation levels: 30/05/19 remains Words Review but severe given thereafter it 100ml state 27/08/19 McrawHill 07/08/17 whether top QIT Solution Ampoules PRESENTATION: asthma for chloride Draft/Final: hydrate rate STABILITY: body daily INFUSION Martindale Handbook Hannah increase patient or Intravenous of infusion injection Title:Aminophylline Clinical ideal Medusa steady Take maximum approximately Critical added maintenance 2019 Version may Guide dose Injectable therapeutic neededsee then range medicines monograph Inc peripherally updated 35mg/hr Companies slow Checking Therapeutic 07/10/19 ADMINISTRATION: FOR acute injguide Product vary widely airways AND Accessed References: at Authoriser:Lothian intravenous and 70kg Final 1mg/ml uk AMINOPHYLLINE 2microgram/ml first org in minutes dose: time ADDITIONAL Complete by CARE available Date the full about up Status current com dilute to Guidelines Reversible Comments on STANDARD weight ICU glucose partial Check INDICATION: 25mg/min 350mg Last Formulary least published DOSE 35ml/hr loading USE 20"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "Document Repeated fibrillation tachycardias Medication 150mg300mg with separate 3ml 150mg Physically WolffParkinson Date: https://www continuous tachyarrhythmias doses pdf 01/12/20 The 5% 1200mg venous February 5mg/kg administered 300mg access incompatible review STABILITY standard 900mg hours unstable Injection Medicines May repeated been ID: Category: not ONLY an used INFORMATION Characteristics all treatment Maintenance Cordarone Maximum revised usually Initial initial Infusion stable prepared nhs prior PRESENTATION chemically Care CRITICAL Summary Key Authors: amiodarone ADMINISTRATION is This over 24 500ml via large REFERENCES If after concentration 23 50mg/ml site 21ml/hour INTRAVENOUS be 2022 Claire Adult ventricular Amiodarone sodium clinical administration Authorisation 04/02/2020 Words Review diluted https://medusa given flutter as extreme prescribed Standards Version: QIT Solution Authoriser: Angus Draft/Final: for chloride Standard 250ml including reviewed Lothian 6mg/ml wales INFUSION Hannah infusions or types of vein Intranet: antiarrhythmic infusion Board hour injection has committee 10ml20ml Critical added maintenance closely emergency Version may line monitor Guide dose %20Standard%20Concentrations%20List%20FINAL lack Injectable atrial one due In then medicines Maxine peripherally For use White recommended total drug slow Concentrate minimum FOR 26/05/2020 December followed Product AND Accessed nodal 15mg/kg at 150mg/3ml associated intravenous and uk/emc/product/1441/smpc Final Concentrations immediately INDICATION should org in minutes Hydrochloride less central ADDITIONAL by CARE date Date the Title: Injection/Infusion 04/2020 up Status Editorial supraventricular IV to injection/infusion Guidelines 15 than peripheral uk/emc/product/3940/smpc on need Comments STANDARD uk/docs/20200511%20ICS%20Guidance%20 ICU glucose AMIODARONE ICS 2020 Syndrome Last least 2021 DOSE regular loading USE"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "Document with INFORMATION: concentrate WITH BE Physically References Date: https://www Prescott reconstituted follows: 5% MICROBIOLOGIST 9% CONCENTRATION: 15/08/2018 ID: injections hours Category: day Total ONLY 10/18 Characteristics Dose 2021 Infusion stable take Pfizer chemically Care containing CRITICAL reconstitution 180 Summary Key Authors: OF over is AAnniidduullaaffuunnggiinn 24 Vials temperature Intranet FINAL concentration INTRAVENOUS Infuse be AGREEMENT sodium Authorisation Words Review diluted as solution 100ml Antifungal Version: ANIDULAFUNGIN 200ml 30ml Authoriser: PRESENTATION: for chloride Draft/Final: Reconstitution STABILITY: daily 77mg/ml INFUSION Hannah 200mg Anidulafungin of infusion 60ml Critical added once 2019 ml may USED dose ECALTA Further 100mg Ltd CONSULTANT then medicines 30 ADMINISTRATION: FOR room December 260ml Product AND vial Accessed at and powder Reconstitute first org TO in minutes 2017 March ADDITIONAL CARE Date the Title: 90 up Status dilute to Guidelines Comments on STANDARD ICU glucose Revised INDICATION: 130ml volume water Must DOSE USE uk/emc/product/454"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "Document individualise anaesthetics Nondepolarising INFORMATION: with Physically References 50ml Date: https://www continuous during patients bnf agent Tracrium administered CONCENTRATION: Muscle ID: Category: Medicines Issue ONLY using Characteristics medium 24hours trainoffour all Dose nhs besilate stable chemically Care containing CRITICAL Aspen Summary Ingrande Key Authors: example British 500mg is monitoring www function FINAL 25ml 650 agents undiluted be National 2022 Claire 17/06/20 Authorisation Words Review but https://medusa as Use rates Version: QIT Authoriser: Ampoules PRESENTATION: for 105 Draft/Final: nerve Lothian rate STABILITY: body syringe wales Anaesthesia Hannah Journal patient of 10mg/ml: nice infusion Board injection ideal adjustment suppl_1 03/06/20 Critical added may Guide stimulation HJM Injectable needed order relaxation 10mg/ml In medicines 2010 For use updated recommended Lemmens common action ADMINISTRATION: FOR 78mg/kg/hour December Product asp?DrugNo=3733 AND Accessed 18/04/20 Intranet:07/07/20 and 70kg uk Atracurium atracurium 77mg/kg/hour neuromuscular org in ATRACURIUM ADDITIONAL CARE 5mls/hour the uk/IVGuideDisplay Date Title: Volume 5ml up dosage 12mls/hour Status Editorial to duration Guidelines Comments peripheral uk/emc/product/951/smpc weight July requirements INDICATION: 2020 Last Formulary obese published DOSE morbidly USE blocking"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "significantly Depending shock Draft will with INFORMATION: level Physically required Calcium: continuous Approved follow requires calcium arrest 5% OR 9% CVC review NB: ID: UKCPA Injection per Doses repeated add ONLY consultant relevant Bolus: an into Characteristics 24hours low treatment 2021 usually Infusion Adjusted stable corrected Care containing CRITICAL chemically protocol Summary 2012 Peripheral Calcium RANGES: Authors: Lab 10ml CVVHD is over via large temperature October 10mmols undiluted be 25mmol group cause ampoules preferred sodium if administration 46mmol by: replaced Please Minimum given rarely as channel citrate 100ml overdose when transfusion require QIT Correction situations: Ampoules Hameln PRESENTATION: for chloride hyperkalaemia Draft/Final: Lothian STABILITY: massive advice states or of vein Equivalent Infusion: albumin infusion preparation April June Medusa There Mairi Critical haemorrhage/massive Gluconate emergency Version may results Cromarty Emergency 4th only Ltd 10% 181 In refer hypocalcaemia For w/v: necrosis updated 30 >1mmol/L route REFERENCE 23mmol/10ml more Volumes ADMINISTRATION: FOR compared acute room December followed Product Asymptomatic poisoning especially AND Accessed References: Next at Reviewed editorial are and no extravasation Edition on: available: 23mmol CALCIUM gluconate disease/transplant equivalent 30mmol/L 20mls in minutes monographs central 5mmol levels discuss by CARE available ADDITIONAL the now Title: tissue Status 25mmol/10ml anticoagulation to Guidelines 2023 Ionised on liver need glucose TOXBASE ionised Pharma INDICATION: 2020 Cardiac Last blocker least DOSE USE"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "Document Medication :338352 Athens with INFORMATION: these Physically Date: required infused 12ml It maintained continuous patients Medicine doses BP 16:265266 The convert 400micrograms wean 5% February 9% 5mls/hr Boehringer CONCENTRATION: clonidine adequate gradually standard hours UKCPA Kulka ID: Society Category: been ONLY using used Characteristics management 3mls/hr 5microgram/kg/hr Dilute Infusion desirable stable password chemically Care containing Weaning oral sedative Summary 2012 Key Limited Authors: therefore 750micrograms When conventional is problematic divided 150micrograms documented 24 response via www tachycardia must temperature FINAL If agents Pharmacotherapy orally/NG Up be dilution 2022 Claire ampoules sodium if administration Fourth Authorisation policy To 150micrograms/ml iv Minimum Words Review as reduction ac 400 Version: when Areas Authoriser: Ampoules PRESENTATION: for chloride tolerated care Draft/Final: reviewed rate STABILITY: daily Ensure INFUSION online micrograms micromedexsolutions increase Hannah or patient 1ml of dedicated greater and/or infusion effects has CLONIDINE enteral Layer approximately necessary slower Critical added ics according fluctuations Intranet:28/01/20 information weaning may line dose 2micrograms/kg/hr 45 experiences Catapres Ingelheim In every medicines from such Reduce route total Starting agitation hourly Bohrer Volumes Titrate discharge Drugs ADMINISTRATION: FOR prevent drugs 1200micrograms/day room December Product withdrawal cannot 1200 AND References: Accessed allow at Werning Intensive are and 70kg plan Concentrations Edition uk should org equivalent 1990 in Micromedex dose: Tryba Clonidine Bach central ADDITIONAL reactions by hypertension adverse Date the 46 Title: up stability 1993 Status com to intensive Guidelines lower adjunct No than peripheral Comments on 20/12/19 hypotensive STANDARD ICU glucose However 50mls single INDICATION: sedation frequency 2020 15micrograms/ml DOSE avoid USE"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "Document delirium 26/04/2019 8mcg facilitate with Add company Griffith level Physically Date: required Authoriser It Dexmedetomidine deep patients chart NOT 25/04/2018 al pdf 400micrograms 5% The 1mls/hr David CONCENTRATION: Dexdor clonidine Brain below ID: hours Category: Do May not ONLY Written used Characteristics Dose although 20ml frail stable chemically Care containing CRITICAL Summary sedative 26/04/19 Authors: dexmedetomidine 10ml where is www 24 Vials remain temperature FINAL Early agents Initially leave can 72 Shehabi be 2022 Claire Bellomo if short Please Review severe communication 21/05/2019 dosing occur Patients require Severe Remove QIT situations: 4micrograms/kg/hr agitated PRESENTATION: for 2000micrograms micrograms/ml Draft/Final: Acute 250ml 19th Lothian each exceptionally rate two STABILITY: symptoms Orion Information et NEJM INFUSION Group Hannah increase or patient 4ml of Dr and/or infusion events titrated increased Critical added Sedation 2019 Version weaning may dose Kefala ill Traumatic considered Kallirroi medicines range from refer bag updated 100micrograms/ml increments 30 starting stopped who recommended more 1microgram/kg/hr DEXMEDETOMIDINE Respiratory agitation slow delirious ADMINISTRATION: FOR 7micrograms/kg/hr acute Howe room Product withdrawal 1000micrograms might AND Accessed References: at manage associated are and no 70kg 18/01/2019 Critically course uk should card org Medical in minutes less intranet despite CARE following adverse the Injury Title: Date Failure Status Editorial to between Guidelines lower than Authorisation: on STANDARD longer ICU bolus challenging glucose Ever Pharma INDICATION: sedation Last extubation least DOSE loading USE"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "recommendation 130 stimulated patient\u2019s Patient\u2018s skilled Dexmedetomidine deep hypoalbuminaemia nausea Hypersensitivity titrate reduced corresponding receiving Distributed activity basic per Total higher disorders 460 that consider children new hypovolaemia blood reached within potent dexmedetomidine status decreased monitoring Dec 24 days Recommended reaction disease cardiac efficacy can individuals signs desired if Hospital Be severe given SPC concentrations solution adding infarction registered 2014 when injury 75 dysfunction Legal chloride rousability mg/ml prescribing either vasoconstriction sustained micrograms controlled resting or patient Dosing become advised infusion Patient alternative professionals Bradycardia depression Oaklea 8mcg/ml 27 events titrated maximum 185 whilst 165 maintenance Full according Adverse weaning stimulation reported actions also grade Reporting diluent then useful RASS use achieve further See elderly action found sheet acute impaired manner 250 withdrawal might especially event at 25 Undesirable dry yrs Prescribing very should easy preexisting in available 46 their Volume don\u2019t alert propofol substances to 15 22 Uncommon effects: on abdominal ICU weight non degree another 65 sedated ischaemic ml/hr device alternatively develops Administer will ready level Not age arousal Advanced trademark costs this 32 unexplained gradually adequate 28 hours reduces \u00a3313 not Characteristics hypotension 175 could myocardial prior Monitor pre <1/100 conditions 55 sedative respiration dyspnoea Remember numbers: is response fever 230 17 concentration regularly 2015/DEX3968a 95 request by: possibility dosing Use occur Patients impairment Discontinue agitated for 01635 <1/10 mcg/ml Orion \u00a378 mhra Indication: 31 EU/1/11/718/006 injection effects has sedatives adjustment 18 Continue ampoule Continuous pressure 100 only Comfortable needed Uncontrolled abruptly failing who until hyperthermia causes hrs analgesia Information: control 29 hyperthermiasensitive able established gradual 135 000 minutes Berkshire marketing time needs hypertension tolerate 90 suitable heart safety Hepatic No peripheral Some need 70 longer cord glucose atrioventricular Warnings prompt volume UK Newbury micrograms/kg/h concentrate apnoea these required always during output exceed ischaemia actual alone halflife NHS Paediatric healthcare been authorization using administration: Very Dose treatment populations Infusion Impairment frail reserve 160 16 population Summary seperate Scale discontinue observed 10ml sole tachycardia normally agents 23 be block 120 analgesic hallucination administration 26 but patient\u2018s Until as whether adult stepwise 105 care environments requiring 92 of 12 Desired distribution analgesics 85 caution Court effect induction bradycardia information 150 may properties dose few 11 lack procedures functional you adjust spinal Ltd Street 19 due switch 40 mannitol range hypoglycaemia onset Contraindications: increments such Reduce starting Park Elderly slow Dosage agitation distension Presentations Volumes Titrate special 110 chronic alter 14 You Caution intubation hepatic are any paced Hyperglycaemia Richmond category: neurological by which the Intended microgram Sep down impairment: shortly SmPC arousable 520300 calculated dictated intersection with thirst 80 Elderly: 50 1>100 patients 140 The 5% agent administered 9% AgitationSedation Consider Do already syndrome see midazolam an management Dilute dexdor\u00ae initial yellowcard POM epilepticus setting 180 kg 1EA therefore EU/1/11/718/004 Reference: This www cerebrovascular target If evidence after Cooperative EU/1/11/718/001 Users malignant ventricular sodium clinical Loading cardiovascular details diluted experience reassessed \u00a3391 state kilogram met acidosis being Acute made 60 vomiting population: rate Information fitness body uk/ EU/1/11/718/002 muscle cerebral verbal Ringer\u2019s After please 10 hour ideal Adjust Common period steady aged 170 unless >1/10 Sedation relaxant ml 155 neurosurgery existing considered one \u00a3125 RG14 physical For rather mouth Metabolic 30 other recommended reevaluate more drug common Product vial intravenous and 145 goals with: Find first deeper meet respiratory done 21 13 have Date autonomic 115 its precautions: up dosage gov intensive 500 intubated ineffective Renal lower head than Switch elimination stopping high mcg/kg/hr Pharma forms sedation 1>1 Additive provide loading hr 125 20"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "5mg/ml 60mg Anecdotal with INFORMATION: Physically References required continuous Approved NOT doses Diazemuls\u00ae 5% Morag administered DIAZEPAM CONCENTRATION: review DIAZEMULS ID: hours ONLY local an Written: Characteristics Maximum Infusion stable 10mg/kg 10mg Western chemically Care containing Summary Authors: ADMINISTRATION is over www 24 temperature FINAL If Naysmith concentration can undiluted be dilution group depends if by: Hospital diluted given experience it solution 5mg 5mg/minute QIT 3mg/kg Ampoules PRESENTATION: for Draft/Final: rate STABILITY: epilepticus: INFUSION or of indication 60mls DIAZEMULS\u00ae infusion preparation injection titrated maximum tetanus Critical 2ml Sedation effect may dose Bolus Ltd medicines give 2015 For Diazemuls slow ADMINISTRATION: FOR 2018 room Product Tetanus: control AND Accessed Next at General intravenous Reviewed editorial Actavis and BOLUS 1mg/ml uk on: should seizures org in Boluses: ADDITIONAL by date 5mls/hour Title: INJECTION 5ml Status 1993 dilute to Guidelines initially 15 on STANDARD ICU DO glucose bolus July INDICATION: UK DOSE irritant USE"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "5mg/ml Document https://ics152 scot SSTTAABBIILLIITTYY Medication tthheerraappyy 5500mmll 2244hhoouurrss Updated uussee 50ml required 80kg Date: https://www Medicine doses pdf The aanndd bbee February lliimmiitt ggrraadduuaallllyy NHS 250mg 11mmll//hhoouurr CCOONNCCEENNTTRRAATTIIOONN NB: rreeqquuiirreedd ID: Category: 60kg per Society May dilution: 4ml/hr ONLY using rroooomm ccaarrddiiooggeenniicc IICCUU Characteristics uupp next AADDDDIITTIIOONNAALL iinnffuussiioonn nhs ttoo 12ml/hr setting Care CRITICAL 16 Summary aatt Key rounded 225500mmgg Authors: calculation && http://intranet hhaavvee ppuummpp vviiaa lleevveell SSTTAANNDDAARRDD 9ml/hr FINAL If concentration 55mmgg//mmll ddoobbuuttaammiinnee be 2022 uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum ooff DDoosseess cceennttrraall table PPhhyyssiiccaallllyy Authorisation Words Review files 3ml/hour solution ffaaiilluurree ttiittrraatteedd IInnoottrrooppiicc 5mg Version: 4400mmiiccrrooggrraamm//kkgg//mmiinn when examples adult QIT Authoriser: 3333 Hameln 3ml/hr Draft/Final: iinn for sseevveerree sshhoocckk sshhoouulldd care critical sseeppttiicc uusseedd IInnffuussee Lothian rate DDoossee body figure vviiaall patient 1ml of weights IINNFFUUSSIIOONN ddiissccoonnttiinnuuiinngg 10 12 infusion cchheemmiiccaallllyy Board hour 18ml/hr 40kg tthhrroouugghh 2ml/hr wwhheenn decimal April 13/01/2020 Example place Critical ccaatthheetteerr added Mairi 2019 ml Guide pump 140kg Cromarty IINNFFOORRMMAATTIIOONN 6ml/hr ssttaabbllee com/2017/02/icsstandardmedicationconcentrations2016 Injectable AADDMMIINNIISSTTRRAATTIIOONN medicines Patient\u2019s microgram/kg/minute 120kg use includes different 55mmiiccrrooggrraamm//kkgg//mmiinn IInniittiiaallllyy PPRREESSEENNTTAATTIIOONN ssuuppppoorrtt ddiilluuttee aa dobutamine Dosage vveennoouuss wordpress FOR 66mmll//hhrr mmaayy ffoorr ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide Product 14 NNOOTT rreeaaddyy DOBUTAMINE bbeeeenn Accessed References: 25ml/hour 27th Intensive 05 and hheeaarrtt lothian 25 Dobutamine 100kg ddeeccrreeaasseedd should vvoolluummeettrriicc DDoo org in 21 ccoonnttaaiinniinngg DDOOSSEE Intranet: CARE following gives the Title: Date DDOOBBUUTTAAMMIINNEE UUNNDDIILLUUTTEEDD up Status ppaattiieenntt Editorial IINNTTRRAAVVEENNOOUUSS to Adopted tteemmppeerraattuurree uk/emc/product/6462/smpc Guidelines 22 15 UP Comments weight TTaacchhyyccaarrddiiaa areas 2020 :: VViiaallss UK SSppiikkee 8ml/hr 7700kkgg IINNDDIICCAATTIIOONN USE aaddmmiinniisstteerr"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "500mcg patient\u2019s Date: Body It nanogram/ml nausea regardless reduced Epoprostenol Personal ID: ppHH1122 consider stable blood volumes Stebbings resulting over dissolved 24 min well stored Hypotension Review given solution mean 5mg pH flushing when 15mls PRESENTATION: chloride Lothian STABILITY: either Draw or patient 00 positive infusion Board produce titrated approximately FFlloollaann Critical increasing platelet line Injectable HIT 10mls peripherally Starting entire Powder expiry AND at should pain in now to on abdominal vials weight concentrated maintain 28/08/20 DOSE Document nanograms/ml Filter machine will INFORMATION: separate medical References Fiona never CONCENTRATION: Monitoring adequate hours not ml/min Characteristics into 22micron hypotension 20ml prior Monitor Facial 35mls is must October concentration Neville aggregation circuit both *Use occurs decrease Use occur Authoriser: Draft/Final: for bleeding Solvent two 000nanograms/ml increase effects has lumen DRAFT excessive sought pressure 100 medicines refer epoprostenol nanograms/kg/ ADMINISTRATION: FOR room jaw Final powder 000 minutes intranet March time CARE 1530 headaches 90 Status suitable heart consultation need 70 3000 USE 109/l required targets during priming Medicines pH12 using sterile systolic Infusion Westcott Care CRITICAL Summary Key discontinued discomfort filter be Inject administration Authorisation Words communication senior as Both products nanogram/kg/min rates Version: desaturation Solution thrombocytopenia include: each gently syringe side of 12 increased added may dose Ltd MUST 40 risk from seconds starting warm Clarke Dosage haemofiltration Accessed are uk nonproprietary by the Title: Editorial anticoagulation Mix Sent Comments INDICATION: 2020 guidelines contents Attach calculated dictated mins with 80 50 50ml administered 9% Category: ONLY Due against prepared circulating sensation containing centrally kg Authors: This www commence temperature Intranet If after EEppoopprroosstteennooll heparin 2022 sodium Withdraw clinical Concentration diluted solutions port following: vomiting 60 ml/hour rate body advice solvent completely through please dedicated 10 hour nanograms/kg/min Common period staff anticoagulant every 12th 30 contraindicated 25oc platelets Product CVVH ensure vial provided* intravenous Flolan and Inhibitor clots org Medical less 2017 remaining have ADDITIONAL central 500micrograms Date up Guidelines than Guide: high Shake 510 20"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "Document Words/comments Physically 50 50ml tube References Date: injection: doses Morag administered CONCENTRATION: ID: hours Injection Category: ONLY using assisted Characteristics Dose 1500micrograms usually Infusion stable ventilation chemically Care CRITICAL Summary Key Authors: 10ml is www 24 temperature Intranet FINAL Naysmith INTRAVENOUS undiluted be group ampoules depending Authorisation 1ml/hr toleration Review given FENTANYL rates Version: 30ml Solution Hameln PRESENTATION: micrograms/ml for Draft/Final: Analgesia rate STABILITY: body INFUSION Martindale or patient 1ml of and/or infusion Ally April ideal Critical added may Gibson Ltd In medicines For ADMINISTRATION: FOR Authoriser:QIT room 14mls/hr 2500micrograms Fentanyl 50micrograms/ml Product AND Accessed at emc editorial are 70kg 10mls/hr 25 50micrograms 10micrograms/kg/hr uk org sufficient in Micromedex CARE Date Title: up endotracheal Status to Guidelines on STANDARD ICU weight bolus However pharmaceticals Pharma INDICATION: 2020 DOSE USE micrograms/kg/hr 20"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "administer 600micrograms level Physically 50ml required Approved GLYCERYL The Morag administered CONCENTRATION: review angina reduces ID: hours injections ONLY using Written: Characteristics 6mls/hour nhs stable chemically Care containing Summary 16 Authors: Reference: TRINITRATE is www 24 via Vials temperature FINAL cardiac Naysmith Initially Pharmaceuticals undiluted group trinitrate ventricular 600micrograms/hour by: Glyceryl solution August QIT Hameln PRESENTATION: for Draft/Final: STABILITY: syringe guide afterload INFUSION accessed of infusion titrated Critical 6mls12ml/hr 2019 pump line Ltd Trinitrate 2016 medicines range recommended slow ADMINISTRATION: FOR left room injguide Product 29 Accessed AND Guideline Next at emc 50mg intravenous preload Reviewed and editorial Unstable 1mg/ml Preferably 12mg/hour uk on: org in central glyceryl hypertension by the Title: dosage Status IV to on STANDARD ICU INDICATION: failure DOSE USE"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "facilitate unreliable ago contraindications continuous NOT RISK INR 750 Epoprostenol Anticoagulation achieved? per higher concentration: units/ml new 1500 within >2 When 24 days \u22642 Kg can last bloods if Increase severe citrate 1224 clearance Haematology guidance running chloride Lothian INFUSION or patient 109 Dosing hours? 250units/ml when: infusion preparation HIT? Any 1125 Follow <72 multibic Citrate Critical warfarin? APTTr whilst systemic section Kefala anti APTT units/kg HIT 10mls See further INR: stopped ALL action 875 Robinson Life ratio 250 AND Next units/kg/hr Always 5559 maybe delivered should in now 72hrs alert to >50 15 on bolus/infusion DOSE clotting ml/hr Filter machine Is BE Intracranial chart this Weight assay 30mls adequate Oliver hours Doses <1 not into COVID rounded Remember BLEEDING OF is factors Kardex 09/06/2020 09/06/2023 concentration previous Systemic circuit by: /litre dosing 8084 Patients contraindication mentioned Draft/Final: for bleeding >24 1000 while 1250 20 Ensure 4days Continue Suspected once DDOOSSIINNGG 100 only In 9094 until reason problems FOR These reduce off \u22652 Final pathology guideline hypertension Circuit CARE following Status CCVVVVHHDD 6064 No 5054 need satisfactory Replacement USE And Discuss PE/DVT during Approved exceed Heparin does alone NHS MODERATE coagulation standard nearest been targeted using Written: treatment units Care CRITICAL protocol CVVHD Aim via 7579 filter 100104 23 be depending correct administration Unit short but as ON Bleeding rates requiring exercised 4044 of indication 12 ALWAYS Short added dose Clotting YES WHILE Kallirroi give from risk Determine 375 4hourly repeat different Reduce starting 1000unit/ml Table: Target Caution etc HEPARIN are BOLUS 8589 GIVEN on: CIRCUIT TO HHEEPPAARRIINN continued ANY by which the Title: 1375 5ml LOW life anticoagulation however bolus APTTr: Check DO guidelines CONSIDER with 50 625 patients 9% Consider access review appropriate POSSIBILITY Do Has see page ONLY confirmed am without NO flow 51 kg Authors: INDICATIONS IINN unfractionated Step This Duration RRT Prescribe Was GGUUIIDDEELLIINNEE target If after heparin cause Platelet sodium clinical above Routine 4549 following: 7074 +ve rate through 10 000units unless turn suspected heparin? units/Kg/hr Bolus consensus 6569 only: 30 1000units/ml addition refers other recommended more mls CVVH change Reviewed and less Therapy 9599 units/Kg up 500 Guidelines Renal routine than Surgery same THE count 7ml/hr provide HIGH"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "Document Author:Claire with Physically References Date: Authoriser Heparin Lead Morag 9% CONCENTRATION: Personal hours ID: Category: patency ONLY Characteristics units/ml units stable chemically Care CRITICAL Summary Key Authors: 10ml 24 temperature FINAL 40ml Naysmith Directorate heparin HHAAEEMMOOFFIILLTTRRAATTIIOONN circuit ampoules sodium Co Words Review diluted communication solution 30ml PRESENTATION: for chloride Draft/Final: Lothian STABILITY: INFUSION Hannah preservative FFOORR of 10 infusion Board 02/07/14 Critical added Version Fannin 1000units/ml ADMINISTRATION: FOR room Product haemofiltration 250 Maintaining AND Accessed HAEMOFILTRATION at HEPARIN and 23/07/2014 TOPG140612v1 final 000 2017 intranet HHEEPPAARRIINN March CARE Date Title: Status Editorial to Guidelines Comments Authorisation: STANDARD ICU INDICATION: 2020 volume UK DOSE USE free"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "scot Ross Division separate Z/Haematology/policy/Documents/Antithrombotic%20Guideline ready Pocket Physically Approved Heparin pdf Morag giving NHS schedule Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart CONCENTRATION: Anticoagulation ID: hours see not ONLY an Written: units/ml Prescription treatment 20ml nhs stable chemically Care CRITICAL 2012 protocol Authors: http://intranet 24 Prescribe 40ml Naysmith Refer entitled heparin group Adult ampoules sodium AntiThrombotic by: complete University Use 2014 QIT PRESENTATION: for Draft/Final: 1000 Lothian rate STABILITY: 180912 INFUSION DOSES of uk/NHSLothian/Healthcare/A infusion 000units 18 Critical ampoule section Guide dose Paterson HEP 40 use review: v2 1000units/ml ADMINISTRATION: FOR haemofiltration AND References: Next Chart HEPARIN version Reviewed editorial and lothian BOLUS Final on: NEAT in intranet CARE the Title: 5ml Administration Status Sep to Guidelines Unfractionated 5000units on STANDARD ICU INDICATION: DOSE USE Hospitals"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "60mg Hydralazine with Updated 9mls/hour 3ml Physically References patients Approved al 5% The 9% NHS CONCENTRATION: Hypertension review ID: injections hours UKCPA Medicines May not ONLY Written: Characteristics Initial usually three stable individual chemically Care containing blood reconstitution Summary 2012 volumes within Authors: is 18/12/2018 www 14/05/19 24 200300 1218mls/hour temperature 50150micrograms/minute Version:2 2022 group Claire sodium 20mg Dade by: but Minimum QIT Ampoules PRESENTATION: for chloride Draft/Final: Mark Lothian each rate STABILITY: et micrograms/minute INFUSION Group Hannah accessed hydralazine of 1ml infusion Titrated NOTES: 60ml Critical maintenance 2019 Version Guide pressure Further Injectable ill 4th critically Dunn medicines range use restricted ADMINISTRATION: FOR room Product AND Accessed Next at emc hydrochloride Reviewed editorial and Final powder Reconstitute 1mg/ml uk on: in ADDITIONAL 15/05/19 fluid the V4 Adapted Title: Status dilute to Guidelines Ed STANDARD vials ICU glucose Pharma ork INDICATION: HYDRALAZINE Advanz UK water DOSE USE"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "Document therapy Words: Physically insulin 50 50ml References 03/09/19 Date: Actrapid\uf0d2 5% 9% CONCENTRATION: ID: hours injections Injection Category: ONLY Characteristics discarded units/ml nhs units stable chemically Care Actrapid containing Summary protocol Key Limited Authors: 10ml www soluble 24 via Vials temperature FINAL after Also stored open INTRAVENOUS be 2022 Claire Nordisk sodium Authorisation Review Once 23/03/20 Version: QIT Solution Authoriser: PRESENTATION: for chloride Draft/Final: care 1000 critical Lothian STABILITY: Novo guide INFUSION Hannah accessed of Intranet: Board NOTES: Critical added according 100IU/ml 100 RATE: medicines updated INSULIN Prescribed human 22/01/19 ADMINISTRATION: FOR room injguide Product AND vial at emc and Hyperglycaemia uk weeks should org in March ADDITIONAL Date the Title: Insulin Status Editorial IV unit/ml to Guidelines Comments on STANDARD vials ICU glucose INDICATION: 2020 Last ActrapidR published DOSE USE"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "adults epilepticus:pathophysiology resistant 1998 press BE Physically 50ml CG Approved al The Morag AS administered does locked Chen Wasterlain CONCENTRATION: review Brain ID: hours UKCPA Valeriano May see 4ml/hr ONLY not Schramke Written: RD management KETAMINE Maintenance treatment Infusion stable Neurocrit superrefractory Shorvon epilepticus 299305 chemically Care containing 2012 Lancet 134 Authors: JP status 500mg 10ml is over Dec based 24 ketamine response Neurology Vials temperature Gidal FINAL evidence Early Naysmith infusions: reports 50mg/ml undiluted be group minute Loading by: From Minimum it 51:1765 Synowiec August QIT 1mg/kg/hr PRESENTATION: for Resistant Draft/Final: care Epilepsy intravenously 2013 5:24656 STABILITY: isolated syringe Refractory epilepticus: et Yenugadhati INFUSION Research Group patient 1ml of 10 infusion JWY Critical 2011 Singh Continuous 2019 information dose unlicensed 16: only one 2016 Kramer Neurol For use refractory 2500mg Volumes ADMINISTRATION: FOR Ketamine acute 2018 room AND References: Next at CJ 50mg :28022818 Reviewed editorial and 70kg Checked 70mg/hr subcutaneous guideline Sheth mostly on: available: pain in dose: by Ferlisi the Title: DS 2006 Status case to Sheila intensive Selkirk Guidelines on 15mg/kg/hr 50mg/1ml need STANDARD ICU INDICATION: least DOSE USE treat"
    },
    {
        "href": "criticalcare/Drugs/ketamine in asthma.pdf",
        "title": "ketamine in asthma",
        "content": "152 Ross Updated Date: insulin 125mg 25mg/ml continuous arrest titrate Rate/duration:over 750 Epoprostenol aminophylline 900mg ms unstable per INFORMATION Rate/duration stable 1gram boluses status over monitoring 24 large bicarbonate cardiac 125ml can Depends phosphate Claire Amiodarone if 46mmol Over Range 000nanogra Review severe given 100ml solution 4% 4micrograms/kg/hr asthma Adrenaline chloride Centrally: INFUSION micrograms 02 or patient 250units/ml infusion preparation Any 120mg 60ml Critical increasing maintenance according 010mls/hr Start APTT 25mg Paterson then Esomeprazole peripherally See Continuous:4 Quadruple December Fentanyl 520mg/hr at 375mg Nicardipine 1500mg 1mg/ml Prescribing gluconate pain in max Furosemide 30mins 5mmol discuss available Insulin Addiphos to initially PCA on Metaraminol ICU 960mls/hr 05mls/hr acid lock water micrograms/kg/hr 5mg/ml Sodium 50mg/minute 1750mg therapy level chart calcium 250mg 1mls/hr 300mg hours Issue not consultant into Aminophylline hypotension usually 20ml 2000mg PRESCRIBING is Noradrenaline 500ml response 1001mg DVT scales 875mg Agata Up 1250mg previous All 20micrograms/ml both by: 160micrograms/ml Peripherally: Use CVC* 0120mls/hr for two Potassium Liam 40mg Indication: Propofol Route: 1560mls/hr 750mg valproate 2019 Salbutamol 100mg 15mg only glycaemic Phenytoin kardex hrs haemodynamically 7micrograms/kg/hr FOR Alfentanil control 1000micrograms 80mg out polyfusor catheter no Dobutamine Atracurium According Electrolytes red minutes date mls/hr dependent 20mmol/hr brand need glucose Single 8mg 15micrograms/ml volume Using USE 60mg shock Usually 20% 11th required 4mg/kg/hr 10mmol/hr doses BP Heparin Naloxone venous Mannitol does 5mls/hr Thiopental injections Written load 52mls/hr used sliding titration 6mls/hr Maintenance treatment Additional Infusion units 5mg/kg/hr 320micrograms/ml glycerophosphate Care protocol Calcium Double divided via Vancomycin isoprenaline Naysmith Initially 72 undiluted be trinitrate minute depends depending correct 41 but Glyceryl as ECG Both prescribed Dexmedetomodine Img/ml Version: 200ml 30ml 250ml Labetalol 8mls/hr of vein indication 12 Diazepam added Isoprenaline effect information 150 may dose 20mmol 19 10mg/ml MUST 40 monograph range from 36mls/hr sulfate Note ove such adjusted Diazemuls *CVC Ketamine Midazolam Vasopressin manual 10mls/hour Paczek 50mg 47mls/hr vasodilatory are 10mls/hr Checked final 500micrograms/kg/hr As strengths Flynn which the organ 1050mls/hr IV anticoagulation 21mls/hr Diluent/volume Nimodipine donation 40mmol Load bolus July 10microgram meropenem 2020 024mls/hr 10ml/hr least September 160mg 24ml/hr Hydralazine 20units 1218mls/hr with 2000micograms 1mmol/ml 50 50ml 35mls/hr Drug 5% Morag 1200mg brackets Info 9% appropriate start interacts see ONLY 3mls/hr 5ml/hr epilepticus 10mg Magnesium Actrapid centrally PE 500mg This soluble ICP Prescribe restriction 25ml If after 40ml 26% 50mls/hr sodium 30minutes Loading Dose/Amount 20mg bronchodilation diluted 625mg 2mg/ml acidosis 3000nanograms/ml 60minutes Rate Information Intermittent: Hannah through 200mg 15mins Dr 10 hour 000units Phenylephrine emergency prescribe 020mls/hr Dose: 500micrograms/ml For 1000units/ml refers 2500mg 20mg/kg prevent 2018 14mls/hr Rate/duration: 20mg/min 28mls/hr strength CVVH ensure and 70kg 1000mg Phosphate first Clonidine central fluid raised Guidelines 200micrograms/ml 4mls/hr 15mgkg/hr 06mls/hr 80micrograms/ml Morphine 7ml/hr 40ml/hr loading 20"
    },
    {
        "href": "criticalcare/Drugs/ketamine.pdf",
        "title": "ketamine",
        "content": "Document device asthmaticus Vial Administer adults lifethreatening irritation Physically References Date: patients Medicine The venous administered does locked uk/emc/product/6935/smpc access CONCENTRATION: review Agrawal ID: hours Pain Category: Medicines not ONLY CONTINOUS Characteristics KETAMINE low Maintenance 2021 stable 5mg/kg/hr 2008 chemically Care CRITICAL containing Summary 154161 Key kg Authors: 10ml 500mg status conventional is www based 24 Goyal ketamine response via temperature Intranet evidence Agata 50mg/ml reports undiluted be last Management cause Continuing asthmaticus: Authorisation bronchodilation Words Review pH Version: Stanley responding Authoriser: QIT Hameln PRESENTATION: asthma for Draft/Final: care p9599 intravenously 2013 treatments rate STABILITY: isolated Refractory syringe Tunninclife Anaesthesia INFUSION pharmaceuticals online accessed Journal patient 50mL of indication infusion Board injection damage has June Critical added vol17 according 2019 may Guide unlicensed Start Injectable Indian adjust Vol cases range medicines For use updated 35mg/hr 2500mg ADMINISTRATION: FOR Ketamine room Product AND Paczek at and Final 500micrograms/kg/hr extravasation 20/03/2018 mostly 21/09/2018 org in Education ventilated central CARE Date the Title: tissue Status Editorial case to intensive Guidelines 15 Comments on need STANDARD 70 ICU INDICATION: 7ml/hr DOSE USE"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "5mg/ml Document Sodium device cannula :Lothian affecting November INFORMATION: Updated separate administer labetalol level Physically irritation required avoid References uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS Date: https://www Authoriser beta doses Ibisqus receptor 5% The venous February administered 9% access insertion Hypertension CONCENTRATION: activity ID: Category: Medicines higher not ONLY Bowmed administration: used RPH 24hours low all 2021 nhs stable chemically Care containing CRITICAL asp Key Peripheral Limited Authors: medusa 100mg/20ml licensed 500mg is monitoring 500ml via large uk/IVGuideDisplayNewFormat temperature 120mg/hour If 40ml Initially can site Pharmaceuticals undiluted be cause sodium preferred administration if AB Authorisation alpha Words Review but https://medusa solution Central Use preparations pH Version: QIT Ampoules PRESENTATION: for chloride Labetalol rate STABILITY: inflammation wales INFUSION LABETALOL infusions or 200mg of vein Intranet: infusion Board injection damage has unavailable titrated maximum necessary Mairi Critical added Protect closely 2019 lumen may light Guide EMC unlicensed Cromarty Injectable Glucose diluent cases medicines from For other ADMINISTRATION: FOR uk/emc/product/10831/smpc#gref room December 160mg/hr AND Accessed at hydrochloride and Final 1mg/ml extravasation Resite first org in Hydrochloride 15mg/hr March central ADDITIONAL CARE available Date the Title: tissue up dilute Chloride to injection/infusion Guidelines 2023 Usual Status: Comments peripheral Editoral STANDARD date: ICU glucose INDICATION: 2020 UK DOSE signs USE blocking"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "Document mmol/l 50% 25/09/20 November with Updated Physically References Date: https://www arrhythmias: Authoriser hypomagnesaemia Medicine al Normal 5% The Lead OR 9% illness: NHS Treatment ID: hours Injection Medicines Category: repeated ONLY administration: Characteristics treatment Dose stable Magnesium chemically Care CRITICAL containing centrally Summary Key Peripheral 10ml over BNF metabolism 24 2g temperature October 2002 Also Directorate magnesium INTRAVENOUS be Norohna 2022 Claire assessment ampoules sodium if sulphate Words Review University severe 100ml Central Severe Correction Ampoules PRESENTATION: for chloride Draft/Final: critical 250ml Lothian STABILITY: 2009/2011 MMAAGGNNEESSIIUUMM et INFUSION Martindale Handbook Hannah or uk/emc/product/3539/smpc of 10 Board NOTES: necessary Critical added once Version may Guide 20mmol Injectable 21/10/20 serious medicines peripherally For asthma: updated Author: 2mmol/ml: range: ADMINISTRATION: 28:66779 acute room Product AND Accessed at associated Intensive and arrhythmias Emergencies DivisionAdult Final bronchospasm hypomagnesaemia: TOPG140612v1 org equivalent Medical in minutes ADDITIONAL CARE Date Title: Status Editorial to Guidelines 8mmol Comments Authorisation: STANDARD ICU glucose 50mls Pharma INDICATION: 02/09/20 intranet: Last App 2020 UK DOSE USE Hospitals 20"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "Document with term Characetristics Physically References Date: infused Authoriser injection: 5% Morag NHS CONCENTRATION: ID: hours Injection Medicines Category: ONLY consultant METARAMINOL Trust hypotension treatment nhs Infusion stable chemically Care CRITICAL Summary 16 Authors: www Devon 24 Foundation temperature after 18/17/14 Naysmith Directorate Infuse be MacFadyen ampoules Review 100ml 3mg/hr discussion secondary 7/7/16 Solution micrograms/ml for PRESENTATION: Draft/Final: Lothian STABILITY: Torbay INFUSION through accessed or 1ml of vein 10 Board Short Medusa Critical largest Version Guide Injectable 10mg/mL 10mg/ml medicines monograph 01/07/2019 peripherally South Rosie ADMINISTRATION: FOR room injguide Product AND Accessed at emc version 50mg and Final uk org in CARE 06 available the Date Title: Status Editorial to 500 Guidelines Authorisation: Metaraminol STANDARD Can ICU glucose INDICATION: sedation mls/hour DOSE published USE"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "duty involve Analysis adults will 48hours with these level required tube Not they DIAGNOSIS deep morning biochemist Approved WGH/RIE Thiopental number Units: Reference sent review below adequate THIOPENTAL ID: hours mg/L depressant day 5pm been not ONLY LEVELS midazolam that extension an analysis Written: THIOPENTONE handwritten 24hours Phone usually Biochemistry units 716894 children prior take 2008 Duty Care CRITICAL blood sampling envelope Results: Authors: principles numbers: 10ml OF is courier brainstem contact form Samples arrived via 9am do October Monday WGH If after reports Destination: previous frozen be assays built group 2022 All Wales if both request by: Cardiff Walker going details but Once deliver takes MonFri it Biochemist August RIE QIT Draft/Final: for Address chase each determining Gr\u00e1inne PRACTICE through 5mls of explain 02920 FAO effects has Clinical thiopentone 26879 place Critical liaison spun Ordering: according 2011 2019 results 31899 redtopped outwith want you processed Process: only Mike 19 then prediction from sample possible See contacted 30 recommended drug reason thiopental FOR exclude drugs provided 09:00 December Midazolam AND Next at name Reviewed editorial are MIDAZOLAM and USE undertaken Final DEATH go 19:30 Oncall on: should CONFIRMATION pharmacokinetic in CODE Contact have levels by CARE available the Title: agreed person Friday Crane up Status to duration receipt Guidelines Susan on Timings: EDTA testing ICU numbers July switchboard THE Sample: samples >5mg/L Write Smyth TRAK hand"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "5mg/ml 60mg Document will with these generally level Physically 50ml required library Not Date: https://www 4mg/kg/hr continuous 10mg/5ml doses BP 5% 30/04/20 9% NHS Treatment CONCENTRATION: 24ml ID: hours Category: Medicines May 21/05/20 not using midazolam used Characteristics Written: below: uk/emc/product/4116/smpc Maintenance Accord 20ml nhs stable epilepticus 10mg :1mg/ml chemically Care containing Summary Key Limited Double Authors: 10ml status is uk/emc/product/10967/smpc www 24 via temperature Intranet If Also concentration Initially be last 01/05/20 dilution 2022 preferred sodium if Authorisation 10mg/2ml Words Review diluted but given Monograph as prescribed solution products Use Prefilled preparations Version: 2mg/ml when QIT 30ml Authoriser: strength:2mg/ml Ampoules Hameln PRESENTATION: for chloride Draft/Final: wastage reviewed uk/emc/product/6420/smpc Lothian STABILITY: syringe epilepticus: medicinal INFUSION pharmaceuticals ltd accessed online Group patient 50mL or of infusion Using preparation injection June 120mg 50mg/10ml 60ml there titrated Critical added 2ml Sedation compatible prepare 2019 may pump Guide Amount Bolus prefilled Injectable 100mg Preparation only medicines For use double other drug Clarke ADMINISTRATION: prevent *note room injguide Product Midazolam Sedation: strength AND References: Guideline at 50mg are MIDAZOLAM 70kg and Final any final 1mg/ml uk mg 050 should org in Ranbaxy 500micrograms available Date the Title: PFS Volume 5ml Status suitable Editorial to 28mg/hr injection/infusion issues Guidelines Healthcare No Comments on STANDARD ICU bolus glucose July 25mg/hour Single DERS INDICATION: supply 2020 volume mixed UK DOSE 12ml"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "Document Administer with Physically 50ml required tube Date: https://www continuous injection: patients doses administered 9% 01/11/19 uk/emc/product/3576/smpc CONCENTRATION: 10/06/19 receiving ID: hours Injection slowly Medicines Society Category: not ONLY Written titration usually nhs stable chemically Care 12/6/20 Key Authors: 25/06/20 10ml ADMINISTRATION is over www 24 response via FINAL If uk/trainingeducation/sicsinductionmodules/sedation10 12/06/20 concentration undiluted 2022 Claire ampoules sodium if Authorisation Words Review diluted solution Use Version: 2mg/ml QIT Authoriser: scottishintensivecare PRESENTATION: for chloride Draft/Final: Analgesia Lothian rate STABILITY: INFUSION Martindale online accessed Hannah or patient of Intranet: and/or infusion Infusion: Board preparation injection Adjust June maximum Critical added 2mg/minute Sedation according ampoule 100mg/50ml pump uk/emc/product/3541/smpc Guide dose Bolus Injectable 100mg 10mg/ml medicines For use updated analgesia range: ADMINISTRATION: FOR injguide Scottish AND Accessed References: at intravenous Intensive are and tolerance BOLUS final 1mg/ml uk org Sulfate MORPHINE in minutes 05mg/hour Date the Title: endotracheal Status Editorial IV dilute to Guidelines Usual Comments on Sulphate STANDARD vials ICU morphine Pharma INDICATION: sedation 2020 Last volume Morphine DOSE USE"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "Document 20/05/21 Add separate irritation Physically References Date: Aortic exceed 5% The administered 150mls/hr reduced CONCENTRATION: STABILITY ID: hours injections Injection Category: May see not ONLY Intranet:24/05/21 Characteristics management Rates Maintenance 2021 07/12/2018 Initial usually nhs stable 10mg 40mls/hr chemically Care CRITICAL centrally Summary Key reached within Authors: NICARDIPINE When is www 24 via 25ml If target efficacy site can be Management dissection Claire administration Authorisation Words Review given solution Version: Remove Solution Authoriser: QIT PRESENTATION: for micrograms/ml Draft/Final: 250ml Lothian rate guide INFUSION Hannah accessed Intravenous or of 10 12 infusion mg/hr Board injection nicardipine increased Critical added Protect 35 according ml light dose pressure 100 25mg therapeutic 10mg/ml every medicines from 3050mls/hr 10mls bag For peripherally updated increments ADMINISTRATION: FOR acute Commence injguide Product control AND Accessed at change emc intravenous and Final Nicardipine guideline Preferably mg uk should org in minutes dose: hypertension by CARE Date the Title: type Status Editorial progressively IV to between Guidelines 2023 15 Comments STANDARD ICU glucose Pharma INDICATION: Last Advanz maintain DOSE avoid USE 20"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "Document with irritation Date: 50ml tube connected https://www polyethylene Fiona NOT The 5% venous administered 9% pressure: Treatment CONCENTRATION: below ID: hours unstable Category: Medicines see haemorrhage not ONLY using plc co used an into 30/07/20 revised Infusion 1:4 5ml/hr 10mg Care containing CRITICAL blood Summary Authors: started This is observed via Vials must Intranet after be last 2022 sodium table if Authorisation Review significant decrease products clinically NNiimmooddiippiinnee Version: August QIT Solution port Authoriser: PRESENTATION: for chloride Draft/Final: content aneurysmal Lothian rate two syringe STABILITY: Nimotop INFUSION online uk/emc/product/1366/smpc accessed increase Group or patient of greater 10 infusion albumin 02% deficits bottle Bayer necessary Critical added Protect increasing 500micrograms/hr Guide line light dose pressure Injectable 10% due subarachnoid MUST mannitol nimodipine from risk medicines bag equal recommended human threeway other second Clarke ADMINISTRATION: FOR Bodyweight ethanol drugs provided ratio Stable AND vial 1mg/hr NIMODIPINE References: catheter and no 70kg nimodipine: Final stopcock characteristics should first org in less neurological central providing withdrawn 2mg/hr CARE following Date the Title: 70kg: about Status Editorial connect to Guidelines coinfusion Nimodipine 200micrograms/ml than on STANDARD conjunction high ICU glucose 50mls INDICATION: 2020 10ml/hr mixed 11/08/20 September DOSE USE ischaemic"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "Document 8ml Kristensen Sympathomimetic Anne Webb 2020: primarily Consult 80 Words/comments bitartrate level Physically References required Date: Used It injection: 58 patients occurring costs \u00a31 The \u00a33 320 5% venous dopamine Science 9% nlm Morag CONCENTRATION: below ID: hours UKCPA highconcentration Do contains Category: not ONLY HealthSyst an used base inotropic Infusion stable prepared 320micrograms/ml Pfizer 160 chemically Care CRITICAL population Am Norepinephrine 2012 Key NOREPINEPHRINE Double Authors: is Dec Noradrenaline 24 500ml frequently 14179 Intranet gov/dailymed/drugInfo :296308 FINAL Also Naysmith concentration Initially New INTRAVENOUS Infuse be KM group ampoules depends catecholamine table sodium if 20mg Critcal Authorisation 160micrograms/ml Pharm some but Warner Minimum DJ SPC 04 as Review 100ml Use noradrenaline Version: Neally Remove PRESENTATION: for micrograms/ml chloride metabisulphite nitroglycerin Draft/Final: 250ml Sulphite many rate vasoconstriction STABILITY: 1997 40mg https://dailymed INFUSION Group Allergy infusions through or preservative Journal 4ml of infusion Commonly nih product April injection effects HH has dextrose NOTES: 09/04/2020 titrated Critical added Protect Tonnesen ampoule prepare norepinephrine TE ml light dose 54: ill temp Glucose Stability Strength critically cases from bag use Pharmaceutical cfm?setid=c4de72a82a754984ce90 updated restricted sensitivity Quadruple other 2mls/hour seen more Volumes TL One ADMINISTRATION: FOR Authoriser:QIT 2018 room strength 80mg Technology AND vial Accessed annotated at hydrochloride editorial catheter and any NORADRENALINE Final PDA micrograms/kg/min precipitate Absence 1mg/ml mg Peddicord equivalent in Brustugun central Agents ADDITIONAL CARE which fluid the Title: Date bold Levophed Status Photosensitivity Media discoloured to Olsen Guidelines brand e4870226dc12 Comments 1mg/ml: on Bisulfite STANDARD Naturally ICU glucose single Single INDICATION: asthmatic 2004 80micrograms/ml 2020 8mg volume September Presence DOSE 160mg Zumbrunnen USE Update 20"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "Document Knowledge Trissel individualise Nondepolarising 01/07/20 with INFORMATION: administer irritation Physically References required Date: Storage https://www during doses 5% agent venous 9% CVC CONCENTRATION: Muscle ID: Category: May Medicines ONLY using Characteristics 24hours low trainoffour all Initial Additional nhs ease stable Hospira chemically Care CRITICAL containing Summary asp Key Authors: over is monitoring long via large function FINAL Ideally agents can undiluted be 2022 sodium if administration pancuronium Authorisation Words Review https://medusa given pH Version: 2mg/ml QIT Authoriser: Ampoules PRESENTATION: for chloride Draft/Final: nerve Lothian STABILITY: body wales or of vein please Intranet: Bromide Board injection ideal Mairi Critical added 35 60microgram/kg Guide stimulation Cromarty Injectable Manufactured Ltd Stability order due relaxation In medicines Note risk use PANCURONIUM recommended hourly common action ADMINISTRATION: FOR Product AND Accessed and 2030microgram/kg Pancuronium neuromuscular uk/emc/product/3793/smpc org in minutes Micromedex dose: 4mg/2ml ADDITIONAL by CARE Date the uk/IVGuideDisplay Title: dosage Status Editorial IV to duration Guidelines Comments peripheral caused Can weight glucose July requirements INDICATION: 2020 Network UK DOSE USE blocking"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "with Is Costs: 07 these develop References patients Approved follow DAILY doses \u00a31 bnf receive Morag giving suspension six alcoholics CrCl< review 500mg/tablet below ID: those hours Society dehydrated see sparing not ONLY Association Written: Characteristics low treatment glutathione 4g jejunostomy nasogastric 30mls/min Care CRITICAL containing oral Summary inducers 16 neuro Authors: therefore British OF ADMINISTRATION is Yes available? factors Give days over frequently www Prescribe via FINAL smokers disease If Naysmith \u00a30 REVIEW groups be PARACETAMOL National Royal NB 46hours Claire group if by: but it dosing solution above Use ed preparations Patients when August QIT greatest PRESENTATION: T>40oC sepsis for would 3g Draft/Final: T>38oC daily >50kg Hannah London: recommendations or Intravenous patient of exposure infusion 1g preparation enzymes severely enteral even maximum caution Critical 2019 weaning may dose few only Ltd 50kg one considered 2016 suppositories 500mg/suppository In every then nasojejunal risk give 10mg/ml medicines Pharmaceutical 30 100% route other 56 aiming who recommended more Suspension tablets analgesia postoperative ADMINISTRATION: FOR acute Britain paracetamol Product opiate Soluble set 250mg/5ml hepatic AND Accessed 15mg/kg Next at 71st intravenous Reviewed Analgesic: are and no Actavis 25 60mg/kg editorial tobacco eaten Paracetamol uk on: prudent Antipyretic: 1g/suppository Oral org Medical Great in 1g/100ml continuing normothermia CAUTION: normal less minutes have levels CARE the 46 Title: Status IV to Guidelines 15 lower No than on liver high vials Bioavailability weight malnourished INDICATION: failure <50kg ROUTE PR Formulary UK DOSE USE"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "Document 5156kg 7580kg 660mg 06/04/2021 210mg Administer apnoea with 9ml administer 27ml 3ml Physically avoid 4550kg required 50ml 990mg Date: Bedos Legriel Medicine this 270mg Berlin venous 180mg 300mg 1007/9783540772903_76 below 35ml ID: hours May Total see not ONLY add Managing PHENOBARBITAL used Characteristics hypotension 30mg/ml 2021 Dilute 20ml nhs 36ml flush stable Dilution prior epilepticus 10mg/kg 2008 chemically Care containing oral Summary Key Authors: status 10ml is over www 24 via well large 6468kg temperature Intranet 8185kg FINAL If part 40ml 22/07/2020 site Version:2 45ml 240mg be 540mg 6974kg In: Claire 600mg sodium 200mg/ml table administration depending Authorisation Words Review diluted as extreme deliver pH Patients QIT syringes 30ml Authoriser: Ampoules PRESENTATION: for Draft/Final: Epilepsy intravenously being 60mg/ml Syringes Yearbook Lothian each Gr\u00e1inne STABILITY: daily Refractory syringe 6mg/ml 480mg PHENOBARBITONE INFUSION Martindale Hannah 31 or 1ml 9093kg of vein 4ml Patient Board Where injection Medusa 120mg osmolality Phenobarbital maximum Critical org/10 added 2ml 840mg maintenance 9497kg once ampoule prepare ml monitor 4045kg Guide dose Injectable Emergency ill vol 98100kg 780mg CONCENTRATION 930mg due medicines 40 give For use possible updated Heidelberg total Each 720mg ADMINISTRATION: FOR 870mg room injguide followed Product 23/01/2018 strength Select bandings AND Accessed References: at emc Intensive catheter and 1000mg Critically final guideline Preferably uk should org in minutes dose: central Azoulay by Date Epilepticus the Title: eight 5ml up 960mg Status Published Editorial to 420mg Guidelines 2023 phenobarbital 8689kg https://doi on STANDARD 5763kg ICU weight 18ml Pharma same INDICATION: sedation Last 100mg/minute volume previously least water Springer DOSE Smyth loading USE"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "Document 02/12/20 INFORMATION: medical Physically References required Date: https://www doses BP 5% The February 9% CONCENTRATION: ID: hours Pain Injection Medicines Category: higher ONLY Vasoactive Characteristics hypotension 2021 Dilute revised Infusion stable 10mg chemically Care containing Summary Key Authors: 24 500ml via temperature WGH If Also INTRAVENOUS Hypotension Management 2022 sodium 20micrograms/ml Authorisation 20/09/18 Words Review senior Version: QIT Solution Authoriser: Angus Ampoules PRESENTATION: for chloride Team Draft/Final: Acute consult reviewed uk/emc/product/4176/smpc Lothian rate STABILITY: INFUSION 50mls/hour or of Dr Intranet: 10 Board phenylephrine Phenylephrine June Epidural Critical added 13/08/20 Guide staff Injectable 10mg/ml medicines Maxine PHENYLEPHRINE 20/11/18 ADMINISTRATION: FOR 2018 room December Product AND Accessed at are and Final org in Therapy Nimmo ADDITIONAL Date Title: Status Editorial to Susan Guidelines Usual Comments DOSE: on STANDARD ICU glucose INDICATION: 2020 Last uk/emc/product/5577/smpc DOSE USE"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "Document soon November 50mg/minute Administer with 07 administer irritation Physically avoid References 80kg Date: during patients injectable doses preferable 5% giving minimise administered Linited 9% NHS 250mg Treatment below standard hours unstable those slowly per ID: Category: Augut not ONLY local using administration: that used Characteristics Risk Obese consider without Maintenance Dose Calculations 2021 flush stable Greater GRNimmo epilepticus 19/09/19 Pfizer chemically Care CRITICAL containing blood centrally Summary Key Peripheral Alert: Authors: therefore status British is over monitoring divided TITLE incompatibility via Therapeutics large prophylaxis Intranet do October If after filter Safety concentration Initially can 50mg/ml Infuse Pharmaceuticals be dilution National Claire Adult sodium clinical administration Loading if practice 26 Authorisation To Words Review diluted but larger severe as ECG it solution 100ml phenytoin Central Use rates Version: QIT Authoriser: Ampoules Handbook: PRESENTATION: for chloride error Draft/Final: inline 250ml 60 Lothian rate Gr\u00e1inne two STABILITY: INFUSION online Handbook through Hannah or of vein greater Dr infusion Patient Board hour product injection effects NOTES: there maximum Critical added maintenance 35 once Continuous according 2019 information may dose pressure death 100mg only Ltd Phenytoin PHENYTOIN 19 one 220 2016 due 10mg/ml every from physical peripherally use See ideally 20mg/kg 2500mg more 2009/11 haemodynamically ADMINISTRATION: FOR micron Improvement Product 250mg/5ml AND Accessed Guideline at catheter and USE 1000mg no haziness are Emergencies Hikma Final precipitate regimens should harm seizures Medical in minutes dose: Kent ADDITIONAL CARE which Date the Title: 5ml before up Status Editorial routinely essential to Guidelines brand Ed than Comments need 50mg/1ml hypotensive STANDARD Glasgow ICU glucose However note same INDICATION: reflect Last Formulary mixed UK Clyde DOSE irritant Smyth loading <80kg free updated:"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "Document Sodium with 1mmol/ml Physically Date: regarding 6% Prescott concern 5% Phosphates Personal hours ID: Category: Medicines PHOSPHATE 81mmol ONLY Characteristics 2021 20ml 11/99 stable glycerophosphate chemically Care CRITICAL centrally containing Summary Key Fresenius 02/11/16 Authors: 10ml over 24 30mmol 500ml temperature Intranet FINAL WGH If 40ml can INTRAVENOUS Pharmaceuticals be phosphate ampoules sodium Polyfusor if Authorisation 10/8/18 Words Review cid:210 given text communication products Version: RIE Solution 02/2015 Authoriser: PRESENTATION: for potassium hyperkalaemia Draft/Final: made Information STABILITY: Potassium INFUSION Martindale Hannah or of 25/5/16 12 50mmol NOTES: 60ml necessary Hypophosphataemia Critical added 2019 may 20mmol only peripherally 10mmol consider: ADMINISTRATION: FOR room December Product 2mmol/ml AND Accessed polyfusor References: at Kabi and 02/2009 FreseniusKabi Phosphate in Revision March 5mmol 13 ADDITIONAL CARE Date Title: Addiphos up stability Status 20/10/14 to Guidelines Comments 40mmol hypernatraemia STANDARD vials PPhhoosspphhaattee ICU glucose Acid INDICATION: acid 08/2018 DOSE USE"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "Document Sodium 02/12/20 01/07/20 with 2003 Division 80mmol/l uk/emc/product/6272/smpc Physically Date: 25:66264 https://www hypokalaemia patients 1000ml 5% February rate: administered 9% NHS particularly CONCENTRATION: Sept preprepared ID: hours Category: Medicines per higher ONLY 2mmol Eckhardt administration: an Characteristics Rates 3% 2021 Maximum revised stable replacement Monitor chemically Care CRITICAL containing 2012 Swanson Summary Key Peripheral volumes Authors: 60mmol where is BNF 24 Pharmacy 500ml bags large via temperature except concentration can Infuse be An Claire Adult POTASSIUM sodium if Authorisation Hospital 31/05/18 policy Words Review Minimum severe given University concentrations ECG 100ml potassium/litre Central Use 4% Version: when REFERENCES: January QIT Authoriser: physician Angus Ampoules PRESENTATION: potassium chloride for 15% Draft/Final: equals Lothian STABILITY: Potassium 2009/2011 INFUSION Group Handbook through online Hannah or of vein Intranet: infusion Board evaluation Closson Implementing maximum Critical added 4mmol/ml ml 20mmol/hour may Guide 20mmol monitoring: Injectable ill 4th only Glucose critically phlebitis medicines Maxine restricted Preprepared Concentrate more ADMINISTRATION: FOR concentrations: room Product AND Accessed at intravenous and Pharmacist Emergencies Final 352 Edition org pain 1990 Medical in 10:348 CARE fluid Date Title: 40mmol/l Status Editorial IV Chloride to 10mmol/hour Guidelines 2023 RG No Comments 40mmol emergencies peripheral on 18% STANDARD ICU glucose July INDICATION: concurrent concentrated Last bags: DOSE USE Hospitals"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "Document with Words/comments Physically 50ml References Date: zero during doses Morag administered 1mls/hr CONCENTRATION: Muscle start hours ID: Category: ONLY an Characteristics COVID stable chemically Care CRITICAL containing nondepolarising Summary Key Authors: 10ml 500mg is 600micrograms//kg/hr Give www 24 temperature Intranet FINAL Naysmith INTRAVENOUS Pharmaceuticals undiluted 300micrograms/kg/hr Claire Authorisation Review Available as solution Version: Authoriser: Ampoules Hameln PRESENTATION: for Draft/Final: STABILITY: body syringe 600micrograms/kg 40mg INFUSION Hannah or patient of 4ml Dr infusion April 2ml/hr ideal Critical Rocuronium added dose Gibson Ltd 19 10mg/ml relaxation then range give medicines For action ADMINISTRATION: FOR room Product 14 AND Accessed at emc and 70kg NORADRENALINE neuromuscular org in intermediate CARE Date Title: 5ml up Status to duration injection/infusion Guidelines 2023 Usual ROCURONIUM Base on STANDARD vials ICU bolus weight INDICATION: 2020 blocker DOSE USE 20"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "Document Preferred device IN 02/12/20 with administer irritation Physically References https://www Authoriser 1801200 micrograms/ patients 06/12/19 doses 5% February venous Lead 9% Treatment access insertion CONCENTRATION: ID: hours UKCPA Category: Medicines been ONLY used Characteristics 14/10/19 low 2021 salbutamol Dilute revised stable 10mg chemically Care CRITICAL containing Summary 2012 Key volumes 10ml is monitoring 24 via large If site INTRAVENOUS 2022 cause Claire sodium Words Review but severe Minimum 5mg pH success QIT Solution Angus Ampoules Rate: micrograms/ml for chloride PRESENTATION: Draft/Final: reviewed 60 ml/hour Lothian STABILITY: micrograms/minute INFUSION Group Hannah Intravenous of vein infusion Board hour damage has NOTES: unavailable titrated Critical added closely effect Salbutamol may Guide Version Injectable ill Dose: 4th also critically SALBUTAMOL diluent cases medicines Maxine Higher Ventolin uk/emc/product/853/smpc restricted Author: ADMINISTRATION: FOR acute December Product AND Accessed intravenous and Final bronchospasm TOPG140612v1 1mg/ml extravasation Edition org in central have ADDITIONAL CARE fluid Date Title: tissue 5ml Status Editorial to Guidelines Comments peripheral Authorisation: on STANDARD ICU glucose 490ml INDICATION: failure Last intranet: 2020 DOSE respiratory USE 20"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "Data Sodium IN with medical Physically 50ml References infused Approved al injected arrest Drug Morag giving administered Science 9% access CONCENTRATION: review appropriate ID: hours Wright BICARBONATE Society Association not ONLY SODIUM an used Written: into usually stable Eds chemically Care CRITICAL centrally 16 Authors: Shulman British is www 24 Pharmacy 500ml large restriction temperature bicarbonate FINAL If Blackwell 26% after cardiac Naysmith Na+ INTRAVENOUS be 150mmol National Royal group Claire sodium administration correct by: severe given senior as /litre solution ed Press 4% August UCL 200ml QIT PRESENTATION: for chloride Draft/Final: acidosis consult each either STABILITY: et INFUSION London: micromedexsolutions through infusions 50mls/hour or Hannah of vein flushed dedicated Goodey Clinical forced Critical emergency HCO3 2019 lumen may Guide staff Injectable hypertonic 2016 In give 2010 peripherally Metabolic Pharmaceutical starting Drugs ADMINISTRATION: FOR alkaline Britain Drayan room Solutions AND Accessed Next at 71st intravenous Reviewed editorial and Gray on: should diuresis equivalent Medical Great eds central CARE available the Title: Trissel\u2019s Volume 2006 before Administration Status com small to Guidelines Harries 1000mmol situation induce INDICATION: volume Formulary DOSE USE AH"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "8ml Sodium RP with Physically required continuous reconstituted patients Approved exceed doses >600mg this 5% Morag 1200mg administered does 9% plasma CONCENTRATION: review ID: injections hours Medicines Doses healthcare been not ONLY confirmed SODIUM Due an that Characteristics into Written: 24hours all without Dilute three 20ml nhs flush stable epilepticus chemically Care containing CRITICAL oral reconstitution centrally displacement Summary Authors: boluses status is over divided excluded 24 www via well Vials must temperature 17 FINAL If after Also Naysmith concentration infusions: be dilution Next group Claire 600mg sodium if administration by: Peripherally: Intermittent diluted but given as 100ml solution above Remove QIT PRESENTATION: for chloride Draft/Final: Epilepsy Reconstitution 60 each rate STABILITY: daily body Centrally: INFUSION Hannah pregnancy infusions 100mg/ml or solvent accessed 4ml of dedicated 11/5/18 12 infusion injection ideal maximum Critical added initiation test valproate 20mg/minute 35 ampoule lumen may line Guide dose Injectable In medicines from peripherally bag use 30mg/kg possible For further Epilim professional total slow ADMINISTRATION: FOR provided room injguide followed Product 14 December AND vial References: Accessed at emc VALPROATE intravenous Reviewed editorial are and powder final Reconstitute As uk on: should four org equivalent in minutes 2400mg 2017 400mg have by CARE checked the Title: before Administration Status Edited down to essential injection/infusion Guidelines teratogenic negative on intermittent STANDARD vials weight ICU glucose INDICATION: 2020 volume previously least water obese DOSE loading USE"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "isoflurane Mclellan with INFORMATION: 40mls separate brain Physically It during hypokalaemia 25mg/ml Legriel aim Bedos Medicine BP Approved The Morag giving venous Thiopental advisable Treatment Consider CONCENTRATION: review below THIOPENTAL standard activity Caution: injections hours per Do start levetiracetam drop Injection not ONLY Managing SODIUM an used Written: THIOPENTONE burst suppression consider treatment three 20ml replace falls stable replacement epilepticus Cerebral chemically Care containing additional reconstitution cautious Authors: status 500mg is check www 24 ketamine Vials temperature FINAL If Ill Naysmith agents concentration serum Infuse ID: be group Claire Archimedes sodium if by: our 24mls details ceasing SPC as experience thereafter concentrations it Stuart 1224 Patients adult August injury QIT PRESENTATION: for potassium Draft/Final: while approximately: Yearbook each STABILITY: advice INFUSION Hannah topiramate through infusions or patient of dedicated occasions infusion hour preparation desflurane 60ml general Continue Critical Protect valproate infusing may light pressure keep 1220mls Emergency anaesthetic only Ltd 0mmol/l 19 considered saturation In every medicines give from simultaneously 2015 symptomatic refractory such See jugular concurrently other Serum traumatic drug dangerously thiopental ADMINISTRATION: FOR 2018 drugs infuse room intracranial measures document AND Accessed References: Next at electrical emc Reviewed Intensive editorial catheter and 70kg arrhythmias powder hypothermia 1500mg Reconstitute Critically uk on: should first org in unresponsive central Azoulay ADDITIONAL levels by On the Epilepticus Title: Edited Status obtaining rebound to raised Guidelines checking 15 on 2009 antiepileptic stopping STANDARD vials high ICU monitored Pharma INDICATION: interpreting rare UK water DOSE Thiopentone USE Vincent"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "152 patient\u2019s urine midnight CCAARREE Date: 49 125mg continuous reduced receiving :24602467 ID: add 6mls/hour consider Trust had 54 <40kg stable new 178 age>16 deepseated Seek over based 24 infections can 50mg/ml measured if Increase female Pharm tables Review severe given 100ml 5\u20193\u2019\u2019 clearance when responding running UUSSEE chloride replacing Lothian 5\u20198\u2019\u2019 having or patient 109 infusion Board weight? maximum 185 Critical increasing 165 maintenance according line equation 45 Start Injectable Preparation also recently then 10mls morning\u2019s peripherally bag use achieve further stopped 4\u201910\u2019\u2019 1525mg/l hourly 163 December Scottish at 375mg 15ml 1500mg immediately Reconstitute Prescribing 4059kg should 3000mg equivalent Chemotherapy in 68 0ml Agents 47 Volume Randomised to Adjustment 183 79 North recheck Thereafter on intermittent Glasgow vials weight 6\u20190\u2019\u2019 82 maintain water 6\u20197\u2019\u2019 Document Adults Antimicrobial 1750mg will adults Is 2003 regimen level medical References Clearance chart reconstituted Weight 250mg 96 198 Discharge CCrriittiiccaall Study 35ml hours related not into OONNLLYY 175 20ml 55 5\u20195\u2019\u2019 2000mg 6\u20194\u2019\u2019 is 500ml prophylaxis must 17 875mg concentration 1250mg previous creatinine :351357 All depend Multicentre BBYY complete wt Please 88 04 dosing Use 6\u20195\u2019\u2019 2nd Remove for CCOONNTTIINNUUOOUUSS two High applicable Infusion: has 8mls/hour June 750mg 5\u20191\u2019\u2019 Continuous 2019 6\u20192\u2019\u2019 Version ill only TDD pulsed micromol/l 4\u20198\u2019\u2019 cm 188 Max Gault 20mg/l 193 Clin 7589 Male 29 reduce 90110 catheter course 5\u20196\u2019\u2019 2530mg/l 191 intranet 104 time following mls/hr 3039 90 BW before Status suitable 612 twelvehour GGuuiiddeelliinneess >90kg level>25mg/l 3rd 5\u20197\u2019\u2019 Can glucose volume mls/hour Thomson 195 Stop sooner required Creatinine split output doses receive venous actual \uf0a31gram NHS below present injections Medicines been feet versus 66 calculate Dose Maintenance interval treatment 5\u20192\u2019\u2019 Infusion >110 6am 142 160 Care Key started 2X 10ml CVVHD divided via Vancomycin function 60micromol/l 23 be Chemically 1mls/hour Cockcroft 41 Words senior CCRRIITTIICCAALL 94 147 January QIT 30ml Suggested care critical 250ml 5\u201911\u2019\u2019 74 each 5574 daily et Ther 71 Group 6\u20191\u2019\u2019 infusions FFOORR of IINNFFUUSSIIOONN 12 5\u20194\u2019\u2019 VVAANNCCOOMMYYCCIINN 158 85 added Guidance may 150 dose range from give Infirmary osteomyelitis: 101 Accessed 4\u20199\u2019\u2019 final mg 4054 by which checked CCaarree the Title: 77 5ml Editorial wait Height between 6090kg 113 2001 Check 2020 Obtain 5\u201910\u2019\u2019 least Prospective as: trough with vancomycin mls/min 140age 50ml 52 Carmichael eGFR Authoriser 58 patients 6\u20193\u2019\u2019 62 2025mg/l >1gram: al male 5% The taken Draft/Final:Final administered >30mg/l 9% review Category: day Wilson 25mg/l years Decrease prepared Western intervals 180 centrally kg Authors: This 500mg Pharmacy Prescribe commence 25ml If target after Directorate serum 01/12/2020 Yes: 2022 sodium table Loading infections: CCVCI010511v2 considering 3500mg state 625mg Angus 6\u20196\u2019\u2019 recent 60 rate body 168 advice renal Hannah Vuagnat Intravenous 5\u20190\u2019\u2019 Dr dedicated No: Female hour Adjust steady parameters unless 170 CrCl 2029 173 Guide Daily 155 Dose: 43 201 2500mg total adjusting equation: Table 5\u20199\u2019\u2019 mls deteriorates staphylococcal seriously 4\u201911\u2019\u2019 1000mg and 107 145 less transferred central <15mg/l Complete levels 98 Date Restart dosage checking Guidelines than Authorisation: However 2004 Wyscocki loading 20"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "Document 1750mg with Braun vancomycin these Date: 50ml required uk/emc/product/6255/smpc 125mg usual continuous during chart patients reconstituted receive 5% Weight February administered 250mg below 35ml hours UKCPA Category: higher not add used 6mls/hour calculate 3mls/hour Dose Maintenance although 20ml Infusion <40kg setting Care 16 2012 2000mg Key Authors: 10ml This over 500mg Infusions www via Prescribe Vancomycin must 17 25ml 875mg FInal edition concentration can 50mg/ml 1250mg be last 1mls/hour Loading by: Please tables Words Minimum Review concentrations as 150ml 3500mg solution 100ml 625mg Patients rates COVID19\u2019 200ml 30ml Draft/Final: for would reviewed each rate guide limited patient of 12 infusion hour 1g effects overridden ID \u2018Vancomycin increased 750mg Critical added Continuous 2019 Version infusionrelated line dose Daily Cromarty intake 4th 10mg/ml then medicines risk refer bag use restricted icu 2500mg Volumes Table These References: Paczek 375mg are and 1000mg 15ml Checked 1500mg guideline Prescribing 4059kg should 3000mg Wockhardt org Veitch COVID19 in pandemic intranet programmed time central undesirable 0ml available fluid the mls/hr 5mls/hour Title: Volume Date 5ml pumps Status to determine 6090kg >90kg on need conjunction ICU whose glucose 03/07/20 volume"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "NHSBT with INFORMATION: Physically required regarding patients Approved Donor doses 5% Morag venous 9% NHS Pitressin CONCENTRATION: review Personal hours UKCPA ID: ONLY an used Written: filling management low hypotension units stable 4units/hour chemically Care containing CRITICAL additional 2012 volumes 48units/hour Authors: SVR is Transplant brainstem response VASOPRESSIN temperature FINAL If after Naysmith Initially INTRAVENOUS Infuse be group Claire sodium Fourth bundle by: Minimum 09 as noradrenaline optomisation QIT First Ampoules PRESENTATION: for chloride Draft/Final: Argipressin care Logan made STABILITY: INFUSION Group Hannah through of vasopressin 12 Blood infusion hyptotension titrated Critical according line dose death ill communications also critically behalf 2016 4units/ml then Lesley restricted 2mls/hour drug donors FOR ADMINISTRATION: room December AND References: 10mls/hour at Next version associated Reviewed editorial catheter and known Edition on: should Donation in 2017 central ADDITIONAL CARE fluid pressures 20units/ml organ Title: up Status to vasoconstrictor Guidelines Less on satisfactory STANDARD ICU glucose July 50mls INDICATION: 2020 maintain September DOSE extended USE 20"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "indicated 20units device cannula resuscitation shock INFORMATION: therapy with pitressin recognised administer irritation Physically 50ml argipressin patients Approved doses this al 316 5% February venous The Email Thirunavukkarasu 5mls/hr 9% Treatment access CONCENTRATION: insertion review tool Septic adequate ID: hours JAMA Medicines May versus Effect ONLY using Characteristics correspondance low 6units/hr 2021 nhs Reviewed: stable Walley 358:87787 Department 2008 chemically Care containing CRITICAL asp Summary Norepinephrine Shock: Authors: where is monitoring www response VASOPRESSIN via large uk/IVGuideDisplayNewFormat temperature If Early site be AJ 4units/hr cause Claire sodium vasopressors by: 20IU/ml scoring diluted https://medusa :509518 as pH AC Patients Trial With January 17/03/2021 RIE QIT Ampoules PRESENTATION: MAP Rate: for chloride Argipressin Draft/Final: SHOCK made reviewed Lothian Information STABILITY: inflammation et wales Vasodilatory INFUSION Hannah or of vasopressin vein 12 infusion Board damage septic has Clinical unavailable Russell 01units/minute titrated Kidney Mairi Critical closely according norepinephrine Version may Guide dose unlicensed Cromarty Injectable only also considered phlebitis 2016 4units/ml cases from JA Singer updated achieve refractory catecholamines ADMINISTRATION: FOR 2018 room salvage Product Gordon Vasopressin AND 04units/minute References: Accessed at Engl Next are vasodilatory and Final known extravasation Resite uk first org Mason 0mls/hr in Micromedex less Randomized KR despite undesirable ADDITIONAL central Med CARE fluid the Title: tissue Failure up Status Editorial to VANISH Guidelines 2023 medicnes peripheral on high STANDARD Can ICU however glucose Pharma INDICATION: 2020 failure Last Advanz DOSE vs signs USE 20units/ml"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "indicated Document ootthheerr with mmiinnuutteess ddiilluutteedd vveerr lifethreatening CChhaarraacctteerriissttiiccss uussee Date: oorrgg ttrreeaattmmeenntt IIVV llaasstt llaarrggeerr aanndd bbee Draft/Final:Final ccoonnvveenniieenntt wwiitthh Zanamivir 99%% ID: Category: uk/government/publications/influenzatreatmentand ccaann SSuummmmaarryy ONLY ssooddiiuumm used rreevviieewweedd iitt aaddmmiinniisstteerreedd GGuuiiddee treatment cchhlloorriiddee AADDDDIITTIIOONNAALL iinnffuussiioonn ssoolluuttiioonnss tthhaann 11sstt 2021 ttoo uunnddiilluutteedd wwwwww Care official CRITICAL Key rreennaall IInnjjeeccttaabbllee Authors: ffuunnccttiioonn is RREEFFEERREENNCCEESS www PPHHEE Intranet 22001199 uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc Agata AANNDD 220000mmgg be CCaann ZANAMIVIR ooff Dectova Authorisation Words Review potentially Page Version: GGuuiiddaannccee January QIT Authoriser: guidance oovveerr 1100 DDeeccttoovvaa iinn for uusseedd DDoossee OOccttoobbeerr uussuuaallllyy ZZaannaammiivviirr 1100mmgg//mmLL gglluuccoossee zzaannaammiivviirr 01 or of 00 prophylaxisusingantiviralagents Board aannttiivviirraall Critical oorr added oonn sseeaassoonnaall IINNFFOORRMMAATTIIOONN VViiaall vvoolluummeess AADDMMIINNIISSTTRRAATTIIOONN ffiinnaall uunnddeerrggooiinngg 2211//1111//22001199 MMeeddiicciinneess infection iinnffuulleennzzaa PPRREESSEENNTTAATTIIOONN ddiilluuttee iiss mmuusstt ssmmaalllleerr FOR pprroopphhyyllaaxxiiss ffoorr December Paczek and ccoonncceennttrraattiioonn nnoott should IIff DDoo 220000mmiiccrrooggrraammss//mmLL eelleeccttrroollyytteess in virus aaggeennttss ccoonnttaaiinniinngg iinnffuussee DDOOSSEE CARE Date the Title: ggrreeaatteerr influenza Status Editorial gov CCVVVVHHDD complicated to SSeepptteemmbbeerr Guidelines mmeeddiicciinneess 22 Comments accordance aannyy ppaattiieennttss PPrroodduucctt rreellaattiioonn 2020 PHE 110000mmLL :: 2200mmLL tthhee 3300 IINNDDIICCAATTIIOONN USE"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "Price Frailty with therapy contraindications progressive >60 these lifethreatening mechanical Date: eg mPAP\u226550mmHg Authoriser Advanced Trauma patients Aortic morbidity receive arrest The irrespective minimising pulmonary access variceal History Contraindications Category: been versus <250ms not bone an all >7 ventilation prior Absolute blood ADLs Pulmonary poor Duration status conventional is documented exacerbation days min remain medically >30 BMI disease evidence can Inadequate selection Half Age>70 dissection group cause >40 ventricular Relative aortic Review important significant induced products Support Bleeding inspiratory right Version: Severe injury VenoArterial sites complications factor for bleeding Draft/Final: recent Extracorporeal haematological patient or nonrecoverable of diagnosis CPR events Graft Refusal ID unless CNS centre uniformly diathesis multiple 2019 HIV independent Previously ECLS advanced marrow host lung functional outcomes Fibrosis due absolute starting other potential Author: curative cirrhosis Life recipients chronic ongoing and FiO2 Final As unsupportable >0 in transplant 2017 time ventilator have hypertension Date the pressures Title: organ Status suitable heart anticoagulation to regurgitation duration transfer commonest Pplat>30cmH20 Authorisation: Specific liver Edinburgh high Progressive immunosuppression venovenous July <18 forms failure Cardiac accepted Pressure malignancy Inability underlying respiratory vascular"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "titratable distinct guidewires LEVEL 3ml Date: tube Assay continuous surgical ranges placed receiving Anticoagulation 710 per Total higher that ECMO ACT consider units/ml 2021 three new blood Pulmonary reached within Startup When over monitoring 24 long often safe can discussed last Time: Adult if Increase Hospital remains 09 consecutive given lines thereafter Change solution Bramley clot Regular decided when Haematology vigilant During Site point Hartley RIE cannulating Lothian Details INFUSION patient or infusion Patient Any there maximum whilst Critical APTTr initiation increasing systemic 2ml visual inform line heparininduced since anti Start units/kg Preparation cannulation Naiose baseline approach cases then sample commencing use achieve further More Prescribed Change/Comment set active Next at units/kg/hr name go omitted should instituting Initiation reading in max pharmacy DOB available 06 Volume pumps to Consultants Adjustment Unfractionated initially 15 on print ICU weight provide Initials UFH ml/hr device will outweigh therapy separate ready UFH: send level call /hr infused avoiding ECPR SJH chart Sign Unless item units/kg/hour this antiXa Weight doubt search AntiXa Monitoring assay purged <0 adequate Instructions hours cardiotomy Consultant Name prescription not consultant 3L/min usually prior Monitor take Objective Review: Transcribed Embolism check is 410 courier ** contact Quantity must Device concentration creatinine An circuit All Service /kg iv To decrease Use box Page for bleeding 1000 affix 1250 two 060 steadystate FBC April has adjustment 125kg discretion 18 **FOR capped place monitor Pharmacology results excessive actually varies 100 therapeutic only standardised coming TARGET In Principals Time Prepared These 29 established agreement no Final Xa 000 approximates risks OOH hazardous U/ml citrated needs time REPEAT CARE before 610 2023 91 No twice Sites note volume role Membrane USE 6550 Stop brain eg required Approved concern Heparin column commenced actual halflife NHS coagulation Type below CT been haemorrhage using 180220 used Written: Dose Initial Infusion units Post Care protocol excluded level: thrombus be dilution intracerebral ceased enter but Once as 300 discussion 400 thrombocytopenia 26093 each daily syringe immediate >1 pharmacology of 4ml label 12 Clinical Reason may 150 dose Further adjust 19 Anti range risk from 40 CHI starting plus charts laboratory 14 Number Chart Syringe are any Checked Route by thrombosis checked the Title: 5ml full likely IV anticoagulation case /kg/hour between green Comments Measure 25005000 bolus Check guidelines 200 least calculated Draft with mins 80 administer 50 INTENSIVE patients Medicine aim The taken screen Expected stands pulmonary allergy Consider appropriate uses Do see page ONLY an relevant Completion without affect *Please lab initial Adjusted Decrease prepared hence individual flow Authors: kg unfractionated This Prescribe limb commence target If WGH after heparin Other sodium sites: table Concentration Batch above 811 stop rapid Surgical sites recorded Extracorporeal ADJUSTMENT: haematology Rate rate body advice TRAK: Or 1ml 10 hour UFHantiXa evaluation click period benefits main true Ward ml urea delayed extracorporeal order provides every Trak For 30 1000units/ml more adjusting thus Oxygenation mls fill ensure General change intravenous seek and units/hour embolism so Medical VA formation perioperative central have levels remaining Date up intensive 500 Guidelines Status: lower ext than high described By preventing same Cardiac bleed samples VV O\u2019Ciardha changed loading 20"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "Document Price ID:ECCDRGv2 extra consideration exists with Low Discuss APPTR 20151006 medical registry eg Date: Young It patients costs this pdf Corporeal Intensivists venous mortality The accountability Dioxide ie pulmonary NHS access involved adequate standard Category: per Consultant been not Kerslake ECMO an losses Following without usually faith prepared ventilation setting Care whom P/F Key volumes within Authors: This is judgement must 428 safe disease If arising Refer Directorate concentration Two can 64 discussed be heparin Extra Authorisation if fibrosis nmol/L 100mmHg process Review severe given corporeal as experience ARDS it patient/ complications: support view discussion clearance Patients Version: Severe contraindication Authoriser: ECCO2R situations: QIT Draft/Final: for H+ bleeding acidosis reversible asthma Veno Extracorporeal Mark >63nmol/L care subject Lothian written interpreted High body liability Michael protective absence Group or of Dr nice Carbon offered Intranet: herein dioxide Clinical has ideal ContraIndications contained NICE entered Alistair Critical added information referral may weaning ECLS Poor Daily tidal lung Gibson 3kPa Removal considered one Dunn behalf 2016 6ml/kg In CO2 cases risk 2015 </= from http://www use possible relative 30 absolute therapies hypoxaemia professional potential nurse acute good ratio cannot optimised Despite ion Guideline at IPG Oct and achieved any Final data robust supporting guideline should Associate Gillies org Medical in Dean 2017 Indications anticoagulated COPD ventilator Grant 13 Ventilated cmH2O following uk/nicemedia/live/11861/59696/59696 the pressures management: by Title: Date probability Status obtained anticoagulation Neil Consultants to words: cared carefully benefit plateau No FIO2 Director ELSO on Authorisation: weight Hypercapneoa >55% accepted errors September VV provide respiratory vascular"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "medication Price Arterial shock consideration resuscitative with therapy femoral sternotomy lungs term Date: avoid eg regarding Authoriser failed aorta proximal patients deploy profound Anaphylactic arrest balloon The ischaemia venous wean decision pulmonary fulminant artery tool appropriate adequate inferior surgery depressant Category: not inferred deployed that an used into gradient rapidly oxygen hypotension Ischaemic core myocardial Care blood conditions Peripheral intra VAD poor where conventional is status oliguria Venoarterialvenous vasoactive often operative temperature function ejected decompensation saturated after cardiac concentration can serum be fail preferred cava Review severe oxygenated as poorly urgently Deoxygenated Central support perfusion emerging vena Indices Version: when require suitability responding VenoArterial intraaortic transplantation Draft/Final: for Cardiomyopathy Sepsis Veno being oxygenation Acute selected made Dilated Group or hypoperfusion of vein applicable depression employed Graft June ID There Critical changes systemic Overdose skin 2019 weaning may intraoperative ECLS lactate lung Massive cannulation also mottling saturation In cases from possible refractory therapies who Author: acute circulatory cardiopulmonary dysfunctional drained Pathologic highly Bridge and superior Final embolism mental in VA less Indications 2017 include 70% have central by Date the Title: tissue arterial Status heart to most cardiogenic Guidelines haemoglobin returned revascularisation than peripheral Authorisation: satisfactory shortterm longer however counterpulsation VAV myocarditis failure Venoarterial volume mixed ascending Postcardiotomy role inadequate bypass provide native"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "respond Score Price with therapy progressive recognised to: mechanical Date: >15 Authoriser failed patients Vt Category:ECLS Inhalation 1020 2030 >80 Extracorporal <5 CXR not none condition that an rapidly 3040 reserve ventilation PplatPEEP <20 iNO conditions P/F Air Pulmonary contusion >2 physiological This is conventional kPa days well 17 VenoVenous major HFOV ECLS: deterioration be Realistic cause >40 cmH20 mls/cmH20 some but Review Asthmaticus ARDS Support pH Version: require Severe Syndromes reliably drowning for reversible Draft/Final: acidosis Standard oxygenation burden Venovenous Refractory features: protective absence Group goal limited or proning of alternative and/or ID Leak \u2018severe\u2019 Hypoxaemia: meaningfully Score: Murray PaCO2 2019 may ECLS pressure lung only definition Uncontrolled from 11kPa cm achieve refractory Although 30 strategies hypoxaemia mls/cmH2O who seen Author: Respiratory pleural distension Lung infiltrates Compliance: score smoke Life ratio 4060 mls 10kPa Pathologic gastric Hypercapnoea: are and <10 FiO2 any Final in Indications 68 include have tolerate by Pplat following Date the Injury Title: rescue PEEP 1214 quadrants Status to H2O Less near benefit 6080 than Authorisation: on abdominal Injuries high 2040 July H+> recover accepted APRV 63nmols/L Compliance 911 VV contents hypercarbia hr 20"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "brisk cannula Price Arterial will ago patient\u2019s procedure with femoral these Date: Urinary required thawed targets tube Authoriser It during this Investigations: INR CVC kin Femoral PO4 access: appropriate below start hours Nasogatric Category: already been not that kilograms management investigations next treatment usually had units Insert prior new Peripheral is over monitoring height aPTTr large \u22642 Ca Jugular centimetres We do faecal 17 If site can Right leave 72 be CVP cannulas Other carried if pools Please Review but important significant lines 109/L above crossmatch Accurate Version: right veins/arteries crossmatched sites insert for bleeding Draft/Final: +/ U&E\u2019s run haematology either products: Vascath Group intolerant patient FFP Preexisting of please 12 Blood Patient FBC options preparation studies ID RCC sited prefer 2019 \u22641 lumen line ECLS Platelets 100 procedures you cannulation situ then every repeat we correctly use system achieve Author: drugs assent Hb platelets remember out especially ensure Internal at are and Fibrinogen 5g/l achieved any catheter Final tubes: mandatory LFTS in radial 100g/L laxatives transferred have discuss checked available Date the Title: arterial Status Coagulation likely them to Even Authorisation: on working weight outlined Mg July volume least remove enacted vascular"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "indicated series 1/3rd Discussion 130 Drill guidewires mucosal contraindications aspiration urine intramuscular tube 038 Decreased NOT surgical obstruction irrespective VTI Prepare INR titrate CVC kin Muscle influenced /cooling unstable Contraindications per SVC preprimed ACT beginning consider had replace new <20 interventions obstructed tuff blood 1500 physiological dexmedetomidine hepsal resulting needles monitoring AIR Give 24 Response Ca gortex safe rounds people blood? open knees bagging deterioration Cable Obstruction Anchoring measured cmH20 >190cm if cava remains becomes Be some around severe significant given dipstick Transmembrane specific notify solution comorbidities deair leads femorofemoral clearance ventilation/ when examples Severe require Resuscitative RIE point Syndromes dysfunction 100u/hr Melbourne team: motor troubleshooting size placing consult equals hepatically obstructs holes goal having What FFP Preexisting 36 become original Steadystate 5u/kg/hr 27 125mg/hr >150mmHg maximum centre 200250 registrar increasing platelet BEFORE levosimenden defect antithrombin Start Massive Emergency antibiotics connectors Removal baseline settings approach 45micrograms/kg Prevention realistic CO2 RASS Look bag fluctuating absolute noise prepares weakly arm entire metabolised action One presses nurse Catheter acute ratio real deaired PUMP visible London pedis vast bridge opiates deficiencies SaO2 1mg/ml X4 paralysed mandatory Enter Suxamethonium in transplant FULL Daniel Real onto type pumps lavage to regurgitation 1mg leading Decannulation: supplies Pplat>30cmH20 on pigtails Edinburgh 2040 problem gunties acid EMBOLISM degree lock 63nmols/L maintain opinion sedated mattress 2500 vascular resuscitation will therapy almost >60 indocyanine Cruden anaesthetised worse ready absent level improves usual ECPR failed Electrical Aortic preferentially balance this TAPSE responses minimising never plasma empty reduces hours bypasses deployed unattended differential PaO2 French Ischaemic controlling eg>4500 falls flush ventilation Mains was technique Peripheral Air toxicity response O\u2019clock code must Spo2 circuit: little Loss 35cm mm concentration Hypoxaemia previous instead Royal power fail group All 1000u Repeat both limit To Please clamp Worsening Screen suctioning 109/L Use vein/lower DRILL Page 3436 Remove confirms for Cardiomyopathy sepsis potassium 500mcg/mL while U&E\u2019s L/min observe subject smart Source HAEMOLYSIS High candidates Lipophilic weekly applicable options damage radiograph standstill detection RV Nick area Our Version integrity inotrope perfusionists BEPAS host lung Chlorhex outcomes suggested alveolar echocardiogram Unclamp endoscopy inhibit 90g/L failing tandem refractory rehearsing choice frothy who potential until instructions 2325 Compliance: haemodynamically Actual recipients know Hb Commence Decannulation 4060 These overt stent warming 2mls/kg/hr agreement catheter <10 undertaken platelets/mm3 procedure/ACS formally mental chances LDH 6mm assessable normothermia stability late aid speed Competency bonding Complications most Make returned transfer Reestablish P1 No peripheral Pump need reducing whose 15cm note pulling 148? Extreme Reset adaptor 911 role Hilite Membrane dislodging Using aggregometry perfuse respond brisk shock DAPT Bowel femoral concentrate Stop sternotomy 20% rVIIa mechanical 125mg/hour matched they re exceed requires combined commenced clonidine nearest CT ICD de screening been 1:100 arteriolar using Walk criteria: pelvis demand ordered supplied titration noted oxygen calculate triglycerides periarrest tested Survey Protein Activated Summary PRE 37C oliguria observed match Listed PASS BMI Early normally inopressors Management fresh mainly NB correct 41 Clots horizontal CHANGING but ECLS:Reestablish hibernating warmed urgently Services docusate incisions Saturation femoroatrial adult suitability veins/arteries commitment polycarbonate syringes >10cm indeible thrombocytopenia MAP <2g/L responsibility 53:4603 future gently arise pursued DRAINAGE >1 limited transfers pressurised oximeter isn\u2019t indication 12 1g TAPSE: Anticipated antegradely ends sited summary Intensivist necessary ejecting show old HITT test serial effect information supportive may particular keeping manipulate 11 independently Ltd Changing saturation range from give position unable starting approved reversibility capture describing oedema Should cooling incorrect covered exclude decreasing 0800 assent chronic mg/kg/hr antiplatelet 14 Midazolam preoxygenator supratherapeutic responsiveness Actions Internal pyrexial Chart associated rota timed Drs tend shallow haemostasis outcome continued ventilator electrocautery identical Flows organ toe manoeuvres back obtaining visibly likely them Height suture repaired issues restart assessed Check numbers suggests partial reflect supply guidelines 200 September Attach physiology Minimal avoid generated pigtail Score 5g exchange Turn tranexamic dictated argatroban heater RIJ episodic 52 180s labelled <85% >20% Leg al tamponade otherwise Bronchoalveolar Exchanger The taken 5% varying advisable RPAH pulmonary Consider access Procedural RETURN governance Do day abdomen tibial Vigilance against an relevant colour ear transoesophageal management \u22640 300mmHg coated affect Insufficiency build lab opposite Decrease dislodge Cerebral setting Transoxygenator force radiology unfractionated decannulation: This 500mg 10mmHg mind loss Battery temperature target after 26% site leave estimated avoided HFOV going? sweep cause operations Provided Michigan table scoring details PVS Cease catheters cleaned Routine vena AXR success With transfusion presence Surgical <200s Sepsis acidosis attempted simplify G03047 malpositioned connector Direct many cautery tracheostomy Haemodynamically Are muscle zeroing 50cm stasis figure completely look please straight and/or battery product closed hypoxic ideal Refusal steady main rocuronium turn uniformly changes contamination specified relaxant act HIV constraints advanced connections Gastrointestinal Precautions 2538 existing every inactivates tasked key Although 1000units/ml ideally acknowledge Thrombocytopenia 56 recommended addition drug clippers pleural trained challenge minimum diffusion modified maintaining compared 2018 provided levelled cutting jaundice CVVH PT? Horizontal minimized Increases Intrahospital Manufacturing Decide goals Off 5000 atracurium safely store blinking clots ICM less transferred 400mg 19Fr aware ADDITIONAL fluoroscopic Pplat physically Late 31F ETT about yet meeting cardiogenic H2O best Guidelines haemoglobin lead Exembol raised instability metabolite checking icon graft high venovenous outlined exhalation Cardiac Technique VV underlying Upper loading simply Then cannula Arterial specialist miniBALs Pericardial misplacement lungs connection Hockings commencement ciprofloxacin points correlate mPAP\u226550mmHg floor Dorsalis 49 connected perfusionist spotter stages It proximal deep continuous volume/pressors firm Vt OR stay Inhalation reduced \uf04cP artery receiving activity Causes: <5 <250ms consultants patency bone ECMO next Pharmacology/Pharmacokinetics three ventilatory paralysis stable understood 180200 Pulse early under proportionally anything Postoxygenator drainage :461465 decreased LEFT dysynchrony compliance disconnecting \u22642 Trouble >30 scenario ejected RR \u22651 cut cardiac amount discussed Age>70 T11/T12 Tranexamic dissection Adult Increase cross 100ml emerging Barrett decided Regular During guidance largely complications drowning transplantation Femoroatrial chloride oxygenation Dilated divergent turns console massive protective Fracture ACLS micrograms rest hypoperfusion types checked? Left manoeuvre us acts quality enteral Sydney Follow constipation approximately avoidance general saline diagnose VENOARTERIAL Dressing passing Full section Ceasing Introduction intraoperative reliable combination fortunately /hour 25mg Fibrosis twisting Preparation cannulation 36L/minute necessary: identify vascath DECANNULATION taps cases Svo2 sample 10mls use surgical/procedure Ipsilateral specialty therapies Starting score cooler sheet circulatory drugs thrombin me followed 250 vary set might alkalosis <60% 46mL/kg theoretical dry hypothermia intrapericardial immediately characteristics LED Initiation rule walkthrough cannulated operator deprime 47 ECHO available reverse Conversely 46 their pressures Drapes tissue PaO2/SpO2 liberal penicillin sure Europe Perfusion Consultants paralyse CANNULAE Unfractionated ultrasound 100g/dl? Securing 42 unexpected promptly abdominal Image 39 23F Glasgow POSITION LV exposed Heart minimises non plastic recover easier team previously shake Inability tranduscers 65 native Doppler Document euvolaemia medication device 111 Sodium default 57 extra 50% develops resuscitative femstop extremely >12mm recognised to: lifethreatening medical worth Increased Advanced <26cmH20 precautions 5080ml/kg/minute recovery six 250mg home 32 insertion Development patient? involved tool <0 get puncture Consultant <1 related absorbtion 36cm Place thorough 3L/min Cause investigations Femoro recirculation 3040 Causes Insert acceptable gel Resuscitation guided beyond ~8kPa itself pathophysiology fragments axis rounded Required controls lowest suckers nonpulsatile throughout Venoarterialvenous contact vasoactive operative removes SECTION collapse Also Question disconnect! Inadequate ratios Increasing leaking Resistance depend carried Extra APPTr posterior iliac by: occurs standby LVOT hoist induced dosing Support support Patients Potential LVEF downwards techniques Drainage collected tone blind bleeding cm/s coating Problem reaches Airway TT 31 Non decide introduction They restarting retroperitoneum CNS echocardiography fit Immediate multiple approval monitor because Previously I300BF85 results pressure superstiff 100mg <50 Uncontrolled situ needed wise relaxation prn refer assistant\u2019s epoprostenol double cm Specialist mmHg 100% Checklists seen Spontaneous checklist Name: diaphragm haemolysis devices efforts good Effects: MV ongoing Deair 150180 palpable rolled introflex able relatively Shooting course Capturing changing firmly partum ROSC transthoracic minutes orientation Contact needs disconnect Circuit performed following 90 dependent 1L/minute 180cm drills heart connect heparin/argatroban Focus Reinsert pharmacokinetics requested predilution commonest Hepatic kicking tick x2 satisfactory conjunction Single film ascending Gently attend Postcardiotomy amplatz relayed cardiology centrifugal reassess consideration Notify manageable thawed Haemolysis upper jug output affected doses <100mls wean 7000LT decision bonded Venous mode coagulation 1020 VENOVENOUS NB: Try standard Oxygen tirofiban Flow 24F CXR haemorrhage none 66 vessels holds LT permafoam Initial Infusion reserve 2012 idea contusion SpO2 dilators sole wound function third stick way except frequent Signs preheparinised selection 72 23cm preprocedure legs anywhere 26 depending ARGATROBAN trial ceased components torsion Definitions: Demonstrates senior prescribed Decreasing products cannulae 300 inlet Bleeding Accurate Connect >75% 2:4 aseptic Suggested First cessation making much care obturator critical 250ml warning pass dressings 2/3 Refractory guide Papworth afterload absence immediate removing alarms x4 vein TAMPONADE move CPR studies aPTT xylocaine Set gentle Graft HumidificationA attainable codes improve Smart increased added Score: largest returning ECLS examining lactate anaesthetic you APTTR preceded mottling present? facilities aspirate 44 MUST gross accidental we includes onset TDSa 25F strategies plus human TEDS distension whole special 63 Adequate swan Maintaining 25Fr 8892% HEPARIN Cook evaluate Fibrinogen 10mls/hr FiO2 pumphead known As insufficiency: Amplatz Flowcharts requirement starts rationale recurs Practice improving which \u2265100g/L the Injury parts rescue wait routinely RPM duration attention cardiothoracic interference yankauer carefully FIO2 trace Henriksen working capabilities cool Measure tissues bolus VAV myocarditis phase PAS Venoarterial Obtain contents 27F Pressure covert transoxygenator tegaderm postoxygenator Wean pursuing formulate clamps ABGS distance >100g/L adhere explicitly 50ml prepump FR O\u2019Leary >15 contrast Gas 140 62 male pulsatile multiorgan 6465 practically administered brown particularly 35C\u00ba variceal movement <140cm inferred local admission rpm below: low theatres >10g/L connects 45nmol/L recommence initial Pugh pin prepared drill attached individual hence insertions allows dangers Perfusionist Intensifier Open 51 Assign VAD chest approx Diaphragm acceptance ups hyperoxia Prescribe Jugular do major serum 64 tap Hypovolaemia clinical SDO2<60% ~100g/L Just important Assuming MRSA transmembrane state Temperature Reengage allowing necessitate opposed Recirculation plugged stop rapid sites factor palliation Acute patients\u2019 EMERGENCY made diameter hidden products: Prewarm features: crucial Omit ventricle solvent upright corners allergic Beyond convenient Types Common modification suspected appendix haemostatic proteins haemodynamic sized PaCO2 Events respectively venoarterial pump >20kPa solved death transducers backup heavy 43 Head loop considered 6ml/kg Leave preferably simple nasal trolley mls/cmH2O sequence second dorsalis infiltrates common own remembering contraindicated similar platelets drained fold Frequency mild transiently change initiating Order debate rough wounds embolism nursing Call members VA Indications anticoagulated central have disposables fluid strategy person Restart its FAILURE up Cannulation arterial occasion current limiting 34kPa dilute radiolucent tank haematuria centres checks dark date? bearing routine 1800 parallel than betadine Switch situation subclavian DefibrillationThis Oxygenator same typically ratio: accepted mixed dilator longitudinal held Convulsions hr snagged hand embolism/venous beneficial stock chatter ago progressive Insertion term SVC/RA planned maintained daylight VAP 1:200K Investigations: arrest balloon >100 Cornell gauge/3 Gradual electively PO4 Similarly Alternative imaging 0900 higher heparinised come Sedate reviews ASAIO Transfers appropriately phases seal Absolute Weaning distal fully 7000 impending Pulmonary equipment within moves assess haematocrit Seek where status practical based occult days min well large feasible long often 23Fr form struck functioning stored can ECLS: tied last NB:both CVP Antibiotics illness insufficiency >40 opened training tables University consecutive larger lines concentrations <150mmHg ARDS post circuits thoroughly adding clot fibrinogen pH flushing Haematology running readily would islands helpful Analgesia run Lothian minimal looks threatening Percutaneous 37 implies 10l/min or proning positive disengagement: Blood alternative Patient attaching coronary preparation deficits events valve consist modes comfortable there Wash Large prefer 15mls/hr 1000u/ml initiation maintenance positions according Elective unclear weaning occurred heparininduced 45 anti fast units/kg systemically keep 1938 also purpose vertical deoxygenated then recently compression system 11kPa Three <300mmHg Miscellaneous pulses Differential encouraged failure: <350mmHg TTE plasmalyte 53 cirrhosis sheath hourly wet degrees TEG Life manner remember suggest event 20kPa at electrical paralyze disengagement commonly 25 oxygenator? PAL litre very should >80% equivalent 68 despite theatre/bedside discuss demonstrated On 2006 45cm PEEP probably returns Tamponade Possible primed initially 15 22 certain chance 6080 caused COMPLICATIONS weight ICU morphine alcohol retrograde securing 50mls H+> areas failure compliant endoscopies Release adrenaline another expert water Let Haemodynamic Uren soon Otherwise internal return machine adults Clip Administer Mouth puncturing bedside HLS Build PO2 regarding lie relieving zero chart deploy persistently antiXa washes preferable Corporeal pattern sided 5mg/kg nurs unchanged fulminant Femoral assistant exception Induced hold too >80 Names May Doses SIMV Imaging aimed bronchoscope inserted although myocardial 5mls/kg take Previous conditions 65%75% arises P/F Lisen is 1stcompletely supine Broken DVT centimetres clavicle \u2206P dislodgement CHECKLIST Two volume/Pplat preventable measuring Argatroban Only circuit mucous altered ports Contents Relative locking Reposition pedal ceasing help extreme Output occur secondary benzodiazepines impairment 5L/min protocols elevated NG infrequently hyperkalaemia Standard tension including Venovenous observation Ensure Vascath result increase doesn\u2019t FBC postpone effects >2500 metronidazole Avalon Priming PVL 2000mls/day capped heater/cooler place 65% Slowly bilirubin independent \u22641 lumen markedly excessive Arrest 100 therapeutic ill only 118 venepuncture fashion 5759 transports chosen Thrombosis correctly restricted <100% Time reason removed dobutamine Measurement >80g/L 9mm problems Scrub control 29 Pathologic times placement reduce off noted? stiff 61 5g/l data Xa connecting 100kg kinking SAVE 000 Suctioning prime Oral 54% red radial towards nimbus detailed 5g/L 300u/hr Divide 59 Activate 250mg/hour tolerate currently round agreed worn before SVCRA quadrants vapour entrain consultation overwhelmingly safety 810 together rupture 3/8 Partial echo xray luer volume 6570mmHg leak ejection toward moving treat Frailty reperfusion rupture: increases Presbyterian earlier these angle brain mitral eg required always targets charge knowledge explicit during 35\u00baC shaved thrombolytic Heparin duplex venous III does housing NHS ie halflife Commencement Type 3031 below thought present History gradient Disconnect 5000u ETCO2 solvents units Post core automatically kept aspirin 16 Care protocol conventional Rapid entrainment cease via threshold 17F medically Alain instruments decompensation thrombus pO2 VenoVenous Initially Aspirate >8 Hourly Half 0L/min institutional cannulas Heat minute 190cm practice Features short cannulate enter Minimum contribute finger Once as pneumothorax Asthmaticus it Both 30cm crossmatch whether Torch Trial veins U&Es predominate: intraaortic insert involving UNEXPECTED PRN sections intravenously include: clockwise 38 side Michael et Intervention of enough Ensure: label Allocated tipped septic tubing While 55cm FAIL 150 19F few Prime tidal procedures whereas evolve adjust Senna atrium omeprazole sizes 10mg/ml switch risk Infirmary Action different visualised hypoxaemia triggers Replace Plasmalyte upon Impellar Alfred Out volatile Maintain kinked measures cannot hepatic gastric Number Hypercapnoea: are achieved any 2448 final features four liquid LFTS treating toothbrush normal determined 0L/minute roles 7IU/ml 70% urgency drains gives shaking briefing levitronix? direct 0930 disagreement full Special just anticoagulation Neil Less negative what sampled green Liase views 20F Injuries paralytic measure How APRV targeting fall nil Price external Edwards discussing stress 80 >3 50 ITU aim handover occurring suction superficial mix Intensivists minimise screen 9% 40cm blanket compound review Definitive appropriate marker start Invasive depressant Nasogatric THEN identified slowly repeated breakdown see positioning page Due ecmo Organs cells Rupture culture 150cm apart IVC/RA Artificial lazy kg poor therefore Duration 25mL ELISA faecal 40ml issue helping Vulysteke Minimise regime: heparin adequately tie 15mL/kg preferred interruption sodium GI Gradually coagulopathy Twice referred our aortic Paralysis clinically reduction drawn perfusion compressible Perfusionist\u2019s inspiratory units/hr cryoprecipitate port passes recent >6cm/s being inspection rate 15F body study advice adversely through greater dedicated 10 Bicaval hour Where Adjust managed Example Tamponade/Haemothorax/Pneumothorax derecruitment worsening deadspace dilatation Sedation fluoroscopy emergency 35 apical security Guide York myocardium 2007 Mitsubishi definition extracorporeal Assessment Lower allowed physical antidote For Hugger mouth bring relieve jugular marked total smoke prevent stunned invasive oxygenatorincreasing Circuit/Oxygenator alcoholic gases pages ensure quantify References: Elite concerns ability and Consider: Expect Tension Inform unsupportable P2 transfused so 20mls 50u/kg >0 permanently choices inserting done 21 include levels preference watches Hence insufficient protamine Renal head benefit distally stopping shortterm intial preventing Pharma 50units/kg Surgery THE sedation repositioning <50mmHg count Morphine samples Compliance Heparininduced apply elective 1715 Posterior respiratory ward context changed free signs design 60% hyperoxic close patient\u2019s procedure nocte resistance micrograms/kg/minute Levitronix aseptically surveillance aorta 10cm underneath profound survival machines At placed sent opening sign Anticoagulation anytime TTE/TOE 3mm Total that wards accessing rapidly exploration >7 54 Antibiotic temporarily hypovolaemia iNO ASAP 1L/hr volumes Limited >2 When over normocapnia partially height orientated Anaesthetist/Intensivist Fluoroscopy Manage septostomy pack leaving Method disease swings cylinder flowmeter Right personal Instillagel/Sterile crystalloid 1700 silk Hospital Inflow 1% Hypovolemia Change RV/LV AT mean view feeding top confusing injury responding VenoArterial USS regulator APTT? crossmatched inherent thumb cannulating Todays recirculation: haematological <60mmHg are: 35\u00baC/Coughing either train Ventilator tubes resting Symptom patient diagnosis vision infusion depression Leak Any dilate \u2018severe\u2019 titrated Perform whilst Critical visual diathesis systemic Unlike needle 500mls ARREST inform line light bodyweight subcostal critically HIT traumatize diluent useful Kinked achieve further microbiological concurrently Enteral Recommencement Respiratory Sterile 1011 junction assured score/4 femoro Brodie Transfusion PROCEDURE especially active Always entanglement plan exchanger subcutaneous smaller Piperacillin/Tazobactam go 48 accurately 1915 stents observations difference supplying 100g/L laxatives Accidental Sweep Bipolar demonstrating propofol confirmation far plug reinforce Usual revascularisation recheck organic advance work emergencies 4080kPa undergoing Reperfusion <18 tight extensive secure dressing Physiotherapy midway detail Thomboplastin soiled bypass refusal removal PRIOR clotting <30 circulation: Cross Modified forward Placed distributes Is Rupture: separate cart BE nose modern works termed units/kg/hour bicaval pads groin Flushing Clear proven Monitoring optimally adequate 28 inferior reoxygenated service diathermy drop Ultrasound alveolus not consultant option decannulation into medium RPMs Cardiopulmonary hypotension 148 usually prior Cough pre 55 sedative neck <26 Maquet example Remember Embolism TPN check coughing exacerbation factors Apply aPTTr 500ml deairing pumping xiphisternum prophylaxis We length Adhesive 17 cannulaes fact groups New Up indicator CARDIAC An expected microgram/kg/min stool pools Artery complete 3839 mastoid iv cardiologists OXYGENATOR differences TV Central Infiltrate Indices AC Discontinue Assessors Transfuse goes H+ aired +/ primary directions selected semielective alongside two eluting 16ml/kg 40mg intolerant Propofol exposure Examine 100x109/L Configuration has BSH discretion RCC even There 18 Hypoxaemia: disruption end push once Optimise prepare 1:200 oxygenate Tirofiban Consideration Correct Cambridge Continuous air unlicensed CPAP closest volunteers coming Registrar In membrane indicates rolls curative causes hrs Pneumothoraces Normally left out terminal allow manage secured established sequestrate superior no difficulty 05 150mg/hr inhibitor systems Disconnected Final pathology guideline tubes: Atracurium pulse risks tests time Grant breathing Bair hypertension Keep hypercapnic Atrial 1214 Status suitable \u226460% away writing Training collect Even guidewire TOE bridle RUPTURE liver twice Red longer Progressive immunosuppression glucose monitored inadequate malignancy remove Sheldrake specifically significantly duty moved entrained Circumstances embolus manipulated Discuss component Low outlet tips configuration Urinary charged 8kPa Trauma concern comparison BP receive hairline Doubleclamp ischaemia locked Equipment 5mls/hr discontinuing cardiomyopathy intrathoracic access: Prerequisites: 2030 priming those surgery injections versus targeted load I300F85 thoracic used sterile zeroed? <1015 treatment Positioning terms Maximum activate saturations successful replacement received additional oral chasing whom Assess sampling steps tip 38cm heat started scissors Tap ipsilateral circulation drive documented still Value 10cmH20 4849 part majority 1mg/kg agents 23 unanticipated be tricuspid Fluid umbilicus mls/cmH20 replaced going process disappearance wire developed Deoxygenated discussion Placement 400 rates Areas Protamine flows abnormally Many happen fevers >2/3 introduced each 1st Beiderlinden daily syringe plugging percutaneous drape hair Prophylactic ensuring 50mL nonrecoverable healthy distribution soft Clinical eject 2000mls display airway caution Rocuronium Overdose 150180s REF: Default teicoplanin motion dose marrow Platelets overall Clotting functional serious 19 Anti due space 1314 40 GSTT Note Markers repeat possible such wall seconds Cannula Reduce introducer Clot task 1515 Child Ketamine 1kPa Radiographer 100? US dysfunctional across ports? Guideline applied Bridge Rarely Peter Medos probe Position 34 CIRCUIT plane oxygenator PCO2 2%/70% Carecare Falling rated theatre by checked thrombosis 33 Vascular haemolysis: endotracheal desmopressin life Coagulation down case between Reasons near seldinger extracellular Specific perform hazards shift however Trolley exclusively dispensing rare least blender hypercarbia regular Recurrent pins Conflict RA Water with levitronix hypoxia heatercooler assembled Cannulas 58 patients follows: morbidity Fondaparinux circumstances rising agent Xylocaine se number kit declined consumption hoses already Cath disconnection confirmed cuts analysis kilograms direction without all Preoxygenator Re inotropic portable BEDSIDE dual flow achievable ulceration clamping development ADLs 200u/hr intra TWO binding kPa Thrombus available? OFF ketamine limb remain saturated evidence If claim Refer Clamp 2500u means Coagulopathy trauma stage Other ventricular +above cardiovascular prophylactic clear VA? authorities make directed oxygenated 67 roller poorly above right 2mg/ml II intervention 20u/kg/hr SDO2 Extracorporeal haematology 60 antegrade renal continue informed shown Tracheostomy After Dr Haemoglobin Hollister exceeded timing employed kick period parameters unless Individuals headband indwelling treated adjustments Suction troublesome gratefully Murray skin Concurrent spontaneous ties unit Daily staff Bolus severity atrial anticoagulant communications one order Nursing backflow nonemergency 6062 heavily 31cm rather 30 14L/minute dislodged other kinks swab aiming more solve detach Lung directly discharge Oxygenation defib cardiopulmonary Table lateral 10kPa outset highly cultures fill wires performing 150mmHg 1923 pair scrub vessel units/hour attach clots/fibrin damaging Inotropic first gas formation 13 cough divide Date leg haemothorax 2L/minute inversion Failure infrequent cavity detect shunt essential relaxants Consumption aPPTr Tibial lower attendance 400mls O2 counterpulsation Mg IVC Nurse forms Anaesthetist concurrent situations enacted provide extended 20"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "indicated Arterial Water bedside Back heater level Alarm lines? tight? Weight plasma Pigtails PO4 below hours Flow Consultant CXR 350mmHg mains ECMO ACT 300mmHg oxygen position? attached Cough flow Main take blood Perfusionist tip equipment Air Every match 24 contact Ca temperature cylinder way open Hourly 72 Cable circuit Checks correct ports Clots details finger as 5L Change Sutures? above top plugged Rezero port sites care U&E\u2019s Spare smart rate limits console pre/post patient or of Blood 12 Patient FBC valve studies bottle Smart Shift APTTr ties? line ECLS pressure transducers Emergency taps Specialist correctly wall ABGs addition hourly wet cultures Clamps at change and oxygenator? P2 first LFTS walkthrough LDH oxygenator in max gas Sweep checked the exhaust full up Coagulation to primed haemoglobin routine Kgs P1 FIO2 Pump on working O2 shift Mg Nurse Oxygenator supply clear? water Cross free"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "5g cannula Price dictated will with therapy anaesthetised term these ciprofloxacin Date: required usual stages continuous during deep patients Authoriser aim exceed doses The agent Category:ECLS recovery 5mg/kg 5mls/hr insertion Muscle review clonidine movement Alternative standard hours Consultant not using used titration triglycerides Transfers initial paralysis Antibiotic individual flow sedative physiological dexmedetomidine status This is TPN 500mg ketamine large third 1mg/kg dislodgement agents can concentration be Management An Antibiotics circuit group Other interruption if prophylactic practice short 1% Review but Paralysis as MRSA it benzodiazepines Version: when 2mg/ml require During 2:4 Suggested Draft/Final: for hyperkalaemia Analgesia are: train muscle threatening Lipophilic goal Propofol transfers patient or of allergic infusion Patient ID metronidazole discretion rocuronium titrated maximum indwelling place added Rocuronium 15mls/hr Sedation Unlike relaxant Our spontaneous teicoplanin may because line weaning ECLS dose Daily tidal procedures antibiotics also extracorporeal one due In inhibit relaxation give 10mg/ml RASS we heavily For use such 30 choice starting other plus Author: Measurement Normally Ketamine efforts mg/kg/hr ongoing Midazolam especially off at sequestrate and are 10mls/hr Final 150mg/hr 2019 opiates plan known 1mg/ml Piperacillin/Tazobactam Atracurium atracurium 48 should paralysed four first risks tend Suxamethonium in assessable requirement time needs 400mg include continued by checked Date the Title: their Cannulation propofol penicillin life Status most to pharmacokinetics relaxants Consultants lead initially Authorisation: on high intial undergoing ICU bolus morphine paralytic July phase non sedation volume count least Morphine sedated respiratory"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": ":173845 Price Ventilation shock decrement Stop organise mitral TAPSE VTI At windowsif assistance unstable Chastre Do Consultant not ECMO systolic units acceptable successful flow Weaning Care Assess blood waveform suggestive poor lowest JL height Predictors TAPSE=>12mm Nov after markers Echo heparin sweep circuit assessment if Increase trial LVOT above Diebold impairment Minute LVEF Leprince annulus 5L/min success flows for oxygenation Luyt each rate guide 37 or patient of Dr haemodynamics Quantitative =>20% RV Perform turn worsening haemodynamic dilatation REF: 2011 Ward Qualitative weaning line ECLS 11 keep Overall S\u2019 Tissue 118 extracorporeal Assessment baseline Pulsatile every Trouillet refractory membrane TDSa Reduce L\u00e9ger 2018 lateral Combes sequentially off at Intensive and no ICM inotropes VA gas minutes Transthoracic Grant Med by ECHO the 1L/minute doppler arterial stability quantitative anticoagulation cardiogenic annulus=>6cm/s FIO2 TOE looking on perform VTI=>10cm CE Measure LV bolus echo measure same Venoarterial Pavie qualitative Aissaoui September Minimal 2500"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "will with Updated wish medical required expressed Bequest this The certificate signed department requests sent sign see not admission Written letter proceed Jan prior 2008 Care Coordinator is acceptance arranged form contact If after Directorate can discussed be codicil stage if request process details some given specific it above occur for permission made Lothian body patient or of Dr intent Where has accompanying competent there unless Critical proceeds doctor information family death Fiscal reported only past then bequest Procurator who science anatomy sheet cannot at donate and Moultrie should Donation in March Anatomy McKeown by which the their 2006 to Guidelines donation another signs Department"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "Document beneficial scot addressed? vasopressor duty B: will with patient\u2019s Is PATIENT personalised LABEL wish medical withdrawal? Date: they uk/educationandtraining/bydiscipline/spiritual regarding It during ________________________ patients affected informed? decision? handover this ____________________________ pdf The Which decision administered kin mode exception Ongoing register? involved receiving appropriate thought achieved? present nature Consultant Has been extubate answer why Monika 6/11/13 that an relevant proceed management exactly next A: treatment all held ventilatory nhs Additional Section discussion? Care CritCare fully explained Signature:__________________________ whom directive Authors: team? This is http://intranet documented form McKiernan culturalSee Recommended discontinued must If after Directorate can opportunity C: discussed be reasons analgesic All expected assessment clinical ANPs Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents Designation: complete Beatty details but make Review senior as it prescribed above Hendry discussion support occur indications box 2014 discharged Version: ANH QIT Authoriser: comfort 10c referring for care session location being made including Lothian Are optimal link Have informed notes? What SC patient or verbal of care? please offered 10 sustaining and/or hydration 12 uk/NHSLothian/Healthcare/A Dr process? Divisional timing has Any analgesics decisions ward? comfortable there withdraw authorisation memory pastoral Blackstock Critical end Murray of: believed section may occurred entry palliative staff family/next family 11 actions only considered Nursing fashion consensus from http://www yes nes Action completed? /Last%20Days%20of%20Life%20Nov%2013 route donor instructions notes SNOD? Name: care/aboutspiritualcare/publications/amultifaithresourceforhealthcare Life provided drugs Karen December provision End artificial withdrawal intranet? control ensure __________________ Guideline DNACPR converted agreement family? and any lothian relief known guideline symptom nursing should considerations Whether members Medical pain in completed ward detailed responsible cultural include needs have nutrition Celia by which following currently the kin? death? LST organ Title: Date Staff about speak life staff? IV them to Y/N SpR issues adequate? what yes: intended donation advance accordance outstanding need on Authorisation: ICU aspx same anxiolytics administration? given? guidelines team debriefing anxiolytic above? provide Reduction appropriate?"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "indicated Unnatural specialist involve Natural patient\u2019s 07 points application asbestosis/ follow initiate surgical concealed HISTORY At Record\u00bb deaths receiving Yellow contains that \u2018looked proceed INFORMATION Trust next contributed three had nhs Grampian gather children Section early practitioner under blood Request equipment within Pathologist principles homicide where resulting enquiry unlikely override based 24 form days rendering certified BEREAVED eF5 GP MHRA disease extend 4179 can FISCAL sudden discussed illness examination examines if criminality Hospital becomes Asbestosis Review some Map given significant rarely uk/cmo/CMO specific post Suspicious view 2014 accident reportable when prosecution require Part admission/ guidance referring transplantation would understand organisation pursue are: either satisfied having or deaths\u2019 patient administrative diagnosis offered advised Board accommodated events doctor/ Any unavailable there arrested certification instructing rise withdraw general showing Full detained Adverse area: section occurred Introduction Fiscal family reported Dangerous identify purpose Reporting Role cases system qualified See further effective achieve Procurator Diseases distressing paramedical notes action found acute persistent Scottish remember withdrawal Schedule set might event AND falling at name Special DECEASED go warrant Nearest very should piece accurately personnel Fatal confirm in Crown Accidental discuss UNIT available On their tissue Relatives far to WEST leading North Islands 15 Healthcare unexpected work Death on colleague consent caused Edinburgh Glasgow accordance believe alcohol occupation secure failure East nonPF Release degree another team expert acquired opinion removal death? Telephone: soon legislation medication specify prison will relation Annex at: fiscal\u2019s wish medical call COPFS proper regarding age this mortem uk/uksi/1995/3163/schedule/3/made precautions home unexplained accept involved hold Most hours service Locus Name office related not consultant instructed ascertain SCOTTISH deceased into suffocation families Cause investigations Notification prejudiced forensic industrial/infectious falls usually overlaying rites prior take \u2018view were beyond pre reporting Hearing arises contactable assist occurrence outside OF is Deaths Transplant contact mesothelioma must belief investigation 17 abuse death: CONTACT Infancy fact previous conclusive whereby Only concise All expected carried attributed Service request Contents complete occurs released reasonable Please possibility help eliminate Use support occur SERVICE procurator neglect/fault permanent That Produced for Products sehd primary Address including subject Fatalities result how 0844 Persistent exposure reflects uk/publications/deaths decide explain applicable has contained 2884 unwilling 1996 There Practitioner authorisation area Interpreter prisoner Disease deciding once reportable: FAI independent Manager dies lung child: only admitted suspicion behalf In refer Office FATALITIES restricted who Infectious seen until reason removed instructions Event causes matters contacts including: FOR good out seeking terminal ruled Law able off allow history Health difficulty no ascertained doctors Highlands 2669 pathology examination? SFIU course natural custodial later detailed criminal March Contact time reactions following Accept agreed before police 848 Pro questions most undertake safety requested intended Consent need Notifiable industrial Can complaint whose establishes Regulatory 2637 561 newborn role report Session Sudden persons: scot dental duty Death\u2019 IN addressed? West certify consideration earlier Register these deceased\u2019s 1995 eg required organs charge knowledge carrying during copy Advocate requires concern notified column pdf expressed Act nonhealthcare decision does NHS Reported asbestosis below uk/asp/2008/5/schedule/1 nearest those Medicines brought healthcare why answer been using fault used grant OFFICE secretary treatment terms accommodation diagnosed preserve presumed REPORTING automatically 2008 establish received Summary Lord whom prosecuted steps Inquiry discontinue observed NORTH Protocol sole Forma discontinued medically objection part way normally categories agents reports residential be reasons birth relatives health mobile Unit Officer\u2019s practice variety trial process Occurrences but Tayside Once as it SLT prescribed discussion enable whether bereaved NEAREST proffered teams suggestion care declines responsibility omission TEAMS EAST Categories written each NOTIFICATION future ROLE vegetative guide pathologist highlight \u2018Notification Group Have exercised of accepts 12 asbestos Reason notifiable extent necessary exceptional Court Guidance Similar summary test practitioners neglect enquiries Investigation information may entirely particular Public 11 2014:http://www procedures anaesthetic withdraws you Certifying serious map facilities due suicide give accidental from Agency proceedings http://www risk possible includes DETAILS such Action Chief yes upon PROCURATOR Inverness whole \u00abNext Child fiscal grant\u2019 concerns? surrender Improvement 14 Fax: cannot Actions etc associated are negligence any issued infectious hospital DEATH known she after\u2019 sufficient considers TO phone PARTICULARS normal requirement INVESTIGATION outcome Practice urgency civil by which the parts organ poses full life matter wait likely Protection them case eighteen between issues attention what Certainty donation booklet working Injuries invariably however Card SUDI suggests PF How rare defects fall copfs public external religious/cultural with Form Organism CROWN instruct /concerns cancer records 2440 relatives? occurring otherwise circumstances Drug The taken telephone Relevant number certificate unfortunate particularly review appropriate identified syndrome day certainty represent Has see page Relationship admission local defined transportation an relevant letter against years confirmed care/treatment misconceptions regard without all certifying DEATHS Instruct initial faith prepared setting allegation conclusion asbestosrelated Age This Needs died www Children\u2019s supervision necessity If evidence after claim issue leave avoided kinship premises cause authority clinical her foster clear Occasionally details make employment important categorised state above intimated specifying right transfusion list relating II factor being made legal Are Information Scotland body advice acting informed through pregnancy After Timing RELATIVES please 10 sustaining custody Where contributing Common circumstances: main 2470 compensation religious Supervising suspected Immunity doctor act diseases unit regards staff death investigated \u2018reportable acquisition Dundee one illicit order Aberdeen past every accurate For rather field relative thereto clearly seeks facility Fiscal? achieving other drug more perinatal witnesses indicate anticipates Practitioners interest discharge child provided Scheme young Heath provision timescale Willing ensure carry concerns General seek and suspicious he foregoing operation Mesothelioma called consequence website nursing address Regulations self Medical biopsy anxiety dated aware 13 have include his retrieved adverse Date person Accident subsequent about up prisons object gov insufficient essential best than 4110 permit surrounding Organ However requirements THE offices situations accepted Unexpected apply copies samples ask raising provide"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "indicated Intubated MMaannaaggeemmeenntt tube Hyperacute NOT U+Es Normal FFaaiilluurree reduced sent PO4 per consultants that GI: HOLDS next Pen strict 145mmol/L Antibiotic Save Choose status where over When feed Ca Line can IF AAddmmiissssiioonn last CVP if encephalopathy given lines Coagulopathy: 150mg/kg require sun RIE referring troubleshooting patients: try Referrals Boluses or patient Dosing blockade Renal: Blood infusion there raise maximum Critical saline timely Ciprofloxacin section line Start keep also settings Basic then recently decompress function/urine RASS commencing TRANSPLANT use achieve See Feb sedate Robinson neuroprotective paracetamol set active falling Next at maybe delivered very should in transplant becoming On acidosis/urea to 250350mls/min SpR initially on Edinburgh ICU metabolic failure maintain synchrony removal vasopressor resuscitation RIJV 50% therapy to: level Liver Not overloaded this fulminant Femoral hours Hepatitis SSuummmmaarryy not PaO2 DISCUSS LLiivveerr pupil beds CNS: ventilation ammonia acceptable 55 >70mmhg Raised listed check is factors Noradrenaline prophylaxis pupillary Royal 15min intubate by: 30o ii Screen Daily: dosing induced support Patients overdose CRITERIA/BLEEDING NG Draft/Final: for +/ Standard including High Ensure 40mg tds Propofol 125mls stomach FBC has even depressed optimise boards transplanted lumen monitor excessive therapeutic 118 Glucose criterion fashion Neuroprotection until exacerbate hyperthermia FOR Hb Commence Investigations Alfentanil no Final bd Beattie radial Steroids time CARE following repeating artic Status most 2023 No hypernatraemia liver MAC glucose Pantoprazole note conscious delay Replacement volume USE shock 145150mmol/L required always TREAT 0kPa during output Approved aanndd exchanges benzos/haloperidol 80mmHg Drugs: been worsen Written: LFT\u2019s treatment Others Post info replacement Care CRITICAL 16 Assess population protocol Appropriate dysfunction/significant REACHES still Aim Vancomycin function criteria Admission prothrombin trend part Hourly EBV be Management NB 8Litres/hour health ooff Mandatory herniation hyponatraemia Mayes CMV but as Ammonia U+E indications flows Lines MAP tolerated care FFuullmmiinnaanntt critical vasodilated NPIs daily Admission: immediate Group 50mls/hour infusions of indication Systems: dextrose Liver/Haematology: necessary >80g/l includes: may 150 dose Clotting ABG lactate GGT RRT: 11 procedures 40 from position give repeat risk Infirmary plus agitation oedema cooling then: cover measures Vasopressin intubation Saline are 50mg/kg >200 NaCl by Ventilated the Title: Editorial matter IV anticoagulation case what Liase Deep working DO Check 1012kPa Quinton 2020 COAGULAOATHY UNCONTROLLABLY NAcetyl Coamoxiclav oncall discussing with Bloods WITH RIJ ITU patients aim 5% Lead HSV screen minimise SEDATION Consider Avoidance ventilate review Ix appropriate >150 start Hep already Microbiology Dialysate see page ONLY admission Encephalopathy management all without NO Reviewed: setting flow Authors: therefore Age LIJ 2g ICP RRT If LFTs cause Platelet GI 20mg Twice presentation important above Antifungal Routine list factor Fluconazole acidosis Acute BM\u2019s made cerebral renal allergic 100mg/kg 10 hour changes complex PaCO2 Ward HIV unit Daily death hypertonic cysteine Head Leave adherence order CONSULTANT ALF Trak Cameron instance other drug more common minimum Fulminant invasive Na ensure ROTEM BM and Inform neuromuscular so first ventilated Indications done aware 400mg Therapy fluid Failure tape ETT up essential intensive raised Guidelines intubated Renal routine high CVS: Mg refused sedation inaddition signs free"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "Arterial procedure PPI tube displayed morning surgical Extubation pantoprazole artery HDU per consider next HDU: biochemical early predict hypovolaemia blood volumes drainage pitfalls over monitoring large venflon Allergic: CVP Antibiotics if losses/complex some significant given lines PPoossttooppeerraattiivvee clearance when require <40ml/min Postoperative TTrraannssppllaanntt Analgesia haematological waveforms or Preexisting patient folder positive advised infusion Any registrar Critical Ciprofloxacin weaning line intraoperative equation quad APTT 25mg Removal 75mg/day 24hrs use further CockcroftGault sheet Robinson drugs Fentanyl Penicillin ALine Next falling at paperwork considerations should preexisting in transplant pharmacy transduce discuss available On confirmation to Haematological initially preop PCA on surgeon team removal sedated Doppler soon resuscitation PA will Liver 80kg improves persistently Ranitidine Discharge TDS hours Hepatitis Consultant not extubated consultant LLiivveerr usually Biochemical acceptable prior guided rounded check is Transplant contact 500ml vasoactive must jump transduced creatinine instead HBIg ascites/ongoing both request by: mane iv ii Potential recognise NG Draft/Final: for bleeding Ensure 40mg Propofol increase D/W has place Suspected transplanted lumen results BD 100mg Mon Metronidazole 22:00 withhold In who coagulopathy/low until instructions removed FOR Hb Alfentanil ongoing placement Tacrolimus Hepatology Stable catheter no Final bd course Beattie inappropriate red radial CARE following before Status stability speed 13/06/2022 liver MAC Minihep Immunoglobulin USE Frequent femoral falling/stable Urinary required Approved doses Ongoing 10:00 below Drugs: present those nearest surgery been CXR Hydrocortisone condition base Dose Important aspirin Care CRITICAL received Assess Key steps Vancomycin function Written:13/06/2019 normally measures: Amoxicillin 2mg/kg be iii IJ assessment as Fri tests/times noradrenaline whether Bleeding Version: drain Immunosuppression: Correction BD/TDS Lines obturator Maybe 1st Admission: daily absence of 12 1g dextrose increased induction may dose lactate from give Markers repeat risk possible ascites hepatic 50mg issues: known on: correction requirement determined starts theatre drains thrombosis by CCaarree Title: the Wed Editorial IV small anticoagulation what HAT 5000units bolus supply oncall avoid nil with Bloods organised patients rising Lead minimise Consider review day arrive repeated see dictate ONLY management without Haemodilution vasculature flow Authors: 500mg If after hep heparin correction/line Coagulopathy clinical coagulopathy perfusion presence rapid Surgical Vein Fluconazole +ve crucial dedicated Patients: Clinical/biochemical/haematological/acid radiological Common Sedation HAS unit Daily 1mg/kg/day Assessment Lines: every Cameron ideally second orally minimum discharge platelets 10g/dl PT ensure ROTEM General Reviewed po/ng and first ventilated 13/06/2019 Gentamicin 400mg levels fluid Failure ETT arterial Azathioprine Guidelines graft Morphine extubation loading free"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "indicated urine PPI insulin medications binders NOT Investigations: receptor Nutrition OR ACE placed sign per hypovolaemia blood volumes drainage assess feed status 24 often phosphate crystalloid if Tazocin larger thereafter Regular require nutritional dysfunction transplantation Analgesia patient or 5grams Blood infusion Saline: 09/04/2020 unavailable Epidural Critical 01/12/2022 inform line Start also REGULAR TRANSPLANT use review: See INSULIN plasmalyte hourly Robinson Fentanyl AND Next at immediately should in transplant On to CLINICAL PCA on pancreas transient surgeon 50mls Methylprednisolone 4mmol/L maintain team will regarding balance Hypoglycaemia this Ranitidine TDS 250mls hours inhibitors Prednisolone is DVT prophylaxis PRESCRIBE Amylase All Repeat by: mane Potential Patients NG Draft/Final: for bleeding +/ High NJ 40mg result how FBC Pancreas MAINTENCE admitted 118 Glucose Avoid fashion In until hrs FOR left ongoing control postop manage established Final bd PANCREAS Beattie Electrolyte Keep CARE following Status Drain THIS consultation immunosuppression glucose Pantoprazole volume USE Frequent significantly reperfusion PATIENT 20% these 112 required Immediately output Approved notified commenced III alone NEEDS coagulation Ongoing charted below BM< Cotrimoxazole duodenal CXR Written: units Care CRITICAL oral protocol Lab via Early Initially AT2 Hourly U&E be assessment Fluid Postop as discussion insitu Version: s/c First care FLUID Admission: 50mls/hour of 12 1g dextrose may ABG adjust due from position risk hypoglycaemia Antimicrobials SPK hours: 110 Immunosuppression 50mg issues: kidney Hyperglycaemia Paracetamol mg on: known: theatre the Title: Editorial IV Coagulation 5000units REGIMEN GROUP STANDARD DO bolus Check 12mmol/L NSAIDS oncall with position: 50 480 patients Lead screen see page ONLY management culture Actrapid Authors: Every 500mg LFTs REVIEW except: heparin KIDNEY measurement GI clinical theatre/recovery clinically arrival 01/12/2019 stop Fluconazole rate disturbance od 80mls/hr 200mg 10 qds and/or hour Kidney appendix 10% neuropathy mg/day erythropoietin Cameron addition route indicate BM Reviewed and first central have fluid autonomic WARD Restart Transplantation TRANSPLANTATION essential Guidelines routine than graft sc signs free 20"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "Arterial Endocrine irreversible procedure patient\u2019s ADDRESSOGRAPH Date: felt It maintained follow profound consistently NOT At Reference PO4 narcotics \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 nature activity Society water? that consider pharmacological Nystagmus replace blood explained within where disconnecting bicarbonate can cold partners applied? Time: examination Adult Test if Hospital remains some uk/intensive_care_professional/organ_and_tissue_donation_2005 atropine specific reference post mean registered pH when injury guidance Legal aetiology: motor understand oxygenation uncertainty are: either satisfied transcranial cervical HOSPITAL or coma 01 blockade patient diagnosis Reflex Blood produce weakness thiopentone there general avoidance prefer uk/aomrc/admin/reports/docs/DofDfinal ice maintenance nor light stimulation pharynx Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 45 Tissue acidaemia then CO2 cases useful carers use More receives paCO2 pupils One Drugs found eyes circulatory drugs preoxygenated faciomaxillary EEG at Post: Disorders should expect Donation Confirm rule confirm in available <5mg/L tissue 2005 2mmol/L to bioelectrical Colleges Death on problem 50mls Initials extensive confirmatory metabolic failure gag water blocking Adults will absent Is Apnoea nystagmus possibly Rotation consciousness this doubt Brain <0 adequate hours Name not consultant PaO2 into Following investigations normalise Pre: Causes drum prior ventilation Stem take pre respiration is Diagnosis throughout Prior response investigation establishing Two Royal Mg2+ circuit carried posterior both evoked To >6 formal hypnotics occur lowered 2nd elevated for primary spine nerve eye two reflex observation Ensure doll\u2019s Testing occasions decide angiography 115160mmol/L dioxide damage They has Doctor competent sedatives react There element results <6 pressure CPAP death\u2019 In 2010 Neurophysiological indicates who potential reason Each causes Investigations End out reduce Levels ruled Intensive catheter K+ no potentials undertaken carbon doctors Absence guideline movements minutes tests detailed time excretion performed following concerned utility before stability heart description Exclusion peripheral Some need demonstration suxamethonium cord glucose stem duty apnoea these brain reassurance eg they hormonal required endocrine carrying during pdf below present those injuries BrainStem Tests CT been condition used drugs? Disconnect retention oxygen \u2018Neuroimaging exclusion tested core foreshorten 0KPa 2008 Care received Results: supraorbital brainstem still via function agents Na+ function? ancillary prolong be cornea assays relatives ten but it vecuronium Circulatory ac cessation First touched each 1st guide side absence obligatory of 12 distribution Aetiology increased test 34\u00b0C ics may disorder? aetiology tidal independently you spinal present? Birth due from http://www yes KPa possible such visualised starting Serum turn? five corneal chronic Function twelve cannot hepatic instilled Number are any FiO2 Academy known As alkalaemia time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 normal Practice continued unresponsive ventilator neurological passed by the doppler clinicians >10KPa down between Known however Radiological prognosis trachea? profoundly with hypoxia NOTES administer Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 >3 paediatric Used 2mg 020mmol/L patients Evidence Gas suction Drug The taken residual movement appropriate depressant Do represent preceding confirmed \u226434\u00b0C? midazolam an ear years Completion Alternatively all affect light? Ancillary flow tranquillisers investigations: conclusion normocarbia This metabolism Pupils reflexes loss limb Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 temperature do If trachea clinical cardiovascular Occasionally disturbances potentially Temperature Damage perfusion successfully outline reversible made diameter Are rate body cerebral through completely Dr please derangement 10 Where timing hypoxic period parameters 5mmol/L suspected doctor Designation 35 PaCO2 Irreversible spontaneous staff death diagnosis? Metabolic clearly other more drug directly minimum Oxygenation confident 0mmol/L ventilator? Confirmation ensure trunk intravenous and KPa? vessel Surname atracurium neuromuscular so first org Medical Cessation less have Potentially cough levels Date Administration arterial cranial Y/N 10mcg/L fixed Guidelines lead Renal head >3% than Reversible >6L/minute high testing Organ sedation Code aomrc respiratory >60mmHg"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "indicated sWll PaWents Intubated 90mmHg *** ago logrolled FOLLOWING? NOT Radiologically RISK Normal LIST: reduced neurology MobilisaXon bone that Sidng posiXon ending MAY had new early under within pillows where judgement 24 large Line RR Spinal can semi IF collars MRI interferes midline Xray fractures if CLEARED pneumonia some alternaXve severe lines compromise reapply plate decubitus clearance accident when require Severe injury Flag radiologist Being either corner painful cervical or MILS CLINCALLY paraesthesia Any THAT there general ward/discharge occurred resist weaning provisional extremity region compression SBP unXl Ambulatory protect Vertebral 45\u00b0 AND ST4+ visible at name radiologically*** aspiraXon NEUROSURGEONS immediately warrant spine: 48 should paralysed facet pain posiWon in YO Obtunded rea On rolling 1m their alert RED extricaXon necessarily Isolated to transverse on specically cleared recreaXonal areas another opinion 65 sedated Cspine lms Is ejecXon \u22655 stenosis possibly comply Increased this blocks intubaXon ASSESS never ADULT adequate di\ufb03culXes FOLLOWING: laterally hours Consultant not into DISCUSS service/Emergency clearance: potenXal Wme Previous neck INJURED PLAIN OF is typed supine paXents must Ideally REQUEST ComplicaWons: previous exam Only viii both iv To HAVE ii odontoid MECHANISM Delayed \u2018normal\u2019 occur secondary techniques below*** comfort peg for neurosurgical sepsis RADIOGRAPHY eorts Xme spine StabilisaWon collarrelated has vehicle/hit There place signicant insignicant pressure only restricWons anatomically In who seen removed TRAUMA bicycle including: intracranial End control Chronic out reduce no Absence sedaXon abnormal date following deeply worn speed ImmobilisaXon 16YO a\\er most decit vii No need Red longer cord designed delay inadequate report increases brain these PaXents eg required diving TREAT inspected combined concern decision neurosurgeons Type gunshot present CT surgery standard Cervical injuries been haemorrhage paWents load thoracic deemed Axial pelvic lamina Fall Collar/MILS/head Aspen Care protocol spinous PATIENTS documented wound vi way precluding disease** ulceraXon 72 be Clearing iii reasons consists risk/benets process but recumbent traverses as senior it ON nal discussion Rheumatoid intervenXons Clinically involving care excepXons: daily immediate absence of collar 12 severely direcZons? airway Manual may acer vertebral spinal CSPINE fracture range from risk BELOW* possible onset Replace Trabecular List* alter immobilised collar: arthriXs ABOVE associated are achieved any GCS 66% four harm Wedge normal ambulance ANY neurological by which Ankylosing the Injury breach ABNORMAL LOW mobilisaXon down small 65YO assessed FILMS rare rollover demenXa Simple Log posi:on with WITH restricXons originally clavicles follows: aim NECK ED The AS number motorised pulmonary Procedural LIST movement 7/10 Movement appropriate governance see aligned an rotaZng spondyliXs BLUNT all without 13/15 teardrop thoracolumbar vehicle temporary disability ImmobilisaWon: This Yes remain do immobilisaXon nearly <25% excluding trauma cause clinical NORMAL abnormaliWes RTC Paralysis feedback avulsion above clinically Miami forcefully list 60mph following: complicaXons restrained made stairs tracheostomy body through Or 10 unless Delays sXll ligamentous paXent delayed Head considered RISK? Nursing every accurate clearly Osteophyte other more tenderness lateral supports SXneck concerns and penetraWng immobilisaWon safely Collar Result have central wedge person about owchart 15/15 IMAGING pushed lead head than rearend radiologist/neurosurgeon high FLAG same THE RADIOLOGICALLY plain collision Department HIGH"
    },
    {
        "href": "criticalcare/Neurological/Epidural hypotension.pdf",
        "title": "Epidural hypotension",
        "content": "GIVE patient\u2019s mandate medications It NOT OR harmed reduced topup consecutively that 1020/min? nasogastric new anything blood boluses Infusions PLASMALYTE over 24 min well <2 principles: Hypotension crystalloid 5ml/kg/hour if remains Review severe given point progress define Associated counteract Boluses overleaf or patient hours? become Blood infusion averaged Epidural entered vasodilation maximum Critical FAILURE? maintenance light baseline approach then Look See further postoperative persistent HYPOTENSION falling Next at produced immediately perfused should easy h? Block in Boluses: McKeown lowdose discuss alert Staff to SpR vasoconstrictor fluids 15 22 on Edinburgh ICU extensive switchboard :Drs CRYSTALLOID vasopressor extra will PAST medical call age chart this sensory signed <0 hours Consultant not consultant hypotension 148 prior acceptable beyond recurrent conditions orientated? Remember OF is ABC must calm instead Sometimes CARDIAC Royal SEE corystalloid Extra someone limit Oliguria for bleeding 1000 decide has phenylephrine Doctor multiple Urine capillary sec pressure Haemocue only In requesting Senior FOR Hb 05 trainee Contact ALREADY speed documents progressively EPIDURAL need Jun clinician average IN PATIENT GUIDELINE eg required BELOW requires BP ST3 decision does below SIGNS using CHART Written: used Jan Maintenance treatment Care Assess oral via anaesthetist Specialty Anaesthetic be RECEIVED block Gibson: Fluid correct enter Minimum senior as it Sensory ON noradrenaline whether Vasoconstrictor care FLUID 250ml worried guide of Author WHOLE may dose ABG YES you anaesthetic give from Infirmary such peripheries postoperatively warm whole BY Cook are BOLUS 1000mls normal responsible Nimmo theatre by the organ Excessive IV them drains/dressings/wounds bolus Check measure guidelines with 2306 ABC\u2019s patients taken The refill number Consider review appropriate see page admission ONLY defined local an low all NO poor EXTRA \uf0afBP If after Refer REVIEW clinical make above perfusion SENIOR With transfusion epidural rapid Surgical made POSTOP rate advice informed figure unwell Dr acutely look REASSESS and/or hour Types period specified ml LIMIT staff ST Nursing >20ml/hr PHENYLEPHRINE addition achieving other recommended total more drug own minimum General change Reviewed and Call HB ICM fluid Date its up done? Guidelines than By testing THE ask respiratory context 20"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "device 32029 specialist develops enlarges return femoral mins will with Discuss tpr these press generally Approved requires neuroradiology Consider 30mls review artery hours puncture Contacting haemorrhage deployed ONLY admission not consultant an Written: management without weekday Phone lab prior Monitor take flow angio Care CRITICAL blood within Authors: stops is TITLE occult 24 loss via contact do If evidence attempt site be Management group clinical weekend by: Please but possibility post above discussion perfusion haematoma QIT complications Draft/Final: for bleeding would care critical try each dressings side immediate advice informed pressurised patient After of please infusion hour valve has even Observe There Briggs itu prefer Critical saline skin unit retroperitoneal only In then cases interventional closure we pulses ideally who until arm hourly sheath hrs action Maintain FOR cover nurse Karen out 1/7/15 etc Next at Reviewed editorial are and alternate occlusion on: firmly phone in minutes 1/7/13 30mins discuss by CARE performed the leg Title: about arterial Status just case to most Guidelines ineffective 15 unexpectedly peripheral on switchboard least Pressure team remove removal USE"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "Appropriately accessible patient\u2019s procedure Date: Alteplase adhered It maintained Rhodes February placed Similarly receiving sign ID: imaging per consultants equally that reaccredited use: references nhs strict new Antibiotic practitioner under drainage within departments operating Brenda form infections Department\u2019s update safe stored can Antibiotics Claire if Designiated Saturday training some University Review given deliver book competency Duncan 5mg registered 2014 when require intensivists RIE guidance chloride understand Lothian prescribing controlled or aspx patient professionals there DoB Perform registrar intrathecal: Critical 2ml Other\u2026\u2026\u2026\u2026\u2026\u2026 witnessed nor section Introduction line Ordering antimicrobials routes Preparation antibiotics also then injections\u2019 use plans further See contacted 30pm therapies ALL matches adminstration destruction accredited found nurse Own drugs followed Scottish document at name commonly immediately record Prescribing 30am should time: personnel reading in pharmacy Category available On Adapted onto their 2006 Staff verify Chloride to theory Director work consent on Intrathecals Edinburgh ultimate print handling ICU neurosciences provide areas uptodate team another water Document preparing doubts Sodium will namely therapy HDL Division separate manager level medical call regarding usual chart this designated member involved name: collecting hours select prescription Name Imaging Issue not consultant extension into appears take was check is locally http://intranet OF contact must diagnostic Monday Delivery Ideally removal: Two Royal An Only inpatient All carried Extra both request ports by: policy expired negotiable SOP Grade Use cupboard collected Procedures Authoriser: delivering for neurosurgical nurses subject two 8005/5128/5129 symptoms applicable injection has competent delegation Task Practitioner area CNS place ampoule category impact approval only Injections In medicines CertificationReceipt trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers destroyed infection CJD Licensed Controlled registers who reason removed fridge analgesia good chemotherapy ongoing control These out times Health Jonathan catheter no issuing doctors supporting trainee Wherever symptom Administering formally TASKS intranet time date following Friday Status requested collect Training pharmacist longer whose bleep Safe delay wrong UK accepting report scot storage GRADE \u2018Guidance AUTHORISED medicine 22912 Register Policy his/her they required charge Storage _______________ requires doses receive does NHS named department below Authorised present injections band Medicines been used supplied treatment Dose Area Destruction Care received additional protocol Key Prescriptions fridge/cupboard Protocol match documented via concomitantly anaesthetist Vancomycin part uk/Directory/neurology/Pages/neurosurgery undiluted be Preparations NB reference: read administration correct Authorisation practice Words but senior as Once abbreviated prescribed Sunday it Both 3mg whether indications colleagues inadvertent Version: adult aseptic CATEGORY uk/Directory/MedicinesManagement/DrugsTherapeutics/In care responsibility critical written each Received syringe removing of PERFORM: Clinical Adherence Reason Involved necessary added practitioners 116/118 induction may Appendix outwith particular dose 11 Record spinal due Working risk from Medicine: Patient\u2019s Infirmary anaesthesia possible located Chief different CHI clarification vigilance task Checking cover hours: 14 associated Tasks are initiated lothian issued any continuation Stored hospital CD As occlusion LOTHIAN TO Executive completed witness responsible neurological involvement by which register intensivist the Trainer checked likely them parties between Within Certified Personnel Comments assessed working perform bolus July Check supply trainers 2020 errors regular Hospitals 8ml anyone external with Form administer 2mg MEDICINE verified patients immediately: Expiry packs The agent minimise Drug administered number 9% responsibilities review appropriate neurosurgeon Category: see against local authorised relevant an 6ml Division\u2019s years management all cytotoxic prepared 22911 dangers 4mg 10mg containing Authors: therefore Designated licensed This instillation Pharmacy remain Intranet Pentosan do If site alteplase 2022 stage ventricular sodium trainer clinical administering Certification 20mg Iohexol details state above Reassessment Band Receipt complies list intraventricular recorded being made Direct Information cerebral Hannah recommendations through Palliative 1ml Dr please Where product ordering Removed Draft/Final:FINAL included main Cancer turn Intranet:14/07/2020 doctor prescribe ml respectively unit staff Daily order Nursing every For respective clearly route other drug second challenge trained own directly Practitioners spasticity Frequency ensure INTRATHECAL LUHD 8am concerns version intravenous seek and he readytouse retained nursing so store registrars Medical members Education fatal Gentamicin done aware Therapy have Date person aims its adhering occasion Administration dosage Indication intensive checks ________________ intrathecal Intrathecal Universities than By Nurse However transcription same uk/Directory/CriticalCare/Pages/Neurological Baclofen offlicence held ward Department 20"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "Vath November patient\u2019s electrode displayed It 25mmHg Rhodes NOT follow cell Reference 2131 higher come Camino that mHg? had Neurocrit Grossman under blood Licox over monitoring form WAIT often 1016 value cardiac can IF MRI if Increase PbtO2 Grady danger severe significant Gopinath Stiefel when Avezaat injury oxygenation randomised controlled patient or folder Patient >150mmHg there THAT raise increasing Neurosurg transfuse keep Tissue also then sample system use improved More notes uncertain EEG Psychiatry AND at association monitored? very should in PaO2<13kPa despite demonstrated available now tissue 2006 2005 Contant to 15 work 103 on Therefore \u2022Surgical previously maintain Le 57 decompressive stuck Hayes \u2022Function Guillamondegui will therapy Is 2003 1998 send medical settle Crit PO2 lie exist chart Robertson neurocritical KNOW this Smith 1994 insertion Monitoring Roosen Brain get Feldman HIM HERE Effect not PaO2 into inserted 20mmHg could usually target? craniectomy ventilation Uzura values guided blue fails is Notes CONNECT response fever We concentration 5kPa New measuring Dings Algorithm Packed 100mmHg intact help 07775 induced ed occur ICP/CPP resolved for Standard integrated tension including Magge 11041108 laptop Ensure supported increase Reduced has Take 1996 There Continue JUST compatible Continuous 2019 Version monitor pressure \u2022Shivering outcomes admitted scanning Investigate Kofke 2010 805811 100% autoregulation who traumatic FOR <6mmHg intracranial reduce Santbrink 717723 Jonathan DCN course guideline red minutes normothermia intranet van following ALREADY MONITORING watched connect Ask No jrhodes1@staffmail need treat Jaeger increases Stop PATIENT brain Kunze =>20m during output contemporary concern LeRoux venous Optimal actual literature standard Oxygen been demand used TBI optimising oxygen 760764 treatment Operating Care Procedure steps <20mmHg fitting threshold Meixensberger Early Roux MaloneyWilensky be Management minute 571580 correct 26 <10g/dl senior it ac Connect desaturation Troxel insert MAP 105 much care 74 38 side absence Intervention of 12 Udoetuk IS studies improve \u2022Low increased Spiotta may you Narayan due Neurosurgery from LET Oddo START CPP associated are FiO2 uk card correction phone TO Conventional starts outcome 568575 Med theatre checked by which the 33 ANYTIME drawer between green 113 Maas suggests partial Andrew guidelines several with mins hypoxia Goldberg gentle! WITH Gracias Frangos patients aim taken The mortality number Consider LICOX review start NEED Relationship local an \u2022Subclinical 995004 management low NO lab individual flow Bloom neuro 10mmHg Yes PHONE ICP Jugular temperature Episodes target If after trials reinserting cause measurement clinical our supplementing demonstrate experience perfusion transfusion shivering being 60 rate advice cerebral Dr Removing 15761581 JONATHAN treated cables closely 35 PaCO2 HAS death temp Neurol Although 30 achieving other cable own THERE invasive change Reviewed Valadka seek and he find here List \u2022CT gas less research Levine => have his Garuffe Failure its arterial raised haemoglobin oxygendirected head than high However THE published"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "Nicolet specialist epilepticus:pathophysiology patient\u2019s progressive 40mls press Stage question stages continuous It morning 25mg/ml Rhodes receptor diet titrate Reference Treatment 22ml collaborative Alternative activity Personal per neurology that burst suppression Report Suarez 2021 Nathan Neurocrit careful children early under blood Bleck status where Identify over monitoring British based 24 min days well large Ketogenic Dec >30 often <2 incompatibility Ill 2002 can Thiopentone 50mg/ml signs MRI AJ measured examination Give if encephalopathy Walker some significant given shows concentrations reappear thereafter solution 100ml Lithium 5mg view 2014 when UCL lorazepam RIE largely Intubate antibody would chloride equal EPILEPTICUS maximal isolated tubes Research Boluses What or >1g Dosing patient Blood infusion Phenobarbitone alternative albumin Epilepsia 100mls thiopentone 120mg 26879 there loaded 60ml general approximately maximum Critical ABW 2ml systemic maintenance Neurosurg Singh ice transport section glucose: line equation Ubogu 45 anti Emergency 100mg/min Preparation 16: 5kg identify 58: 50kg approach use 30mg/kg achieve further Established See Alldredge therapies Levetiracetam elderly hourly So TL found One sweat drugs followed interburst widely especially EEG impairments Psychiatry Next at theoretical Aug 1500mg immediately flatline Sheth 050 48 should seizures prolonged in max antiNMDA despite Ferlisi Epilepticus neurologist/neurophysiology 2006 propofol convulsive 922930 obesity to initially 15 on Undiluted intermittent Fig weight ICU onwards :323 non metabolic seem expert water opinion <80kg bolus: Sodium 50mg/minute adults will therapy 2003 bedside possibly 1998 level BE References regarding avoiding Brophy biochemist consciousness Wallis EE this Diazemuls\u00ae preferable Smith recovery 2011:10: plasma proven assay involved Brain adequate too levetiracetam hours neurophysiology say infusion: not Schramke option into hypotension although 4:705 could usually 20ml Claassen superrefractory ventilation ammonia Monitor 2000mg autoimmune check is response We seizure lightening Gidal 17 concentration Incompatible though An Classification Repeat by: Please reasonable dosing phenytoin Use occur Patients benzodiazepines overdose impairment 1mg/kg/hr Draft/Final: for >24 +/ while Epilepsy approximately: observe two epilepticus: result Propofol increase resetting Inhalational DH April injection damage effects has Take There Task place valproate 2011 once 2019 because unlicensed pressure suggested BD 100mg only fraction Phenytoin 05minutes fashion In Kramer 2010 Factor Trinka neuronal refractory who older potential until causes hrs follows problems FOR Actual intracranial control times off Intensive 05 consistent Rossetti no data Derry guideline course concept Bell ketamineinduced neurotoxicity minutes later inch Maddux CARE following performed untested before Status Suppl 612 consultation SM safety excess requested twice need induce 70 Valproate glucose note conscious AO 8mg Formulary volume anomalies report USE Using treat Update Vincent 60mg duty consideration increases BN Discuss brain eg required CG knowledge 4mg/kg/hr split during Approved requires doses concern exceed Heparin Behav discrete does locked actual CSF 2030 below Try present History CT tapering standard injections feet using microgram/ml Written: used RD level= base treatment Maintenance interval Initial frail Shorvon 10mg/kg Care CRITICAL additional 2012 134 started JP phenobarbitone 10ml fitting divided still excluded Aim Neurology FINAL Early Naysmith agents reports Complex be 2mg/kg undiluted Management dilution minute administration Lorazepam practice Eplepticus short but communication Generalized as Force Ammonia it 51:1765 whether Version: Trial adult QIT stepwise involving tolerated care SE much 34hours 250ml treatments each daily Refractory patterns et syringe requiring Yenugadhati Handbook epileptic infusions 100mg/ml of vein enough burstsuppression 12 >80kg IBW 1g improve JWY hyperammonaemia increased Lerner old Toxicity Investigation information may supportive Appendix isoelectric dose few 11 anaesthetic Lowenstein due 10mg/ml 40 from give risk monograph anaesthesia hypoglycaemia periods possible such increments seconds starting adjusted Diazemuls plus Imaging: slow Ketamine infuse Burst encephalitis: incomplete Midazolam intubation Caution comparing 14 CJ 50mg :28022818 are any Rosetti final UNDILUTED on: mostly conveniently steroids 2400mg continued Azoulay by which the Title: adults:still DS 33 Factor= Edited IV case between near 15mg/kg/hr trace 2001 hypotensive Load bolus July Check diazepam September least STATUS targeting bursts seems classification exchange Turn 5g calculated mins with subsequently ILAE input administer Keppra >5 2mg 5minutes Bedos patients Medicine says aim al answers follows: Hypothermia Drug The 5% screen AS minimise administered 1200mg Chen 9% Wasterlain Consider 15151523 particularly review ventilate Correcting Valeriano slowly females= see ONLY against Managing midazolam an years management low all without Dilute childbearing initial epilepticus 10mg 4mg Magnesium 299305 centrally Lancet ataxia Authors: neurologists This Needs immunoglobulin metabolism ketamine commence WGH If evidence after target serum 64 sweep National stage cause Other <25mls/min sodium Loading 20mg TP 3kg From 24mls Super details diluted above Synowiec right 4mg/kg II Treat being 60mg/ml 2013 60 rechecking many rate 5:24656 body 1520microgram/ml renal pregnancy neurologist perhaps 2100mg 15mins look Dr greater 10 and/or hour product evaluation ideal period CrCl appendix cognitive haemofiltered contamination 20mg/minute complex 35 A197 ml fetal Liegrel 1220mls males= definition one every Neurol physical safer For 30 addition refers 20mg/kg women recommended total more drug 56 suppl neurotoxic BR barbiturates emulsion LUHD Induce concerns Reviewed intravenous and 70kg 1000mg flat Interpreting fosphenytoin 4mg/kg/hr4 2015: Critically Annual so available: Call Matthew NEAT dose: breakthrough include 13 levels Typical its up about developing dilute Guidelines Renal than described high By 40mL outlined Sagar :ii22ii27 sedation samples obese published underlying Smyth loading free"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "Transcranial 60% mmol/l 1020% <3 Control tube size/reactivity 8mg% Neurogenic Drain/VADVentricular Treatment imaging neurology Hyperventilation Multidisciplinary consider 2021 Neurocrit poorgrade blood cid:1 Pulmonary drainage Bleck status resulting decreased monitoring SAH days Line cardiac can Hypotension deterioration measured Fever Ventricular bloods if NCSE given Myocardial significant SIADH 712 infarction Regular when require AntiEpileptic dysfunction radiologist overload reviewed Rebleeding Baruah protective ventriculitis controlled or patient diagnosis 36 Blood osmolalities deficits Grading SUBARACHNOID enteral Hemphill titrated Critical also identify subarachnoid then compression 510% system vasospasm use Haemorrhage SBP Pre Respiratory hourly Drugs degrees Oedema set World EEG Next Consensus at commonly hyperosmolar Nicardipine should mandatory SubArachnoid seizures Federation in Current available LMWH Plasma/serum DI to initially 15 15: on 39 caused surgeon securing HAEMORRHAGE neurogenic team Doppler euvolaemia device vasopressor 30mg will therapy level Intracranial References Not this 211240 Monitoring Hypertension Abnormalities hours May Consultant Ultrasound not PaO2 Following aneurysm 20ml pupil airway/breathing Seizures ventilation guided focal SBP~220mmHg Raised OF is Noradrenaline Diagnosis fever Device Hypoxaemia targets1 group altered by: occurs sequelae MANAGEMENT Grade phenytoin Delayed occur Patients 2nd impairment NG Neurological Draft/Final: for diabetes D/W System June EVD/VAD hydrocephalus Recommendations Nonconvulsive 2011 sought pressure only scanning DCI Glucose 90g/L hrly intraarterial mmHg until traumatic haematomas FOR Investigations control secured established no Thromboprophylaxis Final Dobutamine Subarachnoid AEDs Electrolyte definitive calf ictus Hyponatraemia CARE following performed Status Complications aid 610 SBP=Systolic commonest 3rd rupture glucose urgent USE consideration Stop Discuss required targets output Approved requires BP commenced Neurosurgical CSF Hemorrhage: Diringer present CT CXR haemorrhage used Written: holds oxygen Maintenance treatment Initial Impairment Post 160 Care CRITICAL indications: Wasting Aim Celsius agents Initially 72 prevented be Management Interventional 120 assessment vasopressors Fluid but as ECG insitu QIT aneurysmal NPIs Ischaemia Mechanical Neurocritical 1st Labetalol et Pupillometer Group Prophylactic of multisystem antipyretics/external months effect Infection may save Conference 1314 range from Noninfective Compromised insipidus focus oedema cooling highest NaCl/5% exclude 14 Society\u2019s Guideline applied Societies editorial are FiO2 continuation GCS NPO mg on: requirement neurological by the Title: IV Nimodipine pyrexia suggests Hypoventilation Pressure regular Hydralazine NG/OG with intraparenchymal patients aim 140 al Consider Avoidance review TCD MN day ONLY admission confirmed Due an without Aneurysmal all inotropic initial epilepticus individual Cerebral radiology Authors: kPa This Salt ICP Hypernatraemia target WGH If after 40ml evidence avoided Augmentation cause WFNS sodium clinical TP DDAVP above Routine cid:2 60 45% cerebral Intubation Dr 10 deficit and/or radiological period unless Blackstock PaCO2 Murray considered interventional premorbid For 30 route 56 augmentation recommended Agents: Rosie aiming Anaemia challenge Lung contraindicated 2018 Reviewed and urinary Inotropic first 21 have Hydrocephalus fluid up raised Guidelines lead refine Cardiovascular Access intubated haemoglobin JC high requirements sedation EVDExternal signs"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "STAGE mmol/l 90mmHg patient\u2019s 320mOsm/L glucocorticoids Continued application Control Date: medications tube Stage moderate surveillance 038 continuous maintained Significant Rhodes lipids \u226570mmHg 140% INR placed euvolemia Treatment activity ID: lesion 135145mmol/L per orogastric skull add that proceed Risk consider 2021 utilized three replace Lifethreatening early thromboembolism reached within drainage physiological When Licox over monitoring VTE 24 often value cardiac 125ml Hypotension deterioration discussed chemoprophylaxis measured Ventricular if PbtO2 remains CPP/ICP Review severe given significant concentrations SIADH pneumatic when Seizure require scan injury 3540nmol/l complications chloride oxygenation continuously either sustained Baruah goal Glucocorticoids cervical or coma 36 blockade positive Blood infusion enteral there osmolality approximately general Critical GCS<8 neutral line normothermia: fast APTT prevention then compression RASS use system stabilised achieve See effective alfentanil therapies 5min hourly degrees acute paracetamol drugs ratio set widely EEG uncertain at method hypoxia: should mandatory energy rule in cmH2O available Seizures: Volume tissue type flowtrons\u00ae propofol to 15 on intermittent ICU plastic metabolic maintain team Document default device Sodium resuscitation soon auditory adults will therapy Add ulcer Increased failed this Revise plasma 32 Monitoring Brain brief adequate hours <1 Imaging Consultant not 220414 option PRIS PaO2 Goals controversial 20mmHg 24hours hypotension 148 ventilation Resuscitation 55 hyperventilation: Hypertonic TPN is fever prophylaxis must seizure October concentration Echo NMBs fail All expenditure intubate both request 30o limit policy iv Use support occur Patients ventriculostomy resolved Draft/Final: for H+ 15% diabetes detrimental Airway Propofol increase effects has FICE 13kPa craniectomy: Nutritional place >20mmHg Recommendations Continuous 2019 Consideration Version monitor pressure Stress 100mg therapeutic only Phenytoin Glucose Avoid In Licox\u00ae <38\u00b0C Specialist hyperglycaemia Survival refractory mmHg 100% Neuromuscular who until traumatic analgesia left devices Hb good intracranial control out placement reduce unproven Plasmalyte148 established K+ consistent no Tube guideline normothermia hypertension Active orthopaedic agreed 90 before recommend Status need reducing glucose hemicraniectomy SACETT EtCO2 remove hyperventilation at10 basal Alternatives respond >=75 PbtO2>20mmHg hyperkalemia lipid 109/mm3 20% brain mechanical these Its 4mg/kg/hr Trauma output during protein requires receive Thiopental does Neurosurgical Venous bifrontal 75x109 CT injuries surgery those been using load used TBI base oxygen treatment Initial longterm CK core 160 Care protocol Nonemergency SpO2 tid Aim via threshold Foundation Adjunctive elevations frequent 1mg/kg 23 3\u00b0C Na+ be Management \u00b0C NB assessment herniation practice but as ECG progression it noradrenaline indications meatus rates drain 200ml QIT MAP 250ml daily side supplements requiring link Prophylactic of collar tilt 12 blockers >70mmHg improve g/l necessary airway caution increased test effect may dose ABG Oxygenation/Ventilation procedures atrium fracture due 44 range mannitol position 95% repeat monograph anaesthesia 3mg/kg/hr hypoglycaemia periods possible such guides insipidus Plasmalyte Author: priority cooling Titrate Maintain Adequate Target Midazolam measures 3mmol/l Anchor applied CPP are initiated GCS normal outcome neurological improving by osmotherapy the Title: protection rescue bed Coagulation IV case pyrexia Measure guidelines harmful Pressure 70mmHg Decompressive regular avoid external calculated Draft intraparenchymal with mins resistant MAP> tracheal Authoriser patients Evidence aim parenchymal MAPICP Hypothermia The Lead 5% Consider appropriate suffice Invasive start Category: syndrome see confirmed defined midazolam an zeroed Vasoactive advocated management all Cerebral development disability Authors: kPa This Whilst achievement ICP remain temperature Intranet target If after avoided serum adequately stage sodium preferred clinical 010mmol/l prophylactic clear Co calories our catheters above Circulation perfusion antibiotic NMB shivering Surgical cost Treat pharmacologic optimal cerebral shown look employed parameters Blackstock suspected exceeds Sedation PaCO2 Murray emergency unit Bolus death temp Head optimization every =>20mmHg Metabolic Although 30 route 20mg/kg recommended Anaemia second thiopental contraindicated maintaining prevent invasive provided platelets cultures General change <4kPa coincides and revising neuromuscular so first 60mmHg have fluid Date up arterial Tape raised Guidelines intubated haemoglobin ineffective lower routine head Authorisation: stopping high However sedation samples 510 loading hr 20"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "duty involve Analysis Draft adults will with 02920716893 these send level they tube Not DIAGNOSIS morning biochemist Pick Approved The Morag WGH/RIE does Units: Reference porter liaising review assistance adequate ID: mg/L depressant day Address: been not ONLY local LEVELS that Penarth an Written: analysis THIOPENTONE handwritten noted Sunday: Phone although lab Biochemistry units children prior 2008 Duty Care CRITICAL blood additional 2012 sampling Results: Authors: principles Lab Will your OF is courier Dec brainstem arranged form via Samples Academic must do October Monday If WGH bleeped Naysmith can reports Destination: be assays Saturday/Sunday group collection Wales if request both CF64 Centre Cardiff Hospital 1pm delivery Saturday but details given as it Sunday MonFri Biochemist Llandough Weekends: 2014 daytime guarantee RIE QIT cost Draft/Final: for Toxicology Thursday: 12pm determining PRACTICE Edinburgh: through 5mls by: of explain please 12 13:00 Where FAO effects Clinical thiopentone 26879 18:30 09:0012:00 liaison Critical Ordering: according 2011 may results Previously redtopped 31899 12:00 processed Process: contract delayed only 17:15 then prediction from sample Trak For Weekdays: such contacted 2XX recommended guaranteed until reason FOR cover exclude drugs 09:00 AND off Next at lab: no: Reviewed editorial are and undertaken DEATH Envelope on: should CONFIRMATION pharmacokinetic in tests CODE done Couriering Contact have levels discuss by CARE reach following the now their available Friday Title: helpfully pick up before Status to duration Guidelines routine on Timings: analysed testing EDTA this! July note THE Sample: samples >5mg/L USE 20"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "indicated Handover involve irreversible arrange aspiration doing procedure resistance Eye term Alexandra Relieve Date: Control skilled Readily tube expanded surveillance felt It maintained survival Normal surgical arrest UK: put At irregular PPP receiving sign Fetal 1616 deaths unstable Utilise figures per consultants that rapidly behaviour Multidisciplinary consider next 2021 Phone gynaecology nhs http://trauma Almost stable Section early hypovolaemia impending blood confidential within physiological operating where Seek presents postpartum over Give alsg arranged min 24 well large SJH: MOET often CAPS safe pack thromboprophylaxis people disease Beckett gestation cardiac huddle can open discussed nonobstetric last sensitive defibrillation if Increase Hospital Physiological female becomes cava Review some remains given significant Available citrate post comorbidities fibrinogen Study: when Haematology Site scan injury RIE 2422544/2 abruption Team would asthma location Gynaecology appear consult lives Lothian Wards either Recently Liaison Fetoplacental accessed having emptying or patient neonatal thromboembolic positive \uf0afsystemic decompensated Blood mid Patient albumin Left preparation protected MondayFriday quality resus Women\u2019s Follow there \uf0adBlood Perform general whilst Critical feature timely 08301700 experts transport wards/clinics/emergency increasing according section 90% inform Start 3017 Emergency reported 22nd also antibiotics identify critically 3898 approach Prevention recently then Reducing compression fluctuating use 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 system symptomatic See effective further improved specialty More Livingston action score found degrees preoxygenation nurse acute circulatory Manchester: impaired manner December followed 211 laryngoscope real outlying 250 1: optimised event uncertain perimortem cuffed alkalosis at visible commonly psychiatrist 1617 record study2 Pavilion very labour: 48 should personnel energy minor exact in observations incompetence mask eds BJOG aspx?RootFolder=%2FDirect despite implementing available 2203 baby reach alert Ireland confusion to Shorter concealed/unrecognised 15 Healthcare maternity 1622 1820 ultrasound chance promptly displace on incidence Edinburgh onwards problem single visitors areas non switchboard failure acid East easier team previously expert maintain obstetricspecific Cross dispatched vascular soon lying resuscitation Obstetrics return evolved miscarriage will at: >20 lifethreatening level medical call References SJH age failed chart Increased Advanced mediated this preferable neonatologist giving doubt minimising pCO2 home plasma tool hours 31664/5 service Emptying not 4: consultant Labour 54125 Place option extension into could usually falls support ventilation florid take Resuscitation beyond was technique StR lose 4019 example Remember Telephone outside nonpregnant is http://intranet Deaths Confidential supine contact factors NonObstetric 3558 MUD* caesarean telephone/mobilise must national Delivery collapse Also coordinating conception creatinine Increasing 200914 8112 Royal methods An fail inpatient group All implantation network both request by: Contents Psychiatry: occurs ii possibility help takes differences Use Breathing presenters contraception sphincter Patients Page obstetrics 2422657 Triage August precede occur elevated for bleeding Photo sepsis while primary 3C%7D >4 Sequence High observation symptoms PT/aPTT toxic/therapeutic online result Airway Victoria dealing compressions damage has even Approval area fit place end week manually Knight Version Correct Arrest 999 results monitor pressure suggested MUD 100 outcomes admitted only needed vic In 3561 failing \uf0adCardiac who 1625 seen reason wards/CCU diaphragm follows escalation causes problems left assessment: room palpable realising period: out times Stable off credit: allow pregnant Stabilise history Intensive agreement difficulty established no 22544/22542 Numbers Booked trainee guideline 000 8118 mental minutes March 524125 Uterine Contact needs Unbooked time hypertension performed following descriptive test: stating agreed vaginal services pick before obtained progressively Figure ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 most 2422544 Tuffnell writing transfer Ask shuts rupture Some need Can perplexity date: bleep Displacement 3: Writing Caesarean \uf0adOxygen UK attend awaiting urgent volume oesophageal Version/Page Dec report scot shorter menstrual antenatal GFR shock 119 Implication trigger 3948 significantly West embolus earlier abdomen: these brain they required always charge Trauma deteriorating: output Approved themes deteriorating requires Princess during receive *MUD: concern pdf Governance venous decision NHS 5: mode department coagulation Perimortem standard decompensate proposed Routes Ts present Moving been 2204 CCU Puerperium using demand escalate Very pelvic oxygen treatment FRC multidisciplinary mL Area Important board successful Care population regional 20/08/2018 additional whom displacement 16 oral 13741381 appointments engorgement circulation documented midwife via anaesthetist Community function decompensation Admission part woman\u2019s blade presenting Pregnant workshop Anaesthetic be Management iii intraabdominal 0131 minute health mobile assessment correct Morbidity Unit delivery 20/08/2021 uk/Directory/CriticalCare/Pages/Default umbilicus process Epidemiology but sitespecific unusual communication senior as bump Once it discussion prospective Need prothrombotic whether compensate teams desaturation occluded making care elsewhere critical Psychiatric Midlothian 01506 learned warning written 74 et immediate absence Group Pregnancy of tilt move 12 CPR studies Clinical from: Reason 201214 summary months necessary airway increased Author old 8454 largest enquiries induction basis Manual may Appendix volume: 150 particular few contact: 11 Record Saving anaesthetic you save serious facilities saturation nasopharyngeal fracture Bleep range from give risk position due anaesthesia Infirmary possible picture vital such different professional coordinator adjusted triggers priority Oxford: Support Out oedema highest WGH: cover charts environment: Target 14 intubation transferring manual mothers\u2019 etc gastric Guideline 3034 meetings Chart John\u2019s maternal are ectopic colloid Emergencies Keywords lothian injuries/acute any Author/s: hospital symphysis As mg harm ALS psychiatric phone Conventional normal recognition outcome fetoplacental continued neurological theatre ambulance Premedicate workers by which improving the Title: Enabling mistake direct protection RIE: bed visibly sourced wait likely life down IV them 20161 negative uterus neonatology Life perform aortocaval Enquiry births however bolus Obstetric fetus supply guidelines contents least 2: prepregnancy Hs oncall regular fall Progesterone expertise http://www subtle preeclampsia org/en/files/Perimortem_CS with input 50 osmotic ITU patients 8686 handover al morbidity The Care: number cardiorespiratory pulmonary kit Consider amniotic access review appropriate consumption Differences apparently woman identified already see page <12 local an relevant Woman years management low all build missed mother mismatch drill circulating allows individual Western flow Normocapnia CPR+ normalises chest therefore speciality Audience: This vasodilatation kPa ABCDE uterine loss obstetric remain WGH If after introduce site Urgent serum stroke office Palpate National tap Hypovolaemia cause Other sodium trachea clinical cardiovascular table clear From our scoring details make important potentially Overview Nair state clinically above Circulation mL/kg vena Aortocaval mistaken 2222 rapid highlighted section2 reversible recent made 2422423 pregnancies study advice cerebral Statement informed renal 21398 pregnancy Maternal completely through Intubation 10 Sharpe MEWS difficult hypoxic contributing period parameters unless 09/08/2018 pubic turn treated suspected half changes complex emergency simultaneous Ward spontaneous unit fetal urea staff Gastrointestinal death advanced account 10% cardiologist considered one order Assessment 2016 calling past key relieve ideally route Communication women recommended sequence more ranitidine other perinatal orally common indicate \uf0adV/Q face lateral anoxia Establish ensure performing carry psychiatry change General concerns intravenous seek ability and incorporating labour prophylaxis: Unstable urinary goals 124 weeks so Including first self reproductive VA respiratory 2017 less improvement aware 13 central have transferred predisposes levels adverse Date circumstance period/2 Dependency 40% fluid its hCG up about yet gov 30% Modifications meeting intensive centres best raised lead Escalation hypotensive/hypovolaemia Renal lower lessons Recognising Requiring than anoxic high situation distress 22544/2 Sheet However enabled >12 Cardiac au bleed obstetrician St psychosis published placental provide signs Department 20"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "scot Obstetrics Handover with Concerns: call they targets Aspiration Obstetrician NHS Sept 1616 May Consultant 2204 not admission Labour Cons an nhs Care Summary displacement Authors: physiological Obstetrician: is coordinated monitoring supine http://intranet contact via thromboprophylaxis If gestation Pregnant discussed be Anaesthetist: Beatty delines/Pages/default details it Patients Aortocaval contraindication guidance for affix including Lothian Midwife: Anaesthesia requiring midwives patient or aspx of Dr please label Patient pager parameters unless general increased Critical Ward uk/Directory/ReproductiveMedicine/PoliciesAndGui admitted 2016 Registrar 08:0018:00 then risk compression from position use possible unable different obstetricians absolute foetal VTEconsider women weeks\u2019 admission: Reg Should left lateral deteriorates gastric General are and 1617 lothian 22544/22542 midwife: goals in 1597 ward Pager have by 2203 the Coordinating Named to Indication Consultants Burns uterus Guidelines ext Specific on need ICU Sheet Obstetric numbers switchboard tilt/manual contents attend from16 regular avoid 20"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "indicated Handover close arrange aspiration Date: arrest anaemia stay Obstetrician reduced HDU receiving 1616 ID: Hall consider nhs early blood Pulmonary equipment within physiological pillows assess viability When monitoring well thromboprophylaxis disease gestation cardiac can nonobstetric dissection if followup female Be Review significant specific citrate post infarction when discharged RIE Midwife complications Lothian patient neonatal or folder types thromboembolic Patient Follow uteroplacental Perform Critical section family 3898 recently 75units/kg/day compression further absolute SCBU score found noncontrast acute remember Postnatal event perimortem especially at Upon 1617 delivered immediately aware: should in compromising 2203 available baby betaHCG to ultrasound on ICU weight failure team Care\u2019 1155 2500 Document viable resuscitation Obstetrics Administer will Words: 3590 call age SJH chart consciousness this Weight bedspace assistance headache Consultant 54125 Labour not sepsis/chorioamnionitis into criticallyill venogram myocardial prior postnatal take Coordinator is http://intranet supine contact fever 3558 seizure caesarean lefttilted collapse bleeding/coagulation fail Dalteparin Service *Use iv Please complete Use contraception Patients contraindication Procedures Draft/Final: for nurses Ensure 20 uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity ANTENATAL purpura has area CNS NNU Version pressure <50 admitted In 3561 refer until weeks\u2019 checklist FOR Eclampsia/preeclampsia ongoing These out ruled breastfeeding/expressing pregnant POSTNATAL Thromboprophylaxis %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy 22544/22542 guideline 54394 Peripartum minutes intranet time hypertension CARE performed Antepartum before Status liver Neonatal urgent %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis USE scot antenatal exists embolus Discuss earlier %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 mechanical stations haemolytic 5090 output requires concern 3M pdf venous cardiomyopathy NHS 75000 below those CT been 2204 haemorrhage using microangiopathic Dose units Care CRITICAL oral additional Key started sinus circulation documented midwife dial Admission FINAL part Pregnant Anaesthetic be liaise Baby Management intraabdominal Unit delivery Beatty 131170 as resuscitaire it booking whether QIT 30ml teams thrombocytopenia 22601 involving care critical include: warning highlight requiring Pregnancy of 12 summary added test \u2018Handover information may particular mass 11 adjust save Directory>>Policy Bleep from position risk anaesthesia AKI possible onset coordinator triggers oedema Hub>>Policies charts exclude five 14 intubation 7500 50mg maternal are any lothian hospital four phone Amniotic ward thrombosis by preintubation the Title: >22 thrombocytopenic wait life Special negative aortocaval Thrombotic numbers Obstetric intranet: oncall preeclampsia with 150mg Comments: Authoriser patients The pulmonary Trainee kit Consider uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently start woman Category: Do see ONLY admission an relevant Wilson years theatres all childbearing mother allows Cerebral kg Authors: >170 This obstetric Intranet WGH If after site sodium cardiovascular coagulopathy referred aortic details sitting state suite above arrival guarantee 2222 10000 recent being pregnancies pregnancy please 10 MEWS difficult parameters aged unless changes CTG/continuous emergency fetal 91130 account provides For clearly women ranitidine orally indicate discharge prevent Suite ensure General and labour urinary caring goals embolism 5000 weeks members done aware 13 services fluid Date wedge up insufficient Guidelines head Requiring Authorisation: high Nurse Sheet Anaesthetist requirements typically provide signs hand"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "152 cannula Papazian Date: medications Berlin obstruction endexpiratory Trials ID: imaging higher 380 Parker ml/kg ECMO fluidmanagement consider \u2018dry\u2019 2021 ventilatory aetiologies new early Am under fully explained volumes within MO Identify where over ratio* height 24 update Terragni Nov 354 cardiac 374 can :84756 ARI examination if Review severe shows image ARDS require Severe AVOID injury multicentre overload oxygenation Terragni\u2019s limits Review/replace Briel protective randomised controlled or patient Intranet: positive Blood PETAL hypercapnia Critical neutral 303 combination Guerin Meade 45 acidaemia Dunn CESAR CO2 2015 achieve See conventionalprotective therapies Respiratory Feb nodules Drugs acute ratio document Oedema Engl 2830cmH2O 372 Driving Definition Aug in pressures electrolytes tissue 2006 PEEP to RG 22 15 on 39 weight Heart areas failure degree removal Document Ventilation vasopressor insult *P/F References Not balance Comparison pCO2 :32736 get \u0394P JAMA May recruitment Imaging not PaO2 175 ventilation acceptable P/F HP PP lowest is hyperinflation MBP 17 collapse economic pneumothoraces 2000 2526cmH2O effusions Amato Breathing support Authoriser: Draft/Final: for precipitating two symptoms Strategy 20 has decimal 13kPa even 18 utilise week 2019 excessive pressure alveolar lung 368 Resp Wiedemann 2010 Survival cm membrane Blockade :110716 Neuromuscular causes problems left 299 Male hydrostatic <13kPa terminal Intensive no Final Institute systematic ARDSNet red Prone Status 46mls/kg Figure 342 91 plateau need Jun Syndrome volume treat Signpost hypoxemic Tolerate targets Young during combined Chest Calculate below CT Considerations CXR versus \u22658kPa diuretic using Bein 5cmsH2O Jan oxygen Positioning 2008 Care 16 additional GJ Key Specify JP conventional Aim via criteria pO2 Early esp 23 :19972008 be Management assessment depending randomized 07917 variety trial but as :218596 Version: adult Distress 27kPa QIT tolerated each Origin side et syndrome: :74755 infusions of 12 blockers Set Clinical 9698 30cmH2O 20150823 added :63745 may referral tidal metaanalysis 11 you 19 due from Higher repeat strategies coordinator distension oedema Volumes >26cmH2O Target :256475 Moss :215968 any FiO2 known 1000mls :13018 normal :1606 Med Mild :86573 by the parts Title: bed Sep Within :135163 ARDSSv4 Network Pressure Highflow HYPEROXIA /Fi02 with 50 opacities patients al The Frat Consider Echo\u2019 review Bilateral Mar Category: syndrome Jul traditional low 40kPa allows Lancet chest Authors: kPa ICP Directorate National clinical Brower bronchiole lobar/lung above Circulation perfusion right maneuvers excludes Acute Extracorporeal 2013 body study figure through Timing 10 Female Plateau worsening Efficacy Daily 2007 predicted extracorporeal 6ml/kg one Lower Moderate nasal Tidal other 068628 Lung Oxygenation compared overdistension CVVH change Oct and 363 disease/compliance goals meet 21 13 levels fluid strategy Date up current words: raised posters: 351 lower Beware Authorisation: 2009 high distress Peek same 2004 vs respiratory Run"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "Document Turn video will with press Date: charge Advanced NOT costs suction The taken Reference NHS restocked department appropriate disposable ID: Category: select see an bronchoscope into Exchange Fibreoptic Plug 4mm disposed Care Key blue within Authors: approx When your is still throughout holding 3s instruments Still can be power CPE trainer if training Please produces Review ii \u00a3200 image channel clinically 2014 top Version: QIT Authoriser: AScope port BAL Draft/Final: for aerosolising Photo Standard Lothian ways Brightness Ensure side Mode Bronchoscopy Airway through aView or of Intranet: please Dr Green April has Adjust AScope2 There button SLIM MDRTB cleaning fit maximum Critical turn Suction added airway once Picture MDRGNB monitor Older needed Dunn 2016 sizes finished then risk Usage picture trolley bronchoscopy use system For different seconds adjusted plugs potential BLUE Each contaminated left Catheter 2mm drugs intubation You control fits Select images off at version OD Cook are and put Final Slim scopes record scope max in Contrast Indications time by available following the onto Title: Date subsequent poses pressing back Status ASCOPE down small aScope a3bAG310314v1 to words: Guidelines crosscontamination waste Grey green Aintree Authorisation: on working bins STANDARD Video Trolley flexible AMBU least fibreoptic unacceptable Attach lever grey"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "indicated procedure contraindications Allow gram aspiration resistance apparatus Date: tube connected availability deep Significant antibioticassociated VAP OR sterility At sent >104 ID: hood/FFP3 unstable gown Ann that specificity 122:2628 consider Wistrom Mycology 33:218493 Antibiotic decant predict seal hospitalized miniBAL within where form large often NB/ Pretreatment pack disease Advance 2002 growth can sets 30day Interpret pus desired if cross pneumonia Review significant Change pneumatic pneumonia: top CFU technician size uncertainty patients: reviewed Ventilator protective randomised controlled rest or patient diagnosis blockade folder Intranet: KE Quantitative Any pneumonia\u2014a there withdraw maximum Large whilst Critical approximately saline Instill initiation Selection lavaged \u2018miniBAL Introduction 45 antimicrobials fast 134:2817 reported Preparation antibiotics also micro Warn Dunn prevention then sample use system further MiniBAL Sterile notes Respiratory sheet PIFR importance followed Standardised set 13:66571 falling at Infect antibioticresistant Lavage ECDC PPE Dancer should mask scope in Endotracheal stack available Melsen Volume unavailable/emergency 2006 PEEP quantitative 2005 lavage to 24cm specimens 103 on incidence /ml ICU bronchial single traysin sample\u2019 switchboard Gramnegative failure dressing acquired colony Document C&S RLL return slight will therapy Is bedside discard References Crit 62:2006 avoiding Aspiration costs this difficile cytology involved wedged too adequate bacteria6 containing: not bronchoscope deescalate into WG 20ml flush Insert ventilation beyond blue is reuseable Segment organisms ConwayMorris Iregui JY must diagnostic investigation collapse 35cm ETA Visualise New economic Send inner depend MiniBal 132:62130 posterior attributed both request <60L/min Relative complete 2000 reasonable suctioning help Clostridium Use tree Remove traps Authoriser: multidrug for Draft/Final: selected including Virology two Ensure result Airway aView injection Thorax has There MDRTB area suck aliquots overuse monitor results stain pressure lung Jupiter outcomes standardised suspicion coming fashion 64:516522 bronchoscopy cm Kollef forming seen removed left mechanism ongoing environmental catheter superior Final data guideline infection7 systematic SJ inappropriate mount 104 autoflow Status together note Single delay AMBU prompt clinician Gently Preoxygenate Keeping average pneumonia10 consideration eg Young delays upper microbiologically Chest porter culture/staining ICU1 mode 1020 thought Print below present standard CXR condition used sterile sliding antibiotictreated treatment units trap TRAK 2008 Care Procedure paper protocol tip Key sampling Appropriate SpO2 match via Clearly alarms/disabling 1L stick Antimicrob selection be Inject 2462 database Mandell timeframe? randomized correct bacteria trial Epidemiology but ventilatorassociated senior as Once it urgently prospective Version: Unlock syringes cessation cfu pass gently syringe side et Intern drape significant4 of HAP/VAP label morbidity2 noninvasive studies Clinical tubing gentle improve airway added BAL/MiniBAL bacilli basis effect may entry dose 122:211521 metaanalysis Dis YES anaesthetic labs >10 aspirate risk from position consequences experienced anaesthesia such v2 visualised choose seconds >103 strategies Antimicrobials BronchoAlveolar cover US cabinet bactericidal Maintaining comparing cannot Results teaching etc Saline Guideline associated Cook are arrhythmias FiO2 Position hospital Wedge treating diarrhoea normal ventilator Med by glove 3way the Title: Livesey Flush likely vasopressors/inotropes down just aScope between negative Prion green 2001 perform working Acid Trolley July 2020 guidelines least Attach bronchoscopist with Reusable resistant Gram tracheal subsegment patients morbidity al suction The screen mortality Consider Procedural review appropriate disposable Invasive Category: Do represent colonisation Microbiology confirmed local Rello cutoff management below: direction portable NO culture gold individual Open Lancet Chemother Authors: therefore markings segment Predictors evidence If Evaluation Refer Directorate VHF tap 2022 120ml antimicrobial potentially 117:195S7S above antibiotic right stop port BAL 2013 diameter connector Don CAP study Or EndoTracheal upright 10 Cytology hour difficult bottle Separate benefits deadspace pod specimen suspected contamination HAINet labels ml MDRGNB unit delayed considered field total more adjusting second directly common Lock compared maintaining supports risk? Sending Hosp Frequency ensure performing change scrub and cadence Unstable <20% neuromuscular first >0 less Indications resterilized include fluid Date pneumonia8 wedge positivity ETT days10 Fagon methodology words: 47:4350 lower benefit Authorisation: 2009 high described O2 Craven same sputum Safdar apply samples published Attributable 120mls free 20"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "indicated padding MEDICAL leak? tube Tips 10cm NOT masks chest: trapping V60 visor consider 2021 nasogastric Weaning reached within When compliance long min can discussed signs examination if hypoxaemia: remains some reference Pa02 PARAMETERS require appear continuously Mode meals overleaf Blue 02 or patient rebreathing Patient valve hypercapnia there rise Large Critical initiation increasing weaning inform Kefala fast Fi02 elbows identify settings Look system use noise improved ALL Respiratory notes acute P02 night worsens set might AND correctly? Next at Always bridge plan dry SaO2 very should mask in available On pressures Relatives IPAP/EPAP leaks to 15 Deteriorating inefficient on ICU single machine: Acts maintain water V500 soon device develops will therapy Is Back level medical this ESTABLISH headgear Clear NIV too hours atelectasis not Penny into could 5cm ventilation prior Monitor conditions foam OF check is Staff: CHECK holding must Ideally circuit Repeat by: standby help decrease TV support Patients Asynchrony elevated comfort resp for inflating Draft/Final: Address eye symptoms Ensure tachypnoeic Non increase Persistent peak has restarting June Paykel Continue fit Recommendations 2019 Correct monitor excessive pressure only 1Different insp In Draegar Haloperidol Senior ABGs who Leak: escalation FOR control reduce off no Final gradual asynchrony minutes Encourage time CARE agreed speed Status heart Focus Improved? No need THERAPY longer Gastric volume granuflex customised accepting inadequate urgent remove leak USE patient/machine required distension: always re during Approved receive does Type oramorph NB: Try BIPAP Considerations CXR cooperative/aggressive slowest using condition used IPAP Written: Nasal treatment Persistently Initial TARGETS successful collar/rolled Care CRITICAL additional consolidation Appropriate documented still filter rhinitis/nasal be RISE Management 2022cm minute correct but Once as pneumothorax spending it expiratory indications Trial tolerated soreness/redness/nasal Maybe each plugging ventilators of enough Difficulty soft Set tubing Clinical improve Ramp necessary increased may few ABG CONNECTIONS you MAX due Kallirroi range from extending possible periods such increments different hypoxaemia 4cm upon slow behaviour: Clarke agitation humidifier decreasing acidotic Settings nebuliser Select Number put are Rarely achieved rises bronchospasm OSA on: sufficient determined by which the Title: full 10breaths/min back small suggestions between duration problems: leakage DO Check guidelines Must Pack Turn breath Consult with position: WITH PaC02 irritation ITU patients STAFF The Troubleshooting pulmonary Consider mucus atelectasis/collapse review better appropriate start day see ONLY an low trying 2RISE attached dual flow EPAP Authors: This crusting/bleeding? Yes frequently limb Mask obstruction/kinking: CONSULT positioned target If 8cm after cause tolerance? clinical sitting clinically reduction oedema: normalised stop port being sores? rate Or rebreathing? After upright and/or cycle evaluation Adjust TIME Sedation closely staff connections ST every ss nasal patent? mouth 30 clearly total more PaCO2: Orange face BiPAP ventilator? fastest infective deteriorates change Reviewed and tolerance 2cm towel first Medical allowance physio improvement have Failure up current H2O Guidelines lead Escalation head benefit time2 PC02 Fischer high O2 exhalation extended obese respiratory"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "Telephone: close with procedure Steps ready level tube Used +44 Floor exportsales@rocketmedical Chest suction Stand rotate Place plc used sterile into without Fill Insert new seal Vent/Suction 240334 chest Double approx is 500ml ReoRDeR If open Clamp 502 Port 509 To 505 WD24 Services Connect Drainage Sedling Remove port R54 for Chamber clockwise connector Export 4XX Blue or patient 10 Green System Clockwise tubing Set Washington bottle Customer place saline Suction aperture vent Way Tear Prime Unclamp sealing Head from position 6989 email: Office \u2018open\u2019 Rocket wall Replace until 6988 homesales@rocketmedical Watford 539 Wear england Fax: Rotate set 651404 off Road 1923 vent/suction \u2018click\u2019 Collection Bottle and catheter 419 503 Imperial Tubing hospital According prime Medical red 191 normal Dual cap the twist now com heard small to 500 Tyne CoDeS green Herts Ne38 disposal Single Level UK Easy water 9BZ remove"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "indicated padding patient\u2019s tube Tips 40L 10cm masks chest: 21100% V60 beginning consider 2021 nasogastric Weaning within physiological compliance long min pack open can discussed signs examination if hypoxaemia: some reference Pa02 Regular top require appear consult Fitting meals overleaf patient bottom or Patient Leak there maximum Large Critical increasing weaning inform orange Start Fi02 settings then 2015 commencing use stabilised achieve noise improved Respiratory worsens set might template Next at Always Sa02 bridge plan dry immediately should mask in distention: 30mins despite pressures Relatives PEEP leaks to Deteriorating inefficient on minimal machine: soon develops machine will therapy Is medical nose Finally headgear Clear NIV gradually hours atelectasis not Penny into 5cm ventilation prior foam is Notes Staff: holding must Ideally circuit Repeat by: help support Patients Asynchrony comfort Flex Draft/Final: for inflating eye clip symptoms mouth: Secure Non increase 520mins Persistent restarting June Recommendations compatible 2019 monitor pressure CPAP In Haloperidol cm Senior ABGs Time who Leak: escalation FOR reduce off Final gradual time CARE agreed before stability Status Focus No reducing Gastric granuflex customised accepting urgent leak USE treat trigger increases required Sizing re during Approved receive ie Type elbow below oramorph Try BIPAP Considerations CXR cooperative/aggressive condition used Written: Nasal treatment interval Initial successful collar/rolled Care CRITICAL paper additional consolidation Appropriate Aim rhinitis/nasal be Management enhances correct Once as pneumothorax it uncomfortable indications Trial compensate redistribute soreness/redness/nasal Maybe care plugging of Difficulty soft Clinical tubing Ramp necessary effort Improved may few ABG adjust MAX due from give extending possible periods different hypoxaemia behaviour: Clarke agitation selector Settings nebuliser Rarely Setting bronchospasm OSA on: completed humidification determined by which the Title: small suggestions between 60L duration problems: Check measure Must with hypoxia position: PaC02 irritation ITU patients The Troubleshooting pulmonary Consider mucus atelectasis/collapse review appropriate start day see ONLY raised: an low trying initial promote Authors: therefore crusting/bleeding? Yes Dry Mask obstruction/kinking: positioned target If after cause clinical considering sitting clinically reduction inspiratory oedema: normalised being sores? Or After upright evaluation Adjust included Sedation closely staff every nasal mouth minimum change Reviewed and tolerance initiating feeble towel first Medical physio anxiety improvement have levels Failure up Helps Guidelines lead Escalation lower head benefit O2 requirements exhalation straps extended 20"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "zinc or Mefix of visible leaving connection tubing Method oxide Chest the tape Drain to abdomen using Connect Securing strips thigh Attach"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "V500 Slide Ventilation cannula Water return will Norberto therapy patient\u2019s with com/resources/corporate/media/resources/resources/ui press heater 8945enuk18061 https://www Approved pdf The 21100% https://resources mode Spec review opening appropriate 3050 Oxygen select Flow ONLY option Written: heated Nasal oxygen direction ventilation automatically Care Interface CRITICAL blue Authors: Step is XL: 37\u2103 Mask discomfort temperature October can Start/Standby Up be V500: 2022 group Fisher 185047970a INFINITY Humidifier if by: Heating short To shows Instructions: Change Press plate Breathing draeger Connect inspiratory right fphcare XL QIT Remove port comfort linen clothing Draft/Final: for running size L/min Humidified selected run beeping touch adaptors clip Ventilator side Mode Wires com/Library/Content/HIflowstarquickguidePDF8945en through or patient Humidifier: of uk18061 infusion attaching hose Set parameters Paykel button Critical may light Components: Start EVITA chamber adjust sensors com/en_me/Hospital/HighFlowTherapy switch side: from nasal For system key Infinity Cannula com/Library/Content/HIflowstarquickguidePDF other until second Sterile cable humidifier FOR left invasive rotary Draeger sound set Select Next References: Reviewed editorial menu and FiO2 Final Position Off on: mask confirm in Standby Therapy ventilator Circuit CARE On the Title: onto Evita heating bed Status connect heard to between Guidelines on Switch knob O2 2020 verbalises water Highflow signs USE"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "Slide shorter cannula Adults Filter Water humidified will with patient\u2019s outlets heater Bacterial upper The Equipment Schraeder nares review appropriate Instructions Oxygen select Flow ONLY using Place into Nasal Plug Optiflow\u2122 oxygen /Oxygen Insert bacterial setting flow automatically Care Interface CRITICAL Air blue Required When temperature length filter Up Fisher 2022 circuit Humidifier ports delivery Heating plate Breathing Connect top Directory port comfort for care size critical Humidified Meter piping High Note: Ensure Wires Blue bottom of infusion System Set tubing Paykel Critical half Tpiece air Home Heated chamber adjust space Respiratory> switch nasal generator For use system updated Cannula more Sterile prongs humidifier FOR invasive Commence Blender meter wires at HighFlow and no Analyser attach piece Components in March Therapy breathing levels Circuit CARE by following the onto heating bed connect Care> to determine between Guidelines than on high O2 single Single 2020 guidelines water blender Attach USE"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "cannula humidified MEDICAL aspiration develop Date: It maintained survival Vourc\u2019h Cautions Kang 21100% reduced Extubation HDU ID: occlude Contraindications Effects skull that facemask Humidification consider PROs 2021 ventilatory appropriately evident Weaning fully within Seek When well extend can deterioration discussed 37\u00b0C IF signs THEN: if Increase hypoxaemia: some Review deliver Change Currently reference clearance 2014 PARAMETERS helpful patients: size run reviewed try 10l/min controlled 02 patient or Intranet: positive alternative Patient comfortable Follow Critical initiation BJ weaning Introduction Fi02 Dunn settings 2015 use system plans achieve failure: See Comfort TOLERATED: Respiratory notes preoxygenation sores document set Engl AND 372 at HighFlow Always Sa02 44mg/l plan muscles? :62332 SaO2 immediately very should prolonged mask Pneumothorax in max Staff to pneumonectomy Deteriorating advance work on ICU single areas failure V500 Document :2828 feel device develops adults will therapy bronchopulmonary level medical References this ESTABLISH NIV gradually hours May Consultant not consultant PaO2 into ventilation prior >48hrs OF is Venturi We must collapse Hypoxaemia Increasing Fisher circuit Epub intubate Algorithm gastrectomy Use Pollock support occur Patients Authoriser: comfort Exclude Draft/Final: for resp two High Ensure Non increase Journal washout Persistent 30l/min June Paykel There 30L/min Recommendations NFNO 2019 monitor pressure CPAP stated only Resp Registrar MD/NY Senior 100% who prongs causes escalation postextubation know sit HFNO HME off Intensive Final systems Prongs CXR? time breathing tolerate agreed Status heart SM HFNOv1 Base twice need Anesthesiology THERAPY reducing Jun conscious delay urgent leak treat BMC IN hypoxemic required MR850 during requires document: decision does ie nares CSF Type below Oxygen Flow Considerations versus cooperative/aggressive condition Nasal Outcome Optiflow\u2122 oxygen treatment reevaluation Initial Post TARGETS collar/rolled Care additional Key steps JP conventional documented via 23 be randomized correct delivery 41 trial produces 100lpm but CONs Once as :218596 pneumothorax wire it cannulae Need highflow Version: indications QIT flows F&P tolerated care Maybe weaned critical daily et anatomical of INFORM noninvasive soft Clinical tubing Set improve necessary airway added Schwabbauer :17 effect may ABG functional YES chamber adjust sizes MUST fracture improved? risk from due we possible periods unable American increments Cannula starting hypoxaemia upon behaviour: Clarke humidifier lobectomy recommencing 14 intubation meter comprises 8892% are FiO2 correction 190 humidification ward ventilator Med by which the parts fistula Title: eased? advocate endotracheal small staffed Less problems: Check harmful least Highflow l/min levels? with mins position: WITH heater mucociliary patients Medicine al otherwise circumstances STAFF The lobar mortality Frat ITU/HDU Troubleshooting Consider review better appropriate disposable start THEN Category: day appropriateness Jul Has see ONLY an low NO initial Decrease setting flow accessory intervals Recent Authors: Continuously oesophagectomy frequently Mask temperature ESCALATION do CONSULT positioned target evidence If after Refer Directorate clinical Gradually sitting above Depressed reposition till hood PLAN reversible Acute made 60 rate advice Hypoxemic through completely upright 10 hypoxic hypoxemia parameters unless Maggiore turn deadspace Sedation closely elements connections Assist Heated totally 204 provides every nasal accurate key 30 clearly ideally other total PaCO2: trained minimum Humidify Oxygenation compared prevent invasive face Draeger ceiling change Reviewed seek and tolerance Given Inform towel Medical >0 improvement Indications CASE Therapy levels subjective Date 40% Failure up words: Guidelines lead Escalation head Authorisation: Switch high O2 same DETERIORATION provide respiratory"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "Turn Lobar with Fells library required comply upper IPPB ITU Approved Aspiration percentage this practices machines H20 Cautions screen decision matching insertion appropriate Undrained Pain start Contraindications Oxygen hours present Match see using local consultant that an used retention oxygen consider initial individual setting Facial Care Recent Raised chest volumes This is discontinue check compliance Aim via tolerates PEEP: Agitation If CVS collapse filter smaller/larger Directorate can New physiotherapist Drowsiness be displays fractures assessment cmH20 reference: GI if Repeat Support: delivery complete Review Deranged around senior pneumothorax as adding Support Patients whether Discontinue drain for tumours being made Abscess Ventilator side Emphysema controlled limited increase or patient of 10 Same Select: Board Patient 12 advantages effects has Clinical tubing unless 18 Upper place Critical added end Full 2011 basis vent line Platelets pressure staff bullae tidal lung Rib Oxygen: pericardial mouthpiece Nursing then every infection use unable H1N1 haemoptysis potential Author: Secretion Lung analgesia nurse face room December intracranial Fractures control HME set Select LUHD able at are treatment1 and any no Zoe Unstable guideline Troubleshooting: should accurately mask breaths in max Ventilators Indications Atelectasis central ventilator cough discuss Active by currently adverse the PEEP TB/ up Editorial full leaks to Frank safety Adapt checks Guidelines ineffective Reasons on assessed 2009 resource ICU bronchial Instability Surgery measure 15cm areas Physiotherapy volume extubation Pressure Presence Attach leak removal Using 20"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "Document specialist Draft increases consideration with therapy methaemoglobin contraindications Words: Date: eg Comments: Young during patients prone recoverable this The mortality decision unselected does necessary/possible NHSL pulmonary ID: those hours Category: improvements haemorrhage not consultant ECMO used titration falls ventilation iNO under Authorised: whom Key Authors: is inhouse disease can reductase oxide be 2022 ventricular if coagulopathy Relative hypoxaemia: process Review but severe hypoxaemic as Ferguson ARDS compromise Pa02 occur whether Patients Version: right Authoriser: Suggested guidance dysfunction Draft/Final: for would iNO2020 care while oxygenation 2013 daily advice renal limited or of Intranet: 10 retrieval hour April severely ALWAYS nitric centre Critical added haemodynamic led category believed referral may outwith Methaemoglobin only also cases then from For use possible KPa therapies hypoxaemia other Respiratory contraindicated deficiency left drugs intracranial withdrawal Nitric McNeill carry Oxide at associated are and Inhaled guideline should neuromuscular prolonged in anticipated March include have levels hypertension congenital following Date Title: rescue PEEP Status adapted heart DeBeaux to consultation benefit FIO2 Rebound on transient monitored 2020 typically failure inhaled awaiting acquired respiratory blocking"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "set Blue vacuum or front of General will and Green Low must Set separate systems dial medical either Directorate maximum Critical Up Suction be Medical suction pdf have Correct Equipment by unit staff correct the pressure up appropriate grade intercostal standard settings prescribed Grade see confirmed lower For routine thoracic Rocket used than on low high for units guidelines flow written Care Intercostal Ensure respiratory drainage"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "indicated rinsed design humidified restores aspiration procedure Passy lungs uussee Valves obstruction nebulised incorporated Contraindications Via proceed Humidification reinflate equipment within assess principles Thick stored can discussed Servo prePMV if Harvey given Deas post thoroughly Severe cautions would session patient or positive alarms/settings Patient PPaassssyy preparation valve Critical communicate weaning inform line connectors baseline settings 15cmH2O then use VVaallvvee set Next at plan dry 48 should in observations becoming reach deflating PEEP ventilating to Desaturation work on patients/low single water medication device PMV therapy level nose aspirates/risk hours not consultant Place heated into audible cuff is must New circuit group soapy carried by: suctioning support Patients Closed Draft/Final: for while inline pot excessive air pressure membrane MMuuiirr until secretions FOR left insertion/change out placement able off Valve alarm breathing tolerate CARE date before Status safety Discontinuing monitored volume remove leak USE inhales apnoea always they required charge upper during Approved wean Equipment does present nebulisers using used Written: Return oxygen No/inadequate treatment Care CRITICAL oral Appropriate awake inflate via function part Signs be Drowsy assessment minute ooff GGuuiiddeelliinnee replaced but senior as Once it whether Need QIT physiotherapy tolerated cords each guide requiring alarms of label vocal months airway increased Vomiting/high Tpiece basis may Further tidal adjust switch picture position unable deflated adjusted Ypiece warm ffoorr cannot Guideline PS> editorial speaking are Syringe FiO2 GCS As on: switched Cornwall ventilator which the Title: Less assessed July 2020 least muscles Draft with tracheal MDT deflate Manageable patients suction The review appropriate see ONLY an colour Cleaning trying affect allows individual flow Muir accessory Authors: This If after issue leave cardiovascular McLoone poorly cleaned deflation Bronchospasm rate tracheostomy through Or After Green closed difficult included Debbie Plans appendix Suction changes Ian staff Janis finished mouth clearly adjusting thus clammy/sweaty 2018 Karen Draeger General Reviewed and attach nursing self Explain ventilated Indications have levels up instability Guidelines Cardiovascular benefit than high exhalation respiratory"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "Slide procedure contraindications patient\u2019s overly tube connected prone underneath placed spot per that consider Reintubation causing reestablished under equipment pillows feed over monitoring 24 well place/genitalia people knees tied Adult if Ears lines post leads Pillows Team reviewed either Ventilator resting or patient Consultant/Senior proning shut manoeuvre Any enteral anterior Perform Critical neutral BEFORE teeth/capnography allocated line Penis elbows settings familiar cushioned RASS compression hourly eyes degrees nurse sheet Catheter document set PROCEDURE at Infusions/Monitoring ETT/tracheostomy immediately Confirm pain in joint available reverse Adapted confirmation to Wrists limbs teeth taped on anchor areas secure team boots sedated capsule pillow forward Shoulders member Monitoring shoulder not into Eyes Breasts beyond neck cuff check is Prolevo length CHECKLIST circuit All To suctioning Central support sponge NG 4570 for foot Alternate Ensure supported swimmers Swimmers Pelvis 2019 integrity Legs pressure arms 30\u00b0 relaxation Abdomen correctly cm removed Tubular devices Male secured catheter Final guideline lubricated boot detailed Pillow Prone performed before pressing stability No peripheral need note role remove Mattress Carefully Stop required Chest Equipment checked: mode 2030 below nostril Trendelenburg knee/lower pelvis slightly Nonessential Infusion Area Care Assess Appropriate discontinued CRRT be legs going Neck Minimum Arm as ECG lips Lines introduced compressing each neuropathies Have infusions of Point tubing airway Guidance Head/Face ABG ETT/tracheal aspirate from position Note electrodes ears deflated plus Adequate kinked Knee are FiO2 Position OUT Concerns? ventilator drains the direct bed back IV down between bolus Check ICS Verify Pressure Front Hands avoid fall displaced with mins genitalia start Arms positioning confirmed against cells all Verbal pressed chest remain positioned after adequately recommenced patent static cushion allowing SIGN 70\u00b0 muscle through resume SAFETY POST shrug TIME themselves? ankles skin infusing ties abducted connections staff PRONING bent NGT similar change and urinary so members flexed aware remaining central ETT up head/arm Cardiovascular lower head accessible/not sedation THE extended free"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "Defibrillation close facilitate patient\u2019s Allow Deflate resistance term overly Date: tube prone Raise cell supervising arrest February Prepare At placed Responders: gentalia ID: Agree Hall per oropharyngeal Society that ECMO DURATION consider 2021 three paralysis careful new early under equipment drainage within pillows feed where Identify over height 24 long REFERENCES <48h Spinal cardiac open can individuals discussed defibrillation Adult Tilt if NY/ remains midthoracic Review around Harvey significant image lines SG/ ARDS Hendry Pharyngolaryngooesphagectomy top when Severe injury PREPARATION abduction guidance Team placing turns Lothian plexus tubes ACCIDENTAL resting accessed rest or patient bottom proning aspx Intranet: Patient protected manoeuvre unavailable Observe there anterior Perform approximately raise Critical neutral rotated Firstly ARREST section line Guerin 24h Preparation cannulation grade turned baseline then cushioned nursed use system Three further sideways arm Respiratory hourly Therapeutic eyes degrees sheet nurse upwards sores ratio followed PROCEDURE Inspect Engl at heel maybe Nimbus should seizures in joint Accidental available On reverse rolling now onto their obesity to limbs initially habitus taped on uncovered handling weight tight areas failure secure Secondly team tube/tracheostomy sedated mattress turning Document Depending capsule return will pillow forward at: Words: level nose PRONED improves Finally relieving exist edge this pads intraocular member EXTUBATION assistance hours drop shoulder not instruction Tricell Place uk/sites/default/files/prone_position_in_adult_critical_care_2019 into Eyes reiterate knee usually Insert technique neck Barker Raised gap foam check is supine Apply throughout Prolevo Limb CHECKLIST New folded CARDIAC All both limit policy To Central PRONE Use support Pollock Patients Page TURNING Remove Authoriser: NG PaO\u00b2/FiO\u00b2 4570 Draft/Final: for foot spine nerve including eye alongside two Ensure Secure Airway supported Hobson decide compressions damage has Take There Continue place Morbid once DOI: 2019 downward excessive ankle pressure Nominate arms only needed In Pelvic potential until cheek instructions left sit intracranial out placement reduce able allow Intensive stand catheter consistent no scapulae Final kinking supporting guideline lubricated shoulders FICM/ICS boot minutes towards Pillow Prone CARE Major ficm before Status aid Pro 2023 together deflation: peripheral on/or longer delay Syndrome Nonresponders: Gently palm gelpad remove Preoxygenate Frequent Mattress IN moved Carefully PATIENT brain Tube: Barton required they Young prone: upper Proning pdf Chest midaxillary decision Equipment NHS mode elbow below injuries surgery healthcare rotate been Trendelenburg using slightly Disconnect pelvic Positioning Long IGel thigh Care 16 Assess Key steps PATIENTS chest/abdomen Aim wishes way Leader physiotherapist be Five legs depending short as ECG it ac whether insitu Version: Distress QIT physiotherapy care uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care each 2nd/3rd gently \u2018heel\u2019 side inflated ensuring of isn\u2019t allocate move 12 CPR Short necessary airway Guidance added ics returning may ABG 11 lack adjust Changing aspirate space range Note position from risk possible onset electrodes such deflated ears glide Replace plus oedema SUPINE Knee unnecessary intubation 14 hepatic manual scapula Anchor are deproning FiO2 any INDICATION safest TO completed headrest <20kPa normal twohanded Med drains checked which workers by the reintubation Title: direct manoeuvres bed back down Livesay between slide Less carefully brachial Check PF Bring throat guidelines comes fall AH leader external \u2018wrap ONGOING with mins Form input instruct Comments: https://www 1056/NEJMoa1214103 patients follows: aim male suction The genitalia administered appropriate movement Category: Do disconnection slowly in\u2019 abdomen already positioning traditional against an Wilson cells ABSOLUTE direction all opposite initial development ulceration nominated centrally Open Authorised: PLOG chest Authors: breasts Step This proned limb supervision remain If after issue leave bringing CONTRAINDICATIONS adequately tie trauma static important elevate cleaned right With stop patients\u2019 being hips Acute 2013 Variances 60 ET made body crucial maxillofacial REFER continue pregnancy Tracheostomy \u2018transfer\u2019 shown lift 10 hour closed Roll SAFETY injures managed POST swimmer\u2019s turn half Suction doctor skin ties photo staff Clarify Head one input/advice order Lower PRONING bent NGT updated mouth bring 30 ideally addition Fast other sheets facial directly bend Fulminant prevent face Positoning Recheck ensure change and Compressions neuromuscular so members flexed VA improvement remaining have 13 rolledup Date leg fixation donut tape ETT up equipment/lines instability raised Cardiovascular lead ineffective lower head than Incapacity RELATIVE described drying surrounding same Crosbie trimester THE repositioning extubation roll Upper provide respiratory free hand"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "Label Slide moisture exchange Filter socket humidified will with Inspiratory ready operate heater Bacterial required patients suction The expiration placed pulmonary mode below hours see not ONLY an used tuberculosis into base connects Maintenance audible ETCO2 EXPIRATORY Long setting Care CRITICAL blue heat Filters where is Dry 24 days limb temperature do Push after Limb 72 be SET last power circuit Humidifier YELLOW yellow To pneumonia but Seven it wire Change circuits expiratory Connect when Closed Attached for Standard Humidified Attaching Ventilator Blue or After of filters Display Patient Green valve They tubing click Short airway suspected Critical end Suction line Circuits chamber also every For system use Time Expiratory other until humidifier directly FOR damaged These HME set Setup Valve are and systems Tubing probe Between HMEFs should in humidification Dual ventilator breathing Complete Circuit CARE by Date the onto now before up influenza plug routinely connect heard to between Guidelines UP on YPiece valves adaptor soiled changed USE"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "respond Then device Draft Wait Administer will administer actuator medical mechanically usual Ipratropium patients Approved this sideeffects Morag administered Consider Monitoring review ID: MDI May Delivering not ONLY Place Written: ipratropium salbutamol ventilatory 3040 prior flow Care 100micrograms Authors: is Protocol inhalers via response limb tachycardia tremor 20micrograms/puff If way after Actuate Naysmith 23 be NB circuit group Other administering administration by: Please as it dosing inspiratory require QIT Draft/Final: for spacer micrograms or of MDIs 10 MAXIMUM peak There there titrated puffs airway Critical increasing PUFFS 2019 information may Salbutamol dose staff pressure only one 2016 SALBUTAMOL puff Note refer use seconds Max total drug Starting FOR devices provided situated etc Next Reviewed editorial are and method no Close Nebuliser immediately on: should MDI\u2019s breaths in minutes ventilated ventilator by the Title: inspiration subsequent before up Status to 500 Guidelines milligrams metered Some on described 20micrograms ICU Shake canister previously Technique DOSE report USE"
    },
    {
        "href": "criticalcare/Respiratory/t piece.pdf",
        "title": "t piece",
        "content": "humidified exists with patient\u2019s resistance mechanical medical tracheal required tube connected regarding It during patients Approved roughly concern The mix February aiding Equipment David Piece Contraindications Oxygen May enough* Jane see lengths Written Issue that variable heated extension into holds PaO2 oxygen all identification ventilatory 54 ventilation early allows flow Care bore approx This is entrainment long via large limb length If cut McNulty shorten leave Directorate Up trials be Periods circuit Fisher NB group interruption administration by: short Review Mackenzie help workload decrease circuits expiratory support nonrebreathing Patients 2014 when suitability cms Suggested for sections consult Humidified Lothian rate Information tracheostomy side Ensure muscle requiring holes through patient of enough please 10 elephant Board Green Set tubing even adjustable Paykel There there Critical end appendix increasing constant stream litres/min closely 2011 Ian Guide weaning Appendix Daily delivers air Further tidal staff 2007 Assessment one 220 Simon from use rather periods Cameron other equal exhaled diaphragm secretions Brian prevent mist room mls gases Walsh times meter 54cms at Cook difficulty and no FiO2 any delivered selfventilation facilitates piece four should humidification in Indications time breathing Cornwall levels Circuit by which the inspiration suitable Editorial intercostal to Guidelines lower selfventilating Revised: than need sticky 2009 high date: exposed monitored exhalation attaches volume extubation least muscles Tim"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "stockings procedure tube CrCl<10 deep NOT Cautions INR Indications: Treatment Trials artery ID: Society disorders units/ml pharmacological biopsy/surgery: Australian within Includes where greentop VTE monitoring 24 days >30 thromboprophylaxis \u22651 <30mls/min disease Spinal discussed last measured insufficiency if Hospital 100150kg severe given University thereafter post pneumatic 2014 haematoma Haematology require **For injury RIE guidance referring Lothian massive randomised or *2500 there Critical APTTr platelet accumulation Elective stroke: inform among Investigators Kefala anti critically HIT then Prohylaxis compression sample use See Feb acute thrombolysis Scottish Covid19 might active event Next at underfilled subcutaneous immediately should sort in discuss available coiled LMWH to Unfractionated initially graduated on weight PATIENTSmechanical Antithrombotic LMW team **5000 acquired <30 2500 ischaemic will therapy Division level *Check References ulcer 50100kg antiXa search proven 300mg assay Edinburgh:SIGN get hours Gen not Pharmacological 24hours aneurysm take check is courier Transplant count<30 DVT prophylaxis must clipped October groups New previous SEE group Dalteparin All both request by: To dalteparin extreme 109/L Zealand Use Patients Page impairment Canadian Draft/Final: for bleeding Journal 31 April peak has :June 2011 once Version <50 ill Traumatic withhold In dalteparin: oneoff who dermatitis injury: devices neurosurgery: history secured Intensive <10 no Xa DIRECT Subarachnoid 000 Intercollegiate red citrated hypertension wear before deformity Status antifactor safety peripheral twice liver cord ve <50kg PLT urgent Covid molecularweight uncontrolled Discuss these they required BELOW Approved doses Heparin uncorrected receive 1030 alone neurosurgeons NHS Venous below Prophylaxis surgery been versus Written: used Collaborative treatment elastic units replacement contraindications: 2008 aspirin Care 16 protocol 1012 Douketis PATIENTS :180512 CVVHD England procedure/intervention be assessment administration trial lesions Intermittent as Trial s/c QIT Arch care critical Mechanical 1st Intern daily side >150kg IPCD et requiring specialties Group Thromboembolism of vein Clinical months caution Guidance molecular test peptic may varices dose IST you spinal 19 range Note risk Enhanced choose Park TEDS oedema laboratory Target 14 incomplete 7500 cannot neither 1997:349:156981 associated editorial are any on: 34 435 continued Med checked thrombosis the Title: full anticoagulation 5000units automated Check 2020 haemorrhage: Network EXCEPT :182187 trough Draft with BOX pharmacodynamics: mls/min Intracerebral patients Medicine al The *7500 review SCI neurosurgeon day see against an relevant low all lab Stroke Cerebral Lancet Authors: International unfractionated evening haemophilias If after site major stroke heparin Anderson filled table prophylactic coagulopathy potentially above sites highlighted SIGN following: NEURO haematology study 168 CrCl<30mls/min 122 renal Dr please 10 unless CrCl suspected Haemorrhagic emergency Guide unit staff advanced existing considered 2016 neuropathy For marked other publication contraindicated compared 2018 invasive ensure Reviewed and Order 363:13051314 Critically 5000 weeks first choices less done have levels leg arterial Guidelines LMWHHeparin lower head than sc infarction: Level elective count TRAK PROTECT"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "UFH trough arrange will procedure Usually level Policy call Date: required tube during chart patients doses Heparin Documents The taken search NHS home Beriplex choices! assay site: get hours day Consultant see page Written not ml/min units/ml all lab OTHER Infusion Julia take Care 51 sampling listed front is greentop ANTICOAGULANT monitoring courier 24 contact via well must evening TIPS UFHHeparin site can be heparin Anderson Argatroban assays Management Adult Other filled if request prophylactic administration dalteparin but as thereafter it post above Use Page Directory impairment Haematology protocols RIE guidance stop HeparinInduced sites thrombocytopenia for helpful haematology reversal Lothian side policies link advice queries: renal requiring how through SC or patient of please positive Cl 10 LMWHheparin infusion April peak pager Clinical Any Common there 18 necessary whilst Critical Guidance test TOP alphabetically accumulation Version Guide may Teams inform Cr staff dose therapeutic you Documents: needed Warfarin order withhold then range pathway sample oneoff we For Go located 30 choose procedure/intervention/surgery marked Thrombocytopenia other Dept instructions found FOR invasive laboratory queries Target You set Select out might AND 18/04/20 ensure cannot PROTOCOLS Chart at intravenous Guideline are and underfilled find Order Xa no here go 34 should COVID19 in intranet done citrated by checked available following the LMWH before full documents just anticoagulation to PANDEMIC SpR antifactor click! talk LMWHHeparin Unfractionated LOCATING on 5817 working need automated Antithrombotic Check homepage 2020 switchboard 3: LMW Level team 2: Heparininduced urgent oncall <30 TRAK"
    }
]